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Carbon-carbon (C–C) bonds construct the skeleton of all organic molecules. Hence, 
the development of new efficient methods of C–C bond formation is of great significance 
in organic chemistry. Since the discovery of the Grignard reaction, carbonyl addition has 
been an established method for C–C bond formation. In classical carbonyl additions, 
premetalated reagents or stoichiometric metallic reductants are required. By taking 
advantage of the native reducing capability of alcohols, our lab has developed methods that 
exploit alcohols and π-unsaturates to generate transient electrophile-nucleophile pairs to 
directly convert lower alcohols to higher alcohol. Efforts have been focused on the 
development of transition metal-catalyzed redox-triggered coupling reactions of primary 
alcohols and aldehydes to π-unsaturates as well as aryl iodides. Modern methods to 
construct new C-C bonds in highly selective manner via carbonyl addition were 
undertaken. 
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Chapter 1: Metal-Catalyzed Reductive Coupling of Aryl Halides and 
Carbonyl Compounds beyond Nozaki-Hiyama-Kishi Reaction  
1.1 INTRODUCTION AND HISTORICAL PERSPECTIVE 
Constructing new carbon-carbon(C-C) bonds is one of the most important tasks for 
organic chemists since the skeleton of organic molecules is constructed of C-C bonds. 
Among the C-C bond forming methods, carbonyl addition reactions, especially carbonyl 
allylation, have been broadly used currently in organic synthesis.1-8 Carbonyl addition 
reactions mediated by pre-formed organometallic reagents became a milestone in organic 
synthesis since the seminal work of Butlerov9,10 (1863), Reformatsky11 (1887), and 
Grignard12 (1900). Nevertheless, the issues of safety, requirement of cryogenic conditions, 
disposal of stoichiometric metal byproducts, low chemoselectivity and tolerance of 
functional groups, as well as the low accessibility of the premetalated nucleophiles 
complicate their applications in large-scale synthesis. Notably, the organometallic reagents 
are usually prepared from the corresponding organic halides,13 which are much more 
readily available. Therefore, the metal-catalyzed reductive coupling of organic halides with 
carbonyl compounds is more desirable when contrasted with the use of premetalated 
nucleophiles in carbonyl addition. The reductive coupling of organic halides with carbonyl 
compounds also represents a class of cross-electrophile coupling reactions14, which depict 
the deviation from traditional nucleophilic carbonyl addition with organometallic reagents 
and allow people to explore more chemical space. 
In 1977, Nozaki and Hiyama reported the chromium(II)-mediated Barbier-type 
coupling of allyl halides with aldehydes to form homoallylic alcohols,15 which was the 
initial report of Nozaki-Hiyama-Kishi (NHK) reaction. In 1986, Nozaki16 and Kishi17 
independently found that nickel(II) chloride functioned as a catalyst in the NHK reaction. 
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The discovery of this reaction has had a huge impact on organic synthesis strategy,18,19 but 
also revealed the feasibility of metal-catalyzed reductive coupling of organic halides with 
carbonyl compounds without employing pre-formed nucleophiles. The requirement of 
stoichiometric amounts of the toxic chromium(II) salts limits the application of NHK 
reaction on a practical scale. Consequently the metal-catalyzed reductive coupling of 
organic halides with carbonyl compounds utilizing cheaper and more benign reductants 
has been explored in recent years. However, when compared with metal-catalyzed redox-
neutral couplings of aryl halides and aldehydes to form ketone products, which has been 
extensively studied by many research groups and can be conducted under different metal 
catalyst systems (palladium,20-29 rhodium, 30,31 nickel, 32,33 photo-redox, 34 and cobalt 35), 
metal-catalyzed reductive coupling is more challenging due to the choice of reductants 
(Scheme 1.1).  
 




In this review, the metal-catalyzed reductive coupling of aryl halides with carbonyl 
compounds, including aldehydes, ketones, carbon dioxide, acid chlorides, anhydrides, 
isocyanates and other carbonyl sources, are surveyed and organized on the basis of metal 
catalysts. Related reductive coupling to gaseous carbon monoxide to produce aldehydes36-
47, which is also referred as carbonylation or formylation, is not discussed here, and the 
reader is referred to the provided literature.  
 
1.2 REDUCTIVE COUPLING WITH ALDEHYDES 
1.2.1 Nickel 
Following the original report of the NHK coupling of aryl halides and aldehydes,15 
catalytic NHK reactions had been studied by several research groups due to usage of the 
toxicity of divalent chromium salts (Scheme 1.2). Related NHK reaction catalytic in 
nickel/chromium was first developed by Fürstner and co-workers 48,49 in 1996 using 
manganese as reducing agent to reduce Cr(III) to Cr(II) and chlorosilane as oxophile to 
cleave the stable O-Cr(III) bond and release Cr(III). Upon aqueous workup with Bu4NF, 
alcohol adducts were obtained by coupling of aryl iodides and aldehydes. Later in 1999 
and 2001, electroreductive coupling of aryl bromides/chlorides and aldehydes with iron 
anode in the presence of nickel and chromium catalysts was reported by Durrandetti and 
co-workers50,51. Further studies by Kishi and co-workers52, Ni/Cr-mediated reductive 
coupling of iodobenzene with aldehyde was reported by using manganese as reductant 
together with Zr(Cp)2Cl2 to dissociate the chromium alkoxide and regenerate chromium 
catalyst. The loading of nickel and chromium was 0.2 mol% and 1 mol% respectively, and 
excellent isolated yields were obtained. In 2015, Berkessel and co-workers reported an 
efficient protocol for coupling of aryl iodides with aldehydes under nickel catalysis.53 
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Mn/Cr alloy was used as terminal reductant instead of the classical combination of 
manganese powder and chromium salt, and TMSCl was used as dissociating agent. 




A General mechanism for Ni/Cr-catalyzed aryl halide-aldehyde reductive coupling 
has been proposed (Scheme 1.3). Oxidative addition of aryl halide to nickel(0) to form 
arylnickel(II) intermediate, which underwent transmetalation with chromium(III) to 
generate arylchromium(III) intermediate. Nucleophilic carbonyl addition afforded the 
chromium(III) alkoxide, which was converted to the final alcohol adduct and release 
chromium(III) with the help of dissociation agents. Reducing agents converted 
chromium(III) back to chromium(II), which reentered the catalytic cycle. 
 
Scheme 1.3 Catalytic Mechanism for Ni/Cr-Catalyzed Aryl Halide-Aldehyde Reductive 
Coupling. 
 
In 2000, the first chromium-free (diphenylphosphino)ethane-modified nickel 
catalyzed zinc mediated direct arylation of benzaldehydes was reported by Cheng and co-
workers (Scheme 1.4).54 The chelating ligands was found crucial in promoting the 
coupling, and monodentate phosphine ligands were ineffective. A catalytic mechanism was 
proposed (Scheme 1.5). First, reduction of Ni(II) to Ni(0) by zinc followed by oxidative 
addition of aryl bromide provided arylnickel(II) species. Substitution of bromide ligand on 
nickel center with aldehyde and subsequent carbonyl insertion to the Ni-Ar bond generated  
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nickel alkoxide intermediate. Transmetalation with zinc bromides released the zinc 
alkoxide and regenerated Ni(II) catalyst. In 2015, diazabutadiene ligands were found to be 
effectively promoting the nickel catalyzed reductive coupling of aryl bromides and 
chlorides with benzaldehydes in good to excellent yields by Voskoboynikov and co-
workers.55 Recently, Weix and co-workers reported nickel complexes of bipyridine and 
Pybox catalyzed addition of aryl bromides to aromatic and aliphatic aldehydes with zinc 
metal as reducing agent.56 Less reactive and more steric hindered aldehyes, as well as bulky 
aryl bromide were able to form the resesponding couping adducts with good to excellent 
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yields. Not only aryl bromies, aryl iodide could give comparable efficiency in the reaction. 
While when aryl chloride was used instead, couping adduct was isolated but with much
 
Scheme 1.5 Catalytic Mechanism for Ni-Catalyzed Aryl Halide-Aldehyde Reductive 
Coupling. 
 





lower yield even at hight temperature; aryl triflate could not engage in the coupling under 
the standard conditions. Also a very broad substrate scope was demonstrated in this work. 
In 2004, Cheng and co-workers reported reductive coupling of o-Haloesters with 
aldehydes in the presence of Ni(dppe)Br2, and phthalide derivatives were obtained with 
moderate to good yields (Scheme 1.6).57 When 2-iodobenzoate was subjected to the same 
reaction conditions, much lower yields were obtained, which was due to more 
homocoupling byproducts of both reactants were generated. 
1.2.2 Palladium 
The first palladium(0) catalyzed chromium mediated electroreductive coupling of 
aryl halides and benzaldehydes was reported by Grigg and co-workers in 1997 (Scheme 
1.7).58 Catalytic amount of CrCl2 (10 mol%) was required and LiClO4 was used as oxophile 
to cleave O-Cr bond. Similar yields were obtained from coupling with aryl bromide and 
aryl iodide  
Scheme 1.7 Pd/Cr-Catalyzed Reductive Coupling of Aryl Halides with Benzaldehydes. 
 
 
In 2014, palladium catalyzed intramolecular addition of aryl iodides to aldehyde 
reported by Solé, Fernández and co-workers (Scheme 1.8).59 Simple PPh3-modefied 
palladium enabled the formation of diverse tetrahydroisoquinolin-4-ols with triethylamine 








standard conditions. According to DFT calculations, reaction mechanism was proposed 
through oxidative addition of aryl iodide to Pd(0) followed by the nucleophilic addition to 
aldehyde. Due to the coordination of palladium with nitrogen atom in the palladium 
alkoxide intermediate, β-hydride elimination was not sterically favored, which explained 
why ketone products were not observed. 
In the same year, Beller and co-workers reported palladium catalyzed carbonylation 
of aryl bromides with paraformaldehyde to form aldehydes and esters60. Paraformaldehyde 
was used as a carbon monoxide surrogate and subjected to the aryl bromide with 
Pd(CH3CN)2Cl2, dppb, Na2CO3 and Et3SiH as reducing agent in DMF at 100℃ to deliver 
benzaldehydes. Introduction of N2 gas was to avoid the evaporation of paraformaldehyde 
from the reaction mixture to increase the reaction efficiency. When alcohols were used as 
the solvent instead of DMF, the corresponding esters were obtained under the same 









Insertion of aldehyde carbonyl group to rhodium-aryl complex to form rhodium 
alkoxide was reported to by Hartwig and co-workers in 2002.61 The first rhodium catalyzed 
arylation of aldehydes by coupling with aryl iodides was reported by Li and co-workers in 
2014 (Scheme 1.10).62 NHC ligands showed unique high efficiency in the coupling, and 
the reaction was carried out in water. The mechanism for this method was proposed to 
proceed through transmetalation of arylzinc intermediate, which was generated in situ, to 
rhodium (I) to form arylrhoium (I) species (Scheme 1.11). Coordination of reactant  
 






Scheme 1.11 Catalytic Mechanism of Rh-Catalyzed Reductive Coupling of Aryl Iodides 
with Aldehydes in Water. 
 
aldehyde followed by carbonyl insertion into the Rh-Ar bond generated rhodium alkoxide, 
which upon protonolysis, secondary alcohols was released and regenerate the active 
catalyst Rh(I). Another rhodium catalyzed reductive coupling of aryl iodide with aldehydes 
was recently reported by Krische and co-workers by using sodium formate as terminal 
reductant, which represented the first example of intermolecular carbonyl arylation via 
transfer hydrogenative reductive coupling (Scheme 1.12).63 A very broad range of alcohol 
adducts were obtained, and the reaction was not sensitive to the substituted on the 
benzaldehydes. Notably, lower halides and protic functional groups were tolerated under 
the standard conditions. The catalytic mechanism was proposed based on the results of 
deuterium study (Scheme 1.13). Oxidative addition of aryl iodide to rhodium(I) to form 
arylrhodium(III) intermediate. Coordination of aldehyde to Rh(III) followed by carbonyl 
insertion afforded the rhodium alkoxide intermediate. Ligand exchange with formate 
followed by β-hydride elimination and further reductive elimination to release the coupling 








Scheme 1.13 Catalytic Mechanism of Rh-Catalyzed Formate Mediated Reductive 





There’s only one report on cobalt catalyzed reductive coupling of o-iodobenzoates 
with benzaldehydes to form phthalides with good yields in 2007 by Cheng and co-workers 
(Scheme 1.14).64 Enantiomeric enriched phthalides up to 98% ee were obtained when 
(S,S)-dipamp was used. Notably, when cinnamyl aldehyde was subjected to the coupling 




Scheme 1.14 Co-Catalyzed Reductive Coupling of o-Haloesters with Aldehydes to Form 
Phthalide Derivatives. 
 
that aldehyde carbonyl group competed effectively with the double bond in the insertion 
step. The reaction was proposed undergo a Co(I)/Co(III) catalytic cycle. 
 
1.3 REDUCTIVE COUPLING WITH KETONES 
1.3.1 Palladium 
Palladium catalyzed reductive coupling of aryl halides with ketones are all 
intramolecular cyclization. The first example of Grignard-type nucleophilic addition of 
aryl bromides to ketones was reported by Yamamoto and co-workers in 2000 (Scheme 
1.15)65. In the presence of Pd(OAc)2 and PCy3, o-bromophenyl ketones were converted to 
the cyclization adducts with 1-hexanol as reductant. Other alcohols, such as 1-pentanol and 




Scheme 1.15 Pd-Catalyzed Intramolecular Reductive Coupling of Aryl Halides with 




ketones underwent the arylation, which could get access to five- and six-member ring 
containing products. In 2001, Solé, Bonjoch and co-workers reported triethylamine 
mediated intramolecular annulation of 2-haloanilines and ketones66. From the carbonyl 
addition adducts, which were further subjected to trifluoroacetic acid, indole derivatives 
were obtained in good yields. In the course of studies, a competing cyclization pathway, 
which is enolate arylation, was observed and found to be depending on the structure of the 
starting amino-ketone. Through further studies67, the catalytic mechanism for the 
intramolecular cyclization was proposed (Scheme 1.16). Oxidative addition of aryl halide 
to palladium(0) to form the four-membered azapalladacycle, which could undergo facile 
addition to the carbonyl group. The carbonyl addition is a consequence of the coordination 
of amino group to palladium, which facilitated the chelation between carbonyl and 









In 2010, Kündig and co-workers reported the synthesis of 3-hydroxyindoles via 
palladium catalyzed intramolecular cyclization of aryl halides to α-ketoamides in the 
presence of nBuOH as terminal reductant with good yields (Scheme 1.17)68. Aryl bromide 
and iodide could both engage in the reductive cyclization with similar isolated yields 
obtained. In 2015, Krische and co-workers reported the hydrogen-mediated reductive 
cyclization of haloketones to form 3-hydroxy-2-oxindoles69. By using DiPPF-modified 
palladium, in combination with hydrogen gas as reductant, not only aryl substituted   
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Scheme 1.17 Pd-Catalyzed Intramolecular Reductive Coupling of Aryl Halides with 
Aldehydes to Form 3-Hydroxy-2-Oxindoles. 
 
 
hydroxy oxindoles could be obtained with good yield, heteroaryl and alkyl substituted 
adducts were isolated with moderate to good yields. Notably, α-ketoamide derived from 2-
amino-3-bromopyridine gave good yield under the standard conditions. The asymmetric 
version of the synthesis of 3-hydroxyindoles with (R)-DifluorPhos-modified palladium 
complex was reported by Shibasaki, Kanai and co-workers in 201170. When aryl iodide 
was used, moderate yield and excellent enantioselectivity was obtained. To improve the 
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reaction efficiency, aryl triflate was used instead of aryl iodide and good yield and high 
level of enantioselectivity was obtained. 
1.3.2 Nickel 
In 2011, nickel catalyzed intramolecular reductive coupling of aryl chloride and α-
ketoamides mediated by Me2Zn in DME was reported by Jia, Gao and co-workers (Scheme 
1.18)71. C-Cl bond was successfully activated by electron-rich, bulky phosphine ligand 
PCy3-modified nickel complex. When Et3B and Zn dust were applied as reductant in the 
coupling, no desired product was observed. Both aryl chloride and bromides could engage 
in the carbonyl arylation under standard conditions and comparable yields were obtained. 
 





Notably, chlorine substituents on the aromatic rings remain untouched during the nickel 
catalyzed reductive coupling, which could be utilized in cross-coupling reaction for further 
functionalization. Further studies by Jia and co-workers demonstrated the formation of 3-
hydroxyoxindole and dihydroquinolinone via nickel-catalyzed zinc mediated 
intramolecular reductive nucleophilic addition of aryl bromides to ketoamides72. In this 
transformation, monodentate phosphine ligand, such as PCy3, was not as effective as 
bidentate chelating ligands, for example, 2,2’-bipyridine(bpy). When α-ketoamides were 
subjected to the standard conditions, excellent yields of the desired adduct 3-
hydroxyoxindoles were obtained. When β-ketoamides were subjected to the standard 
conditions, dihydroquinolinones were isolated with good yields when at least one methyl 
group at α-position due to Thorpe-Ingold effect. Also, bromine, chlorine, and fluorine 
substituents on the aromatic rings were tolerated.  
 
1.4 REDUCTIVE COUPLING WITH ACID CHLORIDES AND ANHYDRIDES 
1.4.1 Cobalt 
Acid Chlorides are considered ideal carbonyl compounds for reductive coupling 
reaction due to the higher reactivity. In 2003, Gosmini and co-workers reported the first 
example of cobalt catalyzed zinc mediated reductive coupling of aryl bromides with acid 
chloride, which could be used for preparation of aromatic ketones (Scheme 1.19)73. This 
2-stpes protocol could be conducted in two different manner for the preparation of aryl zinc 
intermediate, electrochemical and chemical preparations. The mechanism of the reaction 
was proposed via oxidative addition of acid chloride to Co(I) complex to form the Co(III), 
which was further converted to arylcobalt(III) via transmetalation with arylzinc reagent 
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formed in the first step. Final reductive elimination released the aromatic ketones and 
regenerated Co(I) to close the catalytic cycle. 
Related cobalt catalyzed reductive coupling of aryl bromides with acid anhydrides 
were discovered by Gosmini and co-workers in 2004 (Scheme 1.20)74. Aromatic ketones 
could be obtained in on step due to the lower reactivity of acid anhydride comparing with 
acid chlorides. Arylzinc was prepared in situ under the presence of CoBr2, allyl chloride 
and trifluoroacetic acid from aryl bromides and zinc dust. Catalytic amount of allyl chloride 
was need in order to enhance the yield of arylzinc species and suppress the formation of 
reductive dehalogenation adducts. Trifluoroacetic acid was added to activate zinc dust. 
 
Scheme 1.19 Co-Catalyzed Reductive Coupling of Aryl Bromides with Acid Chloride to 
Form Aromatic Ketones. 
 
Scheme 1.20 Co-Catalyzed Reductive Coupling of Aryl Bromides with Acid Anhydrides 





In 2003, Cacchi and co-workers reported the first palladium catalyzed reductive 
coupling of aryl iodide with acetic anhydride to synthesize acetophenones(Scheme 1.21)75. 
The use of Pd2(dba)3 in combination with Hünig’s base as reductant, and LiCl in DMF at 
100℃ led to the reductive coupling of acetic anhydride with a wide range of aryl iodides. 
With LiCl added in the reaction mixture, formation of homocoupling adducts from aryl 
iodides was suppressed. For the aryl iodides with strong electron-withdrawing substituents, 
biaryl byproducts from the homocoupling of aryl iodides were isolated in significant yield, 
even with LiCl in presence. The catalytic mechanism was proposed (Scheme 1.22). 
Oxidative addition of aryl iodides to palladium(0) followed by carbonyl insertion to the 
aryl-Pd bond delivered alkoxy-palladium intermediate. Acetophenone adduct was released 
via β-elimination and palladium(0) was regenerated by tertiary amine mediated reduction.  
In 2004, Cacchi and co-workers reported palladium catalyzed reductive coupling 
of aryl iodides with a mixed anhydride, acetic formic anhydride, which could be readily 
prepared from acetyl chloride and sodium formate (Scheme 1.23)76. In the presence of 
Pd2(dba)3, dppe, Hünig’s base and Et3SiH as reducing agent in MeCN at 60℃, diverse aryl 
iodides with various functional groups, including, ether, ester, amide, carboxylic acid and 
keton, were converted to aldehydes with good yields. For electron pool aryl iodides, LiCl 
was added to obtain higher yields. This protocol demonstrated the palladium catalyzed 
carbonylation of aryl halides could be achieved by coupling with acetic formic anhydride 








Scheme 1.22 Proposed Mechanism for Pd-Catalyzed Reductive Coupling of Aryl Iodides 
and Acetic Anhydride to Form Acetophenones. 
 
 
Scheme 1.23 Pd-Catalyzed Reductive Coupling of Aryl Iodides and Acetic Formic 





1.5 REDUCTIVE COUPLING WITH CARBON DIOXIDE 
1.5.1 Palladium 
In 2009, Martin and co-workers discovered the first palladium catalyzed reductive 
carboxylation of aryl bromides with carbon dioxide to form benzoic acids (Scheme 1.24)77. 
In this catalytic process, diethylzinc was used as reducing agent. The choice of ligand is 
crucial in promoting the efficient nucleophilic addition to carbon dioxide. The use of DMA 
favored the carboxylation over other byproducts. The best isolation yield (64%) of 
carboxylic acid adduct was obtained when the reaction was conducted under higher 
pressure of carbon dioxide (10 atm). Aryl bromides with diverse substituents were 
subjected to the optimal conditions and the desired reductive coupling adducts were 
delivered smoothly with moderate to good yields. Various functional groups, including 
amine, ether, thioether, olefin, ester, ketone, aldehyde, epoxide, and heterocycle, were 
tolerated. Notably, aryl chloride remained untouched under the standard conditions. The 
palladium catalyzed mechanism for the reductive coupling of aryl bromides with carbon 
dioxide was proposed based on the experimental results (Scheme 1.25). Initially, oxidative 
addition of aryl bromides to palladium(0) followed by carbon dioxide carbonyl insertion 
into the aryl-Pd bond delivered palladium carboxylate B. Subsequent transmetalation with 
diethyl zinc released the zinc carboxylate C, which was further converted to the carboxylic 
acid via workup, and palladium(II) complex D. Final reductive elimination regenerated the 





Scheme 1.24 Pd-Catalyzed Reductive Coupling of Aryl Bromides and Carbon Dioxide to 
Form Carboxylic Acids. 
 
Scheme 1.25 Proposed Mechanism for Pd-Catalyzed Reductive Coupling of Aryl 
Bromides and Carbon Dioxide to Form Carboxylic Acids. 
 
 
In 2014, Liu and co-workers reported the Pd/C-catalyzed direct formylation of aryl 
iodides by reductive coupling with carbon dioxide (Scheme 1.26)78. Due to the 
thermodynamic stability of carbon dioxide, direct functionalization is usually not easy. 
While it was found that hydrosilylation of carbon dioxide made it could be functionalized 
under relative milder conditions. In the presence of Pd/C, poly(methylhydrosiloxane) 
(PMHS), and DBU, reductive coupling of aryl iodides with carbon dioxide in acetonitrile 
under 80℃ delivered the desired aldehydes with moderate to good isolation yields. The use 
of DBU as base is important for the formation of aldehydes. When inorganic carbonates 
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were used as base in the reaction, no aldehydes were obtained and biaryl compounds were 
isolated with high yields, which formed via homocoupling of aryl iodides. A wide range 
of aryl iodides were subjected to the reaction condition and aldehydes were obtained with 
moderate to good yields. Ortho-substituents didn’t affect the reaction efficiency. Notably, 
electron-poor aryl iodides didn’t engage in the coupling effectively due to the competing 
dehalogenation pathway. The catalytic mechanism for the silane mediated formation of 
aldehydes by coupling of aryl iodide and carbon dioxide was proposed (Scheme 1.27). 
Initially, oxidative addition of aryl iodide to palladium(0) led to the formation 
arylpalladium(II) complex B. Formation of silyl formate C from carbon dioxide and PMHS 
in the presence of DBU was confirmed by 1H NMR analysis. Addition of aryl group to 
silyl formate C generated aldehyde together with silyloxylpalladium complex D, which 
further reacted with PMHS to form polysiloxane E and palladium(II) hydride. Upon DBU 
facilitated reductive elimination of HI, palladium(0) was regenerated.  
Later in 2016, further studies by Liu and co-workers discovered a more general and 
efficient palladium catalytic system for formylation of aryl halides with carbon dioxides 
mediated by PMHS79. In the presence of 1,3-bis(diphenylphosphino)propane-modified 
palladium dichloride complex with DBU, less reactive aryl bromides were converted to 
aromatic aldehydes with good yields in DMF at 100℃. Aryl iodides were also successfully 
converted to the corresponding adducts under same reaction conditions at slightly lower 




Scheme 1.26 Pd-Catalyzed Reductive Coupling of Aryl Halides and Carbon Dioxide to 
Form Aldehydes. 
 
Scheme 1.27 Proposed Mechanism for Pd-Catalyzed PMHS Mediated Reductive 






In 2017, visible-light-driven carboxylation of aryl halides with carbon dioxide was 
reported by Iwasawa and co-workers using palladium and photoredox dual catalysis 
(Scheme 1.28)80. Notably, the reaction was conducted under 1 atm carbon dioxide and light 
irradiation in the presence of Pd(OAc)2, PhXPhos, Ir(ppy)2(dtbpy)(PF6), Cs2CO3 as base, 
and Hünig’s base as reductant in DMA at rt, which were very mild conditions. A wide 
range of aryl bromides and chlorides were converted to carboxylic acids, which were 
further treated with trimethylsilyldiazomethane (TMSCHN2) to give the corresponding 
methyl esters. Steric hindered aryl halide 2,4,6-triisopropylbromobenzene was converted 
to the corresponding methyl ester with 76% yield. The activation of C-Br bond was 
achieved selectively in the presence of C-Cl bond, which was demonstrated with formation 
of 4-chlorobenzoate from 4-chlorobromobenzene. The mechanism for this transformation 
was proposed with two major possible pathways (Scheme 1.29). After the oxidative 
addition of aryl halide to palladium(0) to form arylpalladium(II) complex B, two possible 
palladium species were proposed. One was palladium(II) carboxylate species formed by 
direct insertion of carbon dioxide into Ar-Pd bond (pathway a), which underwent 
photoredox-catalyzed one-electron reduction to form palladium(I) carboxylate species D. 
Subsequent one-electron reduction of complex D released the coupling adduct and 
regenerated palladium(0). Another possible pathway was via coordination of carbon 
dioxide to form palladium(II) complex E, which underwent one-electron reduction first to 
form arylpalladium(I) complex F (pathway b). Subsequent addition of aryl group to carbon 
dioxide gave the palladium(I) carboxylate intermediate D, which underwent same process 




Scheme 1.28 Pd- and Photoredox-Catalyzed Reductive Coupling of Aryl Halides and 
Carbon Dioxide to Form the Corresponding Methyl Esters. 
 
 
Scheme 1.29 Proposed Mechanism for Pd- and Photoredox-Catalyzed Reductive 
Coupling of Aryl Halides and Carbon Dioxide to Form the 






In 2012, Tsuji and co-workers reported the first nickel catalyzed reductive 
carboxylation of aryl chlorides to form benzoic acids under mild conditions (Scheme 
1.30)81. It was found that in the presence of NiCl2(PPh3)2, PPh3, Et4NI, manganese powder 
aryl chlorides were converted to benzoic acids with good to excellent yield in 1,3-dimethyl-
2-imidazolidinone (DMI) at room temperature under 1 atm carbon dioxide. Addition of 
PPh3 was found to enhance the reaction efficiency by improving yield and suppressing 
formation of byproduct. When Et4NI was omitted, desired coupling product was obtained 
only in trace amount. The role of catalytic amount of Et4NI was believed to assist the 
electron transfer from manganese metal to nickel via the bridging of the iodide ion. Diverse 
aryl chlorides were evaluated under the standard conditions, and various functional groups, 
including silyl ether, ester, amide, boronic ester and ketone, were tolerant. Aryl bromide, 
tosylate and triflate were converted to the same carboxylation products under similar 
reaction conditions. A possible catalytic mechanism was proposed (Scheme 1.31). Zero 
valent nickel was generated in situ from nickel(II) through reduction. Oxidative addition 
of aryl chloride to nickel(0) gave arylnickel(II) species, which was reduced to arylnickel(I) 
by manganese metal. Subsequent insertion of carbon dioxide to aryl-Ni bond to delivere 
nickel carboxylate intermediate followed by reduction regenerated zero valent nickel and 
released coupling adduct. Later in 2013, DFT studies on the nickel catalyzed carboxylation 
of aryl chloride with carbon dioxide were conducted by Sakaki and co-workers82. 
Formation of arylnickel(I) intermediate was proved to be the key intermediate for the 
carboxylation reaction. 
In 2016, Durandetti and co-workers reported the direct carbonylation of aryl 
tosylates with carbon dioxide by nickel catalysis83. It was found that in the presence of 
NiBr2(bipy), and manganese powder, aryl tosylates could be converted to carboxylic acids 
29 
 
in DMF under 1 atm carbon dioxide at 60℃. When aryl iodide was subjected to the standard 
conditions at room temperature, benzoic acid was obtained with good yield. 
 
Scheme 1.30 Nickel Catalyzed Reductive Coupling of Aryl Halides and Carbon Dioxide 






Scheme 1.31 Proposed Mechanism for Nickel Catalyzed Reductive Coupling of Aryl 
Halides and Carbon Dioxide to Form Carboxylic Acids. 
 
 
In 2017, carboxylation of aryl bromides and triflates with carbon dioxide by nickel-
photo dual catalysis, whereas K2CO3 was used as the source of carbon dioxide, was 
reported by König and co-workers84. In the combination of NiBr2·glyme, neocuprioine, 
organic photosensitizer and Hantzsch ester (HEH) as reducing agent, carboxylation 
adducts of aryl bromides were obtained in moderate to good yield under room temperature 
with visible-light irradiation. A broad range of functional groups, including free alcohol, 
ether, ester, ketone, Boc-protected aniline, and cyano group, were tolerant under the 
standard conditions. Heteroaromatic bromides were also successfully converted to the 
corresponding heteroaromatic carboxylic acids with moderate yields. Catalytic mechanism 




Scheme 1.32 Proposed Mechanism for Nickel-Photo Dual Catalyzed Reductive Coupling 
of Aryl Bromides and Carbon Dioxide to Form Carboxylic Acids. 
 
1.5.3 Copper 
There’s only one report on copper catalyzed carboxylation of aryl iodide with 
carbon dioxide by Daugulis and co-workers in 2013 (Scheme 1.33)85. It was found that 
with CuI, DMEDA or TMEDA and Et2Zn as reductant, aryl iodides were converted to the 
corresponding carboxylic acid with 1 atm carbon dioxide at 25 or 70℃. Diverse aryl 
bromides were evaluated under the standard conditions, and carboxylic acids with various 
functional groups, such as ketone, ester, and hydroxy group, were obtained with moderate 
to good yields. Steric hindered substrate iodomesitylene engaged in the reductive coupling 
effectively. Aryl iodides could be selectively activated by copper catalyst in the presence 
of lower halides. The possible reaction mechanism was proposed by starting with reduction 
of copper(I) to zero valent copper by Et2Zn. Oxidative addition of aryl iodide to zero valent 
copper afforded arylcopper(I) species, which reacted with carbon dioxide to form copper(I) 
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carboxylate intermediate. Reduction of copper(I) carboxylate with Et2Zn regenerated the 
zero valent copper and released the coupling adduct. 
 
Scheme 1.33 Copper Catalyzed Reductive Coupling of Aryl Iodides and Carbon Dioxide 
to Form Carboxylic Acids.  
 
1.6 REDUCTIVE COUPLING WITH ISOCYANATES AND OTHER CARBONYL SOURCES 
1.6.1 Nickel 
Isocyanate derivatives are very reactive species, which are potential good 
electrophiles for reductive coupling reactions86. The first nickel catalyzed reductive 
coupling of aryl iodides with isocyanates was reported by Cheng and co-worker in 2005 
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(Scheme 1.34)87. Treatment of methyl ortho-iodobenzoate with aryl iodides in combination 
with NiBr2(dppe), dppe, Et3N, and zinc as reductant in acetonitrile at 80℃, led to formation 
of isoindoline-1,3-dione with moderate to excellent yields. The catalytic system could be 
applied to simple aryl iodides and bromides for the reductive coupling with isocyanates to 
form amides. It was observed that aryl bromides led to higher yields comparing with aryl 
iodides, which was due to more dimerization products of aryl halides were obtained when 
aryl iodides were used. 
In 2014, Martin and co-workers reported a nickel catalyzed reductive amidation by 
coupling of pivalates or tosylates with isocyanates88. Limited aryl chlorides were also 
evaluated under reductive coupling conditions, and good yields were obtained in the 
presence of NiCl2·glyme, dppf, NaI, and Mn powder as reductant at room temperature. 
Addition of NaI suppressed the competing dimerization, which was observed in other 
literature.  




Other than the carbonyl compounds mentioned above, acetals used as carbonyl 
equivalent in the nickel catalyzed reductive coupling with aryl iodides was reported by 
Doyle and co-workers in 2015(Scheme 1.35)89. Diaryl ethers bearing diverse functional 
groups were obtained in the presence of NiCl2·DME, bpp, TMSCl, and Zn as reductant in 
DMA at room temperature. The catalytic mechanism was proposed initiated by oxidative 
addition of aryl iodide to Ni(0) to form arylnickel(II) intermediate. Addition of α-oxy 
radical generated from acetel to arylnickel(II) delivered nickel(III) species. Subsequent 
reductive elimination released the diaryl ether and regenerated nickel(I), which was 
reduced back to zero valent form by metal zinc. 
 
Scheme 1.35 Nickel Catalyzed Reductive Coupling of Aryl Iodides and Acetals to Form 




In 2018, MacMillan and co-workers reported photoredox, HAT, and nickel 
catalyzed direct coupling of aryl bromides with primary alcohols to for benzylic 
alcohols(Scheme 1.36)90. The reaction mechanism began with photoexcitation of  
 
Scheme 1.36 Photoredox, HAT, and Nickel Catalyzed Reductive Coupling of Aryl 





iridium(III) photocatalyst, which could oxidize HAT catalyst quinuclidine to deliver the 
radical cation and iridium(II) complex. Lewis acid facilitated deprotonation followed by 
hydrogen atom abstraction afforded α-alkoxy radical, which could combine with 
arylnickel(II) generated through oxidative addition of aryl bromide to nickel(0). 
Subsequent reductive elimination furnished benzylic alcohol and nickel(I) species, which 





In 2013, Manabe and co-workers reported a palladium catalyzed reductive 
carbonylation of aryl halides with N-formylsaccharin as carbon monoxide surrogate 
(Scheme 1.37)91. N-formylsaccharin was first developed by Cossy and co-workers and 
used as formylating agent of amines92. In the same year, Skrydstrup and co-workers 
reported a protocol to synthesize aryl aldehydes by reductive coupling of aryl halides with 
9-methylfluorene-9-carbonyl chloride (COgen)93. In the presence of Pd(dba)2, PCy3HBF4, 
TBAI, and HCO2K as reductant, diverse aryl bromide and iodides were converted to aryl 
aldehydes with good to excellent yields. Notably, isotope labeled aryl aldehydes could be 




Scheme 1.37 Palladium Catalyzed Reductive Coupling of Aryl Halides and Carbon 




Metal-catalyzed reductive coupling of aryl halides with carbonyl compounds were 
developed as an alternative to addition of organometallic reagents but challenges remain. 
For example, enantioselective reductive coupling of aryl halides with carbonyl compounds 
has not been exploited much and only one example showed above. Also, reductive coupling 





Chapter 2: Enantioselective Ruthenium Catalyzed Redox-Triggered 
Carbonyl Allylation Using Alkynes as Chiral Allylmetal Equivalents via 
Allene Hydrometalation* 
2.1 INTRODUCTION 
Carbonyl addition reactions are one of the most important methods to construct new 
carbon-carbon (C-C) bond, and especially carbonyl allylation has been widely used in 
organic synthesis.1 In enantioselective carbonyl allylation, preformed allylmetal reagents 
modified by chiral auxiliaries were first proved to be efficient.2 Achiral allylmetal reagents 
used together with chiral catalysts became an alternative to chiral allylmetal reagents.3 
Nozaki-Hiyama-Kishi type allylation4 by direct coupling of aldehydes with allylic halides 
was developed, which allows people to form the new C-C bond without intervening 
preformed metal reagents, but the use of toxic chromium(II) salts was not ideal. Also metal 
catalyzed umpoled reactions5 coupling with allylic carboxylates usually require 
stoichiometric metallic reductants. In recent years, Krische group has developed transition 
metal catalyzed redox-neutral enantioselective carbonyl allylations6 by exploiting the 
reductive property of alcohols, which enable direct conversion of primary alcohols to 
secondary alcohols, and different pronucleophiles (allylic carboxylates,7 dienes,8 and 
allenes9) were able to engage in carbonyl allylation reactions (Scheme 2.1).  
In 2009, Obora and Ishii reported iridium catalyzed carbonyl aryl allylation by 
coupling of 1-aryl-1-propynes and alcohols, where alkynes was proposed to go through 
iridium catalyzed isomerization to allenes followed by hydrometalation to form iridium 
allyl intermediate.10 In 2014, Krische group reported the ruthenium catalyzed formation of 
(Z)-homoallylic alcohols by coupling of primary alcohol and 2-alkynes via alkyne to allene 
isomerization followed by allene carbonyl oxidative coupling.11 So in this chapter, 
                                                
*This chapter is based on the published work:  
Liang, T.; Nguyen, K. D.; Zhang, W.; Krische, M. J. J. Am. Chem. Soc. 2015, 137, 3161. 
40 
 
enantioselective and diastereoselective carbonyl allylation was described by suppressing 
oxidative coupling to favor hydrometalation pathway in coupling of alkynes and alcohols. 
 





2.2 REACTION DEVELOPMENT AND SCOPE 
Starting from the established condition for the formation of linear (Z)-homoallylic 
alcohol 2.4a by coupling of 4-methyl-2-pentyne 2.1a and p-bromobenzyl alcohol 2.2a, it 
was found that addition of catalytic amount of Bu4NI suppressed the formation of linear 
homoallylic alcohol 2.4a (Table 2.1, entry 2). By introducing of bidentate phosphine ligand 
dppf, a mixture of both linear adduct 2.4a and desired branched adduct 2.3a was obtained 
(Table 2.1, entry 3). Combination of catalytic Bu4NI and dppf gave only branched 
homoallylic alcohol 2.3a in 83% yield as a 15:1 (anti:syn) diastereomeric mixture (Table 
2.1, entry 4). By screening of different bidentate phosphine ligands, single anti-
diastereomer of branched adduct 2.3a could be obtained with more electron rich ligands, 
like dippf and dCypb (Table 2.1, entry 5 and 7). 
With these promising results, diverse chiral chelating phosphine ligands were 
examined. Good level of enantioselectivity was obtained with utilizing the Josiphos ligands 
SL-J009-1 and SL-J002-1 (Table 2.1, entry 8 and 9). By lowering the loading of additive 
2,4,6-tri(2-propyl)-phenylsulfonic acid (5 mol%), desired branched allylation product 2.3a 
was obtained in excellent yield and enantiomeric excess using both SL-J009-1 and SL-
J002-1 (Table 2.1, entry 10 and 11). 
SL-J009-1 was used as the optimal ligand in this transformation due to the 
generality in substrate scope. Catalytic amount of the 2,4,6-tri(2-propyl)-phenylsulfonic 
acid was necessary in the reaction because it suppressed the formation of over-oxidation 
ketone product. Also, in the absence of 2-PrOH, lower yield of desired product 2.3a was 
obtained due to the accumulation of unreacted aldehyde, which formed from oxidation of 
the primary alcohol 2.2a in situ.  




Table 2.1 Selective Optimizations of Formation of Branched Adduct 2.3a by Partitioning 















































59%, >20:1, 84% ee
86%, >20:1, 80% ee
86%, >20:1, 94% ee








































SL-J002-1, R = Ph 
SL-J009-1, R = Cy
PR2
dppf, R = Ph 
dippf, R = 2-Pr
R2P
PR2
dppb, R = Ph 





aYields are material isolated by silica gel chromatography. See supporting Information for 
further experimental details. b2,4,6-(2-Pr)3PhSO3H (14 mol%). c2,4,6-(2-Pr)3PhSO3H (5 
mol%). dTHF (1.0 M).  
evaluated and were able to engage in the formation of branched homoallylic alcohols 








aYields are material isolated by silica gel chromatography. Diastereoselectivities were 
determined by 1H NMR analysis of crude reaction mixtures. See supporting Information 




in good yields with complete anti-diastereoselectivity and excellent enantioselectivity. 
Notably, bromine was tolerable under our condition without formation of dehalogenative  
 




aYields are material isolated by silica gel chromatography. Diastereoselectivities were 
determined by 1H NMR analysis of crude reaction mixtures. See supporting Information 
for further experimental details. b72 h. c75 ℃. d2-PrOH was omitted. e7.5 mol% of 
H2Ru(CO)(PPh3)3, ArSO3H, SL-J009-1, and 15 mol% Bu4NI. f48 h. 
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adduct. Para-, meta-, and ortho-substituents containing alcohols provided adducts 2.3a, 
2.3c-2.3f. For allylic alcohols 2.2g-2.2i, which could be converted to the corresponding 
aldehydes catalyzed by transition metal through internal redox isomerization, adducts 2.3g-
2.3i were also formed in highly stereoselective manner. Also, aliphatic alcohols 2.3j-2.3l 
gave slightly lower yields but still excellent level of diastereo- and enantioselectivity. 
To further explore the scope for this transformation, a series of 2-propynes bearing 
tert-butyl (2.1b), 4-(N-Boc-piperidinyl) (2.1c) and phenyl (2.1d) moieties were evaluated 
under the optimal condition by coupling with both benzylic and aliphatic alcohol 2.2a and 
2.2j, respectively. Desired allylation products 2.3m-2.3r were obtained with moderate to 
good yields and good to excellent enantioselectivity.  
2.3 MECHANISM AND DISCUSSION 
The reaction was proposed to proceed through the catalytic cycle below (Scheme 
2.2). Ruthenium catalyst, derived from acid-base reaction of H2Ru(CO)(PPh3)3 and 
sulfonic acid, was converted to ruthenium alkoxide through ligand exchange. Subsequent 
β-hydride elimination released aldehyde and ruthenium hydride. Allylruthenium species 
were formed via hydrometalation of transient allene12, which formed by isomerization 2-
propyne. Such allylruthenium species were undergoing rapid isomerization between σ-allyl 
and π-allyl haptomers. Coordination of aldehyde to the (E)-σ-allylruthenium species 
triggered the carbonyl addition to form the homoallylic ruthenium alkoxide through a 
closed transition structure. Protonolysis facilitated by the sulfonic acid released the 
homoallylic alcohol and closed the catalytic cycle. The proposed mechanism was 
supported by the deuterium labeling studies. Bu4NI in the reaction helped to suppressed 
oxidative coupling pathway due to the strong σ-donicity of iodide ligand on ruthenium, 
which may destabilize ruthenium(0). 
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In summary, a ruthenium-catalyzed formation of enantiomeric enriched 
homoallylic alcohols was reported, where 2-alkynes were used as reservoir for allenes. It’s 
noticed that subtle changes in the reaction could lead to the partition of different 
mechanism pathways-oxidative coupling vs hydrometalation. And this process further 
expanded the scope for π-unsaturated compounds engaging in transition metal catalyzed 




2.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Resealable pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog 
number 14–959–35C) and were flame dried followed by cooling in a desiccator or under a 
stream of argon prior to use. Tetrahydrofuran (THF) was dried over sodium metal, 
benzophenone, and distilled immediately prior to use. RuH2(PPh3)3 were prepared 
according to literature procedure.1 All ligands were used as received from Strem 
Chemicals Inc. Alcohols were purified by distillation or recrystallization immediately prior 
to use. Preparative column chromatography employing Silicycle silica gel (40-63 µm) was 
performed according to the method of Still.2 Analytical thin-layer chromatography (TLC) 
was carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents F254). 
Visualization was accomplished with UV light followed by dipping in Seebach’s stain 
solution then heating. Purification of reactions was carried out by flash chromatography 




Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-resolution mass 
spectra (LRMS) were obtained on a Karatos MS9 and are reported as m/z (relative 
intensity). Accurate masses are reported for the molecular ion (M+H, M+Na), or a suitable 
fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra were recorded with a 
Varian Gemini (400 MHz) spectrometer. Chemical shifts are reported in delta (δ) units, 
parts per million (ppm) downfield from tetramethylsilane or ppm relative to the center of 
the singlet at 7.26 ppm for deuteriochloroform. Data reported as multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet). Integration and coupling constants were 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) spectra were 
recorded with a Varian Gemini (100 MHz) spectrometer and were routinely run with 
broadband decoupling. Chemical shifts are reported in delta (δ) units, ppm relative to the 




Experimental Details and Spectral Data 
General Procedure for the Couplings of Alcohols 2.2a-2.2l and Alkynes 
To a resealable pressure tube (ca. 13 x 100) was added H2Ru(CO)(PPh3)3 (9.2 mg, 0.010 
mmol, 5 mol%), SL-J009-1 ligand (5.6 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 
mmol, 10 mol%) and 2,4,6-tri(2-propyl)phenylsulfonic acid (2.9 mg, 0.010 mmol, 5 
mol%). At this stage solid alcohol coupling partners (0.20 mmol, 100 mol%) were added. 
The tube was then sealed with a rubber septum and purged with argon. THF (0.20 mL, 1 
M concentration with respect to alcohols) was then added. At this stage, liquid alcohol 
coupling partners (0.20 mmol, 100 mol%) were added. 2-propylalcohol (31 µL, 0.40 mmol, 
200 mol%) was then added. Alkynes (0.60 mmol, 300 mol%) was added via syringe and 
the rubber septum was quickly replaced with a screw cap. The mixture was then heated at 
95 °C for the time stated. After cooling to room temperature, the mixture was concentrated 
in vacuo. The residue was subjected to flash column chromatography (SiO2), under the 








The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:5) to furnish the title compound (42.5 mg, 79%, dr = >20:1) as a 
yellow oil. 
Rf =0.37 (Hexanes: Et2O = 4:1). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.50 – 7.44 (m, 2H), 7.25 – 7.19 (m, 2H), 5.84 – 5.72 (m, 
1H), 5.31 (dd, J = 10.3, 2.1 Hz, 1H), 5.14 (ddd, J = 17.1, 2.1, 0.6 Hz, 1H), 4.59 (dd, J = 
8.2, 2.3 Hz, 1H), 2.12 – 2.04 (m, 2H), 1.52 – 1.41 (m, 1H), 0.86 (d, J = 6.8 Hz, 3H), 0.84 
(d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 142.0, 135.4, 131.6, 128.7, 121.5, 120.8, 74.1, 59.1, 27.7, 
22.0, 17.6. 
LRMS (CI) Calcd. for C13H17BrO [M+H]+: 269/271, Found: 269/271. 
FTIR (neat): 3432, 3388, 2959, 2904, 1638, 1592, 1486, 1190, 1070, 1009, 915, 818 cm-
1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99.5:0.5, 0.50 mL/min, 210 nm), ee = 
94%. 






















The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:12) to furnish the title compound (31.2 mg, 82%, dr = >20:1) as a 
yellow oil. 
Rf = 0.56 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.36 – 7.26 (m, 5H), 5.81 (dt, J = 17.1, 10.0 Hz, 1H), 5.31 
(dd, J = 10.3, 2.0 Hz, 1H), 5.16 (dd, J = 17.1, 2.1 Hz, 1H), 4.61 (dd, J = 8.5, 1.5 Hz, 1H), 
2.16 (td, J = 9.1, 4.1 Hz, 1H), 2.05 (d, J = 2.0 Hz, 1H), 1.52 – 1.40 (m, 1H), 0.85 (d, J = 
6.8 Hz, 3H), 0.82 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 142.9, 135.9, 128.5, 127.8, 127.0, 120.4, 74.8, 59.0, 27.7, 
22.1, 17.4. 
LRMS (CI) Calcd. for C13H18O [M-OH]+: 173, Found: 173. 
FTIR (neat): 3439, 3071, 3028, 2929, 1612, 1591, 1454, 1368, 1194, 1001, 913, 764, 700 
cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%.  























The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:12) to furnish the title compound (31.1 mg, 76%, dr = >20:1) as a 
yellow oil. 
Rf = 0.56 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.25 – 7.21 (m, 2H), 7.19 – 7.13 (m, 2H), 5.81 (dt, J = 
17.1, 10.0 Hz, 1H), 5.31 (dd, J = 10.3, 2.2 Hz, 1H), 5.18 (ddd, J = 17.1, 2.2, 0.6 Hz, 1H), 
4.57 (dd, J = 8.7, 2.1 Hz, 1H), 2.34 (d, J = 7.2 Hz, 3H), 2.17 (td, J = 9.2, 3.9 Hz, 1H), 2.02 
(d, J = 2.3 Hz, 1H), 1.52 – 1.39 (m, 1H), 0.89 – 0.84 (d, J = 6.8 Hz, 3H), 0.82 (d, J = 6.8 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 139.9, 137.5, 136.0, 129.2, 127.0, 120.3, 74.7, 58.9, 27.7, 
22.1, 21.3, 17.3. 
LRMS (CI) Calcd. for C14H20O [M-OH]+: 187, Found: 187. 
FTIR (neat): 3452, 2957, 2925, 2871, 1637, 1514, 1194, 1000, 911, 814, 675 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%. 






















The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:7) to furnish the title compound (32.2 mg, 73%, dr = >20:1) as a 
yellow oil. 
Rf = 0.39 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.30 – 7.24 (m, 2H), 6.92 – 6.85 (m, 2H), 5.81 (dt, J = 
17.1, 10.0 Hz, 1H), 5.31 (dd, J = 10.3, 2.1 Hz, 1H), 5.18 (ddd, J = 17.1, 2.1, 0.7 Hz, 1H), 
4.55 (dd, J = 8.8, 1.5 Hz, 1H), 3.81 (s, 3H), 2.15 (td, J = 9.2, 3.8 Hz, 1H), 2.03 (d, J = 2.1 
Hz, 1H), 1.53 – 1.38 (m, 1H), 0.82 (t, J = 6.5 Hz, 6H). 
13C NMR (100 MHz, CDCl3): δ 159.2, 136.0, 135.0, 128.2, 120.3, 113.9, 74.4, 58.9, 55.4, 
27.7, 22.1, 17.2. 
LRMS (CI) Calcd. for C14H20O2 [M+H]+: 221, Found: 221. 
FTIR (neat): 3446, 3072, 2999, 2873, 1612, 1586, 1512, 1367, 1246, 1174, 1035, 833 cm-
1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%. 






















The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:7) to furnish the title compound (35.1 mg, 75%, dr = >20:1) as a 
yellow oil. 
Rf = 0.31 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3):  δ 6.85 (s, 1H), 6.81 – 6.71 (m, 2H), 5.94 (s, 2H), 5.86 – 
5.71 (m, 1H), 5.31 (dd, J = 10.3, 2.1 Hz, 1H), 5.16 (dd, J = 17.2, 2.0 Hz, 1H), 4.50 (d, J = 
8.7 Hz, 1H), 2.16 – 2.05 (m, 2H), 1.56 – 1.38 (m, 1H), 0.83 (d, J = 2.4 Hz, 3H), 0.81 (d, J 
= 2.4 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 147.8, 147.1, 136.8, 135.8, 120.6, 120.4, 108.0, 107.1, 
101.1, 74.6, 58.9, 27.6, 22.0, 17.2. 
LRMS (CI) Calcd. for C14H18O3 [M+H]+: 235, Found: 235. 
FTIR (neat): 3446, 3073, 2958, 2874, 1638, 1610, 1503, 1441, 1243, 1038, 916, 810 cm-
1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 96%.  






















The residue was subjected to flash column chromatography for purification (SiO2, 300 mL 
of EtOAc: Hexanes = 1:5) to furnish the title compound (33.5 mg, 76%, dr = >20:1) as a 
yellow oil. 
Rf = 0.28 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.31 (dd, J = 7.5, 1.7 Hz, 1H), 7.27 – 7.22 (m, 1H), 6.96 
(td, J = 7.5, 1.0 Hz, 1H), 6.88 (dd, J = 8.3, 0.7 Hz, 1H), 5.82 (dt, J = 17.1, 10.0 Hz, 1H), 
5.22 (dd, J = 10.3, 2.2 Hz, 1H), 5.08 – 4.97 (m, 2H), 3.84 (s, 3H), 2.31 (d, J = 5.4 Hz, 1H), 
2.29 – 2.23 (m, 1H), 1.55 – 1.49 (m, 1H),	0.87 (d, J = 4.8 Hz, 3H), 0.85 (d, J = 4.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 156.9, 136.7, 131.3, 128.4, 128.1, 120.8, 119.1, 110.7, 
70.5, 57.6, 55.4, 28.2, 22.0, 18.1. 
LRMS (CI) Calcd. for C14H20O2 [M+H]+: 221, Found: 221. 
FTIR (neat): 3452, 2956, 2871, 1601, 1588, 1490, 1464, 1237, 1049, 1030, 912, 753 cm-
1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%. 





















The residue was subjected to flash column chromatography for purification (SiO2, 250 mL 
of Et2O: Pentane = 1:7) to furnish the title compound (25.6 mg, 76%, dr = >20:1) as a 
colorless oil. 
Rf = 0.32 (5:1 Hexanes : Et2O). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.74 (td, J = 17.1, 10.0 Hz, 1H), 5.27 (dt, J = 10.3, 2.1 Hz, 
1H), 5.18 – 5.05 (m, 2H), 4.30 (t, J = 8.6 Hz, 1H), 1.89 – 1.77 (m, 3H), 1.76 (s, 3H), 1.72 
(s, 3H), 1.54 (t, J = 2.2 Hz, 1H), 0.88 (dd, J = 6.8, 1.8 Hz, 3H), 0.79 (dd, J = 6.8, 1.7 Hz, 
3H) 
13C NMR (100 MHz, CDCl3): δ 136.43, 136.25, 126.52, 119.83, 68.55, 57.72, 27.97, 
26.10, 22.05, 18.50, 17.79. 
LRMS (CI) Calcd. for C11H20O [M+H]+: 169, Found: 169. 
FTIR (neat): 3390, 2959, 2928, 1676, 1638, 1449, 1385, 1026, 913, 743 cm-1. 
GC (cyclosil-B: Initial temperature: 50 ْ◌˚C; 130 ˚C, rate: 1 ˚C /min), ee = 95%. 





















The residue was subjected to flash column chromatography for purification (SiO2, 200 mL 
of 10% EtOAc/Hexanes) to furnish the title compound (42.6 mg, 90%, dr = >20:1) as a 
colorless oil. 
Rf = 0.50 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.74 (dt, J = 17.1, 10.0 Hz, 1H), 5.27 (dd, J = 10.3, 2.3 Hz, 
1H), 5.18 – 5.10 (m, 2H), 5.07 (tt, J = 6.9, 1.5 Hz, 1H), 4.31 (ddd, J = 9.1, 8.0, 2.6 Hz, 1H), 
2.22 – 2.00 (m, 4H), 1.90 – 1.74 (m, 2H), 1.71 (d, J = 1.4 Hz, 3H), 1.67 (d, J = 1.3 Hz, 
3H), 1.60 (s, 3H), 1.52 (d, J = 2.6 Hz, 1H), 0.89 (d, J = 6.8 Hz, 3H), 0.79 (d, J = 6.8 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ 139.70, 136.28, 131.77, 126.45, 124.11, 119.81, 68.49, 
57.77, 39.90, 27.98, 26.36, 25.83, 22.11, 17.84, 17.77, 16.81. 
LRMS (CI) Calcd. for C16H28O [M+H]+: 237, Found: 237. 
FTIR (neat): 3423, 3073, 2958, 2927, 2870, 1669, 1638, 1446, 1383, 1027, 1001, 909, 684 
cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99.5:0.5, 0.50 mL/min, 210 nm), ee = 
96%. 





















The residue was subjected to flash column chromatography for purification (SiO2, 250 mL 
of 1:9 Et2OAc: Hexanes) to furnish the title compound (29.0 mg, 67%, dr = >20:1) as a 
colorless oil. 
Rf = 0.50 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.43 – 7.37 (m, 2H), 7.35 – 7.29 (m, 2H), 7.27 – 7.20 (m, 
1H), 6.61 (d, J = 15.9 Hz, 1H), 6.20 (dd, J = 15.9, 7.5 Hz, 1H), 5.78 (dt, J = 17.1, 10.0 Hz, 
1H), 5.30 (dd, J = 10.3, 2.2 Hz, 1H), 5.17 (ddd, J = 17.1, 2.2, 0.7 Hz, 1H), 4.26 (td, J = 7.5, 
1.8 Hz, 1H), 1.97 (ddd, J = 9.7, 7.4, 4.9 Hz, 1H), 1.92 – 1.82 (m, 1H), 1.76 (d, J = 2.8 Hz, 
1H), 0.93 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 136.88, 135.92, 131.82, 130.98, 128.69, 127.81, 126.66, 
119.96, 73.32, 57.63, 27.96, 21.88, 17.97. 
LRMS (CI) Calcd. for C15H20O [M+H]+: 217, Found: 217. 
FTIR (neat): 3422, 3073, 2957, 2870, 1637, 1494, 1449, 1386, 1002, 966, 751, 693 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 96%. 






















In modification to the general procedure, 2-PrOH was omitted. The reaction was heated 
for 48 hours at 125 oC, concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, 250 mL of 1:15 Et2O: Hexanes) to furnish the title compound (28.6 
mg, 72%, dr = >20:1) as a pale yellow liquid. 
Rf = 0.74 (1:5 of Et2O: Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.69 (dt, J = 17.2, 10.0 Hz, 1H), 5.21 (dd, J = 10.3, 2.3 Hz, 
1H), 5.06 (dd, J = 17.1, 2.3 Hz, 1H), 3.66 (s, 1H), 1.81 (dt, J = 13.4, 6.7 Hz, 1H), 1.76 – 
1.64 (m, 1H), 1.53 – 1.21 (m, 11H), 0.92 (d, J = 6.7 Hz, 3H), 0.91 – 0.87 (m, 3H), 0.85 (d, 
J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 136.66, 118.88, 71.26, 56.86, 35.35, 32.02, 29.57, 27.89, 
25.73, 22.79, 21.62, 19.29, 14.24. 
LRMS (CI) Calcd. for C13H26O [M+H]+: 199, Found: 199. 
FTIR (neat): 3389, 2956, 2928, 1638, 1467, 1368, 1144, 1038, 1003, 911, 725 cm-1. 
HPLC Enantiomeric excess was determined by HPLC analysis of the 4-nitro-benzoate of 
product (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 0.50 mL/min, 210 nm), ee = 
93%.  






















In modification to the general procedure, 2-PrOH was omitted and the reaction was heated 
at 125 oC. The residue was subjected to flash column chromatography (SiO2, 250 mL of 
1:16 Et2O: Hexanes) to furnish the title compound (28.4 mg, 65%, dr = >20:1) as a yellow 
liquid. 
Rf = 0.46 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.29 (t, J = 7.4 Hz, 2H), 7.24 – 7.14 (m, 3H), 5.71 (dt, J = 
17.2, 10.0 Hz, 1H), 5.23 (dd, J = 10.3, 2.3 Hz, 1H), 5.09 (dd, J = 17.2, 2.3 Hz, 1H), 3.76 – 
3.61 (m, 1H), 2.81 (ddd, J = 13.7, 10.1, 5.5 Hz, 1H), 2.68 (ddd, J = 13.7, 9.9, 6.5 Hz, 1H), 
1.89 – 1.67 (m, 4H), 1.47 (d, J = 4.2 Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 6.6 Hz, 
3H). 
13C NMR (100 MHz, CDCl3): δ 142.46, 136.42, 128.58, 128.50, 125.90, 119.18, 70.72, 
57.00, 37.17, 32.24, 27.89, 21.61, 19.12. 
LRMS (CI) Calcd. for C15H22O [M-OH]+: 201, Found: 201. 
FTIR (neat): 3363, 3067, 2955, 2926, 1637, 1603, 1455, 1385, 1044, 1003, 914, 699 cm-
1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 94%. 





















In modification to the general procedure, 2-PrOH was omitted and the reaction was heated 
at 125 oC. The residue was subjected to flash column chromatography (SiO2, 250 mL of 
1:16 Et2O: Hexanes) to furnish the title compound (32.7 mg, 66%, dr = >20:1) as a yellow 
liquid. 
Rf = 0.40 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.37 – 7.27 (m, 5H), 5.74 (dt, J = 17.2, 10.1 Hz, 1H), 5.17 
(dd, J = 10.3, 2.3 Hz, 1H), 5.00 (ddd, J = 17.2, 2.3, 0.7 Hz, 1H), 4.52 (s, 2H), 3.99 – 3.92 
(m, 1H), 3.76 – 3.60 (m, 2H), 2.53 (d, J = 2.7 Hz, 1H), 1.89 – 1.73 (m, 2H), 1.71 – 1.60 
(m, 2H), 0.95 (d, J = 6.7 Hz, 3H), 0.85 (d, J = 6.8 Hz, 3H).  
13C NMR (100 MHz, CDCl3): δ 138.19, 137.17, 128.57, 127.82, 118.09, 73.44, 70.76, 
69.36, 57.48, 35.34, 28.01, 21.41, 19.91. 
LRMS (CI) Calcd. for C16H24O2 [M+H]+: 249, Found: 249. 
FTIR (neat): 3491, 3067, 2954, 2926, 1496, 1386, 1095, 1028, 913, 737, 697 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 96%. 




















The residue was subjected to flash column chromatography for purification (SiO2, 200 mL 
of 10% EtOAc/Hexanes) to furnish the title compound (42.5 mg, 75%, dr = >20:1) as a 
pale white solid. 
Rf = 0.49 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.44 – 7.40 (m, 2H), 7.16 – 7.11 (m, 2H), 5.89 (dt, J = 
17.2, 10.2 Hz, 1H), 5.10 (dd, J = 10.3, 2.3 Hz, 1H), 5.05 – 5.01 (m, 1H), 4.65 (dd, J = 17.2, 
2.2 Hz, 1H), 1.90 (dd, J = 10.1, 2.6 Hz, 1H), 1.74 (d, J = 4.2 Hz, 1H), 1.00 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 144.5, 133.8, 131.2, 128.0, 120.8, 119.7, 72.9, 62.3, 33.2, 
28.9. 
LRMS (CI) Calcd. for C14H19BrO [M+H]+: 283/285, Found: 283/285. 
FTIR (neat): 3459, 3073, 2955, 2905, 1636, 1592, 1487, 1366, 1230, 1072, 1010, 917, 776 
cm-1.  
MP 55.6-56.2 ˚C 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 94%.  























In modification to the general procedure, the reaction was extended for 72 hours. The 
residue was subjected to flash column chromatography (SiO2, 200 mL of 30% 
Et2O/Hexanes followed by 150 mL of 40% Et2O/Hexanes) to furnish the title compound 
(53.3 mg, 65%, dr = >20:1) as a yellow liquid. 
Rf = 0.30 (50% Et2O/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.49 – 7.44 (m, 2H), 7.20 – 7.15 (m, 2H), 5.73 (dt, J = 
17.1, 10.1 Hz, 1H), 5.22 (dd, J = 10.3, 1.7 Hz, 1H), 4.99 (d, J = 17.5 Hz, 1H), 4.72 (dd, J 
= 6.7, 2.5 Hz, 1H), 4.07 (s, 2H), 2.63 – 2.41 (m, 2H), 2.11 – 2.03 (m, 2H), 1.63 – 1.13 
(m, 14H). 
 
13C NMR (100 MHz, CDCl3): δ 154.88, 142.07, 135.24, 131.56, 128.41, 121.51, 120.53, 
79.47, 73.19, 57.80, 36.50, 34.82, 28.59, 25.43. 
 
LRMS (ESI) Calcd. for C20H28BrNO3 [M+Na]+: 434, Found: 434. 
FTIR (neat): 3424, 2976, 2930, 1667, 1485, 1428, 1366, 1166, 1071, 751 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 90%. 





















In modification to the general procedure, the reaction was heated at 75 oC for 72 hours. 
The residue was subjected to flash column chromatography (SiO2, 300 mL of 5% 
EtOAc/Hexanes) to furnish the title compound (40.6 mg, 67%, dr = >20:1) as a yellow 
liquid. 
Rf = 0.56 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.29 (m, 2H), 7.25 – 7.14 (m, 3H), 7.06 – 6.98 (m, 
4H), 6.27 – 6.18 (m, 1H), 5.36 – 5.18 (m, 2H), 4.80 (d, J = 7.9 Hz, 1H), 3.47 (t, J = 8.4 Hz, 
1H), 2.35 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 140.9, 140.3, 137.6, 131.1, 128.7, 128.5, 128.4, 127.0, 
121.4, 119.0, 76.7, 59.5. 
LRMS (CI) Calcd. for C16H15BrO [M+H]+: 303/305, Found: 303/305. 
FTIR (neat): 3402, 3082, 2974, 2904, 1636, 1559, 1405, 1226, 1071, 1010, 819, 700 cm-
1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 86%. 





















In modification to the general procedure, 2-PrOH was omitted and the reaction was heated 
for 72 hours, concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, 250 mL of 1:9 Et2O: Hexanes) to furnish the title compound (25.9 
mg, 61%, dr = >20:1) as a pale yellow liquid. 
Rf = 0.50 (1:5 of Et2O: Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.85 (dt, J = 17.2, 10.2 Hz, 1H), 5.19 (dd, J = 10.3, 2.5 
Hz, 1H), 4.99 (dd, J = 17.2, 2.5 Hz, 1H), 3.89 (s, 1H), 1.65 (dd, J = 10.2, 0.8 Hz, 1H), 
1.45 – 1.23 (m, 10H), 1.09 – 1.00 (m, 1H), 0.95 (s, 9H), 0.88 (t, J = 6.8 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 135.4, 118.7, 71.0, 59.2, 37.9, 32.8, 32.0, 29.4, 28.7, 26.1, 
22.8, 14.2. 
LRMS (ESI) Calcd. for C14H28O [M+H]+: 213, Found: 213. 
FTIR (neat): 3415, 2954, 2930, 2858, 1637, 1466, 1364, 1006, 913, 727 cm-1. 
HPLC Enantiomeric excess was determined by HPLC analysis of the 4-nitro-benzoate of 
product (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 0.50 mL/min, 210 nm), ee = 
90%. 





















In modification to the general procedure, the loading of Ruthenium catalyst was 7.5%. The 
reaction was omitted 2-PrOH and heated for 48 hours, concentrated in vacuo. The residue 
was subjected to flash column chromatography (SiO2, 200 mL of 30% Et2O/Hexanes 
followed by 150 mL of 40% Et2O/Hexanes) to furnish the title compound (46.1 mg, 68%, 
dr = >20:1) as a yellow oil. 
Rf = 0.33 (50% Et2O/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.68 (dt, J = 17.2, 10.1 Hz, 1H), 5.20 (dd, J = 10.3, 2.2 Hz, 
1H), 5.03 (dd, J = 17.2, 2.2 Hz, 1H), 4.09 (s, 2H), 3.73 (dd, J = 10.0, 5.9 Hz, 1H), 2.78 – 
2.57 (m, 2H), 1.82 – 1.60 (m, 4H), 1.46 – 1.07 (m, 22H), 0.88 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 154.9, 136.1, 119.0, 79.4, 70.4, 55.1, 36.2, 35.9, 32.0, 
30.5, 30.0, 29.5, 28.6, 26.3, 25.9, 25.3, 22.8, 14.2. 
LRMS (ESI) Calcd. for C20H37NO3 [M+Na]+: 362, Found: 362. 
FTIR (neat): 3471, 2952, 2853, 1673, 1427, 1366, 1172, 1073, 911, 669 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 97:3, 1 mL/min, 210 nm), ee = 96%. 






















In modification to the general procedure, the reaction was omitted 2-PrOH and heated for 
48 hours, concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2, 300 mL of 5% EtOAc/Hexanes) to furnish the title compound (40.1 
mg, 77%, dr = >20:1) as a yellow oil. 
Rf = 0.65 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.29 (m, 2H), 7.25 – 7.17 (m, 3H), 6.12 (ddd, J = 
17.0, 10.3, 9.2 Hz, 1H), 5.23 (ddd, J = 10.4, 1.6, 0.4 Hz, 1H), 5.20 (ddd, J = 17.0, 1.7, 0.8 
Hz, 1H), 3.82 – 3.73 (m, 1H), 3.24 (dd, J = 9.1, 7.2 Hz, 1H), 1.78 (d, J = 3.4 Hz, 1H), 1.52 
– 1.12 (m, 10H), 0.85 (d, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 141.85, 138.51, 128.83, 128.13, 126.77, 118.00, 74.10, 
57.57, 34.54, 31.94, 29.37, 25.82, 22.73, 14.22. 
LRMS (ESI) Calcd. for C16H24O [M+H]+: 233, Found: 233. 
FTIR (neat): 3430, 2926, 2856, 1637, 1493, 1453, 1066, 995, 916, 678 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 90%. 















Crystallographic Material for Coupling product 2.3m 
X-ray Experimental for C14H19OBr (2.3m) 
Crystals grew as clusters of clear, colorless prisms by slow evaporation from 
hexane and pentane.  The data crystal was cut from a larger crystal and had approximate 
dimensions; 0.31 x 0.30 x 0.14 mm.  The data were collected at -140 °C on a Nonius Kappa 
CCD diffractometer using a Bruker AXS Apex II detector and a graphite monochromator 
with MoK α radiation (λ = 0.71073Å).  Reduced temperatures were maintained by use of 
an Oxford Cryosystems 600 low-temperature device.  A total of 1280 frames of data were 
collected using ω and f-scans with a scan range of 1° and a counting time of 51 seconds 
per frame.  Details of crystal data, data collection and structure refinement are listed in 
Table 1.  Data reduction were performed using SAINT V8.27B.13 The structure was solved 
by direct methods using SUPERFLIP 14 and refined by full-matrix least-squares on F2 with 
anisotropic displacement parameters for the non-H atoms using SHELXL-2013.15 
Structure analysis was aided by use of the programs PLATON98 16 and WinGX.17 The 
hydrogen atoms were calculated in idealized positions.  The absolute configuration was 
determined by anomalous dispersion effects. 
The function, Sw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.021*P)2 + (2.4901*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.0614, with R(F) 
equal to 0.0318 and a goodness of fit, S, = 1.01.  Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.18  The data were checked for 
secondary extinction but no correction was necessary.  Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).19  All figures were generated using SHELXTL/PC.20  
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 




Table 2.4 Crystal data and structure refinement for 2.3m. 
Empirical formula  C14 H19 Br O 
Formula weight  283.20 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  C 2 2 21 
Unit cell dimensions a = 14.3605(7) Å α= 90°. 
 b = 16.2960(7) Å β= 90°. 
 c = 24.0795(10) Å γ = 90°. 
Volume 5635.1(4) Å3 
Z 16 
Density (calculated) 1.335 Mg/m3 
Absorption coefficient 2.898 mm-1 
F(000) 2336 
Crystal size 0.310 x 0.300 x 0.140 mm 
Theta range for data collection 2.500 to 27.623°. 
Index ranges -18<=h<=18, -21<=k<=21, -30<=l<=31 
Reflections collected 71234 
Independent reflections 6493 [R(int) = 0.0720] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Numerical 
Max. and min. transmission 0.742 and 0.595 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6493 / 0 / 298 
Goodness-of-fit on F2 1.011 
Final R indices [I>2sigma(I)] R1 = 0.0318, wR2 = 0.0560 
R indices (all data) R1 = 0.0542, wR2 = 0.0614 
Absolute structure parameter 0.006(8) 
Extinction coefficient n/a 





Table 2.5 Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters 
(Å2 x 103) for 2.3m. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 x y z U(eq) 
Br1 2739(1) 2598(1) 7154(1) 47(1) 
O1 6106(2) 4599(1) 5695(1) 31(1) 
C1 5455(2) 3750(2) 6424(1) 24(1) 
C2 4633(2) 4199(2) 6454(2) 31(1) 
C3 3833(3) 3865(2) 6675(1) 34(1) 
C4 3849(3) 3068(2) 6865(1) 32(1) 
C5 4649(3) 2603(2) 6841(1) 33(1) 
C6 5444(3) 2949(2) 6625(1) 28(1) 
C7 6323(3) 4096(2) 6169(1) 26(1) 
C8 6916(2) 4608(2) 6578(1) 24(1) 
C9 6496(2) 5440(2) 6672(1) 27(1) 
C10 6054(2) 5670(2) 7121(2) 39(1) 
C11 7969(2) 4650(2) 6432(2) 34(1) 
C12 8462(3) 5155(3) 6881(2) 63(1) 
C13 8395(3) 3794(2) 6441(2) 47(1) 
C14 8157(3) 5028(3) 5864(2) 60(1) 
Br2 1269(1) 5391(1) 6468(1) 48(1) 
O2 5572(2) 6114(1) 5317(1) 31(1) 
C15 4153(2) 6349(2) 5855(1) 23(1) 
C16 3647(3) 5801(2) 5541(1) 29(1) 
C17 2801(3) 5500(2) 5721(1) 31(1) 
C18 2449(2) 5771(2) 6226(1) 30(1) 
C19 2939(2) 6316(2) 6545(1) 32(1) 
C20 3795(2) 6598(2) 6361(1) 29(1) 
C21 5087(2) 6684(2) 5666(1) 24(1) 
C22 4974(2) 7502(2) 5356(1) 22(1) 
C23 4463(2) 7389(2) 4818(1) 25(1) 
C24 3748(3) 7823(2) 4657(2) 34(1) 
C25 5890(2) 8008(2) 5279(2) 27(1) 
C26 6447(3) 8036(2) 5819(2) 41(1) 
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C27 5620(3) 8881(2) 5117(2) 36(1) 
C28 6517(2) 7658(2) 4818(1) 32(1) 
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Table 2.6 Bond lengths [Å] and angles [°] for 2.3m. 
_____________________________________________________________________________________ 
Br1-C4  1.900(4) 
O1-C7  1.438(4) 
O1-H1  0.84 
C1-C2  1.389(5) 
C1-C6  1.392(4) 
C1-C7  1.500(5) 
C2-C3  1.379(5) 
C2-H2  0.95 
C3-C4  1.377(5) 
C3-H3  0.95 
C4-C5  1.378(5) 
C5-C6  1.375(5) 
C5-H5  0.95 
C6-H6  0.95 
C7-C8  1.548(5) 
C7-H7  1.00 
C8-C9  1.500(5) 
C8-C11  1.553(5) 
C8-H8  1.00 
C9-C10  1.307(5) 
C9-H9  0.95 
C10-H10A  0.95 
C10-H10B  0.95 
C11-C13  1.524(5) 
C11-C14  1.525(5) 
C11-C12  1.532(5) 
C12-H12A  0.98 
C12-H12B  0.98 
C12-H12C  0.98 
C13-H13A  0.98 
C13-H13B  0.98 
C13-H13C  0.98 
C14-H14A  0.98 
C14-H14B  0.98 
C14-H14C  0.98 
Br2-C18  1.897(3) 
O2-C21  1.433(4) 
O2-H2A  0.84 
C15-C16  1.377(5) 
C15-C20  1.384(4) 
C15-C21  1.518(5) 
C16-C17  1.380(5) 
C16-H16  0.95 
C17-C18  1.387(5) 
C17-H17  0.95 
C18-C19  1.370(5) 
C19-C20  1.385(5) 
C19-H19  0.95 
C20-H20  0.95 
C21-C22  1.537(4) 
C21-H21  1.00 
C22-C23  1.498(4) 
C22-C25  1.564(5) 
C22-H22  1.00 
C23-C24  1.306(5) 
C23-H23  0.95 
C24-H24A  0.95 
C24-H24B  0.95 
C25-C27  1.525(5) 
C25-C26  1.529(5) 
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C26-H26B  0.98 
C26-H26C  0.98 
C27-H27A  0.98 
C27-H27B  0.98 
C27-H27C  0.98 
C28-H28A  0.98 
C28-H28B  0.98 







































































































































Table 2.7 Anisotropic displacement parameters (Å2 x 103) for 2.3m. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 
] 
 U11 U22  U33 U23 U13 U12 
Br1 50(1)  50(1) 40(1)  11(1) 1(1)  -18(1) 
O1 57(2)  17(1) 18(1)  2(1) -2(1)  -3(1) 
C1 39(2)  16(2) 18(2)  -2(1) -4(2)  -2(1) 
C2 42(2)  19(2) 31(2)  5(2) -3(2)  -4(2) 
C3 42(2)  26(2) 35(2)  2(2) -5(2)  -1(2) 
C4 42(2)  30(2) 24(2)  4(2) -4(2)  -10(2) 
C5 57(2)  22(2) 22(2)  10(2) -5(2)  -7(2) 
C6 43(2)  21(2) 22(2)  4(1) -3(2)  1(2) 
C7 44(2)  15(2) 19(2)  2(1) 4(2)  2(2) 
C8 31(2)  19(2) 22(2)  0(1) 3(1)  2(1) 
C9 29(2)  21(2) 32(2)  -5(2) -4(1)  -1(2) 
C10 38(2)  34(2) 44(2)  -12(2) 0(2)  5(2) 
C11 33(2)  30(2) 40(2)  3(2) 9(2)  4(2) 
C12 25(2)  74(4) 91(4)  -34(3) -1(2)  3(2) 
C13 38(2)  41(2) 62(3)  3(2) 14(2)  12(2) 
C14 49(3)  63(3) 69(3)  26(3) 24(2)  -4(2) 
Br2 47(1)  54(1) 44(1)  2(1) 8(1)  -16(1) 
O2 47(2)  19(1) 27(1)  3(1) 10(1)  13(1) 
C15 32(2)  14(2) 21(2)  1(1) -2(1)  6(1) 
C16 44(2)  21(2) 22(2)  -4(1) 3(2)  3(2) 
C17 46(2)  21(2) 27(2)  -4(2) -3(2)  -8(2) 
C18 37(2)  23(2) 29(2)  6(2) 2(2)  1(2) 
C19 43(2)  31(2) 21(2)  -5(2) 7(2)  1(2) 
C20 38(2)  23(2) 24(2)  -5(1) -1(2)  -1(2) 
C21 33(2)  21(2) 18(2)  -3(1) 0(1)  8(2) 
C22 26(2)  18(2) 23(2)  -3(1) 2(1)  5(1) 
C23 27(2)  21(2) 26(2)  2(2) 3(1)  -1(2) 
C24 32(2)  33(2) 36(2)  4(2) -2(2)  2(2) 
C25 28(2)  21(2) 32(2)  -4(2) 1(2)  1(2) 
C26 38(2)  40(2) 44(2)  -13(2) -6(2)  -3(2) 
C27 35(2)  20(2) 55(3)  -2(2) 6(2)  -4(2) 
C28 28(2)  28(2) 39(2)  -4(2) 1(2)  2(2) 
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Table 2.8 Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 103) for 
2.3m. 
 x  y  z  U(eq) 
H1 5956 4297 5427 46 
H2 4623 4746 6319 37 
H3 3278 4180 6695 41 
H5 4651 2053 6970 40 
H6 6000 2633 6612 34 
H7 6712 3626 6038 31 
H8 6878 4317 6943 29 
H9 6557 5832 6382 33 
H10A 5978 5296 7420 46 
H10B 5809 6210 7147 46 
H12A 9132 5168 6805 95 
H12B 8353 4904 7245 95 
H12C 8216 5716 6880 95 
H13A 9075 3838 6418 70 
H13B 8162 3478 6124 70 
H13C 8223 3517 6787 70 
H14A 7913 5589 5855 91 
H14B 7849 4699 5576 91 
H14C 8829 5038 5795 91 
H2A 5705 5692 5501 46 
H16 3885 5627 5192 35 
H17 2465 5114 5504 38 
H19 2694 6500 6890 38 
H20 4141 6968 6585 34 
H21 5477 6785 6003 29 
H22 4559 7848 5594 27 
H23 4676 6969 4576 30 
H24A 3514 8249 4887 40 
H24B 3462 7713 4309 40 
H26A 6994 8387 5770 61 
H26B 6648 7480 5918 61 
H26C 6056 8257 6117 61 
H27A 5235 9122 5411 55 
H27B 5267 8871 4769 55 
H27C 6184 9212 5068 55 
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H28A 7104 7964 4808 47 
H28B 6201 7708 4459 47 






























































Table 2.10 Hydrogen bonds for 2.3m [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O1-H1...O2#1 0.84 1.99 2.807(3) 163.9 
 O2-H2A...O1 0.84 1.93 2.742(3) 162.2 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x,-y+1,-z+1       
Figure 2.1 View of 2.3m showing the atom labeling scheme. Displacement ellipsoids are scaled 











Chapter 3: Siloxy-Crotylation of Primary Alcohols by Coupling with 
Propargyl Ethers via Novel Hydride Shift Enabled Formation of 
Allylruthenium from Alkynes* 
3.1 INTRODUCTION 
Polyketides are important sources for discovery of medicine due to their bioactivities.1 In 
the present, all polyketide drugs, except one, are prepared through fermentation or modification of 
fermentation products.2 Only very small portion (less than 5%) of the bacteria are able to culture, 
which limit the further study on the polyketides.3 Chemical synthesis for the polyketides synthesis 
is still in demand for more efficient and economic routes. Carbonyl crotylation has been used 
broadly in the construction of polyketides.4 While most of the enantioselective carbonyl crotylation 
protocols require chiral auxiliaries or preformed crotylmetal nucleophiles (Figure 3.1, eq A).5 
Krische group has introduced the redox-triggered carbonyl addition, by which primary alcohols 
can be directly converted to secondary alcohols by coupling with π-unsaturated compounds in 
diastereoselective and enantioselective manner6 (Figure 3.1, eq B). 
 Recently, our group published ruthenium catalyzed coupling of alcohols and 2-alkynes to 
furnish the formation of both linear7 and branched homoallylic alcohols8 (Scheme 3.1). Both 
protocols went through the alkyne-to-allene isomerization facilitated by ruthenium catalysis. 
Inspired by these results, in this chapter, the first enantioselective and diastereoselective alkynes 
mediated carbonyl crotylation (Figure 3.1, eq C) was described and a novel mechanism for the 
formation of π-allylmetal species from alkyne without intervening allene intermediate was 
proposed (Figure 3.1, eq D). 
 
                                                
*This chapter is based on the published work:  














3.2 REACTION DEVELOPMENT AND SCOPE 
Treatment of propargyl ether 3.1a and p-bromobenzyl alcohol 3.2c under the condition 
used in asymmetric formation of branched homoallylic alcohols,8 carbonyl siloxy-crotylation 
product 3.3c was obtained with 70% yield and complete region- and diastereoselectivity as a 3:1 
(Z:E) mixture of olefin geometrical isomers. Notably, both Z- and E-olefin isomers showed good 
enantiomeric enrichment, 87% ee and 94% ee, respectively. Further optimization was conducted, 
and it’s found that slightly higher loading of the sulfonic acid additive (7.5 mol%) at lower 
temperature (85 ℃) was optimal (Scheme 3.2). Due to the not complete olefin geometry selectivity, 
treatment of the C-C coupling adduct 3.3c with TBAF to cleave the TIPS silyl protecting group 
followed by reduction with NaBH4 provided diol 3.5c. The absolute stereochemistry was 
determined in analogy to 3.5c by X-ray diffraction analysis.  




Scheme 3.2 Redox-Triggered Siloxyl Crotylation by Coupling of Proparyl Ether 3.1a and p-













aYields are material isolated by silica gel chromatography. Diastereoselectivities were determined 
by 1H NMR analysis of crude reaction mixtures. See supporting Information for further 
experimental details. b48 h. cH2Ru(CO)(PPh3)3 (6 mol%), SL-J009-1 (6 mol%), ArSO3H (9 mol%), 
and Bu4NI (12 mol%). d2-PrOH was omitted. 
 
tested coupling with propargyl ether 3.1a, and converted to diols 3.5a-3.5o with complete regio 
and anti-diastereoselectivity and uniformly good enantioselectivity. And not only methyl 
substituted propargyl ether 3.1a, ehtyl- and phenyl-substituted propargyl ether, 3.1b and 3.1c, also 
gave the desired diol adducts 3.5p and 3.5q with BINAP modified ruthenium catalyst in good 
enantioselective manner (Scheme 3.3, eq 1 and eq 2). 





To demonstrate the utility of this transformation, diols 3.5a, 3.5c, 3.5e, 3.5f, 3.5k, and 
3.5m, were treated with p-toluenesulfonyl chloride in pyridine resulting in mono-tosylation of the 
primary alcohol, which spontatneously cyclized to form the trans-2,3-disubstituted furans 3.6a, 
3.6c, 3.6e, 3.6f, 3.6k, and 3.6m (Table 3.2). In type I polyketide natural products, 2,3-disubstituted 
furans with 3-methyl substituents were frequently found as as substructures.9 
 










Also, coupling of alcohols 3.2a, 3.2l, and 3.2p with propargyl ether 3.1a under the standard 
condition followed by removal of TIPS protecting group resulted in the crude hemiacetals, which 
were treated with PCC gave the trans-4,5-disubstituted γ-butyrolactones 3.7a, 3.7l, and 3.7p. The 
formation of 3.7p represents a total synthesis of (+)-trans-whiskey lactone from simple starting 
material pentanol.10  
The crude hemiacetal, obtained under standard condition followed by the TBAF treatment, 
can be converted to trans-4,5-disubstituted-2,3-dehydrofuran 3.8a by treated with mesyl chloride 
in trimethylamine (Scheme 3.4, eq 3). Finally, the crude hemiacetal can be converted to enoate 
3.9a with complete E-olefin selectivity by treated with Wittig reagent (Scheme 3.4, eq 4). 
  










Scheme 3.4 Elaboration of Coupling Adducts. 
 
3.3 MECHANISM AND DISCUSSION 
By comparing with the formation of branched homoallylic alcohol8, coupling of propargyl 
ether 3.1a with primary alcohols didn’t go through the mono-substituted allene 3.1d intermediate. 
Initially, the mechanism of this transformation was assumed to proceed through alkyne 3.1a to 
disubstituted allene 3.1e or diene 3.1f isomerization under ruthenium catalysis. However, the 
deuterium labeling experiment results didn’t support for allene 3.1e and 3.1f intermediates. When 
deuterio-3.2c was used in the coupling with 3.1a under standard conditions, Hb and Hd should get 
deuterium incorporation if allene or diene intermediates were involved. And when deuterio-3.1a 
and 3.2c were subjected to the standard conditions, deuterium was transferred to Ha and Hb. These 
data clearly indicated 1,2-hydride shift mechanism (Scheme 3.5).11,12,13  
A general catalytic mechanism for this asymmetric carbonyl siloxy-crotylation was 
proposed (Scheme 3.6). The ruthenium (II) complex LnRu(II)X2 was converted to ruthenium 
alkoxide via ligand exchange with the primary alcohol, which was followed by β-hydride 
elimination to generate aldehyde and LnRu(II)HX. Reductive elimination of HX gave Ru(0) 











induced 1,2-hydride shift, which delivered the vinyl ruthenium(II) carbene species. Also the n → 
σ* interaction between the oxygen lone pair and the propargylic C-H bond played an important 
role in the 1,2-hydride shift. The vinyl ruthenium(II) carbene species was converted to nucleophilic 
siloxy-substituted allylruthenium(II) complex by protonation. The σ-allylruthenium haptomer, 
where ruthenium resided on the carbon adjacent to oxygen, was added to aldehyde through a 
Zimmerman-Traxler transition structure to form 
 





homoallylic ruthenium(II) alkoxide. Protonolysis cleavage released the carbonyl addition product 
and closed the catalytic cycle. 
3.4 CONCLUSION 
In summary, a ruthenium catalyzed redox-triggered carbonyl siloxy-crotylation mediated 
by alkyne through novel 1,2-hydride shift mechanism was reported. Complete regio- and 
diastereoselectivity, as well as high enantioselectivity, were achieved. From the coupling adducts, 





3.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. Resealable 
pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog number 14–959–
35C) and were flame dried followed by cooling in a desiccator or under a stream of argon prior to 
use. Tetrahydrofuran (THF) was dried over sodium metal, benzophenone, and distilled 
immediately prior to use. RuH2(PPh3)3 were prepared according to literature procedure.1 All 
ligands were used as received from Strem Chemicals Inc. Alcohols were purified by distillation or 
recrystallization immediately prior to use. Preparative column chromatography employing 
Silicycle silica gel (40-63 µm) was performed according to the method of Still.2 Analytical thin-
layer chromatography (TLC) was carried out using 0.25 mm commercial silica gel plates 
(Dynamic Absorbents F254). Visualization was accomplished with UV light followed by dipping 
in Seebach’s stain solution then heating. Purification of reactions was carried out by flash 





Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-resolution mass spectra 
(LRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). Accurate 
masses are reported for the molecular ion (M+H, M+Na), or a suitable fragment ion. Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer. Chemical shifts are reported in delta (δ) units, parts per million (ppm) downfield 
from tetramethylsilane or ppm relative to the center of the singlet at 7.26 ppm for 
deuteriochloroform. Data reported as multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet). Integration and coupling constants were reported in Hertz (Hz). Carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded with a Varian Gemini (100 MHz) 
spectrometer and were routinely run with broadband decoupling. Chemical shifts are reported in 





Experimental Details and Spectral Data 
General Procedure for the Couplings of Alcohols 2.2a-2.2l and Alkynes 
To a resealable pressure tube (ca. 13 x 100) was added H2Ru(CO)(PPh3)3 (9.2 mg, 0.010 mmol, 5 mol%), 
SL-J009-1 ligand (5.6 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 mmol, 10 mol%) and 2,4,6-tri(2-
propyl)phenylsulfonic acid (4.2 mg, 0.015 mmol, 7.5 mol%). At this stage solid alcohol coupling partners 
(0.20 mmol, 100 mol%) were added. The tube was then sealed with a rubber septum and purged with argon. 
THF (0.20 mL, 1 M concentration with respect to alcohols) was then added. At this stage, liquid alcohol 
coupling partners (0.20 mmol, 100 mol%) were added. 2-propylalcohol (31 µL, 0.40 mmol, 200 mol%) 
was then added. Alkyne 1a (0.60 mmol, 300 mol%) was added via syringe and the rubber septum was 
quickly replaced with a screw cap. The mixture was then heated at 85 °C for the time stated. After cooling 
to room temperature, the mixture was passed through a short silica pad, washed the pad with EA, and 
concentrated in vacuo. The residue was dissolved in THF (2.0 mL) and TBAF (1.0 M in THF, 0.2 mL) was 
added at 0ºC. The mixture was stirred at r.t for 30 min, then NaBH4 (14.8 mg, 0.4 mmol), EtOH (1.0 mL) 
were added. After 1 h, the reaction was quenched by NH4Cl (aq), and extracted by EA. Organic layer was 
washed by water, brine, dried over Na2SO4, and concentrated in vacuo. The residue was subjected to flash 









The residue was subjected to flash column chromatography for purification to furnish the title 
compound (37.8 mg, 70%, dr = >20:1) as a white solid. 
Rf =0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.38 – 7.24 (m, 5H), 4.41 (d, J = 7.6 Hz, 1H), 3.83 – 3.74 (m, 1H), 
3.71 – 3.61 (m, 1H), 2.68 (m, 2H), 2.00 (d, J = 6.0 Hz, 1H), 1.86 – 1.75 (m, 1H), 1.67 – 1.55 (m, 
1H), 0.78 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 143.75, 128.46, 127.70, 126.79, 79.40, 61.10, 38.54, 36.34, 17.48. 
LRMS (CI) Calcd. for C11H16NaO2 [M+Na]+: 203, Found: 203. 
FTIR (neat): 3355, 3288, 2874, 1456, 1052, 1021, 1000, 768, 700 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 91%. 
[α]25D = - 41.3 (c = 0.75, CHCl3) 




















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 3/19/2015 3:04:33 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\TAO-9505-1ML-30MIN.M
Last changed    : 3/19/2015 2:51:18 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/19/2015 4:26:22 PM by Tao
                  (modified after loading)
Sample Info     : OD
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.912 BB    0.6339 5844.65186  141.50946  49.8516
   2  22.414 BB    0.6877 5879.45801  132.49396  50.1484
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\001-0201.D
Sample Name: Ryan-benzyl
LC 1 3/19/2015 4:26:27 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 3/19/2015 3:04:33 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\TAO-9505-1ML-30MIN.M
Last changed    : 3/19/2015 2:51:18 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/19/2015 4:26:22 PM by Tao
                  (modified after loading)
Sample Info     : OD
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.912 BB    0.6339 5844.65186  141.50946  49.8516
   2  22.414 BB    0.6877 5879.45801  132.49396  50.1484
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\001-0201.D
Sample Name: Ryan-benzyl
LC 1 3/19/2015 4:26:27 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/19/2015 3:48:38 PM                 Inj :   1
                                           Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\TAO-9505-1ML-30MIN.M
Last changed    : 3/19/2015 2:51:18 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/19/2015 4:26:22 PM by Tao
               (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.899 MM    0.6081 1093.50195   29.96907   4.5364
   2  22.251 MM    0.7528 2.30113e4   509.44580  95.4636
 
Totals :                  2.41048e4   539.41487
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\002-0401.D
Sample Name: Ryan-benzyl009-1
LC 1 3/19/2015 4:27:11 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                   Location : Vial 2
Injection Date  : 3/19/2015 3:48:38 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\TAO-9505-1ML-30MIN.M
Last changed    : 3/19/2015 2:51:18 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/19/2015 4:26:22 PM by Tao
                  (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.899 MM    0.6081 1093.50195   29.96907   4.5364
   2  22.251 MM    0.7528 2.30113e4   509.44580  95.4636
 
Totals :                  2.41048e4   539.41487
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-19 14-52-23\002-0401.D
Sample Name: Ryan-benzyl009-1
LC 1 3/19/2015 4:27:11 PM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (24.8mg, 64%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.21 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 7.9 Hz, 2H), 4.39 (d, J = 7.6 
Hz, 1H), 3.86 – 3.76 (m, 1H), 3.74 – 3.61 (m, 1H), 2.34 (s, 3H), 2.26 (s, 2H), 1.99 (d, J = 6.4 Hz, 
1H), 1.88 – 1.76 (m, 1H), 1.67 – 1.55 (m, 1H), 0.78 (d, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 140.77, 137.42, 129.18, 126.71, 79.34, 61.27, 38.43, 36.52, 21.26, 
17.49. 
LRMS (CI) Calcd. for C12H18NaO2 [M+Na]+: 217, Found: 217. 
FTIR (neat): 3314, 3016, 2970, 1739, 1365, 1229, 1217cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 93%.  
[α]25D = - 51.8 (c = 0.65, CHCl3) 




















Acq. Operator   : HSC                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 3/26/2015 12:08:26 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\TAO-9505-1ML-60MIN.M
Last changed    : 3/26/2015 1:09:36 PM by HSC
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9505-1ML-10MIN.M
Last changed    : 3/26/2015 1:39:32 PM by HSC
                  (modified after loading)
Sample Info     : OD
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\001-0201.D
Sample Name: pMebenzyl
LC 1 3/26/2015 1:40:53 PM HSC Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.555 BV    0.6318 4969.22900  121.32995  49.7294
2 17.556 VB    0.4167 5023.30176  182.76692  50.2706
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\001-0201.D
Sample Name: pMebenzyl
LC 1 3/26/2015 1:40:53 PM HSC Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : HSC                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/26/2015 1:10:40 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\TAO-9505-1ML-60MIN.M
Last changed    : 3/26/2015 1:09:36 PM by HSC
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9505-1ML-10MIN.M
Last changed    : 3/26/2015 1:39:32 PM by HSC
                  (modified after loading)




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.496 MM    0.6357  208.66779    5.47067   3.5911
   2  17.395 BB    0.4124 5601.99072  206.54958  96.4089
 
Totals :                  5810.65851  212.02025
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\002-0301.D
Sample Name: pMebenzylchiral
LC 1 3/26/2015 1:39:56 PM HSC Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : HSC                            Seq. Line :   3
Acq. Instrument : LC 1                           Location : Vial 2
Injection Date  : 3/26/2015 1:10:40 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\TAO-9505-1ML-60MIN.M
Last changed    : 3/26/2015 1:09:36 PM by HSC
            (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9505-1ML-10MIN.M
Last changed    : 3/26/2015 1:39:32 PM by HSC
                  (modified after loading)




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.496 MM    0.6357  208.66779    5.47067   3.5911
2 17.395 BB    0.4124 5601.99072  206.54958  96.4089
 
Totals :                  5810.65851  212.02025
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-26 11-56-16\002-0301.D
Sample Name: pMebenzylchiral
LC 1 3/26/2015 1:39:56 PM HSC Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (39.8 mg, 76%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, Methanol-d4): δ 7.47 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 8.2 Hz, 2H), 4.40 (d, J 
= 6.5 Hz, 1H), 3.69 – 3.61 (m, 1H), 3.59 – 3.51 (m, 1H), 1.97 – 1.78 (m, 2H), 1.39 – 1.26 (m, 1H), 
0.81 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, Methanol-d4): δ 144.57, 132.02, 129.74, 121.62, 78.81, 61.13, 38.41, 36.07, 
16.54. 
LRMS (CI) Calcd. for C11H15BrNaO2 [M+Na]+: 281, Found: 281. 
FTIR (neat): 2959, 2929, 2856, 1484, 1050, 1011, 825 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 92%. 
[α]25D = - 6.4 (c = 0.7, CHCl3) 






















Acq. Operator   : Tom                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/6/2015 10:14:06 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-06 10-02-09\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/2015 8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/6/2015 12:00:17 PM by zzc
                  (modified after loading)
Sample Info     : OD
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  19.570 MM    0.7770 1004.88214   21.55487  50.1421
   2  21.617 MM    0.7291  999.18536   22.84135  49.8579
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-06 10-02-09\020-0201.D
Sample Name: WZ-I-66
LC 2 3/6/2015 12:00:49 PM zzc Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tom                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/6/2015 10:14:06 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-06 10-02-09\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/2015 8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/6/2015 12:00:17 PM by zzc
                  (modified after loading)
Sample Info     : OD
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  19.570 MM    0.7770 1004.88214   21.55487  50.1421
2 21.617 MM    0.7291  999.18536   22.84135  49.8579
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-06 10-02-09\020-0201.D
Sample Name: WZ-I-66
LC 2 3/6/2015 12:00:49 PM zzc Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : zzc                            Seq. Line :   5
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/4/2015 6:48:43 PM                  Inj :   1
                                               Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\ZZC\ZZC0281 2015-03-04 17-41-23\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/2015 8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\TTL_TL_VI_41ARACEMATE2.M
Last changed : 4/24/2015 9:42:05 AM by TTL
                  (modified after loading)
Sample Info     : OD
        
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  21.054 MM    0.7062  584.30731   13.79014   4.0868
   2  23.151 MM    0.7959 1.37132e4   287.16132  95.9132
Data File C:\CHEM32\2\DATA\ZZC\ZZC0281 2015-03-04 17-41-23\020-0501.D
Sample Name: WZ-I-67
LC 2 4/24/2015 9:42:16 AM TTL Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : zzc                            Seq. Line :   5
Acq. Instrument : LC 2                    Location : Vial 20
Injection Date  : 3/4/2015 6:48:43 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\ZZC\ZZC0281 201 -03- 4 17-41-23\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/2015 8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\TTL_TL_VI_41ARACEMATE2.M
Last changed    : 4/24/2015 9:42:05 AM by TTL
                  (modified after loading)
Sample Info     : OD
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  21.054 MM    0.7062  584.30731   13.79014   4.0868
 2 23.151 MM    0.7959 1.37132e4   287.16132  95.9132
Data File C:\CHEM32\2\DATA\ZZC\ZZC0281 2015-03-04 17-41-23\020-0501.D
Sample Name: WZ-I-67
LC 2 4/24/2015 9:42:16 AM TTL Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (27.7 mg, 75%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.32 – 7.26 (m, 2H), 7.06 – 6.99 (m, 2H), 4.41 (d, J = 7.5 Hz, 1H), 
3.81 (ddd, J = 10.6, 6.3, 5.1 Hz, 1H), 3.68 (ddd, J = 10.7, 7.8, 4.8 Hz, 1H), 2.03 – 1.91 (m, 1H), 
1.85 – 1.75 (m, 1H), 1.65 – 1.56 (m, 1H), 0.78 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 163.37, 160.93, 139.40, 139.37, 128.22, 128.14, 115.21, 115.00, 
78.56, 60.91, 38.49, 36.03, 17.20. 
19F NMR (100 MHz, CDCl3): δ -115.17. 
LRMS (CI) Calcd. for C11H15FNaO2 [M+Na]+: 221, Found: 221. 
FTIR (neat): 3336, 1604, 1509, 1222, 1056, 1033, 1013, 836 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 92%. 
[α]25D = + 10.0 (c = 0.32, CHCl3) 





















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 6/27/2015 10:54:35 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\TAO-9505-1ML-60MIN.M
Last changed    : 6/27/2015 11:44:11 AM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\VG_6_93_RAC4.M
Last changed    : 6/27/2015 12:21:04 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\010-0201.D
Sample Name: Tao-8-1
LC 2 6/27/2015 12:21:22 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.568 BV    0.9456  794.74628    9.95268  49.6548
 2 18.146 VB    0.3818  805.79523   32.44131  50.3452
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\010-0201.D
Sample Name: Tao-8-1
LC 2 6/27/2015 12:21:22 PM Tao Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Ins rument : L  2                            Location : Vial 10
Injection Date  : 6/27/2015 11:46:45 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\TAO-9505-1ML-60MIN.M
Last changed    : 6/27/2015 11:44:11 AM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\VG_6_93_RAC4.M
Last changed    : 6/27/2015 12:22:33 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\010-0301.D
Sample Name: Tao-8-2
LC 2 6/27/2015 12:24:25 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.099 MM    0.9821   77.15244    1.30927   4.1925
2 18.055 MM    0.4412 1763.08777   66.59743  95.8075
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-27 10-42-34\010-0301.D
Sample Name: Tao-8-2
LC 2 6/27/2015 12:24:25 PM Tao Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (31.5 mg, 75%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.24 (t, J = 8.1 Hz, 1H), 6.90 – 6.86 (m, 2H), 6.83 – 6.78 (m, 1H), 
4.35 (d, J = 7.6 Hz, 1H), 3.79 (s, 3H), 3.78 – 3.72 (m, 1H), 3.68 – 3.59 (m, 1H), 3.01 – 2.87 (m, 
2H), 1.97 (p, J = 6.5 Hz, 1H), 1.83 – 1.72 (m, 1H), 1.65 – 1.53 (m, 1H), 0.78 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 159.71, 145.53, 129.39, 119.23, 112.99, 112.30, 79.26, 60.99, 
55.34, 38.50, 36.32, 17.50. 
LRMS (CI) Calcd. for C12H18NaO3 [M+Na]+: 233, Found: 233. 
FTIR (neat): 3448, 3016, 2970,1739, 1435, 1366, 1229, 1216 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 92%. 




















Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/17/2015 5:37:42 PM                 Inj :   1
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:50:37 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/17/2015 8:05:58 PM by Tao
                  (modified after loading)






















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.360 BB    1.0488 1.12134e4   164.18495  49.8926
   2  37.724 BB    1.2898 1.12617e4   131.41185  50.1074
 
Totals :                  2.24751e4   295.59680
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\002-0301.D
Sample Name: Tao-5-142
LC 1 3/17/2015 8:07:27 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/17/2015 5:37:42 PM                 Inj :   1
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:50:37 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/17/2015 8:05:58 PM by Tao
                  (modified after loading)






















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.360 BB    1.0488 1.12134e4   164.18495  49.8926
 2 37.724 BB    1.2898 1.12617e4   131.41185  50.1074
 
Totals :                  2.24751e4   295.59680
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\002-0301.D
Sample Name: Tao-5-142
LC 1 3/17/2015 8:07:27 PM Tao Page 1 of 2
Create PDF files without this m ssage by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   5
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 3/17/2015 6:52:03 PM                 Inj :   1
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015 03-17 16-23-06\TAO 9505 1ML 60MIN.M
Last changed    : 11/25/2014 2:50:37 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/17/2015 8:05:58 PM by Tao
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.494 MM    0.9963 1054.65125   17.64229   3.9381
   2  37.499 MM    1.4534 2.57259e4   295.01712  96.0619
 
Totals :                  2.67805e4   312.65941
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\003-0501.D
Sample Name: Tao-5-143
LC 1 3/17/2015 8:06:24 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   5
Acq. Instrument : LC 1                     Location : Vial 3
Injection Date  : 3/17/2015 6:52:03 PM                 Inj :   1
                                          Inj Volume : 10.0 µl
Acq. Method    : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:50:37 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\SDR_GERANIOL_EPOXIDE_9901_1ML.M
Last changed    : 3/17/2015 8:05:58 PM by Tao
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.494 MM    0.9963 1054.65125   17.64229   3.9381
2 37.499 MM    1.4534 2.57259e4   295.01712  96.0619
 
Totals :                  2.67805e4   312.65941
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 16-23-06\003-0501.D
Sample Name: Tao-5-143
LC 1 3/17/2015 8:06:24 PM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (23.7 mg, 63%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 6.84 (s, 1H), 6.76 (d, J = 1.0 Hz, 2H), 5.95 (s, 2H), 4.32 (d, J = 
7.8 Hz, 1H), 3.84 – 3.76 (m, 1H), 3.72 – 3.64 (m, 1H), 2.61 (s, 2H), 1.94 (hept, J = 6.7 Hz, 1H), 
1.85 – 1.76 (m, 1H), 1.65 – 1.57 (m, 1H), 0.77 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 147.71, 146.90, 137.73, 120.11, 107.90, 106.88, 100.96, 79.17, 
61.07, 38.48, 36.41, 17.38. 
LRMS (CI) Calcd. for C12H16NaO4 [M+Na]+: 247, Found: 247. 
FTIR (neat): 3323, 2890, 1488,1246, 1037, 1006, 932, 823 cm-1. 
HPLC (Chiralcel AS-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 94%. 
[α]25D = - 58.7 (c = 0.48, CHCl3) 





















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 4/28/2015 6:26:03 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 7:21:35 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-30MIN.M
Last changed    : 4/28/2015 7:24:02 PM by Tao
                  (modified after loading)
Sample Info     : AS2
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\001-0201.D
Sample Name: Tao-6-119
LC 1 4/28/2015 7:24:46 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  28.992 MM    1.3066 4887.03564   62.33603  49.8900
 2 33.065 MM    1.8481 4908.57764   44.26786  50.1100
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\001-0201.D
Sample Name: Tao-6-119
LC 1 4/28/2015 7:24:46 PM Tao Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 4/28/2015 7:22:25 PM                 Inj :   1
                                              Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 7:21:35 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-30MIN.M
Last changed    : 4/28/2015 8:11:39 PM by Tao
                  (modified after loading)
Sample Info     : AS2
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\002-0301.D
Sample Name: Tao-6-118
LC 1 4/28/2015 8:12:22 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.311 MM    1.0546  131.79645    2.08292   3.1037
   2  33.357 MM    1.9357 4114.68604   35.42754  96.8963




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-04-28 18-13-55\002-0301.D
Sample Name: Tao-6-118
LC 1 4/28/2015 8:12:22 PM Tao Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (23.6 mg, 61%, dr = >20:1) as a white solid. 
Rf = 0.4 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.42 (dd, J = 7.6, 1.5 Hz, 1H), 7.22 (td, J = 7.3, 1.8 Hz, 1H), 7.16 
(td, J = 7.3, 1.5 Hz, 1H), 7.13 (dd, J = 7.5, 1.8 Hz, 1H), 4.69 (d, J = 7.8 Hz, 1H), 3.84 – 3.73 (m, 
1H), 3.66 (ddd, J = 10.8, 7.9, 4.7 Hz, 1H), 2.86 (s, 2H), 2.34 (s, 3H), 2.02 (hept, J = 7.0 Hz, 1H), 
1.90 – 1.76 (m, 1H), 1.74 – 1.61 (m, 1H), 0.81 (d, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 141.99, 135.06, 130.37, 127.18, 126.30, 126.22, 75.18, 61.06, 
38.02, 36.22, 19.49, 17.40. 
LRMS (CI) Calcd. for C12H18NaO2 [M+Na]+: 217, Found: 217. 
FTIR (neat): 2958, 2923, 1460, 1378, 1054, 1012, 756, 729 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 87%. 
[α]25D = - 37.9 (c = 0.44, CHCl3) 




















Acq. Operator   : SO                             Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/29/2015 6:26:12 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/29/2015 7:36:05 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  12.582 BB    0.4370 1277.60510   45.58098  49.9202
   2  15.053 BB    0.5332 1281.68738   37.27221  50.0798
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\001-0201.D
Sample Name: WZ-I-167
LC 1 6/29/2015 7:36:19 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SO                             Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/29/2015 6:26:12 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/29/2015 7:36:05 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  12.582 BB    0.4370 1277.60510   45.58098  49.9202
2 15.053 BB    0.5332 1281.68738   37.27221  50.0798
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\001-0201.D
Sample Name: WZ-I-167
LC 1 6/29/2015 7:36:19 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SO                             Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/29/2015 7:28:23 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/30/2015 9:45:54 AM by KHOA
               (modified after loading)
Sample Info     : OD3
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  12.524 MM    0.4181  323.33398   12.88840   6.3609
   2  14.970 MM    0.5924 4759.83838  133.90485  93.6391
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\002-0301.D
Sample Name: WZ-I-168
LC 1 6/30/2015 9:45:58 AM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SO                             Seq. Line :   3
Acq. Instrument : LC 1                   Location : Vial 2
Injection Date  : 6/29/2015 7:28:23 PM                 Inj :   1
                    Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method  C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/30/2015 9:45:54 AM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 
































               Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  12.524 MM    0.4181  323.33398   12.88840   6.3609
 2 14.970 MM    0.5924 4759.83838  133.90485  93.6391
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-29 18-13-39\002-0301.D
Sample Name: WZ-I-168
LC 1 6/30/2015 9:45:58 AM KHOA Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (29.1 mg, 68%, dr = >20:1) as a colorless oil. 
Rf = 0.5 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.52 (dd, J = 7.7, 1.7 Hz, 1H), 7.32 (dd, J = 7.8, 1.4 Hz, 1H), 7.28 
(dd, J = 7.6, 1.3 Hz, 1H), 7.19 (dd, J = 7.7, 1.8 Hz, 1H), 4.95 (d, J = 6.8 Hz, 1H), 3.83 – 3.74 (m, 
1H), 3.68 – 3.58 (m, 1H), 3.26 (bs, 1H), 2.69 (bs, 1H), 2.09 (hept, J = 6.5 Hz, 1H), 1.83 – 1.69 (m, 
1H), 1.68 – 1.56 (m, 1H), 0.90 (d, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 141.23, 132.45, 129.33, 128.38, 128.19, 126.95, 74.73, 60.67, 
37.38, 35.01, 16.92. 
LRMS (CI) Calcd. for C11H15NaClO2 [M+Na]+: 237, Found: 237. 
FTIR (neat): 3315, 2958, 2922,2850, 1438, 1049, 1023, 735 cm-1. 
HPLC (Chiralcel AS-H/AS-H column, hexanes:i-PrOH = 95:5, 0.5 mL/min, 210 nm), ee = 91%. 





















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/6/2015 7:53:47 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\TAO-9505-05ML-60MIN.M
Last changed    : 5/6/2015 7:41:01 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/6/2015 10:12:09 PM by Tao
                  (modified after loading)
Sample Info     : AD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  48.224 MF    1.5389 4011.08301   43.44012  50.3991
   2  51.133 FM    1.7133 3947.55981   38.40157  49.6009
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\001-0201.D
Sample Name: Tao-6-183
LC 1 5/6/2015 10:12:21 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/6/2015 7:53:47 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\TAO-9505-05ML-60MIN.M
Last changed    : 5/6/2015 7:41:01 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/6/2015 10:12:09 PM by Tao
                  (modified after loading)
Sample Info     : AD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  48.224 MF    1.5389 4011.08301   43.44012  50.3991
   2  51.133 FM    1.7133 3947.55981   38.40157  49.6009
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\001-0201.D
Sample Name: Tao-6-183
LC 1 5/6/2015 10:12:21 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 5/6/2015 9:00:59 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\TAO-9505-05ML-60MIN.M
Last changed   : 5/6/2015 7:41:01 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/6/2015 10:12:09 PM by Tao
                  (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  48.082 MM    1.5540 2.71730e4   291.42899  95.4224
   2  51.202 MM    1.2196 1303.53503   17.81412   4.5776
 
Totals :                  2.84766e4   309.24310
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\002-0301.D
Sample Name: Tao-6-182
LC 1 5/6/2015 10:13:12 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator : Tao                    Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 5/6/2015 9:00:59 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\TAO-9505-05ML-60MIN.M
Last changed    : 5/6/2015 7:41:01 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/6/2015 10:12:09 PM by Tao
                  (modified after loading)






























                Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  48.082 MM    1.5540 2.71730e4   291.42899  95.4224
   2  51.202 MM    1.2196 1303.53503   17.81412   4.5776
 
Totals :                2.84766e4   309.24310
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-06 19-41-37\002-0301.D
Sample Name: Tao-6-182
LC 1 5/6/2015 10:13:12 PM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (29.7 mg, 72%, dr = >20:1) as a colorless liquid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.36 – 7.31 (m, 2H), 7.30 – 7.27 (m, 2H), 7.27 – 7.18 (m, 1H), 
6.47 (s, 1H), 3.88 (d, J = 8.3 Hz, 1H), 3.85 – 3.78 (m, 1H), 3.69 (ddd, J = 10.8, 8.1, 4.5 Hz, 1H), 
2.76 (s, 2H), 1.97 – 1.88 (m, 1H), 1.87 (d, J = 1.4 Hz, 3H), 1.86 – 1.79 (m, 1H), 1.68 – 1.58 (m, 
1H), 0.90 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 139.37, 137.42, 128.97, 128.12, 127.52, 126.51, 83.42, 61.24, 
36.78, 34.64, 17.82, 12.98. 
LRMS (CI) Calcd. for C14H20NaO2 [M+Na]+: 243, Found: 243. 
FTIR (neat): 2959, 2923, 1147, 1378, 1057, 1008, 750, 699 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:05, 1 mL/min, 254 nm), ee = 90%.  



















Acq. Operator   : DB                             Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 7/10/2015 5:37:12 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\TAO-9505-1ML-60MIN.M
Last changed    : 7/10/2015 6:05:09 PM by DB
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 7/10/2015 6:51:24 PM by DB
                  (modified after loading)
Sample Info     : OD3
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\010-0201.D
Sample Name: Tao-8-26
LC 2 7/10/2015 6:52:19 PM DB Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.358 BV    0.5027 3442.22559  107.74624  49.9694
 2 19.579 VB    0.5774 3446.44556   91.92495  50.0306
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\010-0201.D
Sample Name: Tao-8-26
LC 2 7/10/2015 6:52:19 PM DB Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : DB                             Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 7/10/2015 6:05:55 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\TAO-9505-1ML-60MIN.M
Last changed    : 7/10/2015 6:05:09 PM by DB
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 7/10/2015 6:51:24 PM by DB
                  (modified after loading)
Sample Info     : OD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\010-0301.D
Sample Name: Tao-8-27
LC 2 7/10/2015 6:51:27 PM DB Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.238 MM    0.4430   82.12747    3.08987   5.1812
2 19.464 MM    0.6189 1502.96655   40.47425  94.8188
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-07-10 17-25-15\010-0301.D
Sample Name: Tao-8-27
LC 2 7/10/2015 6:51:27 PM DB Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (23.1 mg, 73%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.19 (dp, J = 9.0, 1.4 Hz, 1H), 4.12 (dd, J = 9.0, 7.2 Hz, 1H), 3.83 
– 3.71 (m, 1H), 3.69 – 3.57 (m, 1H), 2.40 (s, 2H), 1.79 – 1.65 (m, 8H), 1.62 – 1.51 (m, 1H), 0.86 
(d, J = 6.7 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 136.01, 126.76, 73.00, 61.23, 37.63, 36.76, 26.04, 18.52, 16.66. 
LRMS (CI) Calcd. for C9H18NaO2 [M+Na]+: 181, Found: 181. 
FTIR (neat): 3016, 2970, 1739, 1366, 1229, 1217 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 94%. 




















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 30
Injection Date  : 3/20/2015 10:33:49 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-20 22-21-52\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/21/2015 10:56:04 AM by Tao
                  (modified after loading)
Sample Info     : AD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.903 MM    0.5440 2341.11060   71.72882  49.2486
   2  18.324 MM    0.5742 2412.55249   70.02545  50.7514
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-20 22-21-52\030-0201.D
Sample Name: Tao-5-157
LC 2 3/21/2015 10:56:15 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 30
Injection Date  : 3/20/2015 10:33:49 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-20 22-21-52\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/21/2015 10:56:04 AM by Tao
                  (modified after loading)
Sample Info     : AD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.903 MM    0.5440 2341.11060   71.72882  49.2486
 2 18.324 MM    0.5742 2412.55249   70.02545  50.7514
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-20 22-21-52\030-0201.D
Sample Name: Tao-5-157
LC 2 3/21/2015 10:56:15 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 28
Injection Date  : 3/21/2015 9:28:31 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-21 08-56-40\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/2015 8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/21/2015 10:50:39 AM by Tao
              (modified after loading)
Sample Info     : AD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.115 MM    0.4262   79.13813    3.09482   3.1289
   2  16.382 MM    0.5384 2450.14819   75.85360  96.8711
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-21 08-56-40\028- 201.D
Sample Name: Tao-5-156
LC 2 3/21/2015 10:52:01 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 28
Injection Date  : 3/21/2015 9:28:31 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-21 08-56-40\TAO-9505-1ML-30MIN.M
Last changed    : 2/25/201  8:51:56 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/21/2015 10:50:39 AM by Tao
             (modified after loading)
Sample Info     : AD
                  
 

































              Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.115 MM    0.4262   79.13813    3.09482   3.1289
2 16.382 MM    0.5384 2450.14819   75.85360  96.8711
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-21 08-56-40\028-0201.D
Sample Name: Tao-5-156
LC 2 3/21/2015 10:52:01 AM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (42.3 mg, 72%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 5.19 (dq, J = 9.1, 1.3 Hz, 1H), 5.10 – 5.03 (m, 1H), 4.13 (dd, J = 
9.0, 7.3 Hz, 1H), 3.76 (ddd, J = 11.0, 6.1, 5.0 Hz, 1H), 3.70 – 3.60 (m, 1H), 2.14 – 2.00 (m, 4H), 
1.81 – 1.69 (m, 2H), 1.68 – 1.66 (m, 6H), 1.60 (s, 3H), 1.58 – 1.54 (m, 1H), 0.86 (d, J = 6.7 Hz, 
3H).	
13C NMR (100 MHz, CDCl3): δ 139.39, 131.85, 126.69, 124.07, 72.92, 61.27, 39.86, 37.69, 36.85, 
26.48, 25.83, 17.84, 16.86, 16.62.	
LRMS (CI) Calcd. for C14H26NaO2 [M+Na]+: 249, Found: 249. 
FTIR (neat): 2970, 1739, 1448, 1366, 1229, 1217 cm-1. 
HPLC (Chiralcel OD-H column/OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee 
= 96%. 



















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/23/2015 7:55:11 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\TAO-9505-1ML-80MIN-COLD.M
Last changed    : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 3/24/2015 9:49:55 AM by Inji
                  (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.065 BV    0.4444 2136.06885   74.53375  49.3446
   2  18.226 VB    0.4783 2192.80786   70.60277  50.6554
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\020-0201.D
Sample Name: Tao-5-160
LC 2 3/24/2015 9:50:10 AM Inji Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/23/2015 7:55:11 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\TAO-9505-1ML-80MIN-COLD.M
Last changed    : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 3/24/2015 9:49:55 AM by Inji
                  (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.065 BV    0.4444 2136.06885   74.53375  49.3446
2 18.226 VB    0.4783 2192.80786   70.60277  50.6554
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\020-0201.D
Sample Name: Tao-5-160
LC 2 3/24/2015 9:50:10 AM Inji Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                         Location : Vial 20
Injection Date  : 3/24/2015 9:23:17 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-24 09-09-45\TAO-9505-1ML-80MIN-COLD.M
Last changed  : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 3/24/2015 9:52:34 AM by Inji
                  (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.942 BV    0.3495  126.60713    4.42887   1.7824
   2  18.124 VB    0.5183 6976.73682  211.78230  98.2176
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-24 09-09-45\020-0201.D
Sample Name: Tao-5-161
LC 2 3/24/2015 9:53:22 AM Inji Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/24/2015 9:23:17 AM                 Inj :   1
                    Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-24 09-09-45\TAO-9505-1ML-80MIN-COLD.M
Last changed    : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 3/24/2015 9:52:34 AM by Inji
             (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.942 BV    0.3495  126.60713    4.42887   1.7824
2 18.124 VB    0.5183 6976.73682  211.78230  98.2176
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-24 09-09-45\020-0201.D
Sample Name: Tao-5-161
LC 2 3/24/2015 9:53:22 AM Inji Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (29.7 mg, 72%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.41 – 7.20 (m, 5H), 6.57 (d, J = 15.9 Hz, 1H), 6.22 (dd, J = 
15.9, 7.1 Hz, 1H), 4.08 (t, J = 6.9 Hz, 1H), 3.83 – 3.75 (m, 1H), 3.71 – 3.63 (m, 1H), 2.59 (s, 
2H), 1.91 – 1.71 (m, 2H), 1.68 – 1.55 (m, 1H), 0.97 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 136.81, 131.54, 131.15, 128.71, 127.80, 126.59, 60.87, 37.18, 
36.17, 16.79. 
LRMS (CI) Calcd. for C13H18NaO2 [M+Na]+: 229, Found: 229. 
FTIR (neat): 3260, 3025, 2970, 2944, 1739, 1449, 1366, 1228, 1217, 1011, 970, 693 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 90:10, 1 mL/min, 254 nm), ee = 93%.  
[α]25D = + 8.2 (c = 0.65, CHCl3) 



















Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 3/17/2015 10:37:46 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\TAO-9010-1ML-30MIN.M
Last changed    : 3/17/2015 9:19:29 AM by SDR
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH_NONPOLAR_97.M
Last changed    : 3/17/2015 10:09:17 AM by SDR
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  11.975 MM    0.4547 8727.30273  319.92133  50.0774
   2  23.563 MM    0.9592 8700.32813  151.16803  49.9226
 
Totals :                  1.74276e4   471.08936
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\001-0401.D
Sample Name: Tao-5-139
LC 1 3/17/2015 11:10:57 AM SDR Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 3/17/2015 10:37:46 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\TAO-9010-1ML-30MIN.M
Last changed    : 3/17/2015 9:19:29 AM by SDR
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH_NONPOLAR_97.M
Last changed    : 3/17/2015 10:09:17 AM by SDR
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  11.975 MM    0.4547 8727.30273  319.92133  50.0774
2 23.563 MM    0.9592 8700.32813  151.16803  49.9226
 
Totals :                  1.74276e4   471.08936
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\001-0401.D
Sample Name: Tao-5-139
LC 1 3/17/2015 11:10:57 AM SDR Page 1 of 2
Create PDF files without this m ssage by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/17/2015 9:33:11 AM                 Inj :   1
                                               Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\TAO-9010-1ML-30MIN.M
Last changed    : 3/17/2015 9:19:29 AM by SDR
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH_NONPOLAR_97.M
Last changed : 3/17/2015 10:09:17 AM by SDR
                  (modified after loading)
Sample Info     : OD
        
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  11.890 MM    0.4136  783.43585   31.57117   3.5644
   2  23.349 MM    0.9433 2.11958e4   374.49902  96.4356
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\002-0201.D
Sample Name: Tao-5-130
LC 1 3/17/2015 11:07:31 AM SDR Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 3/17/2015 9:33:11 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method  : C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\TAO-9010-1ML-30MIN.M
Last changed    : 3/17/2015 9:19:29 AM by SDR
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH_NONPOLAR_97.M
Last changed     3/17/2015 10:09:17 AM by SDR
                  (modified after loading)
Sample Info     : OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  11.890 MM    0.4136  783.43585   31.57117   3.5644
2 23.349 MM    0.9433 2.11958e4   374.49902  96.4356
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-03-17 09-20-47\002-0201.D
Sample Name: Tao-5-130
LC 1 3/17/2015 11:07:31 AM SDR Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (14.5 mg, 0.1 mmol scale, 70%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.31 – 7.26 (m, 2H), 7.24 – 7.15 (m, 3H), 3.76 (ddd, J = 10.6, 6.6, 
5.0 Hz, 1H), 3.63 (ddd, J = 10.6, 7.0, 5.0 Hz, 1H), 3.52 – 3.40 (m, 1H), 2.85 (ddd, J = 13.7, 9.9, 
5.5 Hz, 1H), 2.72 – 2.56 (m, 3H), 1.92 – 1.51 (m, 5H), 0.95 (d, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 142.40, 128.57, 128.53, 125.93, 75.34, 60.50, 36.76, 36.39, 35.34, 
32.45, 16.62. 
LRMS (CI) Calcd. for C13H20NaO2 [M+Na]+: 231, Found: 231. 
FTIR (neat): 3026, 2970, 2946, 1739, 1454, 1366, 1229, 1217, 1052, 698 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.0 mL/min, 210 nm), ee = 90%. 



















Acq. Operator   : GANG                           Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/9/2015 8:38:26 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 20-25-58\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/9/2015 9:40:14 PM by RYAN
                  (modified after loading)
Sample Info     : OD
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.904 BB    0.6953 3334.83179   69.80979  50.0286
   2  29.572 BB    0.8201 3331.01636   48.44849  49.9714
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 20-25-58\020-0201.D
Sample Name: Tao-5-113
LC 2 3/9/2015 9:40:21 PM RYAN Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : GANG                           Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/9/2015 8:38:26 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 20-25-58\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/9/2015 9:40:14 PM by RYAN
                  (modified after loading)
Sample Info     : OD
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.904 BB    0.6953 3334.83179   69.80979  50.0286
 2 29.572 BB    0.8201 3331.01636   48.44849  49.9714
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 20-25-58\020-0201.D
Sample Name: Tao-5-113
LC 2 3/9/2015 9:40:21 PM RYAN Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : GANG                           Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 30
Injection Date  : 3/9/2015 7:07:02 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 17-53-02\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/9/2015 8:26:35 PM by RYAN
               (modified after loading)
Sample Info     : OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  24.236 MM    0.7041  658.71326   15.59339   5.2287
   2  29.619 MM    1.2478 1.19394e4   159.47311  94.7713
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 17-53-02\030-0301.D
Sample Name: Tao-5-114
LC 2 3/9/2015 8:27:14 PM RYAN Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : GANG                           Seq. Line :   3
Acq. Instrument : LC 2                  Location : Vial 30
Injection Date  : 3/9/2015 7:07:02 PM                  Inj :   1
                                          Inj Volume : 5.0 µl
Acq. Method    : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 17-53-02\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/9/2015 8:26:35 PM by RYAN
                  (modified after loading)
Sample Info    : OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Mul ipl er:               :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  24.236 MM    0.7041  658.71326   15.59339   5.2287
2 29.619 MM    1.2478 1.19394e4   159.47311  94.7713
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-09 17-53-02\030-0301.D
Sample Name: Tao-5-114
LC 2 3/9/2015 8:27:14 PM RYAN Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (30.5 mg, 81%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 3.75 (ddd, J = 11.3, 6.7, 4.9 Hz, 1H), 3.62 (ddd, J = 10.7, 7.0, 5.0 
Hz, 1H), 3.44 – 3.35 (m, 1H), 2.73 (s, 2H), 1.75 – 1.17 (m, 14H), 0.93 (d, J = 6.7 Hz, 3H), 0.90 – 
0.85 (m, 3H). 
13C NMR (100 MHz, CDCl3): δ 76.03, 60.54, 36.53, 35.36, 34.59, 32.00, 29.55, 25.97, 22.78, 
16.73, 14.23. 
LRMS (CI) Calcd. for C11H24NaO2 [M+Na]+: 211, Found: 211. 
FTIR (neat): 2970, 2928, 1739, 1456, 1366, 1229, 1217 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 230 nm), ee = 90%. 




















Acq. Operator   : Ryosuke                        Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/11/2015 6:55:41 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-11 18-43-47\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/13/2015 7:29:42 PM by Tao
                  (modified after loading)
Sample Info     : OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.257 MM    0.3991  307.82849   12.85460  49.0188
   2  10.266 MM    0.3816  320.15195   13.98154  50.9812
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-11 18-43-47\020-0201.D
Sample Name: WZ-I-078
LC 2 3/13/2015 7:31:54 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/11/2015 6:55:41 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-11 18-43-47\TAO-9505-1ML-60MIN.M
Last changed    : 11/25/2014 2:48:27 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/13/2015 7:29:42 PM by Tao
                  (modified after loading)
Sample Info     : OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.257 MM    0.3991  307.82849   12.85460  49.0188
   2  10.266 MM    0.3816  320.15195   13.98154  50.9812
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-11 18-43-47\020-0201.D
Sample Name: WZ-I-078
LC 2 3/13/2015 7:31:54 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 30
Injection Date  : 3/13/2015 6:56:23 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-13 18-44-11\TAO-9505-1ML-60MIN.M
Last changed    : 3/13/2015 7:14:37 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\HSC 95 5 15MIN.M
Last changed    : 3/13/2015 7:29:42 PM by Tao
                  (modified after loading)
Sample Info     : OD
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-13 18-44-11\030-0201.D
Sample Name: Tao-5-129
LC 2 3/13/2015 7:30:16 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.420 MM    0.3969  448.14063   18.81815  94.8160
2 10.454 MM    0.3367   24.50155    1.21290   5.1840
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-13 18-44-11\030-0201.D
Sample Name: Tao-5-129
LC 2 3/13/2015 7:30:16 PM Tao Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (26.8 mg, 67%, dr = >20:1) as a colorless oil. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 3.86 – 3.75 (m, 1H), 3.73 – 3.63 (m, 1H), 3.43 (ddd, J = 9.3, 6.1, 
3.0 Hz, 1H), 2.54 (s, 2H), 2.47 – 2.27 (m, 1H), 2.25 – 2.03 (m, 1H), 1.84 – 1.55 (m, 5H), 0.97 (d, 
J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 74.47, 60.40, 37.10, 35.29, 31.12, 30.83, 30.55, 30.26, 27.02, 
26.99, 16.60. 
19F NMR (378 MHz, CDCl3): δ 66.34. 
LRMS (CI) Calcd. for C8H15NaF3O2 [M+Na]+: 223, Found: 223. 
FTIR (neat): 2970, 1739, 1366, 1252, 1229, 1217, 1138, 1031 cm-1. 
GC (cyclosil-B: Initial temperature: 110 ̊C, rate: 1 ̊C /min, End temperature: 150 ̊C), ee = 90%.  

























Acq. Operator   : Tao                            Seq. Line :   1
Acq. Instrument : GC                              Location : Vial 1
Injection Date  : 3/26/2015 9:03:10 AM                 Inj :   1
                                                Inj Volume : 1 µl
Acq. Method     : C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\TAO-SLOW.M
Last changed    : 3/26/2015 8:55:37 AM by Tao
Analysis Method : C:\CHEM32\3\METHODS\TAO-FAST.M
Last changed    : 3/26/2015 10:47:38 AM by Tao
                  (modified after loading)
Sample Info     : 110C start, 1C/min till 150C
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: FID1 A, FID1A, Front Signal
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  11.933 MF    0.2926   98.96948    5.63673 50.05408
   2  12.693 FM    0.2884   98.75562    5.70641 49.94592
Data File C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\SDR4-108_1.D
Sample Name: Tao-5-167
GC 3/26/2015 10:48:23 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   1
Acq. Instrument : GC                              Location : Vial 1
Injection Date  : 3/26/2015 9:03:10 AM                 Inj :   1
                                                Inj Volume : 1 µl
Acq. Method     : C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\TAO-SLOW.M
Last changed    : 3/26/2015 8:55:37 AM by Tao
Analysis Method : C:\CHEM32\3\METHODS\TAO-FAST.M
Last changed    : 3/26/2015 10:47:38 AM by Tao
                  (modified after loading)
Sample Info     : 110C start, 1C/min till 150C
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: FID1 A, FID1A, Front Signal
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  11.933 MF    0.2926   98.96948    5.63673 50.05408
   2  12.693 FM    0.2884   98.75562    5.70641 49.94592
Data File C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\SDR4-108_1.D
Sample Name: Tao-5-167
GC 3/26/2015 10:48:23 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : GC                              Location : Vial 2
Injection Date  : 3/26/2015 10:04:59 AM                Inj :   1
                                                Inj Volume : 1 µl
Acq. Method     : C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\TAO-SLOW.M
Last changed    : 3/26/2015 8:55:37 AM by Tao
Analysis Method : C:\CHEM32\3\METHODS\TAO-FAST.M
Last changed    : 3/26/2015 10:45:35 AM by Tao
               (modified after loading)
Sample Info     : 110C start, 1C/min till 150C
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: FID1 A, FID1A, Front Signal
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  12.115 MM    0.2619    4.74180 3.01749e-1  4.89906
   2  12.734 MM    0.4743   92.04816    3.23429 95.10094
Data File C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\032714B0 0003.D
Sample Name: Tao-5-168
GC 3/26/2015 10:46:10 AM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : GC                              Location : Vial 2
Injection Date   3/26/2015 10:04:59 AM                Inj :   1
                                                Inj Volume : 1 µl
Acq. Method     : C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\TAO-SLOW.M
Last changed    : 3/26/2015 8:55:37 AM by Tao
Analysis Method : C:\CHEM32\3\METHODS\TAO-FAST.M
Last changed   : 3/26/2015 10:45:35 AM by Tao
            (modified after loading)
Sample Info     : 110C start, 1C/min till 150C
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                 :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: FID1 A, FID1A, Front Signal
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1  12.115 MM    0.2619    4.74180 3.01749e-1  4.89906
2 12.734 MM    0.4743   92.04816    3.23429 95.10094
Data File C:\CHEM32\3\DATA\TAO\TAO-1SAMPLE 2015-03-26 09-00-42\032714B000003.D
Sample Name: Tao-5-168
GC 3/26/2015 10:46:10 AM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (34.3 mg, 63%, dr = >20:1) as a white solid. 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 4.54 (d, J = 6.5 
Hz, 1H), 3.74 (ddd, J = 10.6, 6.8, 4.7 Hz, 1H), 3.58 (ddd, J = 10.6, 6.8, 4.7 Hz, 1H), 3.35 (s, 1H), 
1.78 – 1.60 (m, 3H), 1.40 – 1.14 (m, 3H), 0.88 (t, J = 7.4 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 143.08, 131.35, 128.20, 121.01, 76.00, 60.69, 45.26, 31.68, 23.66, 
11.43. 
LRMS (CI) Calcd. for C12H17BrNaO2 [M+Na]+: 295, Found: 295. 
FTIR (neat): 3299, 2886, 1070, 1057, 1008, 838, 686, 669 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 230 nm), ee = 96%. 
[α]25D = -30.0 (c = 0.45, CHCl3) 




















Acq. Operator   : DB                             Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 5/23/2015 6:18:49 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\TAO-9505-1ML-60MIN.M
Last changed    : 5/23/2015 6:50:33 PM by DB
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\TAO-9901-1ML-10MIN.M
Last changed    : 5/23/2015 7:16:43 PM by DB
                  (modified after loading)
Sample Info     : OD3
                  
 






















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\010-0201.D
Sample Name: Tao-7-51
LC 2 5/23/2015 7:16:52 PM DB Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.285 BB    0.4783 5161.87988  167.12447  50.0902
   2  14.874 BB    0.5751 5143.28369  137.27925  49.9098
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\010-0201.D
Sample Name: Tao-7-51
LC 2 5/23/2015 7:16:52 PM DB Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : DB                             Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 5/23/2015 6:51:23 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\TAO-9505-1ML-60MIN.M
Last changed    : 5/23/2015 6:50:33 PM by DB
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\TAO-9901-1ML-10MIN.M
Last changed    : 5/23/2015 7:18:30 PM by DB
                  (modified after loading)


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.766 MM    0.4741   34.89495    1.22664   2.0248
   2  15.372 MM    0.6464 1688.51941   43.53523  97.9752
 
Totals :                  1723.41436   44.76187
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\009-0301.D
Sample Name: Tao-7-52
LC 2 5/23/2015 7:18:50 PM DB Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : DB                             Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 5/23/2015 6:51:23 PM                 Inj :   1
                                              Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\TAO-9505-1ML-60MIN.M
Last changed    : 5/23/2015 6:50:33 PM by DB
            (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\TAO-9901-1ML-10MIN.M
Last changed    : 5/23/2015 7:18:30 PM by DB
                  (modified after loading)


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.766 MM    0.4741   34.89495    1.22664   2.0248
2 15.372 MM    0.6464 1688.51941   43.53523  97.9752
 
Totals :                  1723.41436   44.76187
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-05-23 18-06-53\009-0301.D
Sample Name: Tao-7-52
LC 2 5/23/2015 7:18:50 PM DB Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (41 mg, 64%, dr = >20:1). 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, Methanol-d4) δ 7.22 – 7.14 (m, 2H), 7.09 – 7.02 (m, 2H), 7.01 – 6.96 (m, 
1H), 6.95 – 6.89 (m, 4H), 4.58 (d, J = 8.1 Hz, 1H), 3.30 (ddd, J = 10.6, 8.0, 4.5 Hz, 1H), 3.26 – 
3.15 (m, 3H), 2.87 (ddd, J = 11.5, 8.1, 3.7 Hz, 1H), 2.33 – 2.17 (m, 1H), 1.93 – 1.75 (m, 1H).	
13C NMR (100 MHz, Methanol-d4): δ 144.57, 142.79, 131.71, 129.89, 129.84, 129.12, 127.39, 
121.47, 78.79, 61.27, 51.78, 35.43.	
LRMS (CI) Calcd. for C16H17BrNaO2 [M+Na]+: 343, Found: 343. 
FTIR (neat): 2362, 1486, 1070, 1037, 1008, 818, 756, 700 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 90%. 





















Acq. Operator   : Andrew                         Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/2/2015 12:26:45 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\KHOA.M
Last changed    : 7/13/2015 5:10:59 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  30.376 BB    1.0911 8726.72266  124.59850  50.2329
   2  37.348 BB    1.3323 8645.80469  100.04136  49.7671
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\001-0201.D
Sample Name: Tao-7-80
LC 1 7/13/2015 5:11:04 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Andrew                         Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/2/2015 12:26:45 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\KHOA.M
Last changed    : 7/13/2015 5:10:59 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  30.376 BB    1.0911 8726.72266  124.59850  50.2329
2 37.348 BB    1.3323 8645.80469  100.04136  49.7671
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\001-0201.D
Sample Name: Tao-7-80
LC 1 7/13/2015 5:11:04 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Andrew                         Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/2/2015 1:28:57 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\KHOA.M
Last changed    : 7/13/2015 5:10:59 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  30.184 MM    0.9871   95.71881    1.61612   4.7660
   2  37.093 MM    1.4656 1912.62830   21.75019  95.2340
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\002-0301.D
Sample Name: Tao-7-81
LC 1 7/13/2015 5:11:36 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Andrew                         Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date   6/2/2015 1:28:57 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\TAO-9505-1ML-60MIN.M
Last changed    : 4/28/2015 8:11:06 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\KHOA.M
Last changed    : 7/13/2015 5:10:59 PM by KHOA
             (modified after loading)
Sample Info     : OD3
                  
 


































               Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  30.184 MM    0.9871   95.71881    1.61612   4.7660
2 37.093 MM    1.4656 1912.62830   21.75019  95.2340
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-02 12-14-37\002-0301.D
Sample Name: Tao-7-81
LC 1 7/13/2015 5:11:36 PM KHOA Page 1 of 2




General Procedure for Conversion of Alcohols 3.5a, 3.5c, 3.5e, 3.5f, 3.5k and 3.5m to trans-
2,3-disubstituted furans 3.6a, 3.6c, 3.6e, 3.6f, 3.6k and 3.6m  
 
To a solution of alcohol in pyridine (0.4 M) at 0 °C was added TsCl (1.5 eq) in one portion. The 
mixture was stirred at 0 °C for 5 hours and was allowed to warm to room temperature overnight. 
Once TLC indicated no alcohol left, pyridine was removed by vacuo and the residue was 
subjected to flash column chromatography (Alumina, basic, 60-325 Mesh, eluent Hexanes:EA = 









The residue was subjected to flash column chromatography for purification to furnish the title 
compound (81%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.36 – 7.21 (m, 5H), 4.28 (d, J = 8.3 Hz, 1H), 4.10 (td, J = 8.3, 7.0 
Hz, 1H), 4.03 (td, J = 8.4, 4.2 Hz, 1H), 2.27 – 2.15 (m, 1H), 2.15 – 1.99 (m, 1H), 1.71 (dq, J = 
12.0, 8.5 Hz, 1H), 1.08 (d, J = 6.6 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 142.21, 128.27, 127.40, 126.08, 87.91, 67.90, 42.87, 34.95, 16.38. 
LRMS (CI) Calcd. for C11H15O [M+H]+: 163, Found: 163. 
FTIR (neat): 1453, 1097, 1044, 1026, 995, 926, 751, 699 cm-1. 
HPLC (Chiralcel OJ-H/OJ-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 91%. 



















Acq. Operator   : KHOA                           Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/14/2015 12:15:14 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\TAO-9901-1ML-40MIN.M
Last changed    : 6/14/2015 1:06:05 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/14/2015 2:28:59 PM by KHOA
                  (modified after loading)
Sample Info     : OJ2/OJ3
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\001-0301.D
Sample Name: WZ-I-151
LC 1 6/14/2015 2:29:04 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.685 BB    0.3669 3197.04639  135.66116  50.0370
2 40.093 BB    0.5027 3192.31348   98.35523  49.9630
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\001-0301.D
Sample Name: WZ-I-151
LC 1 6/14/2015 2:29:04 PM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/14/2015 1:07:26 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\TAO-9901-1ML-40MIN.M
Last changed    : 6/14/2015 1:06:05 PM by KHOA
               (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/14/2015 2:27:31 PM by KHOA
                  (modified after loading)
Sample Info     : OJ3/OJ2
                  
 




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\002-0401.D
Sample Name: WZ-I-153
LC 1 6/14/2015 2:27:44 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  29.117 MM    0.3720  239.43546   10.72619   4.4972
 2 38.870 BB    0.4801 5084.62305  163.82202  95.5028
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 11-20-32\002-0401.D
Sample Name: WZ-I-153
LC 1 6/14/2015 2:27:44 PM KHOA Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (78%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.44 (m, 2H), 7.23 – 7.19 (m, 2H), 4.24 (d, J = 8.2 Hz, 1H), 
4.08 (td, J = 8.3, 7.0 Hz, 1H), 4.02 (td, J = 8.4, 4.3 Hz, 1H), 2.25 – 2.16 (m, 1H), 2.07 – 1.94 (m, 
1H), 1.77 – 1.66 (m, 1H), 1.07 (d, J = 6.6 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 141.35, 131.36, 127.74, 121.11, 87.21, 67.92, 43.02, 34.85, 16.25. 
LRMS (CI) Calcd. for C11H14BrO [M+H]+: 241, Found: 241. 
FTIR (neat): 2960, 2871, 1486, 1069, 1046, 1010, 819, 800 cm-1. 
HPLC (Chiralcel AD-H/AD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm), ee = 92%. 




















Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 51
Injection Date  : 12/10/2014 6:43:49 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\TAO-9901-1ML-40MIN.M
Last changed    : 12/10/2014 6:16:13 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 9/4/2015 10:28:02 AM by GANG
                  (modified after loading)
Sample Info     : ODH
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   3.135 BV    0.0805   10.37265    1.87540   0.5903
   2   3.280 VV    0.0577    5.95130    1.58947   0.3387
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\051-0301.D
Sample Name: WZ-I-030
LC 2 9/4/2015 10:28:05 AM GANG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 51
Injection Date  : 12/10/2014 6:43:49 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\TAO-9901-1ML-40MIN.M
Last changed    : 12/10/2014 6:16:13 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 9/4/2015 10:28:02 AM by GANG
                  (modified after loading)
Sample Info     : ODH
                  
 



























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  24.081 BB    0.5451  592.29285   15.95542  49.1568
   2  27.161 MM    0.6626  612.61224   15.40874  50.8432
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\051-0301.D
Sample Name: WZ-I-030
LC 2 9/4/2015 10:41:54 AM GANG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 2                            Location : Vial 52
Injection Date  : 12/10/2014 7:25:46 PM                Inj :   1
                                           Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\TAO-9901-1ML-40MIN.M
Last changed    : 12/10/2014 6:16:13 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed   : 9/4/2015 10:24:42 AM by GANG
                  (modified after loading)

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.150 MM    0.6870  631.30402   15.31611  95.9991
   2  26.627 MM    0.7998   26.31081 5.48276e-1   4.0009
 
Totals :                   657.61483   15.86438
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\052-0401.D
Sample Name: Tao-4-31
LC 2 9/4/2015 10:25:20 AM GANG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 2                            Location : Vial 52
Injection Date  : 12/10/2014 7:25:46 PM                Inj :   1
                                        Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\TAO-9901-1ML-40MIN.M
Last changed    : 12/10/2014 6:16:13 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 9/4/2015 10:24:42 AM by GANG
                  (modified after loading)

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & D lution Factor ith ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.150 MM    0.6870  631.30402   15.31611  95.9991
   2  26.627 MM    0.7998   26.31081 5.48276e-1   4.0009
Totals :                   657.61483   15.86438
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2014-12-10 18-20-29\052-0401.D
Sample Name: Tao-4-31
LC 2 9/4/2015 10:25:2  AM GANG Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (80%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.27 – 7.23 (m, 1H), 6.93 – 6.89 (m, 2H), 6.83 – 6.79 (m, 1H), 4.27 
(d, J = 8.1 Hz, 1H), 4.09 (td, J = 8.2, 7.0 Hz, 1H), 4.03 (td, J = 8.4, 4.3 Hz, 1H), 3.82 (s, 3H), 2.25 
– 2.15 (m, 1H), 2.13 – 2.01 (m, 1H), 1.76 – 1.64 (m, 1H), 1.10 (d, J = 6.6 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 159.66, 144.03, 129.24, 118.43, 112.85, 111.45, 87.75, 67.90, 
55.19, 42.79, 34.91, 16.53. 
LRMS (ESI) Calcd. for C12H17O2 [M+H]+: 193, Found: 193. 
FTIR (neat): 1602, 1585, 1488, 1455, 1267, 1158, 1040, 782 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 92%. 



















Acq. Operator   : KHOA                           Seq. Line :   8
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/24/2015 11:49:08 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\TAO-9901-1ML-60MIN.M
Last changed    : 6/24/2015 12:29:24 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/24/2015 1:30:25 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\001-0801.D
Sample Name: Tao-7-176
LC 1 6/24/2015 1:30:27 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  10.591 BB    0.2184  324.96088   23.06670  50.5531
   2  11.376 BB    0.2353  317.84952   20.91154  49.4469




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\001-0801.D
Sample Name: Tao-7-176
LC 1 6/24/2015 1:30:27 PM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   9
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/24/2015 12:31:19 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\TAO-9901-1ML-60MIN.M
Last changed   : 6/24/2015 12:29:24 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/24/2015 1:29:07 PM by KHOA
               (modified after loading)


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                  :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  10.587 MM    0.2284  572.74780   41.79500  95.8270
   2  11.397 MM    0.2063   24.94130    2.01465   4.1730
 
Totals :                   597.68910   43.80965
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\002-0901.D
Sample Name: Tao-7-177
LC 1 6/24/2015 1:29:31 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator : KHOA                  Seq. Line :   9
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/24/2015 12:31:19 PM                Inj :   1
                                               Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\TAO-9901-1ML-60MIN.M
Last changed    : 6/24/2015 12:29:24 PM by KHOA
             (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/24/2015 1:29:07 PM by KHOA
                  (modified after loading)


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  10.587 MM    0.2284  572.74780   41.79500  95.8270
   2  11.397 MM    0.2063   24.94130    2.01465   4.1730
Totals :                   597.68910   43.80965
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\002-0901.D
Sample Name: Tao-7-177
LC 1 6/24/2015 1:29:31 PM KHOA Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (82%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 6.86 – 6.84 (m, 1H), 6.80 – 6.75 (m, 2H), 5.94 (s, 2H), 4.18 (d, J 
= 8.4 Hz, 1H), 4.06 (td, J = 8.3, 7.0 Hz, 1H), 3.99 (td, J = 8.4, 4.2 Hz, 1H), 2.25 – 2.15 (m, 1H), 
2.08 – 1.94 (m, 1H), 1.75 – 1.62 (m, 1H), 1.05 (d, J = 6.6 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 147.70, 146.89, 136.04, 119.65, 107.91, 106.52, 100.89, 87.85, 
67.73, 42.73, 34.87, 16.22. 
LRMS (ESI) Calcd. for C12H15O3 [M+H]+: 207, Found: 207. 
FTIR (neat): 1504, 1487, 1243, 1096, 1036, 934, 808, 784 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 254 nm), ee = 92%. 



















Acq. Operator   : SUSUMU                         Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 6/10/2015 9:42:00 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\TAO-9901-1ML-80MIN.M
Last changed    : 6/10/2015 10:27:16 AM by SUSUMU
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/10/2015 1:15:29 PM by SUSUMU
                  (modified after loading)
Sample Info     : ADH-3 HEX IPA 9901
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Data File C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\010-0201.D
Sample Name: HS_02_89_2
LC 2 6/10/2015 1:17:09 PM SUSUMU Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.514 MM    0.4154  486.51660   19.51870  49.4764
2 19.285 MM    0.6902  496.81357   11.99724  50.5236
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\010-0201.D
Sample Name: HS_02_89_2
LC 2 6/10/2015 1:17:09 PM SUSUMU Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SUSUMU                         Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 6/10/2015 10:28:05 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\TAO-9901-1ML-80MIN.M
Last changed    : 6/10/2015 10:27:16 AM by SUSUMU
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/10/2015 1:15:29 PM by SUSUMU
                  (modified after loading)




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.246 BB    0.2576   28.69911    1.39728   3.9053
   2  18.777 MM    0.6696  706.17615   17.57615  96.0947
 
Totals :                   734.87526   18.97343
Data File C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\009-0301.D
Sample Name: Tao-7-122
LC 2 6/10/2015 1:15:37 PM SUSUMU Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SUSUMU                         Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date   6/10/2015 10:28:05 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\TAO-9901-1ML-80MIN.M
Last changed    : 6/10/2015 10:27:16 AM by SUSUMU
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/10/2015 1:15:29 PM by SUSUMU
                  (modified after loading)



























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  13.246 BB    0.2576   28.69911    1.39728   3.9053
2 18.777 MM    0.6696  706.17615   17.57615  96.0947
 
Totals :                 734.87526   18.97343
Data File C:\CHEM32\2\DATA\HIROKI\TAO_1SAMPLE 2015-06-10 09-24-37\009-0301.D
Sample Name: Tao-7-122
LC 2 6/10/2015 1:15:37 PM SUSUMU Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (77%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 5.15 (dq, J = 8.8, 1.3 Hz, 1H), 5.12 – 5.06 (m, 1H), 4.00 (t, J = 8.7 
Hz, 1H), 3.93 – 3.81 (m, 2H), 2.16 – 2.07 (m, 3H), 2.07 – 2.00 (m, 2H), 1.91 – 1.77 (m, 1H), 1.70 
(d, J = 1.4 Hz, 3H), 1.68 (d, J = 1.3 Hz, 3H), 1.62 – 1.53 (m, 4H), 0.99 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 140.32, 131.50, 124.60, 124.04, 82.24, 66.96, 40.71, 39.76, 34.78, 
26.43, 25.65, 17.66, 16.75, 15.90. 
LRMS (ESI) Calcd. for C14H25O [M+H]+: 209, Found: 209. 
FTIR (neat): 2958, 2926, 2871, 1452, 1376, 1101, 1032, 987, 913 cm-1. 
HPLC (Chiralcel AD-H/AD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 254 nm), ee = 96%. 





















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/11/2015 12:02:07 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 11-49-14\TAO-9901-05ML-60MIN.M
Last changed    : 12/16/2014 11:48:17 AM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/11/2015 1:45:21 PM by Tao
                  (modified after loading)
Sample Info     : AD4AD2
                  
 




















































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.308 MM    0.2399 5197.48584  361.13022  45.2306
   2  16.117 MM    0.2279  383.35046   28.03022   3.3361
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 11-49-14\001-0201.D
Sample Name: WZ-I-145
LC 1 6/11/2015 1:45:28 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/11/2015 12:02:07 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 11-49-14\TAO-9901-05ML-60MIN.M
Last changed    : 12/16/2014 11:48:17 AM by Tao
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/11/2015 1:45:21 PM by Tao
                  (modified after loading)
Sample Info     : AD4AD2
                  
 




















































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.308 MM    0.2399 5197.48584  361.13022  45.2306
   2  16.117 MM    0.2279  383.35046   28.03022   3.3361
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 11-49-14\001-0201.D
Sample Name: WZ-I-145
LC 1 6/11/2015 1:45:28 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/14/2015 2:59:07 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 14-36-54\TAO-9901-05ML-30MIN.M
Last changed    : 6/14/2015 3:26:51 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/14/2015 3:28:04 PM by KHOA
                  (modified after loading)
Sample Info     : AD4/AD2
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 14-36-54\001-0201.D
Sample Name: Tao-7-144
LC 1 6/14/2015 3:28:28 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.479 MM    0.2695  211.74541   13.09471   1.9842
 2 16.600 MM    0.2771 1.04601e4   629.16864  98.0158
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-14 14-36-54\001-0201.D
Sample Name: Tao-7-144
LC 1 6/14/2015 3:28:28 PM KHOA Page 2 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (72%, dr = >20:1) as a colorless liquid. 
Rf = 0.7 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.24 – 7.16 (m, 3H), 3.90 – 3.80 (m, 2H), 3.34 
(td, J = 8.2, 3.5 Hz, 1H), 2.85 (ddd, J = 13.7, 10.8, 5.1 Hz, 1H), 2.67 (ddd, J = 13.7, 10.5, 6.2 Hz, 
1H), 2.15 – 2.04 (m, 1H), 1.92 – 1.69 (m, 3H), 1.59 – 1.48 (m, 1H), 1.03 (d, J = 6.7 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 142.43, 128.38, 128.29, 125.66, 85.24, 66.74, 39.05, 36.23, 34.72, 
32.84, 17.23. 
LRMS (ESI) Calcd. for C13H19O [M+H]+: 191, Found: 191. 
FTIR (neat): 2957, 2927, 1454, 1106, 1039, 1013, 745, 699 cm-1. 
HPLC (Chiralcel AD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 254 nm), ee = 90%. 


















Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/11/2015 7:52:23 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 19-05-18\TAO-9901-05ML-30MIN.M
Last changed    : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/16/2015 1:43:34 PM by SO
                  (modified after loading)



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.370 BB    0.2329  227.55005   14.67808  50.5338
   2   9.866 BB    0.2376  222.74254   14.79539  49.4662
 
Totals :                   450.29259   29.47347
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 19-05-18\001-0301.D
Sample Name: Tao-7-134
LC 1 6/16/2015 1:45:44 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/11/2015 7:52:23 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 19-05-18\TAO-9901-05ML-30MIN.M
Last changed    : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/16/2015 1:43:34 PM by SO
                  (modified after loading)



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
# [min]        [min] [mAU*s] [mAU]        %
----|-------|----|-------|----------|----------|--------|
 1 8.370 BB    0.2329  227.55005   14.67808  50.5338
   2   9.866 BB    0.2376  222.74254   14.79539  49.4662
 
Totals :                   450.29259   29.47347
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-11 19-05-18\001-0301.D
Sample Name: Tao-7-134
LC 1 6/16/2015 1:45:44 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SDR                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/16/2015 12:31:30 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method    : C:\CHEM32\1\DATA\TAO\TAO 2015-06-16 12-19-24\TAO-9901-05ML-30MIN.M
Last changed    : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/16/2015 1:43:34 PM by SO
                  (modified after loading)
Sample Info     : AD3
             
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.633 MM    0.2052    6.22727 5.05894e-1   5.1916
   2  10.208 MM    0.2717  113.72086    6.97588  94.8084
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-16 12-19-24\001-0201.D
Sample Name: Tao-7-148
LC 1 6/16/2015 1:44:55 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SDR                            Seq. Line :   2
Acq. Instrument : LC 1                           Location : Vial 1
Injection Date  : 6/16/2015 12:31:30 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-16 12-19-24\TAO-9901-05ML-30MIN.M
Las changed   : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/16/2015 1:43:34 PM by SO
               (modified after loading)
Sample Info     : AD3
               
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
# [min]        [min] [mAU*s] [mAU]        %
----|-------|----|-------|----------|----------|--------|
 1 8.633 MM    0.2052    6.22727 5.05894e-1   5.1916
   2  10.208 MM    0.2717  113.72086    6.97588  94.8084
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-16 12-19-24\001-0201.D
Sample Name: Tao-7-148
LC 1 6/16/2015 1:44:55 PM SO Page 1 of 2




General Procedure for Conversion of Alcohols 3.2a, 3.2l, 3.2p to trans-4,5-disubstituted lact
ones 3.7a, 3.7l and 3.7p 
 
To a resealable pressure tube (ca. 13 x 100) was added H2Ru(CO)(PPh3)3 (9.2 mg, 0.010 mmol, 5 
mol%), SL-J009-1 ligand (5.6 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 mmol, 10 mol%) 
and 2,4,6-tri(2-propyl)phenylsulfonic acid (4.2 mg, 0.015 mmol, 7.5 mol%). At this stage solid 
alcohol coupling partners (0.20 mmol, 100 mol%) were added. The tube was then sealed with a 
rubber septum and purged with argon. THF (0.20 mL, 1 M concentration with respect to alcohols) 
was then added. At this stage, liquid alcohol coupling partners (0.20 mmol, 100 mol%) were added. 
2-propylalcohol (31 µL, 0.40 mmol, 200 mol%) was then added. Alkyne 1a (0.60 mmol, 300 
mol%) was added via syringe and the rubber septum was quickly replaced with a screw cap. The 
mixture was then heated at 85 °C for the time stated. After cooling to room temperature, the 
mixture was passed through a short silica pad, washed the pad with EA, and concentrated in vacuo. 
The residue was dissolved in THF (2.0 mL) and TBAF (1.0 M in THF, 0.2 mL) was added at 0ºC. 
The mixture was stirred at r.t for 30 min, and then quenched by water, extracted by DCM (3 x 1 
mL). The organic layer was washed by brine, dried over Na2SO4. The organic solvent was 
evaporated down to 2 mL and 4 Å MS (100 mg), NaOAc (8.2 mg, 0.10 mmol) and PCC (129 mg, 
0.60 mmol) were added, and the mixture was stirred at room temperature for 24 hours. The solvent 
was removed by vacuo, and the residue was subjected to flash column chromatography (SiO2, 









The residue was subjected to flash column chromatography for purification to furnish the title 
compound (70%, dr = >20:1) as a colorless liquid. 
Rf = 0.2 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.43 – 7.31 (m, 5H), 4.94 (d, J = 8.3 Hz, 1H), 2.79 (dd, J = 16.9, 
7.7 Hz, 1H), 2.55 – 2.42 (m, 1H), 2.34 (dd, J = 16.9, 10.5 Hz, 1H), 1.19 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 176.07, 137.93, 128.69, 125.90, 88.13, 39.81, 37.21, 16.49. 
LRMS (ESI) Calcd. for C11H13O2 [M+H]+: 177, Found: 177. 
FTIR (neat): 1778, 1278, 1210, 1140, 998, 946, 756, 699 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 91%. 


















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 1
Injection Date  : 6/24/2015 5:50:41 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\TAO-9505-1ML-60MIN.M
Last changed    : 6/24/2015 6:30:51 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\VG_6_93_RAC4.M
Last changed    : 6/24/2015 7:14:00 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\001-0201.D
Sample Name: WZ-I-160
LC 2 6/24/2015 7:14:11 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  19.117 BB    0.3870 1.11370e4   443.40332  49.8286
  2 22.725 BB  0.5887 1.12136e4   271.02835  50.1714
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\001-0201.D
Sample Name: WZ-I-160
LC 2 6/24/2015 7:14:11 PM Tao Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 2
Injection Date  : 6/24/2015 6:31:36 PM              Inj :   1
                             Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\TAO-9505-1ML-60MIN.M
Last changed    : 6/24/2015 6:30:51 PM by Tao
            (modified after oading)
Ana ysis Method : C:\CHEM32\2\METHODS\VG_6_93_RAC4.M
Last cha ged  : 6/24/2015 7:14:00 PM by Tao
                 (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.873 MM    0.3384  150.67789    7.42006   4.4279
   2  22.657 MM    0.5766 3252.25488   94.00772  95.5721
 
Totals :                  3402.93277  101.42779
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\002-0301.D
Sample Name: WZ-I-161
LC 2 6/24/2015 7:15:27 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator : Tao                  Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 2
Injection Date : 6/24/2015 6:31:36 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Meth     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\TAO-9505-1ML-60MIN.M
Last changed    : 6/24/2015 6:30:51 PM by Tao
         (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\VG_6_93_RAC4.M
Last changed    : 6/24/2015 7:14:00 PM by Tao
                  (modified after loading)




























Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
# [min]       [min] [mAU*s] [mAU]        %
----|-------|----|-------|----------|----------|--------|
 1 18.873 MM    0.3384  150.67789    7.42006   4.4279
   2  22.657 MM    0.5766 3252.25488   94.00772  95.5721
 
Totals :                 3402.93277  101.42779
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-06-24 17-38-47\002-0301.D
Sample Name: WZ-I-161
LC 2 6/24/2015 7:15:27 PM Tao Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (76%, dr = >20:1) as a colorless liquid. 
Rf = 0.2 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.43 – 7.27 (m, 5H), 6.70 (d, J = 16.3 Hz, 1H), 6.17 (dd, J = 15.9, 
7.2 Hz, 1H), 4.58 (ddd, J = 8.1, 7.2, 1.1 Hz, 1H), 2.74 (dd, J = 16.9, 7.7 Hz, 1H), 2.46 – 2.33 (m, 
1H), 2.27 (dd, J = 16.9, 10.2 Hz, 1H), 1.20 (d, J = 6.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 176.07, 135.62, 133.88, 128.70, 128.42, 126.73, 125.18, 87.46, 
37.32, 36.78, 16.50. 
LRMS (ESI) Calcd. for C13H15O2 [M+H]+: 203, Found: 203. 
FTIR (neat): 1775, 1209, 1156, 986, 968, 939, 750, 693 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 93%. 




















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/30/2015 12:59:30 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\TAO-9505-1ML-60MIN.M
Last changed    : 6/30/2015 1:36:06 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/30/2015 4:10:25 PM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\001-0201.D
Sample Name: WZ-I-169
LC 1 6/30/2015 4:10:47 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.606 BB    0.5565 2052.90649   56.96287  50.3022
   2  26.351 BB    0.6218 2028.24023   50.36858  49.6978
 
Totals :           4081.14673  107.33145
 
=====================================================================
                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\001-0201.D
Sample Name: WZ-I-169
LC 1 6/30/2015 4:10:47 PM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/30/2015 1:36:50 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\TAO-9505-1ML-60MIN.M
Last changed   : 6/30/2015 1:36:06 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/30/2015 4:09:26 PM by KHOA
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                  :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.396 MM    0.6482 2.29101e4   589.07062  96.5986
   2  26.395 MM    0.5590  806.70642   24.05120   3.4014
 
Totals :                  2.37169e4   613.12181
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\002-0301.D
Sample Name: WZ-I-166
LC 1 6/30/2015 4:09:46 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/30/2015 1:36:50 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\TAO-9505-1ML-60MIN.M
Last changed    : 6/30/2015 1:36:06 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/30/2015 4:09:26 PM by KHOA
                  (modified after loading)































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  23.396 MM    0.6482 2.29101e4   589.07062  96.5986
   2  26.395 MM    0.5590  806.70642   24.05120   3.4014
Totals :                  2.37169e4   613.12181
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-30 12-37-18\002-0301.D
Sample Name: WZ-I-166
LC 1 6/30/2015 4:09:46 PM KHOA Page 1 of 2








The residue was subjected to flash column chromatography for purification to furnish the title 
compound (72%, dr = >20:1) as a colorless liquid. 
Rf = 0.2 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 4.00 (td, J = 8.0, 4.1 Hz, 1H), 2.72 – 2.60 (m, 1H), 2.26 – 2.13 (m, 
2H), 1.72 – 1.56 (m, 2H), 1.55 – 1.44 (m, 1H), 1.42 – 1.30 (m, 3H), 1.13 (d, J = 6.4 Hz, 3H), 0.91 
(t, J = 7.1 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 176.59, 87.44, 37.11, 36.06, 33.68, 27.83, 22.46, 17.47, 13.88. 
LRMS (ESI) Calcd. for C9H17O2 [M+H]+: 157, Found: 157. 
FTIR (neat): 1775, 1210, 1170, 1124, 1077, 984, 942, 926 cm-1. 
HPLC (Chiralcel OD-H/OD-H/OD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 230 nm), ee 
= 90%.  



















Acq. Operator   : xuan                           Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 9/6/2015 9:54:57 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\TAO-9901-05ML-60MIN.M
Last changed    : 9/6/2015 5:53:15 PM by xuan
Analysis Method : C:\CHEM32\1\METHODS\HSC WASHING 90 10 10MIN.M
Last changed    : 9/7/2015 9:10:11 AM by xuan
                  (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  83.137 MM    1.0936  153.15843    2.33419  50.3552
   2  85.727 MM    1.1356  150.99785    2.21610  49.6448
 
Totals :                   304.15628    4.55029
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\002-0401.D
Sample Name: WZ-I-172
LC 1 9/7/2015 9:11:57 AM xuan Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : xuan                           Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 9/6/2015 9:54:57 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\TAO-9901-05ML-60MIN.M
Last changed    : 9/6/2015 5:53:15 PM by xuan
Analysis Method : C:\CHEM32\1\METHODS\HSC WASHING 90 10 10MIN.M
Last changed    : 9/7/2015 9:10:11 AM by xuan
                  (modified after loading)






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  83.137 MM    1.0936  153.15843    2.33419  50.3552
   2  85.727 MM    1.1356  150.99785    2.21610  49.6448
 
Totals :           304.15628    4.55029
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\002-0401.D
Sample Name: WZ-I-172
LC 1 9/7/2015 9:11:57 AM xuan Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : xuan                           Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 9/6/2015 8:02:47 PM                  Inj :   1
                                           Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\TAO-9901-05ML-60MIN.M
Last changed    : 9/6/2015 5:53:15 PM by xuan
Analysis Method : C:\CHEM32\1\METHODS\HSC WASHING 90 10 10MIN.M
Last changed    : 9/7/2015 9:10:11 AM by xuan
                (modified after loading)
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  83.534 MM    0.6246   32.39059 6.15862e-1   5.2003
   2  85.124 MM    1.4763  590.46930    6.66621  94.7997
 
Totals :                   622.85989    7.28207
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\001-0301.D
Sample Name: WZ-I-173
LC 1 9/7/2015 9:10:26 AM xuan Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : xuan               Seq. Line :   3
Acq. Instrument : LC 1                     Location : Vial 1
Injection Date  : 9/6/2015 8:02:47 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\TAO-9901-05ML-60MIN.M
Last changed    : 9/6/2015 5:53:15 PM by xuan
Analysis Method : C:\CHEM32\1\METHODS\HSC WASHING 90 10 10MIN.M
Last changed    : 9/7/2015 9:10:11 AM by xuan
                  (modified aft r loading)
































                Area P rcent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  83.534 MM    0.6246   32.39059 6.15862e-1   5.2003
   2  85.124 MM    1.4763  590.46930    6.66621  94.7997
 
Totals :          622.85989    7.28207
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-09-06 18-37-47\001-0301.D
Sample Name: WZ-I-173
LC 1 9/7/2015 9:10:26 AM xuan Page 1 of 2




Formation of trans-4,5-disubstituted-2,3-dehydrofuran 3.8a 
To a resealable pressure tube (ca. 13 x 100) was added H2Ru(CO)(PPh3)3 (9.2 mg, 0.010 mmol, 5 
mol%), SL-J009-1 ligand (5.6 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 mmol, 10 mol%) 
and 2,4,6-tri(2-propyl)phenylsulfonic acid (4.2 mg, 0.015 mmol, 7.5 mol%). THF (0.20 mL, 1 M 
concentration with respect to alcohols) was then added, followed by benzyl alcohol (0.20 mmol, 
100 mol%), 2-propylalcohol (31 µL, 0.40 mmol, 200 mol%). Alkyne 1a (0.60 mmol, 300 mol%) 
was added via syringe and the rubber septum was quickly replaced with a screw cap. The mixture 
was then heated at 85 °C for 48 hours. After cooling to room temperature, the mixture was passed 
through a short silica pad, washed the pad with EA, and concentrated in vacuo. The residue was 
dissolved in THF (2.0 mL) and TBAF (1.0 M in THF, 0.2 mL) was added at 0ºC. The mixture was 
stirred at r.t for 30 min, and then quenched by water, extracted by DCM (3 x 1 mL). The organic 
layer was washed by brine, dried over Na2SO4. The organic solvent was evaporated and THF (2 
mL) was added, followed by MsCl (45.6 mg, 0.4 mmol) and triethyl amine (121 mg, 1.2 mmol). 
The mixture was refluxed for 1 hour and then quenched by NH4Cl, extracted by ether (3 x 1 mL). 
The organic layer was washed by water, brine, dried over Na2SO4. The solvent was removed by 
vacuo, and the residue was subjected to flash column chromatography (SiO2, eluent Pentane:Et2O 









Rf = 0.3 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 6.45 (dd, J = 2.8, 2.1 Hz, 1H), 4.97 – 4.90 (m, 
2H), 3.04 – 2.90 (m, 1H), 1.23 (d, J = 6.7 Hz, 3H).	
13C NMR (100 MHz, CDCl3): δ 144.74, 142.41, 128.51, 127.70, 125.46, 105.78, 90.15, 45.93, 
20.78. 
LRMS (ESI) Calcd. for C11H13O [M+H]+: 161, Found: 161. 
FTIR (neat): 2359, 2341, 1140, 1095, 1011, 721, 697, 669 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm), ee = 91%.  


















Acq. Operator   : KHOA                           Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 6/24/2015 9:41:29 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\TAO-9901-05ML-40MIN.M
Last changed    : 6/24/2015 10:10:29 AM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 6/24/2015 10:51:50 AM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\001-0301.D
Sample Name: WZ-I-162
LC 1 6/24/2015 10:52:01 AM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.513 BV    0.1425 1.16507e4  1276.80237  47.5093
   2   8.738 VB    0.1637 1.28723e4  1194.92786  52.4907




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\001-0301.D
Sample Name: WZ-I-162
LC 1 6/24/2015 10:52:01 AM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 6/24/2015 10:11:14 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method    : C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\TAO-9901-05ML-40MIN.M
Last changed    : 6/24/2015 10:10:29 AM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed   : 6/24/2015 10:50:50 AM by KHOA
                  (modified after loading)
Sample Info     : OD3
                  
 




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                  :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\002-0401.D
Sample Name: WZ-I-163
LC 1 6/24/2015 10:51:13 AM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   9.209 MF    0.1417  552.51855   64.98923   4.6070
   2   9.486 FM    0.1877 1.14406e4  1016.07440  95.3930




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-06-24 09-16-38\002-0401.D
Sample Name: WZ-I-163
LC 1 6/24/2015 10:51:13 AM KHOA Page 2 of 2




Formation of 3.9a 
To a resealable pressure tube (ca. 13 x 100) was added H2Ru(CO)(PPh3)3 (9.2 mg, 0.010 mmol, 5 
mol%), SL-J009-1 ligand (5.6 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 mmol, 10 mol%) 
and 2,4,6-tri(2-propyl)phenylsulfonic acid (4.2 mg, 0.015 mmol, 7.5 mol%). THF (0.20 mL, 1 M 
concentration with respect to alcohols) was then added, followed by benzyl alcohol (0.20 mmol, 
100 mol%), 2-propylalcohol (31 µL, 0.40 mmol, 200 mol%). Alkyne 1a (0.60 mmol, 300 mol%) 
was added via syringe and the rubber septum was quickly replaced with a screw cap. The mixture 
was then heated at 85 °C for 48 hours. After cooling to room temperature, the mixture was passed 
through a short silica pad, washed the pad with EA, and concentrated in vacuo. The residue was 
dissolved in THF (4.0 mL, 0.05 M) and TBAF (1.0 M in THF, 0.2 mL) was added at 0ºC. The 
mixture was stirred at r.t for 30 min, and then (Carbethoxymethylene)triphenylphosphorane (208 
mg, 0.6 mmol) was added. The mixture was stirred at room temperature for 36 hours. The solvent 
was removed by vacuo, and the residue was subjected to flash column chromatography (SiO2, 









Rf = 0.2 (20% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H), 6.97 (ddd, J = 15.6, 8.4, 6.6 Hz, 1H), 5.85 
(dd, J = 15.6, 1.7 Hz, 1H), 4.43 (d, J = 7.3 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.61 – 2.51 (m, 1H), 
2.15 (ddd, J = 14.2, 8.6, 1.3 Hz, 1H), 2.06 – 1.95 (m, 2H), 1.28 (t, J = 7.1 Hz, 3H), 0.77 (d, J = 6.8 
Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 166.58, 147.83, 143.08, 128.38, 128.36, 127.73, 126.56, 122.80, 
78.34, 60.17, 39.68, 35.13, 15.98, 14.27. 
LRMS (ESI) Calcd. for C15H21O3 [M+H]+: 249, Found: 249. 
FTIR (neat): 1699, 1651, 1311, 1270, 1172, 1041, 982, 762, 701 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1 mL/min, 210 nm), ee = 91%.  



















Acq. Operator   : SO                             Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 2
Injection Date  : 6/23/2015 6:19:06 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\TAO-9505-1ML-60MIN.M
Last changed    : 6/23/2015 7:04:48 PM by SO
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 6/23/2015 7:57:59 PM by SO
                  (modified after loading)
Sample Info     : OD3
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\002-0201.D
Sample Name: Tao-7-172
LC 2 6/23/2015 7:58:02 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  14.401 BB    0.4108 1.94268e4   738.85236  49.7849
   2  16.398 BB    0.5020 1.95947e4   614.55487  50.2151




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\002-0201.D
Sample Name: Tao-7-172
LC 2 6/23/2015 7:58:02 PM SO Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : SO                             Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 3
Injection Date  : 6/23/2015 7:05:36 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method    : C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\TAO-9505-1ML-60MIN.M
Last changed    : 6/23/2015 7:04:48 PM by SO
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed  : 6/23/2015 7:56:41 PM by SO
                  (modified after loading)
Sample Info     : OD3
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                  :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\003-0301.D
Sample Name: Tao-7-169
LC 2 6/23/2015 7:57:08 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  14.872 MM    0.4368 1.67402e4   638.75323  95.4333
   2  16.824 MM    0.4139  801.05170   32.25486   4.5667




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\VG\TAO_1SAMPLE 2015-06-23 18-07-12\003-0301.D
Sample Name: Tao-7-169
LC 2 6/23/2015 7:57:08 PM SO Page 2 of 2




Crystallographic Material for Coupling product 3.5c 
X-ray Experimental for C11H15O2Br (3.5c) 
Crystals grew as clusters of clear, colorless prisms by slow evaporation from Ethyl Acetate 
and DCM. The data crystal was cut from a larger crystal and had approximate dimensions; 0.38 x 
0.27 x 0.08 mm. The data were collected at -140 °C on a Nonius Kappa CCD diffractometer using 
a Bruker AXS Apex II detector and a graphite monochromator with MoKα radiation (λ = 
0.71073Å).  Reduced temperatures were maintained by use of an Oxford Cryosystems 600 low-
temperature device.  A total of 1011 frames of data were collected using ω and φ-scans with a scan 
range of 2° and a counting time of 48 seconds per frame.  Details of crystal data, data collection 
and structure refinement are listed in Table 1.  Data reduction were performed using SAINT 
V8.27B.14 The structure was solved by direct methods using SUPERFLIP15 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms using 
SHELXL-2013.16 Structure analysis was aided by use of the programs PLATON9817 and 
WinGX.18 The hydrogen atoms bound to carbon atoms were calculated in idealized positions.  The 
hydrogen atoms on the hydroxyl oxygen atoms were observed in a ∆F map and refined with 
isotropic displacement parameters. The absolute structure was determined by the method of 
Flack.19 The Flack x parameter refined to 0.006(9).  This assignment was confirmed by use of the 
Hooft y-parameter20, which refined to 0.013(5). 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + (0.0221*P)2] and 
P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.0506, with R(F) equal to 0.0271 and a goodness of fit, 
S, = 1.01. Definitions used for calculating R(F),Rw(F2) and the goodness of fit, S, are given 
below.21 The data were checked for secondary extinction but no correction was necessary.  
Neutral atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).22 All figures were generated 
using SHELXTL/PC.5 Tables of positional and thermal parameters, bond lengths and angles, 





Table 3.4.  Crystal data and structure refinement for 3.5c. 
Empirical formula  C11 H15 Br O2 
Formula weight  259.14 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21 
Unit cell dimensions a = 5.7323(12) Å a= 90°. 
 b = 7.920(2) Å b= 98.524(6)°. 
 c = 12.149(2) Å g = 90°. 
Volume 545.5(2) Å3 
Z 2 
Density (calculated) 1.578 Mg/m3 
Absorption coefficient 3.740 mm-1 
F(000) 264 
Crystal size 0.384 x 0.272 x 0.084 mm 
Theta range for data collection 3.081 to 33.184°. 
Index ranges -8<=h<=8, -12<=k<=12, -17<=l<=18 
Reflections collected 24040 
Independent reflections 3850 [R(int) = 0.0432] 
Completeness to theta = 25.242° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.700 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3850 / 1 / 137 
Goodness-of-fit on F2 1.006 
Final R indices [I>2sigma(I)] R1 = 0.0271, wR2 = 0.0487 
R indices (all data) R1 = 0.0366, wR2 = 0.0506 
Absolute structure parameter 0.006(9) 
Extinction coefficient n/a 





Table 3.5. Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) for 3.5c.  U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C1 8039(4) 5546(3) 3656(2) 14(1) 
C2 8445(4) 4948(3) 2624(2) 15(1) 
C3 6838(4) 3832(3) 2054(2) 14(1) 
C4 4841(4) 3314(3) 2492(2) 12(1) 
C5 4472(4) 3944(3) 3523(2) 14(1) 
C6 6072(4) 5061(3) 4110(2) 15(1) 
C7 3115(3) 2064(5) 1870(1) 13(1) 
C8 4239(4) 335(3) 1754(2) 14(1) 
C9 2425(4) -909(3) 1157(2) 14(1) 
C10 3389(4) -2686(3) 1082(2) 16(1) 
C11 5293(6) -338(3) 2897(2) 33(1) 
O1 2288(3) 2826(2) 807(1) 18(1) 
O2 1669(3) -3674(2) 387(1) 19(1) 
Br1 10228(1) 7057(1) 4472(1) 21(1) 




Table 3.6.   Bond lengths [Å] and angles [°] for 3.5c. 
_____________________________________________________________________________________ 
C1-C6  1.382(3) 
C1-C2  1.391(3) 
C1-Br1  1.903(2) 
C2-C3  1.386(3) 
C2-H2  0.95 
C3-C4  1.394(3) 
C3-H3  0.95 
C4-C5  1.393(3) 
C4-C7  1.519(3) 
C5-C6  1.392(3) 
C5-H5  0.95 
C6-H6  0.95 
C7-O1  1.441(3) 
C7-C8  1.529(4) 
C7-H7  1.00 
C8-C11  1.526(3) 
C8-C9  1.534(3) 
C8-H8  1.00 
C9-C10  1.520(3) 
C9-H9A  0.99 
C9-H9B  0.99 
C10-O2  1.432(3) 
C10-H10A  0.99 
C10-H10B  0.99 
C11-H11A  0.98 
C11-H11B  0.98 
C11-H11C  0.98 
O1-H1O  0.81(3) 

































































Table 3.7. Anisotropic displacement parameters  (Å2x 103) for 3.5c. The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* 
U12] 
 U11 U22  U33 U23 U13 U12 
C1 12(1)  9(1) 17(1)  -2(1) -6(1)  0(1) 
C2 11(1)  16(1) 18(1)  0(1) 1(1)  0(1) 
C3 17(1)  13(1) 12(1)  -3(1) 2(1)  2(1) 
C4 11(1)  9(1) 14(1)  0(1) -2(1)  2(1) 
C5 14(1)  12(1) 16(1)  1(1) 2(1)  1(1) 
C6 16(1)  16(1) 11(1)  -2(1) 0(1)  3(1) 
C7 13(1)  11(1) 14(1)  -2(1) -2(1)  -2(1) 
C8 15(1)  9(1) 15(1)  0(1) -4(1)  1(1) 
C9 15(1)  10(1) 17(1)  -2(1) -3(1)  0(1) 
C10 15(1)  14(2) 19(1)  0(1) -4(1)  -1(1) 
C11 51(2)  14(1) 26(1)  1(1) -23(1)  -2(1) 
O1 20(1)  10(1) 20(1)  3(1) -11(1)  -2(1) 
O2 21(1)  7(1) 25(1)  -2(1) -9(1)  0(1) 






Table 3.8. Hydrogen coordinates ( x 10
4






 x  y  z  U(eq) 
H2 9796 5298 2317 18 
H3 7103 3412 1351 17 
H5 3113 3607 3829 17 
H6 5813 5484 4814 18 
H7 1748 1925 2287 16 
H8 5541 470 1297 16 
H9A 1043 -950 1558 17 
H9B 1876 -487 396 17 
H10A 4880 -2653 762 20 
H10B 3718 -3194 1833 20 
H11A 4023 -570 3334 50 
H11B 6367 506 3283 50 
H11C 6164 -1381 2807 50 
H1O 1210(50) 2280(50) 490(20) 33(8) 



































Table 3.10.  Hydrogen bonds for 3.5c  [Å and °]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 O1-H1O...O2#1 0.81(3) 1.98(3) 2.772(2) 170(4) 
 O2-H5O...O1#2 0.78(3) 2.05(3) 2.832(2) 175(3) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  





Figure 3.2.  View of 3.5c showing the atom labeling scheme. Displacement ellipsoids are scaled 















































































































Chapter 4: Iridium Catalyzed (Z) - Selective Siloxy-Allylation of Primary 
Alcohols by Coupling with Terminal Propargyl Ether via 1,2 - Hydride Shift 
Mechanism* 
4.1 INTRODUCTION 
Carbonyl addition is broadly used in chemical synthesis to construct new C-C bonds.1 To 
come up with an alternative way of using organometallic reagents and metallic reductants, Krische 
group has developed a broad system of redox-triggered carbonyl addition reactions by merging 
carbonyl addition and transfer hydrogenation, which allows the direct conversion of primary 
alcohols to secondary alcohols. 2 Different π-unsaturated compounds were proved to be able to 
engage the carbonyl addition reactions, and many of them are abundant chemical feedstocks, such 
as butadiene3 and allyl acetate.4 
In recent work from the group, internal alkynes were found to engage in the carbonyl 
allylation reactions serving as pronucleophiles by different mechanisms.5,6,7 One possible 
mechanism was proceeding through alkyne-to-allen isomerization followed by either oxidative 
coupling5 or hydrometalation6 pathways. The other possible mechanism was involving 1,2-hydride 
shift enabled formation of π-allylmetal species directly from alkynes.7 In this chapter, we reported 
that terminal alkyne, unsubstituted proparyl ether 4.1a, mediated (Z)-selective carbonyl siloxy-
allylation via 1,2-hydride shift mechanism. This protocol represented the divergence from the 
classical acetylide carbonyl addition reactions8,9, and allowed formation of homoenolate 
equivalents10,11 from propargyl ethers; also demonstrated the generality of 1,2-hydride shift 
mechanism for the formation of π-allylmetal species in the context of transition metal catalysis 
(Figure 4.1). 
                                                
*This chapter is based on the published work:  





Figure 4.1 Enantioselective Carbonyl Crotylation Strategies. 
 
4.2 REACTION DEVELOPMENT AND SCOPE 
Exposure of propargyl ether 4.1a to p-bromobenzyl alcohol 4.2c with 2.5 mol% 
[Ir(cod)Cl]2 and 5 mol% (R)-BINAP in toluene at 95℃ gave the desired γ-hydroxy enol silane 4.3c 
with complete (Z)-selectivity in 14% yield and 87% enantiomeric excess (Table 4.1, entry 1). 
Introduction of catalytic amount of Bu4NI was found to be helpful in improving both yield and ee 
(Table 4.1, entry 2). Catalytic amount of Ph3CCO2H was found to have a beneficial effect on the 
conversion (Table 4.1, entry 3). By combining Bu4NI and Ph3CCO2H, 47% yield and 90% ee was 




Table 4.1 Selective Optimization for Formation of γ-Hydroxy Enol Silane 4.3c. 
 
aYields are of material isolated by silica gel chromatography. See supporting Information for 




using (R)-H8-BINAP and higher loading of propargyl ether 4.1a (Table 4.1, entry 7). Other chiral 
ligands within structural neighborhood were also evaluated (Table 4.1, entries 10-13), even though 
in some cases higher enantioselectivity was obtained but the yield was not relatively low 
comparing with (R)-H8-BINAP. Notably, when [Ir(cod)I]2 was used in the absence of Bu4NI, 
similar isolation yield was obtained, which suggested the role of Bu4NI involved in the formation 
of iodide modified iridium catalyst (Table 4.1, entry 14). 
With the optimal conditions in hand, different primary alcohols were subjected to coupling 
with propargyl ether 4.1a. Benzyl alcohols 4.2a-4.2f were converted to (Z)-γ-hydroxy enol silane 
4.3a-4.3f in excellent yield and uniformly high level of enantioselectivity. Different substituents 
positions were tolerated in the transformation. Allylic alcohols 4.2g-4.2i were able to engage in 
the coupling with propargyl ether 4.1a with good isolation yield and excellent enantioselectivity. 
Also, aliphatic alcohols 4.2j-4.2l were successfully converted to the adduct 4.3j-4.3l with slightly 
lower yields but still complete (Z)-selectivity and high enantioselectivity. 
The absolute stereochemical structure of adduct 4.3a-4.3l was confirmed by subjecting 
4.3a to silyl group cleavage followed by reduction to form (S)-1-phenylbutane-1,4-diol, which is 
a previous reported compound.  
To demonstrate the utility of this protocol, the coupling adducts γ-hydroxy enol silanes 
4.3a, 4.3c, 4.3e, 4.3h, and 4.3j were converted to enantiomeric enriched γ-lactones 4.4a, 4.4c, 4.4e, 
4.4h, and 4.4j by treatment of TBAF to remove the TIPS group followed by PCC mediated 
oxidation (Scheme 4.1, eq 1). Additionally, m-CPBA mediated epoxidation of adducts 4.3a, 4.3c, 
4.3e, 4.3f, 4.3j, and 4.3k occurred in a highly diastereoselective manner and delivered the 




Table 4.2 Iridium Catalyzed Formation of γ-Hydroxy Enol Silanes 4.3a-4.3l. 
 
 
aYields are material isolated by silica gel chromatography. See supporting Information for further 




Scheme 4.1 Elaboration of Coupling Adducts to Form γ-Lactones and Furans. 
 
4.3 MECHANISM AND DISCUSSION 
Deuterium labeling experiments were conducted to confirm the reaction mechanism. When 
propargyl ether 4.1a was treated with deuterio-4.2c under the standard conditions, deuterium was 
observed at the allylic (Hc) and carbinol (Hd) positions (Scheme 4.2, eq 3). When deuterio-4.1a 
was treated with p-bromobenzyl alcohol 4.2c under standard conditions, complete deuterium 
incorporation was observed at both vinylic (Ha and Hb) positions (Scheme 4.2, eq 4). 
These data clearly indicated the catalytic mechanism via 1,2-hydride shift to form p-
allyliridium species (Scheme 4.3). Coordination of alkyne to the low-valent iridium(I) induced 
1,2-hydride shift to form vinylcarbene II. It is worth mentioning that the n ® s* interaction 




Scheme 4.2 Deuterium Labelling Experiments to Probe Reaction Mechanism. 
 
1,2-hydride shift. Protonation of vinylcarbene II gave the siloxyallyliridium intermediate III. 
Coordination of aldehyde, formed in situ, to siloxyallylridium III triggered the carbonyl addition 
via closed transition structure to form homoallylic iridium alkoxide V. Protonolysis of iridium 
alkoxide V by reactant alcohol released the l-hydroxyl enol silane and formed iridium alkoxide 
VI, which went through b–hydride elimination to generate aldehyde and iridium hydride species 
VII. Finally, reductive elimination of HX closed the catalytic cycle. A stereochemical model was 












In summary, iridium catalyzed coupling of terminal propargyl ether 4.1a with primary 
alcohols to form g-hydroxyl enol silanes with complete (Z)-selectivity and high enantioselectivity 
was reported. According to the deuterium labeling studies, 1,2-hydride shift mechanism was 
proposed in the catalytic cycle. This protocol expanded the scope for the p-unsaturated compounds 
in redox-triggered carbonyl allylation reactions, as well as represented the departure from classic 





4.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. Resealable 
pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog number 14–959–
35C) and were flame dried followed by cooling in a desiccator or under a stream of argon prior to 
use. Tetrahydrofuran (THF) was dried over sodium metal, benzophenone, and distilled 
immediately prior to use. RuH2(PPh3)3 were prepared according to literature procedure.1 All 
ligands were used as received from Strem Chemicals Inc. Alcohols were purified by distillation or 
recrystallization immediately prior to use. Preparative column chromatography employing 
Silicycle silica gel (40-63 µm) was performed according to the method of Still.2 Analytical thin-
layer chromatography (TLC) was carried out using 0.25 mm commercial silica gel plates 
(Dynamic Absorbents F254). Visualization was accomplished with UV light followed by dipping 
in Seebach’s stain solution then heating. Purification of reactions was carried out by flash 





Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-resolution mass spectra 
(LRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). Accurate 
masses are reported for the molecular ion (M+H, M+Na), or a suitable fragment ion. Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer. Chemical shifts are reported in delta (δ) units, parts per million (ppm) downfield 
from tetramethylsilane or ppm relative to the center of the singlet at 7.26 ppm for 
deuteriochloroform. Data reported as multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet). Integration and coupling constants were reported in Hertz (Hz). Carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded with a Varian Gemini (100 MHz) 
spectrometer and were routinely run with broadband decoupling. Chemical shifts are reported in 





Experimental Details and Spectral Data 
 
General Procedure for the Couplings of Alcohols 4.2a-4.2l and 4.1a 
 
To a resealable pressure tube (13x100) was added [Ir(cod)Cl]2 (3.4mg, 0.005 mmol, 2.5 mol%), 
(R)-H8BINAP (6.3 mg, 0.010 mmol, 5 mol%), Bu4NI (7.4 mg, 0.020 mmol, 10 mol%), 
triphenylacetic acid (2.9 mg, 0.010 mmol, 5 mol%). At this stage solid alcohol coupling partners 
(0.20 mmol, 100 mol%) were added. The tube was sealed with a rubber septum and purged with 
argon. Toluene (0.20 mL, 1 M) was added to the reaction vessel. At this stage, liquid alcohol 
coupling partners (0.20 mmol, 100 mol%) were added. Propargyl ether 4.1a (0.80 mmol, 400 
mol%) was added to the reaction vessel and the rubber septum was replaced with a screw cap. The 
mixture was heated at 95 °C for 24 hours, at which point the reaction mixture was allowed to cool 










In accordance with the general procedure, the title compound was obtained in 93% yield (59.5 mg, 
0.186 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 6% 
EtOAc/hexanes). 
Rf =0.6 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.41 – 7.30 (m, 4H), 7.28 – 7.23 (m, 1H), 6.45 (dt, J = 5.8, 1.3 Hz, 
1H), 4.78 – 4.72 (m, 1H), 4.47 (td, J = 7.5, 5.8 Hz, 1H), 2.67 – 2.49 (m, 2H), 2.46 (d, J = 3.4 Hz, 
1H), 1.20 – 1.12 (m, 3H), 1.09 (d, J = 5.6 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 144.5, 141.8, 128.2, 127.2, 125.8, 104.6, 74.2, 34.1, 17.7, 11.9. 
LRMS (ESI) Calcd. for C19H32NaO2Si [M+Na]+: 343, Found: 343 
FTIR (neat): 2943, 2866, 2874, 1463, 1116, 1050, 882, 684, 665 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 94%. 


















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/14/2015 11:49:21 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 11-37-10\TAO-9901-1ML-60MIN.M
Last changed    : 4/25/2015 9:38:16 AM by Wandi
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/14/2015 4:59:16 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.221 BB    0.2023 4792.19092  367.16394  50.0134
   2  11.579 BB    0.3049 4789.62354  244.08528  49.9866
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 11-37-10\001-0201.D
Sample Name: Tao-7-27
LC 1 5/14/2015 4:59:41 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/14/2015 11:49:21 AM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 11-37-10\TAO-9901-1ML-60MIN.M
Last changed    : 4/25/2015 9:38:16 AM by Wandi
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/14/2015 4:59:16 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.221 BB    0.2023 4792.19092  367.16394  50.0134
   2  11.579 BB    0.3049 4789.62354  244.08528  49.9866
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 11-37-10\001-0201.D
Sample Name: Tao-7-27
LC 1 5/14/2015 4:59:41 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date : 5/14/2015 4:23:21 PM              Inj : 1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 15-18-06\TAO-9901-1ML-60MIN.M
Last changed    : 5/14/2015 4:22:22 PM by Tao
               (modified after loading)
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/14/2015 5:00:17 PM by Tao
                  (modified after loading)























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.022 MM    0.1924  150.68938   13.05360   3.1547
   2  11.330 BB    0.3024 4626.01172  238.38820  96.8453
 
Totals :                  4776.70110  251.44180
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 15-18-06\002-0301.D
Sample Name: Tao-7-32
LC 1 5/14/2015 5:00:59 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
= = = = ==========================
Acq. Operator   : Tao                            Seq. Line :   3
Acq. Instrument : LC 1                Location : Vial 2
Injection Date  : 5/14/2015 4:23:21 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO TAO 2015-05-14 15-18-06\TAO-9901-1ML-60MIN.M
Last changed    : 5/14/2015 4:22:22 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/14/2015 5:00:17 PM by Tao
                  (modified after loading)























                Area P rcent Report                         
=====================================================================
 
Sorted By          :    Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1   8.022 MM    0.1924  150.68938   13.05360   3.1547
 2 11.330 BB    0.3024 4626.01172  238.38820  96.8453
 
Totals :                  4776.70110  251.44180
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 15-18-06\002-0301.D
Sample Name: Tao-7-32
LC 1 5/14/2015 5:00:59 PM Tao Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 84% yield (56.1 mg, 
0.168 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 7% 
EtOAc/hexanes). 
Rf = 0.6 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.27 (d, J = 7.4 Hz, 2H), 7.15 (d, J = 7.5 Hz, 2H), 6.43 (dt, J = 
5.8, 1.3 Hz, 1H), 4.74 – 4.69 (m, 1H), 4.47 (td, J = 7.5, 5.8 Hz, 1H), 2.67 – 2.56 (m, 1H), 2.56 – 
2.47 (m, 1H), 2.35 (s, 1H), 2.34 (s, 3H), 1.20 – 1.12 (m, 3H), 1.09 (d, J = 5.9 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 141.7, 141.6, 136.8, 128.9, 125.7, 104.7, 74.0, 34.0, 21.1, 17.7, 
11.9.	
LRMS (ESI) Calcd. for C20H34NaO2Si [M+Na]+: 357, Found: 357. 
FTIR (neat): 2943, 2866, 1654, 1463, 1248, 1162, 1052, 881, 817, 683, 666 cm-1. 
HPLC (Chiralcel OD-H/OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%.  

















Acq. Operator   : SDR                            Seq. Line :   5
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 5/12/2015 3:11:45 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-12 12-19-59\TAO-9901-1ML-60MIN.M
Last changed    : 5/12/2015 3:48:53 PM by SDR
                  (modified after loading)
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/12/2015 10:04:11 PM by SO
                  (modified after loading)
Sample Info     : OD/OD
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-12 12-19-59\003-0501.D
Sample Name: Tao-7-25
LC 1 5/12/2015 10:04:19 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.136 MM    0.3097 1468.23145   79.00329  50.0716
2 17.820 MM    0.3454 1464.03186   70.64793  49.9284
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-12 12-19-59\003-0501.D
Sample Name: Tao-7-25
LC 1 5/12/2015 10:04:19 PM SO Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Oper tor   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 8/12/2015 2:49:02 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-08-12 14-36-57\TAO-9901-1ML-60MIN.M
Last changed    : 5/30/2015 11:30:49 AM by SO
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-1ML-30MIN.M
Last changed    : 8/12/2015 3:22:28 PM by KHOA
               (modified after loading)
Sample Info     : OD3/OD2
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.960 MM    0.2703  121.91837    7.51688   2.3742
   2  17.613 MM    0.3414 5013.22412  244.76976  97.6258
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-08-12 14-36-57\001-0201.D
Sample Name: Tao-8-136
LC 1 8/12/2015 3:23:35 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date   8/12/2015 2:49:02 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     C:\CHEM32\1\DATA\TAO\TAO 2015-08-12 14-36-57\TAO-9901-1ML-60MIN.M
Last changed    : 5/30/2015 11:30:49 AM by SO
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-1ML-30MIN.M
Last changed    : 8/12/2015 3:22:28 PM by KHOA
                  (modified after loading)
Sample Info     : OD3/OD2
                  
 






























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  15.960 MM    0.2703  121.91837    7.51688   2.3742
2 17.613 MM    0.3414 5013.22412  244.76976  97.6258
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-08-12 14-36-57\001-0201.D
Sample Name: Tao-8-136
LC 1 8/12/2015 3:23:35 PM KHOA Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 86% yield (68.5 mg, 
0.172 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 7% 
EtOAc/hexanes). 
Rf = 0.55 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.48 – 7.43 (m, 2H), 7.27 – 7.23 (m, 2H), 6.44 (dt, J = 5.8, 1.2 Hz, 
1H), 4.75 – 4.68 (m, 1H), 4.44 (td, J = 7.5, 5.8 Hz, 1H), 2.60 – 2.45 (m, 3H), 1.23 – 1.11 (m, 3H), 
1.08 (d, J = 5.8 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 143.5, 142.1, 131.3, 127.6, 120.9, 104. 0, 73.5, 34.1, 17.7, 11.8.	
LRMS (ESI) Calcd. for C19H31BrNaO2Si [M+Na]+: 421, Found: 421. 
FTIR (neat): 2943, 2866, 1653, 1463, 1118, 1059, 1010, 882, 828, 685 cm-1. 
HPLC (Chiralcel AS-H/AS-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm), ee = 91%. 



















Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 5/3/2015 3:54:09 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-03 14-37-35\TAO-9901-05ML-30MIN.M
Last changed    : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/8/2015 5:25:29 PM by SUSUMU
                  (modified after loading)
Sample Info     : AS/AS
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  21.248 MF    0.2993 1298.96252   72.33195  49.5692
   2  22.052 FM    0.3229 1321.53833   68.20992  50.4308
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-03 14-37-35\003-0401.D
Sample Name: Tao-6-89
LC 1 5/8/2015 5:26:00 PM SUSUMU Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 5/3/2015 3:54:09 PM                  Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-03 14-37-35\TAO-9901-05ML-30MIN.M
Last changed    : 12/19/2014 7:12:18 PM by GANG
Analysis Method : C:\CHEM32\1\METHODS\JACKY_WASH.M
Last changed    : 5/8/2015 5:25:29 PM by SUSUMU
                  (modified after loading)
Sample Info     : AS/AS
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  21.248 MF    0.2993 1298.96252   72.33195  49.5692
2 22.052 FM    0.3229 1321.53833   68.20992  50.4308
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-03 14-37-35\003-0401.D
Sample Name: Tao-6-89
LC 1 5/8/2015 5:26:00 PM SUSUMU Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 7/17/2015 7:16:03 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-07-17 18-05-05\TAO-9901-05ML-30MIN.M
Last changed    : 7/17/2015 7:40:12 PM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\DATA\TAO\TAO 2015-07-14 12-15-44\092-0101.D\DA.M (TAO-9901-1ML-
                  10MIN.M)
Last changed    : 10/9/2015 4:26:52 PM by BOYOUNG
                  (modified after loading)
Sample Info     : ASAS
                  
 
































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-07-17 18-05-05\003-0401.D
Sample Name: Tao-8-53
LC 1 10/9/2015 4:27:00 PM BOYOUNG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  20.692 MM    0.2935 1316.60364   74.75982   4.4808
   2  21.409 MM    0.3004 2.80668e4  1557.28015  95.5192
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-07-17 18-05-05\003-0401.D
Sample Name: Tao-8-53
LC 1 10/9/2015 4:27:00 PM BOYOUNG Page 2 of 2








In accordance with the general procedure, the title compound was obtained in 85% yield (56.8 mg, 
0.17 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 5% 
EtOAc/hexanes). 
Rf = 0.5 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.53 (dd, J = 7.6, 1.4 Hz, 1H), 7.23 (td, J = 7.4, 1.8 Hz, 1H), 7.16 
(td, J = 7.3, 1.5 Hz, 1H), 7.14 – 7.10 (m, 1H), 6.46 (dt, J = 5.8, 1.3 Hz, 1H), 5.00 – 4.94 (m, 1H), 
4.52 (td, J = 7.5, 5.8 Hz, 1H), 2.60 – 2.49 (m, 2H), 2.37 (d, J = 3.2 Hz, 1H), 2.35 (s, 3H), 1.20 – 
1.13 (m, 3H), 1.09 (d, J = 6.4 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 142.5, 141.7, 134.4, 130.2, 126.9, 126.1, 125.2, 104.8, 70.7, 32.8, 
19.0, 17.7, 12.3, 11.9.	
LRMS (ESI) Calcd. for C20H34NaO2Si [M+Na]+: 357, Found: 357. 
FTIR (neat): 2944, 2866, 1654, 1463, 1121, 1104, 1047, 882, 745, 684 cm-1. 
HPLC (Chiralcel AD-H/AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%. 



















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 12/5/2015 2:55:00 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\TAO-9901-1ML-40MIN.M
Last changed    : 12/5/2015 3:18:05 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\DEF_LC.M
Last changed    : 12/5/2015 3:40:38 PM by KHOA
                  (modified after loading)
Sample Info     : AD3AD2
                  
 




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\001-0201.D
Sample Name: 3drac
LC 1 12/5/2015 3:40:50 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  19.411 BB    0.2936 2349.12549  122.59051  50.0210
 2 21.700 BB    0.3499 2347.15088  102.22230  49.9790
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\001-0201.D
Sample Name: 3drac
LC 1 12/5/2015 3:40:50 PM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                            Location : Vial 2
Injection Date  : 12/5/2015 3:39:32 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method    : C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\TAO-9901-1ML-40MIN.M
Last changed    : 12/4/2014 3:04:35 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\DEF_LC.M
Last changed    : 12/5/2015 4:13:05 PM by KHOA
                  (modified after loading)
Sample Info     : AD3AD2
                  
 

























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.420 MM    0.3313   66.17539    3.32879   2.2265
   2  20.707 BB    0.3719 2906.04346  119.41266  97.7735
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\002-0401.D
Sample Name: 3d
LC 1 12/5/2015 4:13:11 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   4
Acq. Instrument : LC 1                   Location : Vial 2
Injection Date  : 12/5/2015 3:39:32 PM                 Inj :   1
                  Inj Volume : 5.0 µl
Acq. Method     : C: CHEM32\1\DATA\TAO\TAO 20 5 12-05 14-42-12\TAO-9901-1ML-40MIN.M
Last changed    : 12/4/2014 3:04:35 PM by Tao
Analysis Method : C:\CHEM32\1\METHODS\DEF_LC.M
Last changed    : 12/5/2015 4:13:05 PM by KHOA
                  (modified after loading)
Sample Info     : AD3AD2
                  
 























Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.420 MM    0.3313   66.17539    3.32879   2.2265
2 20.707 BB    0.3719 2906.04346  119.41266  97.7735
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\002-0401.D
Sample Name: 3d
LC 1 12/5/2015 4:13:11 PM KHOA Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 94% yield (65.8 mg, 
0.188 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 8% 
EtOAc/hexanes). 
Rf = 0.45 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.27 – 7.21 (m, 1H), 6.97 – 6.92 (m, 2H), 6.80 (ddd, J = 8.2, 2.4, 
1.2 Hz, 1H), 6.45 (dt, J = 5.8, 1.3 Hz, 1H), 4.72 (dd, J = 8.1, 4.8 Hz, 1H), 4.48 (td, J = 7.5, 5.8 Hz, 
1H), 3.81 (s, 3H), 2.65 – 2.39 (m, 3H), 1.21 – 1.12 (m, 3H), 1.08 (d, J = 6.3 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 159.60, 146.29, 141.80, 129.22, 118.13, 112.78, 111.15, 104.56, 
74.08, 55.14, 34.08, 17.70, 11.86. 
LRMS (ESI) Calcd. for C20H34NaO3Si [M+Na]+: 373, Found: 373. 
FTIR (neat): 3443, 2943, 2866,1738, 1653, 1258, 1115, 1044, 881, 684 cm-1. 
HPLC (Chiralpak IB column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%. 



















Acq. Operator   : Ryosuke                        Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 12/7/2015 3:05:37 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\TAO-9901-1ML-60MIN.M
Last changed    : 12/7/2015 3:33:17 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 3:39:09 PM by Ryosuke
                  (modified after loading)
Sample Info     : IB
                  
 






















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\009-0201.D
Sample Name: 3erac
LC 2 12/7/2015 3:39:40 PM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.517 BB    0.3197 9010.00000  438.58646  49.8306
2 21.318 BB    0.3913 9071.25293  360.80719  50.1694
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\009-0201.D
Sample Name: 3erac
LC 2 12/7/2015 3:39:40 PM Ryosuke Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   3
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 12/7/2015 3:37:39 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_ SAMPLE 2015-12-07 14-53-41\TAO-9901-1ML-60MIN.M
Last changed    : 12/7/2015 3:33:17 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 4:11:47 PM by Ryosuke
               (modified after loading)
Sample Info     : IB
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\010-0301.D
Sample Name: 3e
LC 2 12/7/2015 4:11:53 PM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.806 MM    0.2970  102.75671    5.76684   2.2609
2 22.153 MM    0.4315 4442.26123  171.60025  97.7391
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\T O\TAO_1SAMPLE 2015-12-07 14-53-41\010-0301.D
Sample Name: 3e
LC 2 12/7/2015 4:11:53 PM Ryosuke Page 2 of 2








In accordance with the general procedure, the title compound was obtained in 91% yield (66.2 mg, 
0.182, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 8% EtOAc/hexanes). 
Rf = 0.45 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 6.90 (d, J = 1.6 Hz, 1H), 6.81 (ddd, J = 7.9, 1.7, 0.6 Hz, 1H), 6.75 
(d, J = 7.9 Hz, 1H), 6.42 (dt, J = 5.8, 1.3 Hz, 1H), 5.93 (s, 2H), 4.70 – 4.61 (m, 1H), 4.44 (td, J = 
7.5, 5.8 Hz, 1H), 2.62 – 2.52 (m, 1H), 2.51 – 2.43 (m, 1H), 2.39 (s, 1H), 1.19 – 1.11 (m, 3H), 1.08 
(d, J = 6.8 Hz, 18H). 
13C NMR (100 MHz, CDCl3): δ 147.6, 146.6, 141.7, 138.7, 119.1, 107.9, 106.4, 104.5, 100.8, 
74.0, 34.1, 17.7, 11.9.	
LRMS (ESI) Calcd. for C20H32NaO4Si [M+Na]+: 387, Found: 387. 
FTIR (neat): 3402, 2943, 1738,1488, 1241, 1113, 882, 810, 684 cm-1. 
HPLC (Chiralcel AD-H/AD-H column, hexanes:i-PrOH = 97:3, 1 mL/min, 210 nm), ee = 94%. 



















Acq. Operator   : Tao                            Seq. Line :   8
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 12/5/2015 4:54:03 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\TAO-9703-1ML-40MIN.M
Last changed    : 12/5/2015 5:20:48 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/5/2015 5:22:18 PM by KHOA
                  (modified after loading)



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.117 BV    0.3096 2330.78101  113.50340  49.9588
   2  18.204 VB    0.3367 2334.62402  104.49120  50.0412
 
Totals :                  4665.40503  217.99460
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\003-0801.D
Sample Name: 3frac
LC 1 12/5/2015 5:22:33 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   8
Acq. Instrument : LC 1                            Location : Vial 3
Injection Date  : 12/5/2015 4:54:03 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\TAO-9703-1ML-40MIN.M
Last changed    : 12/5/2015 5:20:48 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/5/2015 5:22:18 PM by KHOA
                  (modified after loading)



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.117 BV    0.3096 2330.78101  113.50340  49.9588
2 18.204 VB    0.3367 2334.62402  104.49120  50.0412
 
Totals :                  4665.40503  217.99460
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\003-0801.D
Sample Name: 3frac
LC 1 12/5/2015 5:22:33 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :  10
Acq. Instrument : LC 1                            Location : Vial 4
Injection Date  : 2/5/2015 5:31:47 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\TAO-9703-1ML-40MIN.M
Last changed    : 12/5/2015 5:36:36 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/5/2015 5:57:45 PM by KHOA
              (modified after loading)
Sample Info     : AD3AD2
                  
 


























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\004-1001.D
Sample Name: 3f
LC 1 12/5/2015 5:57:51 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.772 MM    0.3545   75.19310    3.53555   2.7092
   2  17.841 BB    0.3265 2700.32568  123.79351  97.2908
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-12-05 14-42-12\004-1001.D
Sample Name: 3f
LC 1 12/5/2015 5:57:51 PM KHOA Page 2 of 2








In accordance with the general procedure, the title compound was obtained in 78% yield (54.0 mg, 
0.156 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 6% 
EtOAc/hexanes). 
Rf = 0.55 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.40 – 7.37 (m, 2H), 7.31 (t, J = 7.5 Hz, 2H), 7.22 (tt, J = 7.3, 1.4 
Hz, 1H), 6.61 (dd, J = 15.9, 1.2 Hz, 1H), 6.45 (dt, J = 5.8, 1.3 Hz, 1H), 6.26 (dd, J = 15.9, 6.3 Hz, 
1H), 4.52 (td, J = 7.4, 5.8 Hz, 1H), 4.40 – 4.31 (m, 1H), 2.47 (ddd, J = 7.5, 6.2, 1.4 Hz, 2H), 2.12 
(d, J = 4.0 Hz, 1H), 1.21 – 1.11 (m, 3H), 1.10 – 1.06 (m, 18H).	
13C NMR (100 MHz, CDCl3): δ 141.7, 136.9, 132.3, 129.8, 128.5, 127.4, 126.5, 104.1, 72.7, 32.2, 
17.7, 11.9.	
LRMS (ESI) Calcd. for C21H34NaO2Si [M+Na]+: 369, Found: 369. 
FTIR (neat): 2943, 2866, 1460, 1654, 1463, 1249, 1120, 1093, 1045, 882, 747, 688, 666 cm-1. 
HPLC (Chiralpak IB column, hexanes:i-PrOH = 99:1, 1 mL/min, 254 nm), ee = 94%. 


















Acq. Operator   : Ryosuke                        Seq. Line :   4
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 12/7/2015 4:09:47 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\TAO-9901-1ML-60MIN.M
Last changed    : 12/7/2015 4:44:47 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 5:28:11 PM by Ryosuke
                  (modified after loading)
Sample Info     : IB
                  
 



















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\020-0401.D
Sample Name: 3grac
LC 2 12/7/2015 5:28:16 PM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.914 BB    0.3038 1918.98425   97.43860  50.0762
2 32.915 BB    0.5747 1913.14270   51.58790  49.9238




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\020-0401.D
Sample Name: 3grac
LC 2 12/7/2015 5:28:16 PM Ryosuke Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   5
Acq. Instrument : LC 2                            Location : Vial 19
Injection Date   12/7/2015 4:48:52 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\TAO-9901-1ML-60MIN.M
Last changed    : 12/7/2015 4:44:47 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 5:28:58 PM by Ryosuke
                  (modified after loading)




















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 A, Sig=254,4 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.077 BB    0.2707  132.74297    7.49196   2.6963
   2  31.694 BB    0.5682 4790.32129  130.51765  97.3037
 
Totals :                  4923.06425  138.00962
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-07 14-53-41\019-0501.D
Sample Name: 3g
LC 2 12/7/2015 5:29:03 PM Ryosuke Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 67% yield (39.9 mg, 
0.134 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 6% 
EtOAc/hexanes). 
Rf = 0.55 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 6.41 (dt, J = 5.9, 1.4 Hz, 1H), 5.23 (dp, J = 8.6, 1.4 Hz, 1H), 4.45 
(ddd, J = 7.7, 7.2, 5.8 Hz, 1H), 4.42 – 4.35 (m, 1H), 2.44 – 2.34 (m, 1H), 2.31 – 2.22 (m, 1H), 1.79 
(d, J = 3.2 Hz, 1H), 1.72 (d, J = 1.4 Hz, 3H), 1.69 (d, J = 1.4 Hz, 3H), 1.19 – 1.11 (m, 3H), 1.10 – 
1.07 (m, 18H). 
13C NMR (100 MHz, CDCl3): δ 141.3, 134.8, 127.8, 104.6, 68.6, 32.2, 25.8, 18.2, 17.7, 11.9. 
LRMS (ESI) Calcd. for C17H34NaO2Si [M+Na]+: 321, Found: 321. 
FTIR (neat): 2943, 2866, 1654, 1463, 1248, 1106, 1046, 882, 800, 684, 665 cm-1. 
HPLC (Chiralcel OD-H/OD-H/OD-H column, hexanes:i-PrOH = 99:1, 0.5 mL/min, 210 nm), ee 
= 96%. 


















Acq. Operator   : Ryosuke                        Seq. Line :   6
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 12/6/2015 4:16:58 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\TAO-9901-05ML-60MIN.M
Last changed    : 12/6/2015 4:17:06 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 9:43:52 AM by Ryosuke
                  (modified after loading)


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  86.805 BB    0.9105 4125.79297   53.93298  49.9627
   2  90.639 BB    0.9316 4131.96094   52.53322  50.0373
 
Totals :                  8257.75391  106.46620
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\009-0601.D
Sample Name: 3hrac
LC 2 12/7/2015 9:43:57 AM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   6
Acq. Instrument : LC 2                            Location : Vial 9
Injection Date  : 12/6/2015 4:16:58 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\TAO-9901-05ML-60MIN.M
Last changed    : 12/6/2015 4:17:06 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 9:43:52 AM by Ryosuke
                  (modified after loading)


















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  86.805 BB    0.9105 4125.79297   53.93298  49.9627
 2 90.639 BB    0.9316 4131.96094   52.53322  50.0373
 
Totals :                8257.75391  106.46620
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\009-0601.D
Sample Name: 3hrac
LC 2 12/7/2015 9:43:57 AM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   5
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 12/6/2015 2:35:18 PM              Inj :  1
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\TAO-9901-05ML-60MIN.M
Last changed    : 12/6/2015 2:49:57 PM by Ryosuke
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 9:43:00 AM by Ryosuke
                 (modified after loading)




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  80.614 MM    1.2822  367.78705    4.78063   2.0068
   2  84.559 BB    1.1233 1.79596e4   223.53833  97.9932
 
Totals :                  1.83274e4   228.31896
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\010-0501.D
Sample Name: 3h
LC 2 12/7/2015 9:43:22 AM Ryosuke Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Ryosuke                        Seq. Line :   5
Acq. Instrument : LC 2                  Location : Vial 10
Injection Date  : 12/6/2015 2:35:18 PM                 Inj :   1
                                                Inj Volume : 10.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1S MPLE 2015-12-06 12-17-39\TAO-9901-05ML-60MIN.M
Last changed    : 12/6/2015 2:49:57 PM by Ryosuke
                 (modified after loading)
Analysis Method  C:\CHEM32\2\METHODS\RYOSUKE90_10_10ML_20MIN.M
Last changed    : 12/7/2015 9:43:00 AM by Ryosuke
                  (modified after loading)




























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
U e Multipli r & Dilution Factor ith ISTDs
 
 
Signal 1: DAD1 C, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  80.614 MM    1.2822  367.78705    4.78063   2.0068
2 84.559 BB    1.1233 1.79596e4   223.53833  97.9932
 
Totals :                  1.83274e4   228.31896
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-12-06 12-17-39\010-0501.D
Sample Name: 3h
LC 2 12/7/2015 9:43:22 AM Ryosuke Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 75% yield (58.5 mg, 
0.15 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 7% 
EtOAc/hexanes). 
Rf = 0.3 (50% EtOAc/Hexanes). 
Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3): δ 7.34 (d, J = 4.4 Hz, 4H), 7.31 – 7.27 (m, 1H), 6.43 (dt, J = 5.8, 
1.3 Hz, 1H), 5.84 – 5.80 (m, 2H), 4.52 (s, 2H), 4.47 (td, J = 7.4, 5.8 Hz, 1H), 4.24 – 4.17 (m, 
1H), 4.03 (dd, J = 4.2, 0.9 Hz, 2H), 2.38 (ddd, J = 7.5, 6.3, 1.4 Hz, 2H), 2.02 (d, J = 4.1 Hz, 1H), 
1.19 – 1.11 (m, 3H), 1.08 (d, J = 6.4 Hz, 18H). 
13C NMR (100 MHz, CDCl3): δ 141.6, 138.3, 135.8, 128.3, 127.8, 127.6, 126.8, 104.1, 72.1, 72.0, 
70.3, 31.9, 17.7, 11.9. 
LRMS (ESI) Calcd. for C23H38NaO3Si [M+Na]+: 413, Found: 413. 
FTIR (neat): 2943, 2866, 1653, 1463, 1248, 1095, 1066, 882, 735, 685, 666 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 254 nm), ee = 92%.  


















Acq. Operator   : HSC                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/13/2015 3:24:56 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-13 15-12-12\TAO-9901-1ML-60MIN.M
Last changed    : 4/25/2015 9:38:16 AM by Wandi
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/13/2015 4:23:07 PM by SO
                  (modified after loading)
Sample Info     : OD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  22.665 MM    0.7374 3316.25366   74.95737  49.8752
   2  25.560 MM    0.8720 3332.84961   63.69908  50.1248
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-13 15-12-12\001-0201.D
Sample Name: Tao-7-26
LC 1 5/13/2015 4:24:02 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : HSC                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/13/2015 3:24:56 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-13 15-12-12\TAO-9901-1ML-60MIN.M
Last changed    : 4/25/2015 9:38:16 AM by Wandi
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/13/2015 4:23:07 PM by SO
                  (modified after loading)
Sample Info     : OD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  22.665 MM    0.7374 3316.25366   74.95737  49.8752
2 25.560 MM    0.8720 3332.84961   63.69908  50.1248
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-13 15-12-12\001-0201.D
Sample Name: Tao-7-26
LC 1 5/13/2015 4:24:02 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 5/14/2015 3:30:46 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 15-18-06\TAO-9901-1ML-60MIN.M
Last changed   : 5/14/2015 4:22:22 PM by Tao
                  (modified after loading)
Analysis Method : C:\CHEM32\1\DATA\SDR\SDR 2015-05-12 09-34-43\JACKY_WASH.M
Last changed    : 5/14/2015 4:25:28 PM by Tao
                  (modified after loading)
Sample Info     : OD3
                  
 


































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                    :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-14 15-18-06\001-0201.D
Sample Name: Tao-7-31
LC 1 5/14/2015 4:26:18 PM Tao Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  21.809 MM    0.7037 9032.18750  213.91315  95.8498
   2  24.568 MM    0.7473  391.08380    8.72204   4.1502
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-05-1  15-18-06\001-0201.D
Sample Name: Tao-7-31
LC 1 5/14/2015 4:26:18 PM Tao Page 2 of 2








In accordance with the general procedure, the title compound was obtained in 68% yield (51.4 mg, 
0.136 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 8% 
EtOAc/hexanes). 
Rf = 0.35 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): 1H NMR (400 MHz, Chloroform-d) δ 7.35 – 7.27 (m, 5H), 6.40 (dt, 
J = 5.9, 1.4 Hz, 1H), 4.54 – 4.51 (m, 2H), 4.47 (td, J = 7.4, 5.8 Hz, 1H), 3.89 – 3.82 (m, 1H), 3.75 
– 3.69 (m, 1H), 3.68 – 3.61 (m, 1H), 2.84 (d, J = 3.2 Hz, 1H), 2.38 – 2.27 (m, 2H), 1.84 – 1.74 (m, 
2H), 1.19 – 1.11 (m, 3H), 1.07 (d, J = 6.4 Hz, 18H).	
13C NMR (100 MHz, CDCl3): δ 141.02, 138.14, 128.39, 127.62, 127.61, 104.91, 73.23, 71.02, 
69.00, 36.02, 31.73, 17.71, 11.88. 
LRMS (ESI) Calcd. for C22H38NaO3Si [M+Na]+: 401, Found: 401. 
FTIR (neat): 2943, 2866, 1654, 1085, 882, 735, 687, 669 cm-1. 
HPLC (Chiralcel AD-H/AD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 85%. 


















Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/23/2015 7:55:11 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\TAO-9505-1ML-80MIN-COLD.M
Last changed    : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 12/4/2015 1:08:29 PM by vg
                  (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.065 BV    0.4444 2136.06885   74.53375  49.3446
   2  18.226 VB    0.4783 2192.80786   70.60277  50.6554
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\020-0201.D
Sample Name: Tao-5-160
LC 2 12/4/2015 1:09:07 PM vg Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : Tao                            Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 20
Injection Date  : 3/23/2015 7:55:11 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\TAO-9505-1ML-80MIN-COLD.M
Last changed    : 3/23/2015 7:33:47 PM by Tao
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 12/4/2015 1:08:29 PM by vg
                  (modified after loading)
Sample Info     : OD2+OD3 at 15C
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  17.065 BV    0.4444 2136.06885   74.53375  49.3446
2 18.226 VB    0.4783 2192.80786   70.60277  50.6554
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-03-23 19-38-04\020-0201.D
Sample Name: Tao-5-160
LC 2 12/4/2015 1:09:07 PM vg Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 1
Injection Date  : 8/10/2015 9:12:36 AM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\TAO\TAO 2015-08-10 09-00-3 \TAO-990 -1ML-40MIN.M
Last changed    : 8/10/2015 9:42:56 AM by KHOA
                  (modified after loading)
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-1ML-30MIN.M
Last changed    : 8/10/2015 12:07:16 PM by SO
               (modified after loading)
Sample Info     : AD3AD4
                  
 































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-08-10 09-00-31\001-0201.D
Sample Name: Tao-8-126
LC 1 8/10/2015 12:07:29 PM SO Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  16.157 MM    0.3582 2374.43384  110.47179  92.5542
2  17.005 MM    0.3118  191.01845   10.21050   7.4458
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\TAO\TAO 2015-08-10 09-00-31\001-0201.D
Sample Name: Tao-8-126
LC 1 8/10/2015 12:07:29 PM SO Page 2 of 2








In accordance with the general procedure, the title compound was obtained in 64% yield (42.0 mg, 
0.128 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 4% 
EtOAc/hexanes). 
Rf = 0.6 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 6.43 (dt, J = 5.8, 1.3 Hz, 1H), 4.48 (td, J = 7.5, 5.8 Hz, 1H), 3.69 
– 3.59 (m, 1H), 2.34 – 2.20 (m, 2H), 1.84 (d, J = 4.0 Hz, 1H), 1.49 – 1.40 (m, 3H), 1.36 – 1.24 (m, 
7H), 1.20 – 1.12 (m, 3H), 1.08 (d, J = 6.4 Hz, 18H), 0.91 – 0.84 (m, 3H). 
13C NMR (100 MHz, CDCl3): δ 141.3, 104.9, 71.9, 37.0, 31.9, 31.8, 29.4, 25.7, 22.6, 17.7, 14.1, 
11.9. 
LRMS (ESI) Calcd. for C19H40NaO2Si [M+Na]+: 351.3, Found: 351.3. 
FTIR (neat): 2928, 2867, 1654, 1464, 1258, 1104, 1055, 882, 684, 666 cm-1. 
HPLC (Chiralcel AD-H column/AD-H column/AD-H column, hexanes:i-PrOH = 99.7:0.3, 0.5 
mL/min, 210 nm), ee = 90%. 


















Acq. Operator   : KHOA                           Seq. Line :   2
Acq. Instrument : LC 1                            Location : Vial 11
Injection Date  : 11/18/2015 2:46:25 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\BOYOUNG\KHOA 2015-11-18 14-34-14\KHOA-99-01-05ML.M
Last changed    : 8/11/2015 1:28:25 PM by KHOA
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/8/2015 1:27:47 PM by KHOA
                  (modified after loading)
Sample Info     : Column: OJH x3 
                  Flow: 0.5 mL/min
                  Hex/IPA: 99/1
                  
 

































                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
Data File C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-18 14-34-14\011-0201.D
Sample Name: rac
LC 1 12/8/2015 1:27:53 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  36.653 MM    1.3654 1.39919e4   170.78845  50.0372
2 40.855 MM    1.3957 1.39710e4   166.83641  49.9628
 




                          *** End of Report ***
Data File C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-18 14-34-14\011-0201.D
Sample Name: rac
LC 1 12/8/2015 1:27:53 PM KHOA Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   6
Acq. Instrument : LC 1                            Location : Vial 14
Injection Date : 11/21/2015 1:09:30 PM            Inj :  1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-21 10-49-09\KHOA-99-01-05ML.M
Last changed    : 11/20/2015 1:41:37 PM by KHOA
Analysis Method : C:\CHEM 2\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/8/2015 1:23:33 PM by KHOA
                  (modified after loading)

























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  36.196 BB    1.1955 2.14855e4   275.60040  94.9778
   2  40.091 MM    1.2029 1136.10657   15.74072   5.0222
 
Totals :                  2.26216e4   291.34112
 
Data File C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-21 10-49-09\014-0601.D
Sample Name: NK_5123A_TolBINAP
LC 1 12/8/2015 1:24:10 PM KHOA Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : KHOA                           Seq. Line :   6
Acq. Instrument : LC 1                            Location : Vial 14
Injection Date  : 11/21/2 15 1: 9:30 PM                Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-21 10-49-09\KHOA-99-01-05ML.M
Last changed    : 11/20/2015 1:41:37 PM by KHOA
Analysis Method : C:\CHEM32\1\METHODS\TAO-9901-05ML-60MIN.M
Last changed    : 12/8/2015 1:23:33 PM by KHOA
                  (modified after loading)

























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 C, Sig=230,8 Ref=360,100
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  36.196 BB    1.1955 2.14855e4   275.60040  94.9778
2 40.091 MM    1.2029 1136.10657   15.74072   5.0222
 
Totals :               2.26216e4   291.34112
 
Data File C:\CHEM32\1\DATA\KHOA\KHOA 2015-11-21 10-49-09\014-0601.D
Sample Name: NK_5123A_TolBINAP
LC 1 12/8/2015 1:24:10 PM KHOA Page 1 of 2








In accordance with the general procedure, the title compound was obtained in 63% yield (35.8 mg, 
0.126 mmol, Z:E = >20:1) as a yellow liquid after column chromatography (SiO2; 5% 
EtOAc/hexanes). 
Rf = 0.55 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3): δ 6.42 (dt, J = 5.8, 1.3 Hz, 1H), 4.55 (td, J = 7.5, 5.8 Hz, 1H), 2.98 
– 2.89 (m, 1H), 2.45 – 2.40 (m, 2H), 1.98 (d, J = 3.3 Hz, 1H), 1.20 – 1.13 (m, 3H), 1.10 – 1.07 
(m, 18H), 0.98 – 0.89 (m, 1H), 0.53 – 0.44 (m, 2H), 0.36 – 0.28 (m, 1H), 0.24 – 0.17 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 141.2, 105.0, 31.7, 17.7, 17.3, 11.9, 2.7, 2.3. 
LRMS (ESI) Calcd. for C16H32NaO2Si [M+Na]+: 307.2, Found: 307.2. 
FTIR (neat): 2944, 2867, 1655, 1464, 1252, 1113, 1058, 882, 683, 669 cm-1. 
HPLC (Chiralcel OD-H column, hexanes:i-PrOH = 99:1, 1 mL/min, 210 nm), ee = 95%.  



















Acq. Operator   : GANG                           Seq. Line :   2
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 8/10/2015 3:47:06 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\TAO-9901-1ML-60MIN.M
Last changed    : 8/10/2015 4:11:25 PM by GANG
                  (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 8/10/2015 4:53:40 PM by GANG
                  (modified after loading)
Sample Info     : OD3
                  
 





















                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\010-0201.D
Sample Name: Tao-8-127
LC 2 8/10/2015 4:54:18 PM GANG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  14.407 BB    0.3855 1688.31445   68.03547  50.1816
2 16.292 BB    0.4481 1676.09619   58.52392  49.8184
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\010-0201.D
Sample Name: Tao-8-127
LC 2 8/10/2015 4:54:18 PM GANG Page 2 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
=====================================================================
Acq. Operator   : GANG                           Seq. Line :   4
Acq. Instrument : LC 2                            Location : Vial 10
Injection Date  : 8/10/2015 4:25:50 PM                 Inj :   1
                                                Inj Volume : 5.0 µl
Acq. Method     : C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\TAO-9901-1ML-60MIN.M
Last changed    : 8/10/2015 4:50:41 PM by GANG
                (modified after loading)
Analysis Method : C:\CHEM32\2\METHODS\JACKY_WASH.M
Last changed    : 8/10/2015 4:55:08 PM by GANG
               (modified after loading)
Sample Info     : OD3
                  
 


























                         Area Percent Report                         
=====================================================================
 
Sorted By             :      Signal
Multiplier:                   :      1.0000
Dilution:                     :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: DAD1 B, Sig=210,8 Ref=360,100
 
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\010-0401.D
Sample Name: Tao-8-128
LC 2 8/10/2015 4:56:56 PM GANG Page 1 of 2
Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [mAU*s]     [mAU]        %
----|-------|----|-------|----------|----------|--------|
   1  18.826 BB    0.4891 2040.42163   64.50284  97.5523
   2  21.811 MM    0.5485   51.19666    1.55563   2.4477
 




                          *** End of Report ***
Data File C:\CHEM32\2\DATA\TAO\TAO_1SAMPLE 2015-08-10 15-34-54\010-0401.D
Sample Name: Tao-8-128
LC 2 8/10/2015 4:56:56 PM GANG Page 2 of 2




General Procedure and Preparation of 4.4a, 4.4c, 4.4e, 4.4f, 4.4h, 4.4j 
 
To a solution of adduct 4.3 (0.20 mmol) in THF (1 mL) at 0 °C was added TBAF (0.22 mL, 110 
mol%, 1M in THF) via syringe. The mixture was stirred at 0 °C for 30 min, at which point water 
was added and the mixture was extracted by DCM (3 x 1 mL). The organic layer was washed by 
brine, dried (Na2SO4) and filtered with the aid of DCM. The filtrate was evaporated to 2 mL and 
4 Å MS (100 mg), NaOAc (8.2 mg, 0.10 mmol) and PCC (86.2 mg, 0.40 mmol) were added, and 
the mixture was stirred at room temperature for 24 hours. The solvents were removed in vacuo and 










In accordance with the general procedure, the title compound was obtained in 73% yield (23.7 mg, 
0.146 mmol) as a colorless liquid after column chromatography (SiO2; 12% EtOAc/hexanes). 
Rf = 0.2 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.44 – 7.30 (m, 5H), 5.52 (t, J = 6.8 Hz, 1H), 2.71 – 2.62 (m, 3H), 
2.27 – 2.13 (m, 1H).	
13C NMR (100 MHz, CDCl3): δ 176.9, 139.3, 128.8, 128.4, 125.3, 81.2, 31.0, 29.0. 
LRMS (CI) Calcd. for C10H11O2 [M+H]+: 163, Found: 163. 
FTIR (neat): 1770, 1365, 1216, 1176, 1141, 1019, 940, 759, 700 cm-1. 
















In accordance with the general procedure, the title compound was obtained in 87% yield (41.8 mg, 
0.174 mmol) after column chromatography (SiO2; 12% EtOAc/hexanes). 
Rf = 0.2 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.49 (m, 2H), 7.24 – 7.18 (m, 2H), 5.46 (t, J = 6.3 Hz, 1H), 
2.72 – 2.61 (m, 3H), 2.21 – 2.06 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 176.5, 138.4, 131.9, 126.9, 122.4, 80.4, 30.9, 28.8. 
LRMS (ESI) Calcd. for C10H10BrO2 [M+H]+: 241, Found: 241. 
FTIR (neat): 1771, 1365, 1216, 1173, 1140, 1010, 938, 806 cm-1. 
















In accordance with the general procedure, the title compound was obtained in 85% yield (32.6 mg, 
0.17 mmol) as a colorless liquid after column chromatography (SiO2; 14% EtOAc/hexanes). 
Rf = 0.15 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.27 (m, 1H), 6.92 – 6.83 (m, 3H), 5.49 (dd, J = 8.0, 6.1 Hz, 
1H), 3.82 (s, 3H), 2.71 – 2.60 (m, 3H), 2.24 – 2.13 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 176.9, 159.9, 141.0, 129.9, 117.3, 113.9, 110.7, 81.0, 55.3, 31.0, 
28.9. 
LRMS (ESI) Calcd. for C11H13O3 [M+H]+: 193, Found: 193. 
FTIR (neat): 1772, 1262, 1157, 1140, 1031, 909, 789, 698 cm-1. 















In accordance with the general procedure, the title compound was obtained in 79% yield (32.5 mg, 
0.158 mmol) as a colorless liquid after column chromatography (SiO2; 14% EtOAc/hexanes). 
Rf = 0.15 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 6.83 – 6.78 (m, 3H), 5.97 (s, 2H), 5.41 (dd, J = 8.5, 6.3 Hz, 1H), 
2.67 – 2.55 (m, 3H), 2.24 – 2.10 (m, 1H).	
13C NMR (100 MHz, CDCl3): δ 176.7, 148.1, 147.8, 133.0, 119.2, 108.3, 106.0, 101.3, 81.3, 31.0, 
29.1.	
LRMS (ESI) Calcd. for C11H10NaO4 [M+Na]+: 229, Found: 229. 
FTIR (neat): 1767, 1504, 1491, 1446, 1248, 1176, 1141, 1035, 931, 910, 805 cm-1. 















In accordance with the general procedure, the title compound was obtained in 77% yield (21.6 mg, 
0.154 mmol) as a colorless liquid after column chromatography (SiO2; 10% EtOAc/hexanes). 
Rf = 0.25 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 5.23 (dp, J = 8.7, 1.3 Hz, 1H), 5.23 – 5.12 (m, 1H), 2.57 – 2.50 (m, 
2H), 2.40 – 2.30 (m, 1H), 1.97 – 1.85 (m, 1H), 1.76 (d, J = 1.4 Hz, 3H), 1.73 (d, J = 1.4 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 177.2, 139.8, 122.8, 77.6, 29.3, 29.2, 25.7, 18.4. 
LRMS (ESI) Calcd. for C8H12NaO2 [M+Na]+: 163, Found: 163. 
FTIR (neat): 1772, 1376, 1228, 1217, 1177, 1007, 913 cm-1. 















In accordance with the general procedure, the title compound was obtained in 74% yield (32.6 mg, 
0.148 mmol) as a colorless liquid after column chromatography (SiO2; 20% EtOAc/hexanes). 
Rf = 0.1 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.40 – 7.26 (m, 5H), 4.77 – 4.64 (m, 1H), 4.53 (d, J = 11.9 Hz, 
1H), 4.49 (d, J = 11.8 Hz, 1H), 3.68 – 3.58 (m, 2H), 2.55 (d, J = 7.1 Hz, 1H), 2.52 (d, J = 6.8 Hz, 
1H), 2.41 – 2.27 (m, 1H), 2.05 – 1.85 (m, 3H). 
13C NMR (100 MHz, CDCl3): δ 177.1, 138.1, 128.4, 127.7, 127.7, 78.2, 73.3, 66.3, 35.8, 28.8, 
28.1.	
LRMS (ESI) Calcd. for C13H16NaO3 [M+Na]+: 243, Found: 243. 
FTIR (neat): 1739, 1365, 1229, 1217, 1093, 905, 742 cm-1. 











General Procedure and Preparation of 4.5a, 4.5c, 4.5e, 4.5f, 4.5j, 4.5k 
 
To a solution of adduct 4.3 (0.20 mmol) in DCM (1.7 mL) at -20 °C was added a solution of m-
CPBA (0.22 mmol, 110 mol%) in DCM (1.0 mL) over one hour via syringe pump. The reaction 
mixture was allowed to stir at -20 °C for 1h, and then was allowed to stir at 0 °C for 24 hours. To 
the reaction mixture was added saturated NaHCO3 (aq). The reaction mixture was transferred to a 
separatory funnel and the organic layer was washed with saturated NaHCO3(aq), water, and brine. 
The organic layer was collected, dried (Na2SO4) and filtered. The solvents were removed in vacuo 









In accordance with the general procedure, the title compound was obtained in 74% yield (49.7 mg, 
0.148 mmol) as a colorless liquid after column chromatography (SiO2; 16% EtOAc/hexanes). 
Rf = 0.5 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.47 – 7.41 (m, 2H), 7.35 – 7.28 (m, 2H), 7.27 – 7.22 (m, 1H), 5.44 
(s, 1H), 5.29 (dd, J = 10.1, 6.1 Hz, 1H), 4.30 – 4.24 (m, 1H), 2.26 (ddd, J = 13.3, 6.2, 1.0 Hz, 1H), 
2.18 (ddd, J = 13.4, 10.1, 4.0 Hz, 1H), 1.73 (d, J = 4.7 Hz, 1H), 1.20 – 1.12 (m, 3H), 1.09 (d, J = 
5.8 Hz, 18H). 
13C NMR (100 MHz, CDCl3): δ 142.8, 128.1, 127.3, 126.6, 103.1, 81.2, 78.8, 41.0, 17.9, 17.8, 
12.0.	
LRMS (ESI) Calcd. for C19H33O3Si [M+H]+: 337, Found: 337. 
FTIR (neat): 2943, 2866, 1463, 1085, 1065, 1025, 996, 882, 755, 699, 682 cm-1. 















In accordance with the general procedure, the title compound was obtained in 73% yield (60.4 mg, 
0.146 mmol) as a colorless liquid after column chromatography (SiO2; 15% EtOAc/hexanes). 
Rf = 0.3 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.46 – 7.41 (m, 2H), 7.34 – 7.28 (m, 2H), 5.42 (s, 1H), 5.24 (dd, J 
= 10.2, 6.0 Hz, 1H), 4.26 (d, J = 4.0 Hz, 1H), 2.25 (dd, J = 13.3, 6.1 Hz, 1H), 2.11 (ddd, J = 13.4, 
10.2, 4.1 Hz, 1H), 1.77 (s, 1H), 1.17 – 1.12 (m, 3H), 1.08 (d, J = 5.6 Hz, 18H). 
13C NMR (100 MHz, CDCl3): δ 142.0, 131.2, 128.3, 121.1, 103.2, 80.5, 78.6, 41.0, 17.9, 17.8, 
12.0. 
LRMS (ESI) Calcd. for C19H32BrO3Si [M+H]+: 415, Found: 415. 
FTIR (neat): 2942, 2866, 1176, 1026, 1009, 995, 881, 816, 683, 661 cm-1. 















In accordance with the general procedure, the title compound was obtained in 66% yield (48.3 mg, 
0.132 mmol) as a colorless liquid after column chromatography (SiO2; 15% EtOAc/hexanes). 
Rf = 0.3 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.25 – 7.19 (m, 1H), 7.04 – 6.97 (m, 2H), 6.81 – 6.76 (m, 1H), 5.43 
(s, 1H), 5.27 (dd, J = 10.1, 6.1 Hz, 1H), 4.29 – 4.22 (m, 1H), 3.79 (s, 3H), 2.24 (ddd, J = 13.3, 6.1, 
1.0 Hz, 1H), 2.17 (ddd, J = 13.3, 10.2, 4.0 Hz, 1H), 1.78 (s, 1H), 1.18 – 1.12 (m, 3H), 1.11 – 1.07 
(m, 18H). 
13C NMR (100 MHz, CDCl3): δ 159.6, 144.5, 129.1, 118.8, 113.0, 111.8, 103.3, 81.0, 78.7, 55.2, 
40.9, 17.9, 17.8, 12.0. 
LRMS (ESI) Calcd. for C20H35O4Si [M+H]+: 367, Found: 367. 
FTIR (neat): 2944, 2866, 1464, 1263, 1078, 1027, 995, 882, 788, 683 cm-1. 















In accordance with the general procedure, the title compound was obtained in 71% yield (54.0 mg, 
0.142 mmol) as a colorless liquid after column chromatography (SiO2; 15% EtOAc/hexanes). 
Rf = 0.4 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.01 (d, J = 1.7 Hz, 1H), 6.84 (ddd, J = 8.0, 1.7, 0.6 Hz, 1H), 6.73 
(dd, J = 7.9, 0.4 Hz, 1H), 5.94 – 5.92 (m, 2H), 5.39 (s, 1H), 5.20 (dd, J = 10.0, 6.2 Hz, 1H), 4.27 
– 4.21 (m, 1H), 2.20 (ddd, J = 13.4, 6.2, 1.0 Hz, 1H), 2.13 (ddd, J = 13.5, 10.0, 3.9 Hz, 1H), 1.74 
(s, 1H), 1.19 – 1.12 (m, 3H), 1.11 – 1.07 (m, 18H). 
13C NMR (100 MHz, CDCl3): δ 147.7, 146.8, 136.8, 120.0, 107.7, 107.3, 103.0, 100.9, 81.2, 78.7, 
41.09, 17.9, 17.8, 12.0. 
LRMS (ESI) Calcd. for C20H33O5Si [M+H]+: 381, Found: 381. 
FTIR (neat): 2943, 2866, 1488, 1446, 1247, 1080, 1025, 937, 882, 804, 682 cm-1. 















In accordance with the general procedure, the title compound was obtained in 61% yield (48.1 mg, 
0.122 mmol) as a colorless liquid after column chromatography (SiO2; 14% EtOAc/hexanes). 
Rf = 0.3 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 7.35 – 7.26 (m, 5H), 5.24 (s, 1H), 4.53 (d, J = 12.0 Hz, 1H), 4.48 
(d, J = 11.9 Hz, 1H), 4.46 – 4.37 (m, 1H), 4.16 – 4.10 (m, 1H), 3.62 (dd, J = 7.2, 5.8 Hz, 2H), 2.03 
– 1.86 (m, 4H), 1.27 – 1.23 (m, 1H), 1.11 – 1.07 (m, 3H), 1.07 – 1.03 (m, 18H). 
13C NMR (100 MHz, CDCl3): δ 138.5, 128.3, 127.6, 127.5, 102.5, 78.2, 76.3, 73.03, 67.7, 38.1, 
38.0, 17.8(3), 17.7(7), 12.0. 
LRMS (ESI) Calcd. for C22H39O4Si [M+H]+: 395, Found: 395. 
FTIR (neat): 2942, 2866, 1101, 1046, 1009, 994, 882, 832, 736, 683, 659 cm-1. 














In accordance with the general procedure, the title compound was obtained in 63% yield (43.3 mg, 
0.126 mmol) as a colorless liquid after column chromatography (SiO2; 12% EtOAc/hexanes). 
Rf = 0.5 (20% EtOAc/Hexanes). 
1H NMR (400 MHz, CDCl3) δ 5.24 (s, 1H), 4.28 – 4.19 (m, 1H), 4.13 (d, J = 3.7 Hz, 1H), 1.96 
(ddd, J = 13.2, 6.3, 0.9 Hz, 1H), 1.89 (ddd, J = 13.3, 9.2, 4.1 Hz, 1H), 1.76 – 1.63 (m, 1H), 1.57 – 
1.39 (m, 2H), 1.36 – 1.19 (m, 8H), 1.11 – 1.01 (m, 21H), 0.88 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 102.4, 79.3, 78.3, 38.0, 37.9, 31.8, 29.3, 26.3, 22.6, 17.8(4), 
17.7(7), 14.1, 12.0. 
LRMS (ESI) Calcd. for C19H41O3Si [M+H]+: 345, Found: 345. 
FTIR (neat): 2929, 2866, 1464, 1107, 1029, 1010, 994, 882, 683, 657 cm-1. 















To a solution of 4.3a (0.2 mmol) in THF (2.0 mL) was added TBAF (1.0 M in THF, 0.2 mL, 100 
mol%) dropwise at 0ºC. The mixture was stirred at r.t for 30 min, then NaBH4 (14.8 mg, 0.4 mmol), 
EtOH (1.0 mL) were added. After 1 h, the reaction was quenched by NH4Cl (aq), and extracted by 
EA. Organic layer was washed by water, brine, dried over Na2SO4, and concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2, eluent Hexanes:EA = 2:1) to afford 
diol 4.6a (95%). 
1H NMR (400 MHz, CDCl3) δ 7.35 – 7.23 (m, 5H), 4.70 (t, J = 6.2 Hz, 1H), 3.68 – 3.58 (m, 2H), 
3.10 (bs. 2H), 1.89 – 1.83 (m, 2H), 1.74 – 1.61 (m, 2H).	
13C NMR (100 MHz, CDCl3): δ 144.7, 128.4, 127.4, 125.8, 74.2, 62.6, 36.3, 29.1.	
The spectroscopy data (1H, 13C NMR) matched the literature data1  
Optical rotation of 4.6a: [α]25D = - 31.0 (c = 1.0, MeOH) (94% ee). Literature1 optical rotation for 
(S)-1-phenylbutane-1,4-diol: [α]20D = - 33.5 (c = 1.0, MeOH) (98.7% ee) 


























Chapter 5: Ruthenium Catalyzed Redox-Triggered Carbonyl anti-(α-
Amino)allylation by Coupling with Acetylenic Pyrrole* 
5.1 INTRODUCTION 
2-Amino alcohols are common moieties found in natural products and fine chemicals.1 
While there are very few reports on the construction of 2-amino alcohol moieties. Barrett reported 
asymmetric syntheses of anti-β-amino alcohols by coupling of allylborane with aldehydes (Figure 
5.1).2 To come up with an alternative to nonstabilized carbanion addition to carbonyl compounds, 
Krische group has developed a broad system of catalytic carbonyl addition reactions by coupling 
of carbonyl compounds with different π-unsaturated compounds, which allowed the direct 
conversion of primary alcohols to secondary alcohol. 3 
In 2009, Krische group reported the carbonyl anti-(α-amino)allylation by coupling of N-
substituted allenes with aldehyde under ruthenium catalysis via 2-propanol mediated reductive 
coupling.4 Later, Krische group also reported the redox-neutral coupling between N-substituted 
allenes and primary alcohols under ruthenium catalysis, which also represented a byproduct free 
protocol.5 However, to achieve a good anti-diastereoselectivity, the protecting groups on the 
nitrogen atom are very crucial. Both p-nitrobenzenesulfonyl and 2,4-dimethyloxybenzyl 
protecting groups were required, so the elaboration of the coupling products was limited. A more 
desirable protecting group for amines was found, by which the amines was protect as 2,5-
dimethylpyrrole and could be removed easily by treatment with hydroxylamine hydrochloride.6  
Also, we found alkynes could be a precursor to allenes7,8 under ruthenium catalysis via 
isomerization, and then allenes were converted to π-allylruthenium species through 
hydrometalation. 8  
In this chapter, a more desirable allyl donor for carbonyl anti-(α-amino)allylation was 
reported, N-propynyl-2,5-dimethylpyrrole 5.1, which served as a pronucleophiles in carbonyl anti-
(α-amino)allylation (Scheme 5.1).  
                                                
*This chapter is based on the published work:  






Figure 5.1 Classical Carbonyl (α-Amino)allylation and Catalytic Carbonyl (α-Amino)allylation 
via Coupling of Alcohols with Alkyne. 
 
5.2 REACTION DEVELOPMENT AND SCOPE 
Initially p-bromobenzyl alcohol 5.2a was subjected to acetylenic pyrrole 5.1 with 
HClRu(CO)(PPh3)3 and bidentate phosphine ligands, and dippf was found to be the optimal ligand 
for this transformation. Further optimization of solvents and temperature, carbonyl (α-













aYields are material isolated by silica gel chromatography. See supporting Information for further 
experimental details. b2-PrOH (200 mol%). c48 h. dDioxane (1.0 M). 
 
The optimal condition was applied to coupling of 5.1 with diverse primary alcohols (Table 
5.1). Benzylic alcohols 5.2a-5.2h and heterobenzylic alcohols 5.2i-5.2m were converted to 
addition adduct with good to excellent yields. To our delight, different substituents on the aromatic 
rings were tolerable. Notably, different heterocycles, such as furan, benzothiophene, pyridine, 
pyrimidine, and oxazole, were tolerant under the standard condition. Allylic alcohols 5.2n-5.2o 
and aliphatic alcohols 5.2p-5.2u were also engaged in the coupling with good yields. The 1 mmol 
scale was conducted with p-bromobenzyl alcohol, and 74% yield was obtained.  
A side reaction was found during the formation of 5.3i, 5.3k and 5.3n, which was formation 
of α, β-unsaturated ketones. By introduction of 2-propanol, the side reaction was suppressed. The 
reaction could proceed not only in redox-neutral manner, but also reductive coupling mediated by 
2-propanol. Exposure of acetylenic pyrrole 5.1 to p-bromobenzaldehyde with ruthenium catalyst, 







Deprotection of the coupling adducts were explored for 5.3b, 5.3n, and 5.3q derived from 
aromatic, allylic, and aliphatic alcohols 5.2b, 5.2n, and 5.2q. The coupling adducts were treated 
with hydroxylamine hydrochloride in aqueous ethanol under heating, followed by N-Boc-
protection of the resulting 2-amino alochols. Vicinal amino alcohols 5.4b, 5.4n, and 5.4q were 
isolated in good yields (Scheme 5.1).  
 







Finally, to demonstrate the utility of this transformation, Boc-protected amino alcohol 5.4b 
was converted to α-amino-β-hydroxyl amino ester 5.5b via oxidative cleavage of alkene9 followed 
by treatment with TMS diazomethane (eq 2). 
5.3 MECHANISM AND DISCUSSION 
To obtain further insight in this transformation, the competition experiments were 
conducted (Scheme 5.2). When equimolar quantities of alcohol 5.2a and aldehyde dehydro-5.2d 
were subjected to the standard reaction conditions, the coupling adducts 5.3a and 5.3d were 
produced with roughly 3:1 ratio. When the oxidation level of alcohol and aldehyde was inversed, 
similar coupling adduct ratio was obtained under the same reaction conditions. These data 
indicated that dehydrogenation of primary alcohols was rapid and reversible and carbonyl addition 
was the turnover limiting step. 
 
 
Scheme 5.2 Competition Experiments Corroborating Rapid Reversible Dehydrogenation with 






In summary, anti-diastereoselective carbonyl (α-amino)allylation by coupling of primary 
alcohols and acetylenic pyrrole 5.1 under ruthenium catalysis was reported. The coupling 
proceeded through two discrete catalytic cycle: alkyne-to-allene isomerization and allene-carbonyl 
coupling via transfer hydrogenation. This process also represented a byproduct free protocol. 
5.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. Resealable 
pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog number 14–959–
35C) and were flame dried followed by cooling in a desiccator or under a stream of argon prior to 
use. Tetrahydrofuran (THF) was dried over sodium metal, benzophenone, and distilled 
immediately prior to use. RuH2(PPh3)3 were prepared according to literature procedure.1 All 
ligands were used as received from Strem Chemicals Inc. Alcohols were purified by distillation or 
recrystallization immediately prior to use. Preparative column chromatography employing 
Silicycle silica gel (40-63 µm) was performed according to the method of Still.2 Analytical thin-
layer chromatography (TLC) was carried out using 0.25 mm commercial silica gel plates 
(Dynamic Absorbents F254). Visualization was accomplished with UV light followed by dipping 
in Seebach’s stain solution then heating. Purification of reactions was carried out by flash 





Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-resolution mass spectra 
(LRMS) were obtained on a Karatos MS9 and are reported as m/z (relative intensity). Accurate 
masses are reported for the molecular ion (M+H, M+Na), or a suitable fragment ion. Proton nuclear 
magnetic resonance (1H NMR) spectra were recorded with a Varian Gemini (400 MHz) 
spectrometer. Chemical shifts are reported in delta (δ) units, parts per million (ppm) downfield 
from tetramethylsilane or ppm relative to the center of the singlet at 7.26 ppm for 
deuteriochloroform. Data reported as multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet). Integration and coupling constants were reported in Hertz (Hz). Carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded with a Varian Gemini (100 MHz) 
spectrometer and were routinely run with broadband decoupling. Chemical shifts are reported in 





Experimental Details and Spectral Data 




To a solution of propargyl amine (2.75 g, 50 mmol, 100 mol %) and 2,5-hexanedione (7.1 g, 50 
mmol, 100 mol %) in toluene (25 mL, 2.0 M) was added acetic acid (0.29 mL, 5 mmol, 10 mol %) 
dropwise. The reaction mixture was allowed to reflux for 1 hour and then cooled to room 
temperature. The reaction mixture was washed with saturated aqueous NH4Cl, NaHCO3, and brine. 
The solvent was removed in vacuo and afforded crude product as a brown solid.2 To the crude 
product dissolved in THF (100 mL, 0.5 M) under argon was added tert-BuOH (4.74 mL, 50 mmol, 
100 mol %) and tert-BuOK (1.68 g, 15 mmol, 30 mol %). The reaction was stirred at 50°C for 4 
hours until complete consumption of starting material as monitored by TLC. The reaction mixture 
was filtered through a short pad of celite and then washed with EtOAc. The filtrate was then 
washed with H2O. The solvent was removed in vacuo and the residue was subjected to column 
chromatography (SiO2; hexanes). The title compound was obtained in 41% yield (2.73 g, 20 mmol) 









Rf=0.4 (100% Hexanes). 
 
1H NMR (400 MHz, CDCl3):  δ 5.80 (s, 2H), 2.34 (s, 6H), 2.12 (s, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 131.0, 106.0, 70.5, 67.4, 12.5, 3.2. 
 
HRMS (ESI) Calcd. for C9H12N [M+H]+: 134.0964, Found: 134.0962. 
 










General Procedure for the Couplings of Alcohols 5.2a-5.2u and 5.1 
To a resealable pressure tube (13x100) were added HClRu(CO)(PPh3)3 (9.5 mg, 0.010 mmol, 5 
mol %) and dippf (4.2 mg, 0.010 mmol, 5 mol %). At this stage the solid alcohol coupling partners 
(0.20 mmol, 100 mol %) were added. The tube was sealed with a rubber septum and purged with 
argon. Dioxane (0.40 mL, 0.5 M) was added to the reaction vessel. At this stage, the liquid alcohol 
coupling partners (0.20 mmol, 100 mol %) were added. Acetylenic pyrrole 5.1 (0.60 mmol, 300 
mol %) was added to the reaction vessel and the rubber septum was quickly replaced with a screw 
cap. The mixture was allowed to stir at the indicated temperature for the indicated time. The 
reaction mixture was then allowed to cool to room temperature. The solvents were removed in 
vacuo and the residue was subjected to column chromatography (SiO2). 
 
1 mmol Scale Procedure  
To a resealable pressure tube were added HClRu(CO)(PPh3)3 (47.6 mg, 0.050 mmol, 5 mol %) and 
dippf (20.9 mg, 0.050 mmol, 5 mol %). At this stage the solid alcohol coupling partners (1.0 mmol, 
100 mol %) were added. The tube was sealed with a rubber septum and purged with argon. Dioxane 
(2.0 mL, 0.5 M) was added to the reaction vessel. At this stage, the liquid alcohol coupling partners 
(1.0 mmol, 100 mol %) were added. Acetylenic pyrrole 5.1 (3.0 mmol, 300 mol %) was added to 
the reaction vessel and the rubber septum was quickly replaced with a screw cap. The mixture was 
allowed to stir at the indicated temperature for the indicated time. The reaction mixture was then 
allowed to cool to room temperature. The solvents were removed in vacuo and the residue was 
subjected to column chromatography (SiO2). 
From Aldehyde Oxidation Level 




mmol, 100 mol %) was added. The tube was sealed with a rubber septum and purged with argon. 
Dioxane (0.4 mL, 0.5 M) was added to the reaction vessel. Acetylenic pyrrole 5.1 (0.6 mmol, 300 
mol %) was added to the reaction vessel followed by 2-propanol (0.6 mmol, 300 mol %) and the 
rubber septum was quickly replaced with a screw cap. The mixture was allowed to stir at the 
indicated temperature for the indicated time. The reaction mixture was then allowed to cool to 










In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 83% yield (53.2 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 10% 
EtOAc/hexanes). 
Comparable yield and equivalent diastereoselectivity was observed when the reaction was 
conducted on 1 mmol scale (74% yield, dr = > 20:1) and from aldehyde oxidation level (70% yield, 
dr = > 20:1). 
 
Rf =0.6 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 7.39 – 7.32 (m, 2H), 7.00 – 6.94 (m, 2H), 6.45 (ddd, J = 16.9, 
10.5, 6.2 Hz, 1H), 5.64 (s, 2H), 5.39 (dt, J = 10.5, 1.5 Hz, 1H), 5.18 (dt, J = 17.2, 1.5 Hz, 1H), 5.05 
(dd, J = 9.5, 2.5 Hz, 1H), 4.58 (ddt, J = 9.6, 6.3, 1.7 Hz, 1H), 2.27 (d, J = 2.8 Hz, 1H), 2.05 (s, 
6H). 
 
13C NMR (100 MHz, CDCl3): δ 140.19, 134.43, 131.38, 127.92, 127.75, 122.03, 119.91, 106.88, 
73.51, 64.18, 14.36. 
 
HRMS (ESI) Calcd. for C16H19BrNO [M+H]+: 320.0645, Found: 320.0643. 
 














In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 75% yield (38.9 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 10% 
EtOAc/hexanes). 
 
Rf =0.41 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.11 – 7.03 (m, 2H), 6.91 (t, J = 8.7 Hz, 2H), 6.47 (ddd, J = 16.9, 
10.4, 6.1 Hz, 1H), 5.63 (s, 2H), 5.39 (dd, J = 10.4, 1.5 Hz, 1H), 5.18 (dd, J = 17.2, 1.5 Hz, 1H), 
5.08 (dd, J = 9.5, 2.1 Hz, 1H), 4.62 – 4.54 (m, 1H), 2.31 (d, J = 2.7 Hz, 1H), 2.05 (s, 6H). 
 
19F NMR (100 MHz, CDCl3) δ -114.2. 
 
13C NMR (100 MHz, CDCl3) δ 162.6 (d, JC-F = 246.2 Hz), 136.9 (d, JC-F = 3.2 Hz), 134.6, 127.9, 
127.7 (d, JC-F = 8.0 Hz), 119.7, 115.2 (d, JC-F = 21.4 Hz), 106.8, 73.5, 64.4, 14.3. 
 
HRMS (ESI) Calcd. for C16H19FNO+ [M+H]+: 260.1451, Found: 260.1445. 
 




















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 96% yield (59.4 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 10% 
EtOAc/hexanes). 
 
Rf =0.40 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 6.47 (ddd, J = 
17.0, 10.4, 6.3 Hz, 1H), 5.65 (s, 2H), 5.42 (dt, J = 10.5, 1.4 Hz, 1H), 5.21 (dt, J = 17.2, 1.5 Hz, 
1H), 5.14 (dd, J = 9.5, 2.3 Hz, 1H), 4.64 – 4.57 (m, 1H), 2.41 (d, J = 2.8 Hz, 1H), 2.04 (s, 6H). 
 
19F NMR (100 MHz, CDCl3) δ -62.5. 
 
13C NMR (100 MHz, CDCl3) δ 145.1, 134.2, 130.2 (q, JC-F = 32.4 Hz), 128.0, 126.4, 125.2 (q, JC-
F = 3.8 Hz), 124.2 (q, JC-F = 272.0 Hz), 120.2, 107.0, 73.5, 64.2, 14.3. 
 
HRMS (ESI) Calcd. for C17H19F3NO+ [M+H]+: 310.1419, Found: 310.1415. 
 



















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 50% yield (27.1 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 10% 
EtOAc/hexanes). 
 
Rf =0.29 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.08 – 7.02 (m, 2H), 6.79 – 6.73 (m, 2H), 6.47 (ddd, J = 17.2, 10.4, 
6.0 Hz, 1H), 5.62 (s, 2H), 5.36 (dt, J = 10.4, 1.5 Hz, 1H), 5.13 (dt, J = 17.2, 1.5 Hz, 1H), 5.07 (dd, 
J = 9.4, 2.2 Hz, 1H), 4.64 (ddt, J = 9.4, 5.9, 1.7 Hz, 1H), 3.76 (s, 3H), 2.17 (d, J = 2.6 Hz, 1H), 
2.07 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 159.4, 135.0, 133.4, 128.0, 127.2, 119.2, 113.7, 106.5, 73.9, 64.3, 
55.3, 14.4. 
 
HRMS (ESI) Calcd. for C17H21NO2Na+ [M+Na]+: 294.1470, Found: 294.1452. 
 
















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 71% yield (38.5 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 7.5-
10% EtOAc/hexanes). 
 
Rf =0.37 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.15 (t, J = 7.9 Hz, 1H), 6.77 (dd, J = 8.0, 2,2 Hz, 2H), 6.57 (t, J = 
2.1 Hz, 1H), 6.48 (ddd, J = 17.3, 10.5, 6.0 Hz, 1H), 5.64 (s, 2H), 5.38 (dt, J = 10.5, 1.5 Hz, 1H), 
5.17 (dt, J = 17.2, 1.5 Hz, 1H), 5.06 (dd, J = 9.4, 2.5 Hz, 1H), 4.63 (ddt, J = 9.4, 6.1, 1.7 Hz, 1H), 
3.70 (s, 3H), 2.31 (d, J = 2.8 Hz, 1H), 2.06 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 159.5, 142.9, 134.8, 129.3, 128.1, 119.5, 118.1, 114.2, 111.1, 
106.6, 74.1, 64.1, 55.3, 14.3. 
 
HRMS (ESI) Calcd. for C17H21NO2Na+ [M+Na]+: 294.1470, Found: 294.1457. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 86% yield (47.4 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 8% 
EtOAc/hexanes). 
 
Rf =0.43 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 7.6, 1.8 Hz, 1H), 7.30 (dd, J = 7.8, 1.5 Hz, 1H), 7.33 
– 7.17 (m, 2H), 6.46 (ddd, J = 17.0, 10.4, 6.5 Hz, 1H), 5.67 (s, 2H), 5.47 (dd, J = 7.9, 3.7 Hz, 1H), 
5.29 (dt, J = 10.4, 1.4 Hz, 1H), 5.05 (dt, J = 17.2, 1.4 Hz, 1H), 5.01 – 4.94 (m, 1H), 2.53 (d, J = 
4.2 Hz, 1H), 2.22 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 138.3, 133.9, 132.6, 129.8, 129.3, 128.9, 128.7, 127.1, 119.6, 
106.8, 72.3, 62.4, 14.5. 
 
HRMS (ESI) Calcd. for C16H19ClNO+ [M+H]+: 276.1155, Found: 276.1147. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 73% yield (43.7 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 7.5%-
15% EtOAc/hexanes). 
 
Rf =0.22 (20% EtOAc/Hexanes) 
	
1H NMR (400 MHz, CDCl3) δ 7.90 – 7.83 (m, 2H), 7.19 – 7.13 (m, 2H), 6.47 (ddd, J = 16.9, 10.5, 
6.1 Hz, 1H), 5.62 (s, 2H), 5.39 (dt, J = 10.5, 1.4 Hz, 1H), 5.18 (dt, J = 17.2, 1.5 Hz, 1H), 5.14 (dd, 
J = 9.3, 2.1 Hz, 1H), 4.62 (ddt, J = 9.4, 6.2, 1.7 Hz, 1H), 3.87 (s, 3H), 2.53 (d, J = 2.9 Hz, 1H), 
2.03 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 167.1, 146.4, 134.4, 129.7, 129.5, 127.9, 126.1, 119.9, 106.9, 73.7, 
64.1, 52.2, 14.3. 
 
HRMS (ESI) Calcd. for C18H21NO3Na+ [M+Na]+: 322.1419, Found: 322.1414. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 73% yield (53.3 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 7.5%-
12.5% EtOAc/hexanes). 
 
Rf =0.28 (20% EtOAc/Hexanes) 
	
1H NMR (400 MHz, CDCl3) δ 7.57 (d, J = 2.1 Hz, 1H), 7.50 (d, J = 8.3 Hz, 1H), 6.91 (dd, J = 8.3, 
2.2 Hz, 1H), 6.45 (ddd, J = 17.1, 10.4, 6.5 Hz, 1H), 5.67 (s, 2H), 5.46 (dt, J = 10.4, 1.3 Hz, 1H), 
5.28 (dt, J = 17.2, 1.4 Hz, 1H), 5.10 (dd, J = 9.7, 2.4 Hz, 1H), 4.51 (ddt, J = 9.6, 6.5, 1.6 Hz, 1H), 
2.56 (d, J = 2.8 Hz, 1H), 2.04 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 149.6, 142.3, 134.6, 133.7, 130.9, 127.8, 123.2, 121.0, 113.5, 
107.6, 72.4, 64.1, 14.4. 
 
HRMS (ESI) Calcd. for C16H17BrN2O3Na+ [M+Na]+: 387.0320, Found: 387.0304. 
 
FTIR (neat): 3458, 2978, 2928, 1736, 1707, 1536, 1393, 1373, 1357, 1291, 1243, 1044, 1031, 















In accordance with the general procedure at 125°C for 24 hours with 2-PrOH (200 mol%), the title 
compound was obtained in 71% yield (32.8 mg, dr = >20:1) as a yellow liquid after column 
chromatography (SiO2; 10% EtOAc/hexanes). 
 
Rf = 0.4 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 7.33 (d, J = 1.8 Hz, 1H), 6.40 (ddd, J = 17.3, 10.5, 5.0 Hz, 1H), 
6.23 (dd, J = 3.3, 1.8 Hz, 1H), 6.02 (d, J = 3.3 Hz, 1H), 5.66 (s, 2H), 5.33 (dt, J = 10.5, 1.6 Hz, 
1H), 5.17 (dd, J = 9.7, 4.5 Hz, 1H), 5.03 (dt, J = 17.2, 1.6 Hz, 1H), 4.95 (ddt, J = 9.4, 4.7, 2.0 Hz, 
1H), 2.41 (d, J = 4.7 Hz, 1H), 2.17 (s, 6H). 
 
13C NMR (100 MHz, CDCl3): δ 153.0, 142.3, 134.5, 128.1, 118.4, 110.6, 107.7, 106.5, 68.6, 61.4, 
14.0. 
 
HRMS (ESI) Calcd. for C14H17NaNO2 [M+Na]+: 254.1151, Found: 254.1151. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 87% yield (51.8 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 5%-1
0% EtOAc/hexanes). 
 
Rf =0.38 (20% EtOAc/Hexanes) 
	
1H NMR (400 MHz, CDCl3) δ 7.81 – 7.75 (m, 1H), 7.67 – 7.59 (m, 1H), 7.34 – 7.25 (m, 2H), 6.80 
(d, J = 0.9 Hz, 1H), 6.45 (ddd, J = 17.2, 10.5, 5.6 Hz, 1H), 5.71 (s, 2H), 5.47 (dd, J = 9.4, 3.1 Hz, 
1H), 5.38 (dt, J = 10.5, 1.5 Hz, 1H), 5.10 (dt, J = 17.2, 1.5 Hz, 1H), 4.80 (ddt, J = 9.3, 5.6, 1.8 Hz, 
1H), 2.70 (d, J = 3.4 Hz, 1H), 2.17 (s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 145.2, 139.6, 139.3, 134.2, 128.3, 124.3, 123.7, 122.5, 121.3, 
119.4, 106.9, 71.2, 63.7, 14.4. 
 
HRMS (ESI) Calcd. for C18H20NOS+ [M+H]+: 298.1266, Found: 298.1255. 
 















In accordance with the general procedure at 125°C for 48 hours, the title compound was obtained 
in 70% yield (38.1 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 20% 
EtOAc/hexanes). 
 
Rf = 0.13 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 7.89 (d, J = 2.4 Hz, 1H), 7.25 (dd, J = 8.6, 2.5 Hz, 1H), 6.58 (d, J 
= 8.6 Hz, 1H), 6.45 (ddd, J = 16.7, 10.5, 5.9 Hz, 1H), 5.64 (s, 2H), 5.38 (dt, J = 10.5, 1.5 Hz, 1H), 
5.16 (dt, J = 17.2, 1.5 Hz, 1H), 5.07 (d, J = 9.5 Hz, 1H), 4.63 (ddt, J = 9.5, 5.9, 1.7 Hz, 1H), 3.87 
(s, 3H), 2.62 (s, 1H), 2.08 (s, 6H). 
 
13C NMR (100 MHz, CDCl3): δ 164.1, 144.8, 136.8, 134.6, 129.4, 127.8, 119.6, 110.5, 107.0, 
72.0, 64.0, 53.6, 14.4. 
 
HRMS (ESI) Calcd. for C16H21N2O2 [M+H]+: 273.1598, Found: 273.1603. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 94% yield (60.0 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 20% 
EtOAc/hexanes). 
 
Rf = 0.14 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 8.38 – 8.34 (m, 2H), 8.33 (s, 2H), 7.51 – 7.42 (m, 3H), 6.44 (ddd, 
J = 17.2, 10.5, 5.9 Hz, 1H), 5.68 (s, 2H), 5.43 (dt, J = 10.5, 1.4 Hz, 1H), 5.27 – 5.19 (m, 1H), 5.07 
(dd, J = 9.8, 2.6 Hz, 1H), 4.64 (ddt, J = 9.6, 5.9, 1.7 Hz, 1H), 3.23 (d, J = 3.3 Hz, 1H), 2.05 (s, 
6H). 
 
13C NMR (100 MHz, CDCl3): δ 164.2, 155.4, 137.2, 134.0, 131.8, 131.0, 128.7, 128.3, 127.6, 
120.3, 107.8, 70.6, 63.7, 14.4. 
 
HRMS (ESI) Calcd. for C20H22N3O [M+H]+: 320.1757, Found: 320.1757. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 77% yield (47.5 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 20% 
EtOAc/hexanes). 
 
Rf = 0.4 (50% EtOAc/Hexanes). 
 
1H NMR (400 MHz, DMSO-d6): δ 7.91 – 7.79 (m, 2H), 7.56 – 7.45 (m, 3H), 7.02 (s, 1H), 6.41 
(ddd, J = 17.3, 10.5, 4.2 Hz, 1H), 6.29 (d, J = 6.0 Hz, 1H), 5.50 (s, 2H), 5..27 (dt, J =  10.6, 1.9 
Hz, 1H), 5.20 (dd, J = 10.0, 5.9 Hz, 1H), 4.95 (ddt, J = 10.1, 4.3, 2.1 Hz, 1H), 4.80 (dt, J = 17.3, 
1.8 Hz, 1H), 2.13 (s, 6H). 
 
13C NMR (100 MHz, DMSO-d6): δ 160.0, 152.2, 135.4, 130.5, 129.1, 127.1, 126.9, 125.6, 125.4, 
116.9, 106.2, 65.3, 60.4, 13.6. 
 
HRMS (ESI) Calcd. for C19H21N2O2 [M+H]+: 309.1598, Found: 309.1603. 
 
FTIR (neat): 3204, 3099, 2931, 1547, 1396, 1300, 1134, 1041, 977, 920, 824, 754, 713, 684 cm-
1. 
 















In accordance with the general procedure at 125°C for 24 hours with 2-PrOH (200 mol%), the title 
compound was obtained in 72% yield (38.5 mg, dr = >20:1) as a yellow liquid after column 
chromatography (SiO2; 10% EtOAc/hexanes). 
 
Rf = 0.38 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.21 (m, 5H), 6.63 (dd, J = 16.0, 1.4 Hz, 1H), 6.41 (ddd, J 
= 17.3, 10.5, 5.6 Hz, 1H), 5.88 (dd, J = 16.0, 5.6 Hz, 1H), 5.80 (s, 2H), 5.39 (dt, J = 10.5, 1.5 Hz, 
1H), 5.19 (dt, J = 17.2, 1.5 Hz, 1H), 4.84 – 4.76 (m, 1H), 4.61 (ddt, J = 7.2, 5.2, 2.6 Hz, 1H), 2.27 
(s, 6H), 2.09 (d, J = 3.9 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 136.6, 134.9, 131.4, 128.8, 128.6, 128.2, 127.9, 126.7, 118.9, 
106.9, 72.8, 63.2, 14.5. 
 
HRMS (ESI) Calcd. for C18H22NO [M+H]+: 268.1696, Found: 268.1700. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 73% yield (32.0 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 7.5%-
10% EtOAc/hexanes). 
 
Rf =0.40 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 6.35 (ddd, J = 17.2, 10.5, 5.6 Hz, 1H), 5.71 (s, 2H), 5.29 (dt, J = 
10.5, 1.6 Hz, 1H), 5.08 (ddq, J = 8.7, 2.8, 1.4 Hz, 1H), 5.02 (dt, J = 17.3, 1.6 Hz, 1H), 4.77 (td, J 
= 8.9, 3.5 Hz, 1H), 4.50 (ddt, J = 9.1, 5.6, 1.8 Hz, 1H), 2.21 (s, 6H), 1.68 (d, J = 3.6 Hz, 1H), 1.64 
(d, J = 1.4 Hz, 3H), 1.59 (d, J = 1.4 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 138.7, 135.0, 128.3, 124.3, 118.4, 106.4, 69.4, 62.9, 26.1, 18.3, 
14.4. 
 
HRMS (ESI) Calcd. for C14H22NO+ [M+H]+: 220.1701, Found: 220.1693. 
 















In accordance with the general procedure at 125°C for 48 hours, the title compound was obtained 
in 62% yield (30.9 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 5% 
EtOAc/hexanes). 
 
Rf = 0.55 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 6.29 (ddd, J = 17.2, 10.4, 5.7 Hz, 1H), 5.77 (s, 2H), 5.27 (dt, J = 
10.5, 1.5 Hz, 1H), 5.01 (dt, J = 17.2, 1.5 Hz, 1H), 4.38 (ddt, J = 9.2, 5.8, 1.7 Hz, 1H), 4.10 (tq, J = 
9.5, 6.3, 4.9 Hz, 1H), 2.20 (s, 6H), 1.82 (d, J = 4.5 Hz, 1H), 1.31 – 1.18 (m, 10H), 0.86 (t, J = 6.9 
Hz, 3H). 
 
13C NMR (100 MHz, CDCl3): δ 135.2, 128.1, 118.3, 106.7, 72.2, 63.5, 33.7, 31.9, 29.2, 25.6, 22.7, 
14.4, 14.2. 
 
HRMS (ESI) Calcd. for C16H27NaNO [M+Na]+: 272.1985, Found: 272.1989. 
 















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 73% yield (38.1 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 7.5%-
10% EtOAc/hexanes). 
 
Rf =0.41 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 6.25 (ddd, J = 16.8, 10.4, 6.2 Hz, 1H), 5.79 (s, 2H), 5.33 (dt, J = 
10.4, 1.4 Hz, 1H), 5.10 (dt, J = 17.1, 1.4 Hz, 1H), 4.37 (ddt, J = 9.4, 6.2, 1.6 Hz, 1H), 4.14 (tt, J = 
9.0, 4.0 Hz, 1H), 2.30 (dddd, J = 20.4, 9.3, 4.5, 2.8 Hz, 1H), 2.21 (s, 6H), 2.17 – 2.02 (m, 1H), 
1.97 (d, J = 4.6 Hz, 1H), 1.55 – 1.40 (m, 2H). 
 
19F NMR (100 MHz, CDCl3) δ -66.0. 
 
13C NMR (100 MHz, CDCl3) δ 134.4, 127.9, 127.3 (q, JC-F = 276.4 Hz), 119.4, 107.3, 70.7, 63.7, 
30.0 (q, JC-F = 29.0 Hz), 26.3 (q, JC-F = 3.3 Hz), 14.3. 
 
HRMS (ESI) Calcd. for C13H19F3NO+ [M+H]+: 262.1419, Found: 262.1416. 
 





















In accordance with the general procedure at 125°C for 24 hours, the title compound was obtained 
in 63% yield (38.9 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 20% 
EtOAc/hexanes). 
 
Rf = 0.17 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 6.35 (ddd, J = 17.4, 10.6, 4.2 Hz, 1H), 5.76 (s, 2H), 5.22 (d, J = 
10.5 Hz, 1H), 4.88 (d, J = 17.3 Hz, 1H), 4.75 (d, J = 6.7 Hz, 1H), 4.51 – 4.39 (m, 1H), 4.22 (d, J 
= 4.2 Hz, 1H), 4.15 – 4.06 (m, 1H), 3.61 – 3.47 (m, 1H), 2.98 (dq, J = 14.6, 4.6 Hz, 1H), 2.17 (s, 
6H), 1.44 (s, 9H), 1.26 (dq, J = 7.9, 5.3, 3.8 Hz, 1H), 1.16 (td, J = 12.1, 11.7, 6.7 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 157.9, 135.8, 128.2, 116.8, 106.6, 80.1, 68.8, 61.9, 36.6, 35.3, 
28.4, 14.2. 
 
HRMS (ESI) Calcd. for C17H29N2O3 [M+H]+: 309.2173, Found: 309.2171. 
 
FTIR (neat): 3368, 2977, 2932, 2361, 1687, 1518, 1448, 1397, 1367, 1290, 1252, 1169, 1006, 















In accordance with the general procedure at 125°C for 48 hours, the title compound was obtained 
in 61% yield (36.5 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 5%-
10% EtOAc/hexanes). 
 
Rf =0.38 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), 6.33 (ddd, J = 17.2, 10.5, 4.5 Hz, 1H), 5.76 
(s, 2H), 5.24 (dt, J = 10.5, 1.7 Hz, 1H), 4.92 (dt, J = 17.3, 1.7 Hz, 1H), 4.51 (d, J = 5.2 Hz, 2H), 
4.46 (ddt, J = 11.8, 4.4, 2.2 Hz, 1H), 4.36 (tt, J = 9.8, 2.1 Hz, 1H), 3.71 (ddd, J = 9.5, 5.4, 4.0 Hz, 
1H), 3.66 – 3.57 (m, 2H), 2.19 (s, 6H), 1.61 (dtd, J = 14.9, 9.3, 4.0 Hz, 1H), 1.43 (dddd, J = 14.8, 
5.5, 3.4, 2.0 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 137.7, 135.3, 128.7, 128.2, 128.0, 127.8, 117.3, 106.7, 73.6, 72.6, 
69.6, 62.5, 32.9, 14.3. 
 
HRMS (ESI) Calcd. for C19H26NO2+ [M+H]+: 300.1964, Found: 300.1960. 
 















In accordance with the general procedure at 125°C for 48 hours, the title compound was obtained 
in 75% yield (39.2 mg, dr = >20:1) as a yellow liquid after column chromatography (SiO2; 3%-
5% EtOAc/hexanes). 
 
Rf =0.38 (10% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 6.29 (ddd, J = 17.3, 10.5, 5.7 Hz, 1H), 5.77 (s, 2H), 5.27 (dt, J = 
10.4, 1.6 Hz, 1H), 5.00 (dt, J = 17.2, 1.5 Hz, 1H), 4.35 (ddt, J = 9.3, 5.8, 1.7 Hz, 1H), 4.26 – 4.17 
(m, 1H), 2.20 (s, 6H), 1.79 (dd, J = 12.9, 3.2 Hz, 2H), 1.73 – 1.44 (m, 4H), 1.31 – 1.04 (m, 4H), 
1.04 – 0.85 (m, 3H), 0.77 (qd, J = 12.4, 3.5 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 135.2, 128.0, 118.3, 106.6, 69.6, 63.8, 41.4, 34.7, 33.8, 32.2, 
26.6(1), 26.5(7), 26.2, 14.3. 
 
HRMS (ESI) Calcd. for C17H27NONa+ [M+Na]+: 284.1990, Found: 284.1985. 
 















In accordance with the general procedure at 125°C for 48 hours in dioxane (1.0 M), the title 
compound was obtained in 63% yield (25.9 mg, dr = >20:1) as a yellow liquid after column 
chromatography (SiO2; 10% EtOAc/hexanes). 
 
Rf = 0.42 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 6.35 (ddd, J = 17.4, 10.5, 5.6 Hz, 1H), 5.77 (s, 2H), 5.31 (dt, J = 
10.6, 1.6 Hz, 1H), 5.11 (dt, J = 17.3, 1.6 Hz, 1H), 4.57 (ddt, J = 9.2, 5.8, 1.8 Hz, 1H), 3.66 (ddd, J 
= 9.3, 6.5, 3.4 Hz, 1H), 2.24 (s, 6H), 1.81 (d, J = 3.6 Hz, 1H), 0.78 – 0.61 (m, 1H), 0.42 – 0.26 (m, 
3H), 0.16 – 0.02 (m, 1H). 
 
13C NMR (100 MHz, CDCl3): δ 135.2, 128.3, 118.4, 106.5, 74.5, 63.0, 14.9, 14.5, 1.7, 0.8. 
 
HRMS (ESI) Calcd. for C13H20NO [M+H]+: 206.1539, Found: 206.1539. 
 











General Procedure and Preparation of 5.4b, 5.4n, 5.4q 
 
To a solution of adduct 5.3 (0.2 mmol, 100 mol %) in EtOH (4 mL) was added hydroxylamine 
hydrochloride (139 mg, 2 mmol, 1000 mol %) followed by H2O (2 mL). The mixture was 
allowed to stir at 100 °C for 24 hours. After cooled to room temperature, the reaction mixture 
was washed with 2N aqueous NaOH and extracted three times with Et2O.The combined organic 
layers were washed with brine and dried over anhydrous Na2SO4. The solvent was removed in 
vacuo and the crude amine was dissolved in THF (1 mL, 0.2 M). (Boc)2O (65.5 mg, 0.3 mmol, 
150 mol %) was subsequently added and the reaction mixture was allowed to stir at room 
temperature overnight. Saturated aqueous NH4Cl was added to the reaction mixture. The mixture 
was extracted three times with EtOAc. The combined organic layers were washed with brine and 
dried over Na2SO4. The solvent was then removed in vacuo, and the residue was purified by 








In accordance with the general procedure, the title compound was obtained in 69% yield as a 
yellow solid after column chromatography (SiO2; 20% EtOAc/hexanes). 
 
Rf = 0.22 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3): δ 7.30 (dd, J = 8.5, 5.5 Hz, 2H), 7.02 (t, J = 8.7 Hz, 2H), 5.68 (ddd, 
J = 16.8, 10.5, 5.9 Hz, 1H), 5.23 – 5.06 (m, 2H), 4.93 – 4.79 (m, 2H), 4.43 (s, 1H), 3.14 (s, 1H), 
1.44 (s, 9H). 
 
19F NMR (100 MHz, CDCl3): δ -115.06 
 
13C NMR (100 MHz, CDCl3): δ 162.4(d, JC-F = 245.7 Hz), 156.2, 136.2(d, JC-F = 3.1 Hz), 133.2, 
128.1(d, JC-F = 8.0 Hz), 117.8, 115.2(d, JC-F = 21.3 Hz), 80.2, 75.8, 58.9, 28.5. 
 
HRMS (ESI) Calcd. for C15H20FNNaO3 [M+Na]+: 304.1319, Found: 304.1328. 
 
FTIR (neat): 3329, 2978, 2925, 1687, 1590, 1550, 1508, 1430, 1222, 1160, 1024, 837, 749, 694 
cm-1. 
 



















In accordance with the general procedure, the title compound was obtained in 62% over two steps 
(35.9 mg) as a yellow oil after column chromatography (SiO2; 15%-20% EtOAc/hexanes). 
 
Rf =0.18 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 7.1 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 7.28 – 7.22 (m, 
1H), 6.72 – 6.63 (m, 1H), 6.20 (dd, J = 16.0, 5.7 Hz, 1H), 5.88 (ddd, J = 16.7, 10.5, 5.6 Hz, 1H), 
5.35 – 5.22 (m, 2H), 4.94 (d, J = 8.2 Hz, 1H), 4.51 – 4.27 (m, 2H), 2.64 (br s, 1H), 1.45 (s, 9H). 
 
13C NMR (100 MHz, CDCl3) δ 156.1, 136.6, 134.0, 132.1, 128.7, 128.0, 126.8, 126.7, 117.7, 80.1, 
74.8, 57.9, 28.5. 
 
HRMS (ESI) Calcd. for C17H23NO3Na+ [M+Na]+: 312.1576, Found: 312.1576. 
 















In accordance with the general procedure, the title compound was obtained in 68% over two steps 
as a yellow oil (38.5 mg) after column chromatography (SiO2; 20%-25% EtOAc/hexanes). 
 
Rf =0.20 (20% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ 5.80 (ddd, J = 17.1, 10.7, 6.5 Hz, 1H), 5.37 – 5.22 (m, 2H), 4.90 
(br s, 1H), 4.18 (br s, 1H), 3.70 (dd, J = 9.9, 4.4 Hz, 1H), 2.73 (br s, 1H), 2.47 – 2.30 (m, 1H), 2.20 
– 2.06 (m, 1H), 1.75 – 1.54 (m, 2H), 1.45 (s, 9H). 
 
19F NMR (100 MHz, CDCl3) δ -66.4. 
 
13C NMR (100 MHz, CDCl3) δ 156.2, 133.4, 127.4 (q, JC-F = 276.0), 118.6, 80.5, 72.9, 58.1, 30.6 
(q, JC-F = 29.0), 28.5, 25.7. 
 
HRMS (ESI) Calcd. for C12H20F3NO3Na+ [M+Na]+: 306.1293, Found: 306.1292. 
 
FTIR (neat): 3347, 2987, 2944, 1740, 1676, 1529, 1449, 1368, 1305, 1246, 1224, 1161, 1131, 



















To a stirred solution of compound 5.4b (0.2 mmol, 100 mol %) in anhydrous DMF (1 mL, 0.2 M) 
were added imidazole (0.6 mmol, 300 mol %) and TBSCl (0.3 mmol, 150 mol %). The mixture 
was allowed to stir at 60 °C for 15 hours. H2O was then added after the mixture cooled to room 
temperature. The mixture was extracted three times with EtOAc, and the combined organic layers 
was washed with brine and dried over anhydrous Na2SO4. The solvent was removed in vacuo and 
the residue was subjected to column chromatography (SiO2; 3%-5% EtOAc/Hexanes). The title 
compound was obtained as a colorless oil in 90% yield (71.3 mg). 
 
Rf = 0.64 (20% EtOAc/Hexanes). 
 
1H NMR (400 MHz, CDCl3) δ 7.32 – 7.25 (m, 2H), 7.03 – 6.95 (m, 2H), 5.72 (ddd, J = 17.0, 10.5, 
6.3 Hz, 1H), 5.06 (dt, J = 10.6, 1.3 Hz, 1H), 4.97 (dt, J = 17.3, 1.4 Hz, 1H), 4.88 (s, 1H), 4.74 (d, 
J = 8.6 Hz, 1H), 4.20 (s, 1H), 1.44 (s, 9H), 0.91 (s, 9H), 0.06 (s, 3H), -0.15 (s, 3H). 
 
19F HMR (100 MHz, CDCl3) δ -115.6. 
 
13C NMR (100 MHz, CDCl3): δ 162.2 (d, JC-F = 244.8 Hz), 155.2, 137.3 (d, JC-F = 3.1 Hz),, 133.23, 
128.1 (d, JC-F = 8.0 Hz),, 117.41, 114.9 (d, JC-F = 21.3 Hz)., 79.61, 75.96, 59.65, 28.55, 25.96, 
18.35, -4.57, -5.06. 
 
HRMS (ESI) Calcd. for C21H34FNaNO3Si [M+Na]+: 418.2192, Found: 418.2184. 
 






















To a stirred solution of compound S1 (0.15 mmol, 100 mol%) in MeCN:CCl4:H2O (1.5 mL, 
1:1:1.5, 0.1 M) were added NaIO4 (0.75 mmol, 500 mol %) and RuCl3·xH2O (0.0075 mmol, 5 mol 
%). The mixture was allowed to stir at room temperature for 12 hours until the complete 
consumption of the starting material as monitored by TLC. The mixture was diluted with DCM, 
filtered through a short pad of celite and washed with DCM. The filtrate was washed with H2O 
and the aqueous phase was extracted three times with DCM. The combined organic layers was 
washed with brine and dried over anhydrous Na2SO4. The solvent was removed in vacuo and the 
residue was dissolved in CHCl3:MeOH (1.5 mL, 2:1, 0.1 M). TMSCH2N2 in hexanes (0.15 mL, 
0.3 mmol, 200 mol %) was then added dropwise. The mixture was allowed to stir at room 
temperature for 2 hours. The solvent was then removed in vacuo and the residue was subjected to 
column chromatography (SiO2; 3%-5% EtOAc/Hexanes). The title compound was obtained as a 
colorless oil in 65% yield over two steps (41.7 mg). 
 
Rf = 0.23 (10% EtOAc/Hexanes). 
 
1H NMR (500 MHz, CDCl3) δ 7.31 (dd, J = 8.4, 5.4 Hz, 2H), 7.01 (t, J = 8.6 Hz, 2H), 5.22 (d, J 
= 8.4 Hz, 1H), 5.00 (d, J = 4.3 Hz, 1H), 4.49 (dd, J = 8.6, 4.4 Hz, 1H), 3.62 (s, 3H), 1.40 (s, 9H), 
0.88 (s, 9H), 0.05 (s, 3H), -0.14 (s, 3H). 
 
19F NMR (125 MHz, CDCl3) δ -115.0. 
 
13C NMR (125 MHz, CDCl3): δ 170.4, 162.4 (d, JC-F = 245.7 Hz), 154.9, 136.5 (d, JC-F = 3.1 Hz), 
128.0 (d, JC-F = 8.1 Hz), 115.0 (d, JC-F = 21.7 Hz), 80.1, 75.2, 60.9, 52.0, 28.4, 25.8, 18.2, -4.7, -
5.2. 
 
HRMS (ESI) Calcd. for C21H34FNO5SiNa+ [M+Na]+: 450.2088, Found: 450.2089. 
 
FTIR (neat): 2954, 2928, 2852, 1712, 1606, 1509, 1365, 1253, 1222, 1156, 1088, 1015, 854, 837, 

















Crystallographic Material for 5.4b 
X-ray Experimental for C15H20FNO3 (5.4b) 
 
X-ray Experimental for complex C15H20NO3F: Crystals grew as long, very thin colorless needles 
by vapor diffusion of pentane into diethyl ether. The data crystal was cut from a longer crystal and 
had approximate dimensions; 0.32 x 0.03 x 0.02 mm. The data were collected on an Agilent 
Technologies SuperNova Dual Source diffractometer using a µ-focus Cu Ka radiation source (l 
= 1.5418Å) with collimating mirror monochromators. A total of 364 frames of data were collected 
using w-scans with a scan range of 1° and a counting time of 53 seconds per frame with a detector 
offset of +/- 42.4° and 120 seconds per frame with a detector offset of +/- 109.8°. The data were 
collected at 100 K using an Oxford 700 Cryostream low temperature device. Details of crystal 
data, data collection and structure refinement are listed in Table 1. Data collection, unit cell 
refinement and data reduction were performed using Agilent Technologies CrysAlisPro V 
1.171.38.43f.12 The structure was solved by direct methods using SHELXT13 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms using 
SHELXL-2016/6.14 Structure analysis was aided by use of the programs PLATON15 and WinGX.16 
The hydrogen atoms were calculated in ideal positions with isotropic displacement parameters set 
to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms). The hydrogen atoms bound 
to N1 atoms was located in a DF map and refined with an isotropic displacement parameter.   
The function, Sw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(s(Fo))2 + (0.0829*P)2 + (1.279*P)] 
and P = (|Fo|2 + 2|Fc|2)/3. Rw(F2) refined to 0.226, with R(F) equal to 0.0859 and a goodness of 
fit, S, = 1.12. Definitions used for calculating R(F), Rw(F2) and the goodness of fit, S, are given 
below.17 The data were checked for secondary extinction effects but no correction was necessary. 
Neutral atom scattering factors and values used to calculate the linear absorption coefficient are 
from the International Tables for X-ray Crystallography (1992).18 All figures were generated using 
SHELXTL/PC.19 Tables of positional and thermal parameters, bond lengths and angles, torsion 






Table 5.2.  Crystal data and structure refinement for 5.4b. 
Empirical formula  C15 H20 F N O3 
Formula weight  281.32 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 5.0624(7) Å a= 90°. 
 b = 10.961(3) Å b= 90°. 





Density (calculated) 1.277 Mg/m
3
 
Absorption coefficient 0.805 mm-1 
F(000) 600 
Crystal size 0.320 x 0.030 x 0.020 mm
3
 
Theta range for data collection 3.353 to 75.126°. 
Index ranges -6<=h<=5, -13<=k<=13, -16<=l<=32 
Reflections collected 3095 
Independent reflections 2260 [R(int) = 0.0495] 
Completeness to theta = 67.684° 98.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.602 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 2260 / 120 / 189 
Goodness-of-fit on F2 1.115 
Final R indices [I>2sigma(I)] R1 = 0.0859, wR2 = 0.2060 
R indices (all data) R1 = 0.1075, wR2 = 0.2259 
Absolute structure parameter -0.1(5) 






Table 5.3.  Atomic coordinates  ( x 10
4





) for 5.4b.  U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
C1 7659(13) 4793(7) 4370(2) 29(1) 
C2 8520(15) 5686(6) 4041(3) 32(2) 
C3 7279(15) 6825(7) 4013(3) 38(2) 
C4 5107(16) 7028(7) 4318(3) 40(2) 
C5 4209(16) 6184(6) 4659(3) 36(2) 
C6 5483(14) 5045(6) 4680(3) 31(2) 
C7 8945(13) 3552(6) 4378(2) 29(1) 
C8 7725(14) 2666(6) 3980(2) 29(1) 
C9 9128(15) 1463(6) 3979(2) 31(2) 
C10 8127(18) 409(7) 4112(3) 42(2) 
C11 5661(13) 3694(6) 3247(2) 27(1) 
C12 4442(13) 4878(7) 2485(3) 32(2) 
C13 2766(15) 3897(7) 2236(3) 34(2) 
C14 6199(16) 5491(9) 2093(3) 44(2) 
C15 2845(15) 5817(7) 2768(3) 36(2) 
N9 7818(11) 3209(6) 3479(2) 28(1) 
O1 8915(9) 2984(5) 4867(2) 30(1) 
O2 3408(8) 3610(5) 3397(2) 31(1) 
O3 6425(9) 4295(5) 2824(2) 33(1) 





Table 5.4.   Bond lengths [Å] and angles [°] for 5.4b. 
_____________________________________________________  
C1-C2  1.379(10) 
C1-C6  1.399(10) 
C1-C7  1.508(10) 
C2-C3  1.399(10) 
C2-H2  0.95 
C3-C4  1.380(11) 
C3-H3  0.95 
C4-F1  1.365(8) 
C4-C5  1.366(11) 
C5-C6  1.406(10) 
C5-H5  0.95 
C6-H6  0.95 
C7-O1  1.433(8) 
C7-C8  1.557(9) 
C7-H7  1.0000 
C8-N9  1.450(9) 
C8-C9  1.497(9) 
C8-H8  1.00 
C9-C10  1.309(10) 
C9-H9  0.95 
C10-H10A  0.95 
C10-H10B  0.95 
C11-O2  1.210(8) 
C11-O3  1.354(8) 
C11-N9  1.359(9) 
C12-O3  1.487(8) 
C12-C15  1.507(11) 
C12-C13  1.518(10) 
C12-C14  1.522(10) 
C13-H13A  0.98 
C13-H13B  0.98 
C13-H13C  0.98 
C14-H14A  0.98 
C14-H14B  0.98 
C14-H14C  0.98 
C15-H15A  0.98 
C15-H15B  0.98 
C15-H15C  0.98 
N9-H9N  0.83(7) 




















































































) for 5.4b. The anisotropic 













 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
C1 25(3)  33(3) 29(3)  -2(3) -6(3)  -3(3) 
C2 30(3)  31(3) 35(3)  1(3) -2(3)  -5(3) 
C3 31(3)  34(4) 49(4)  7(3) -3(3)  -7(3) 
C4 40(4)  25(3) 53(4)  -4(3) -5(3)  -3(3) 
C5 36(4)  28(3) 43(4)  -8(3) 0(3)  2(3) 
C6 24(3)  31(3) 37(3)  -1(3) 4(3)  -4(3) 
C7 21(3)  33(3) 33(3)  2(3) -1(3)  1(3) 
C8 24(3)  31(3) 33(3)  4(3) 0(3)  1(3) 
C9 36(4)  24(3) 33(3)  -4(3) -7(3)  5(3) 
C10 53(5)  31(4) 41(4)  2(3) -2(4)  1(4) 
C11 19(3)  25(3) 35(3)  -3(3) -7(3)  1(3) 
C12 16(3)  40(4) 40(3)  8(3) -1(3)  0(3) 
C13 29(4)  37(4) 37(3)  -1(3) -7(3)  8(3) 
C14 31(4)  61(5) 40(4)  20(4) 1(3)  0(4) 
C15 31(4)  31(4) 45(4)  6(3) -5(3)  -4(3) 
N9 11(2)  36(3) 36(3)  0(2) -3(2)  1(2) 
O1 21(2)  39(3) 31(2)  3(2) 2(2)  3(2) 
O2 13(2)  36(3) 43(3)  4(2) 1(2)  -1(2) 
O3 18(2)  45(3) 34(2)  13(2) 0(2)  0(2) 






Table 5.6. Hydrogen coordinates ( x 10
4





) for 5.4b. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H2 9992 5525 3828 38 
H3 7913 7440 3791 45 
H5 2759 6362 4875 43 
H6 4858 4440 4908 37 
H7 10839 3671 4283 35 
H8 5834 2521 4072 35 
H9 10919 1466 3872 37 
H10A 6344 359 4222 50 
H10B 9185 -306 4098 50 
H13A 3920 3285 2080 52 
H13B 1649 4268 1975 52 
H13C 1649 3506 2492 52 
H14A 7310 6104 2259 66 
H14B 5096 5887 1835 66 
H14C 7324 4877 1930 66 
H15A 1414 5412 2954 54 
H15B 2094 6402 2527 54 
H15C 3989 6249 3008 54 
H1O 7348 2834 4952 46 








































Table 5.8.  Hydrogen bonds for 5.4b [Å and °]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 C13-H13C...O2 0.98 2.55 3.094(9) 115.1 
 O1-H1O...O1#1 0.84 2.01 2.832(4) 164.8 
 N9-H9N...O2#2 0.83(7) 2.06(7) 2.872(7) 167(6) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  





Figure 5.2.  View of 5.4b showing the atom labeling scheme.  Displacement ellipsoids 







Competition Experiment Establishing Rapid Redox Equilibrium 
 
Reaction between Alcohol 5.2a and Aldehyde dehydro-5.2d 
 
 
To a resealable pressure tube (13x100) were added HClRu(CO)(PPh3)3 (9.5 mg, 0.010 
mmol, 5 mol %), dippf (4.2 mg, 0.010 mmol, 5 mol %) and alcohol 5.2a (37.4 mg, 0.2 
mmol, 100 mol %). The tube was sealed with a rubber septum and purged with argon for 
20 minutes. Dioxane (0.40 mL, 0.5 M) was added to the reaction vessel. Aldehyde dehydro-
5.2d (24.3 µL, 0.2 mmol, 100 mol %) and acetylenic pyrrole 5.1 (0.60 mmol, 300 mol %) 
were subsequently added to the reaction vessel and the rubber septum was quickly replaced 
with a screw cap. The mixture was allowed to stir at 125 °C for 24 hours. The mixture was 
then allowed to cool to room temperature and the solvent was removed in vacuo. The 
residue was subjected to column chromatography (SiO2; 7.5%-10% EtOAc/Hexanes) and 





Reaction between Alcohol 5.2d and Aldehyde dehydro-5.2a 
 
 
To a resealable pressure tube (13x100) were added HClRu(CO)(PPh3)3 (9.5 mg, 0.010 
mmol, 5 mol %), dippf (4.2 mg, 0.010 mmol, 5 mol %) and aldehyde dehydro-5.2a (37.0 
mg, 0.2 mmol, 100 mol %). The tube was sealed with a rubber septum and purged with 
argon for 20 minutes. Dioxane (0.40 mL, 0.5 M) was added to the reaction vessel. Alcohol 
5.2d (24.8 µL, 0.2 mmol, 100 mol %) and acetylenic pyrrole 1 (0.60 mmol, 300 mol %) 
were subsequently added to the reaction vessel and the rubber septum was quickly replaced 
with a screw cap. The mixture was allowed to stir at 125 °C for 24 hours. The mixture was 
then allowed to cool to room temperature and the solvent was removed in vacuo. The 
residue was subjected to column chromatography (SiO2; 7.5%-10% EtOAc/Hexanes) and 





Chapter 6: Enantioselective Iridium Catalyzed anti-(α-Aryl)allylation of 
Fluoral Hydrate and Difluoroacetaldehyde Ethyl Hemiacetal* 
6.1 INTRODUCTION 
Alcohol mediated carbonyl reductive couplings has been developed broadly by 
Krische group, by which catalytic enantioselective carbonyl allylations and 
propargylations.1 Branched aryl-substituted allylic acetates were explored in the coupling 
with paraformaldehyde mediated by 2-propanol to form primary homoallylic alcohols and 
high enantioselectivity was observed.2 While when higher aldehyde was used in the 
reductive coupling with branched aryl-substituted allylic acetate, a correlation between 
enantioselectivity and aldehyde electrophilicity was found, which is with the increasing of 
carbonyl electrophilicity enantioselectivity increases. 
There is no systematic study on catalytic enantioselective carbonyl (α-
aryl)allylation in the literatures, and in many of the examples chiral auxiliaries were 
involved,3 modest enantioselectivity were observed.4 Enantioselective (α-aryl)allylation of 
fluoral and difluoroacetaldehyde, which are readily commercial available resources of 
fluorinated moieties, were not reported before.  
In this chapter, iridium catalyzed 2-propanol mediated enantioselective reductive 
coupling of branched aryl-substituted allylic acetates with fluoral and difluoroacetaldehyde 
was reported. The correlation between enantioselectivity and carbonyl electrophilicity was 
explained by different carbonyl binding modes: diastereomeric kinetic and thermodynamic 
coordination. 
  
                                                
*This chapter is based on the published work:  




6.2 REACTION DEVELOPMENT AND SCOPE 
Initially, different p-substituted benzaldehydes 6.1a-6.1f were exposed to 1-(4-
bromophenyl)allyl acetate 6.2b under 2-propanol mediated reductive coupling conditions, 
whereas iridium complex modified by (S)-Cl, MeO-BIPHEP was used (Table 6.1, entries 
1-6). From the results of these experiments, a clear correlation between enantioselectivity 
and carbonyl electrophilicity σ was observed. For the electron-rich carbonyl, such as p-
(dimethylamino)benzaldehyde 6.1a, and p-methoxybenzaldehyde 6.1b, carbonyl addition  
 
Table 6.1 Correlation between Enantioselectivity with Carbonyl Electrophilicity in 
Carbonyl reductive (α-Aryl)allylation. 
 
 
aYields are material isolated by silica gel chromatography. See supporting Information for 




products were obtained in nearly racemic form. When fluoral hydrate 6.1i was used with 
addition of 4Å molecular sieves, carbonyl (α-aryl)allylation product was isolated in 88% 
yield with complete anti-diastereoselecitivity and excellent enantioselectivity (Table 6.1, 
entry 9). Molecular sieves was crucial for this reaction, which is due to it helped with 
dehydration of fluoral hydrate. 
The above conditions were applied to different branched aryl-substituted allylic 
acetates 6.2a-6.2l, and the corresponding coupling adducts 6.4a-6.4l were obtained in 
uniformly high enantioselectivity and complete diastereoselectivity and good to excellent 
yileds (Table 6.2). Not only mono-substituted aryl moieties on the allylic acetates could 
promote the C-C coupling, di-substituted aryl moieties could also engage in the coupling 
with fluoral hydrate under iridium catalysis. Notably, herteroarometic ring bearing allylic 
acetates 6.2i-6.2l also gave the corresponding adducts 6.4i-6.4l. The absolute 
stereochemical structure of 6.4l was determined by single crystal X-ray diffraction 
analysis, and the absolute structure of other adducts were made in analogy to compound 
6.4l. 
With the optimal conditions, difluoroacetaldehyde ethyl hemiacetal in ethanol (90 
wt %), which is the only available source for difluoroacetaldehyde, was tested as an 
electrophile in the carbonyl (α-aryl)allylation. Ultilizing the same set of branched aryl-
substituted allylic acetates, CHF2-bearing β-aryl alcohols 6.5a-6.5l were formed in good 
yields with complete anti-diastereoselectivity and high enantioselectivity as well. As we 
know that ethanol itself could engage in the reodx-triggered carbonyl addition reaction, 
small amount of (3-14% yield) ethanol coupling products were observed as side products. 





Table 6.2 Iridium Catalyzed Enantioselective Reductive Coupling of Fluoral Hydrate 






Table 6.3 Iridium Catalyzed Enantioselective Reductive Coupling of Difluoroacet-






diffraction analysis, and the absolute structure of other adducts were made in analogy to 
compound 6.5l. 
To demonstrate the utility of this transformation, it was successfuly applied to 
synthese of CF3-bearing and CHF2-bearing derivatives of d-hyoscyamine, which is a FDA 
approved alkaloid (Scheme 6.1). The TBS-protection of the free alcohol in the coupling 
adduct 6.4a followed by alkene oxidative cleavage under Johnson-Lemieux conditions5 
delivered α,β-stereogenic carboxylic acid 6.6a, which was treated with tropine under 
Shiina’s esterification conditions6 to form TBS-protected ester 6.7a in good yield with 
some epimerization. Finally cleavage of silyl group with HF-pyridine provided CF3- 






hyoscyamine 6.8a. The CHF2-bearing derivative 6.8b was synthesized in an analogous 
manner. 
6.3 MECHANISM AND DISCUSSION 
The correlation between enantioselectivity with carbonyl electrophilicity was quite 
special (Figure 6.1).7 In the earlier studies on enantioselective carbonyl allylation reactions, 
when the same chiral ligand was used, an inversion in the enantioselectivity was observed 
due to steric difference of the allyl donors. To be more specific, carbonyl allylation8a,b and 
crotylation8c,d have same enantiofacial preferences, while carbonyl tert-prenylation9 has an 
inversion in the enantiofacial selectivity when the same chiral iridium catalyst in use. These 
observations suggested that when the allyl donors were small, the carbonyl additions  
 
 
Figure 6.1 Proposed Stereochemical Model for Iridium Catalyzed Enantioselective 




occurred via the transition structure where aldehyde approached from more open side 
(Figure 6.1, left), and when the allyl donor was big, the allyl group would reside on the 
more open side instead during the carbonyl addition (Figure 6.1, right). For the (aryl)allyl 
donor, which is between these two extreme coordination modes, kinetic coordination was 
preferred for sufficiently electrophilic aldehydes and as soon as the carbonyl coordinate to 
the iridium carbonyl addition would happen. However, for the less reactive aldehydes, 
carbonyl addition could proceed through either coordination mode, which caused the 
erosion in the enantioselectivity.  
6.4 CONCLUSION 
In summary, iridium catalyzed 2-propanol mediated enantioselective anti-(α-
aryl)allylation of fluoral hydrate and difluoroacetaldehyde ethyl hemiacetal by coupling 
with various branched aryl-substituted allylic acetates. Two different coordination modes 
were proposed and rationalized the correlation between enantioselectivity with carbonyl 
electrophilicity in carbonyl allylation reactions. Also, two derivatives of d-hyoscyamine 
with CF3 and CHF2 group were synthesized from the coupling adducts 6.4a and 6.5a, 





6.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon, unless otherwise indicated. 
Resealable pressure tubes (13x100 mm) were purchased from Fischer Scientific (catalog 
number 14–959–35C) and were flame dried followed by cooling in a desiccator or under a 
stream of argon prior to use. Tetrahydrofuran (THF) was dried over sodium metal, 
benzophenone, and distilled immediately prior to use. RuH2(PPh3)3 were prepared 
according to literature procedure.1 All ligands were used as received from Strem 
Chemicals Inc. Alcohols were purified by distillation or recrystallization immediately prior 
to use. Preparative column chromatography employing Silicycle silica gel (40-63 µm) was 
performed according to the method of Still.2 Analytical thin-layer chromatography (TLC) 
was carried out using 0.25 mm commercial silica gel plates (Dynamic Absorbents F254). 
Visualization was accomplished with UV light followed by dipping in Seebach’s stain 
solution then heating. Purification of reactions was carried out by flash chromatography 
using Silicycle silica gel (40–63 µm). Fluoral hydrate (75% in water) was purchased 
through Oakwood Chemical, difluoroacetaldehyde ethyl hemiacetal (90% in ethanol) 
through AstaTech, and potassium carbonate through Fisher Chemicals and used without 
further purification. Allylic acetates 2a1 2b–2c,2 2d,3 2e,4 2f–2l2 were prepared according 





Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-resolution mass 
spectra (LRMS) were obtained on a Karatos MS9 and are reported as m/z (relative 
intensity). Accurate masses are reported for the molecular ion (M+H, M+Na), or a suitable 
fragment ion. Proton nuclear magnetic resonance (1H NMR) spectra were recorded with a 
Varian Gemini (400 MHz) spectrometer. Chemical shifts are reported in delta (δ) units, 
parts per million (ppm) downfield from tetramethylsilane or ppm relative to the center of 
the singlet at 7.26 ppm for deuteriochloroform. Data reported as multiplicity (s = singlet, d 
= doublet, t = triplet, q = quartet, m = multiplet). Integration and coupling constants were 
reported in Hertz (Hz). Carbon-13 nuclear magnetic resonance (13C NMR) spectra were 
recorded with a Varian Gemini (100 MHz) spectrometer and were routinely run with 
broadband decoupling. Chemical shifts are reported in delta (δ) units, ppm relative to the 





Detailed Procedure for Preparation of Preformed Iridium Catalyst 
 
To a sealed tube equipped with a magnetic stir bar was added Cs2CO3 (501.8 mg, 1.54 
mmol, 200 mol%), 4-cyano-3-nitrobenzoic acid (296.8 mg, 1.54 mmol, 200 mol%), (S)-
Cl,MeO-BIPHEP (503.0 mg, 0.772 mmol, 100 mol%) and [Ir(cod)Cl]2 (259.3 mg, 0.386 
mmol, 50 mol%). The reaction vessel was purged with argon and THF (7.7 mL, 0.1 M) 
was added followed by allyl acetate (0.208 mL, 1.93 mmol, 250 mol%). The resulting 
mixture was stirred at room temperature for 30 min, and for another 90 min at 80 ˚C. After 
cooling to ambient temperature, the mixture was filtered through a celite plug with the aid 
of DCM (45 mL). The combined filtrate was concentrated in vacuo and subjected to flash 
column chromatography (DCM:THF = 10:1). The resulting gum-like residue was 
dissolved in THF (2.0 mL). Addition of HPLC grade hexanes (20 mL) led to formation of 
a precipitate. The product was filtered and washed with HPLC grade hexanes, followed by 
removal of trace amount of solvent in vacuo, to provide a light yellow powder (620.0 mg, 
0.577 mmol) in 75% yield as a mixture of stereoisomers. 
Spectral data is reported for the major isomer. 
31P NMR (162 MHz, CDCl3): δ = -5.12 (d, J = 21.3 Hz), -15.70 (d, J = 21.4 Hz). 
 
HRMS (ESI) Calculated for C49H37Cl2IrN2O6P2 [M+H]+ = 1075.1195, Found 1075.1197. 
 
[α]D
28	: –4.0 (c = 1.0, CHCl3) 
 







General Procedure for Iridium Catalyzed Aryl Allylation of Aromatic Aldehydes  
A pressure tube was equipped with a magnetic stir bar and charged with preformed iridium 
catalyst (10.7 mg, 10 µmol, 5 mol%), aldehyde (0.20 mmol, 100 mol%), K2CO3 (27.6 mg, 
0.20 mmol, 100 mol%), 1-(4-bromophenyl)allyl acetate (0.40 mmol, 200 mol%). The 
pressure tube was purged with argon. Anhydrous THF (1.0 mL, 0.2 M) and 2-propanol (31 
µL, 0.40 mmol, 200 mol%) were added via syringe. The sealed reaction vessel was stirred 
at 100 °C. After 24 h the solvent was removed in vacuo and the residue was subjected to 










The title compound was prepared according to the general procedure using 4-
methoxybenzaldehyde (27.2 mg, 200 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 6:1 → 3:1) provided 
the title compound (35.6 mg, 107 µmol, anti:syn = 9:1) in 54% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.37 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.34 – 7.29 (m, 2H), 7.08 – 7.01 (m, 2H), 6.94 – 6.88 
(m, 2H), 6.78 – 6.72 (m, 2H), 6.19 (ddd, J = 17.0, 10.2, 8.7 Hz, 1H), 5.28 (d, J = 10.1 Hz, 
1H), 5.22 (dt, J = 17.2, 1.3 Hz, 1H), 4.76 (dd, J = 8.0, 1.7 Hz, 1H), 3.76 (s, 3H), 3.51 (t, J 
= 8.3 Hz, 1H), 2.22 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 159.1, 139.9, 137.8, 133.8, 131.5, 130.2, 128.0, 120.5, 
118.7, 113.6, 76.8, 58.7, 55.3. 
 
HRMS (ESI) Calculated for C17H1779BrO2 [M+Na]+ = 355.0304, Found 355.0299. 
 
FTIR (neat) 3430, 2999, 2907, 2836, 1612, 1513, 1248, 1175, 1034, 1010, 921, 830 cm–1. 
 
[α]D
34	: –9.0 (c = 1.0, CHCl3) 
 























The title compound was prepared according to the general procedure using 4-
methylbenzaldehyde (24.1 mg, 201 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 10:1 → 5:1) provided 
the title compound (43.7 mg, 138 µmol, anti:syn = 4:1) in 69% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.43 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.36 – 7.29 (m, 2H), 7.03 (s, 4H), 6.97 – 6.90 (m, 2H), 
6.19 (ddd, J = 17.1, 10.3, 8.6 Hz, 1H), 5.27 (dd, J = 10.3, 1.6 Hz, 1H), 5.20 (dt, J = 17.1, 
1.3 Hz, 1H), 4.78 (d, J = 7.8 Hz, 1H), 3.53 (t, J = 8.2 Hz, 1H), 2.29 (s, 3H), 2.25 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 140.0, 138.7, 137.7, 137.4, 131.5, 130.2, 128.9, 126.7, 
120.5, 118.7, 77.0, 58.4, 21.2. 
 
HRMS (CI) Calculated for C17H1779BrO [M-H]+ = 315.0385, Found 315.0373. 
 
FTIR (neat) 3439, 2918, 2861, 1487, 1402, 1179, 1073, 1010, 919, 816, 743 cm–1. 
 
[α]D
32	: –6.3 (c = 1.0, CHCl3) 
 
























The title compound was prepared according to the general procedure using benzaldehyde 
(22.1 mg, 208 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 0.40 mmol, 200 mol%). 
Flash chromatography on silica (Hex/EtOAc 6:1) provided the title compound (46.6 mg, 
154 µmol, anti:syn = 4:1) in 74% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.36 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.34–7.30 (m, 2H), 7.27–7.19 (m, 3H), 7.16–7.12 (m, 
2H), 6.95–6.90 (m, 2H), 6.20 (ddd, J = 17.1, 10.3, 8.4 Hz, 1H), 5.28 (dd, J = 10.3, 1.5 
Hz, 1H), 5.21 (d, J = 17.1 Hz, 1H), 4.80 (d, J = 7.7 Hz, 1H), 3.53 (t, J = 8.4 Hz, 1H), 2.29 
(s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 141.7, 139.8, 137.5, 131.5, 130.2, 128.2, 127.8, 126.8, 
120.6, 118.9, 77.2, 58.6. 
 
HRMS (CI) Calculated for C16H1479BrO [M–H]+ = 301.0228, Found 301.0222. 
 
FTIR (neat) 3434, 3062, 3029, 2920, 1487, 1074, 1010, 920, 814, 762, 726, 700 cm–1. 
 
[α]D
34	: –3.8 (c = 1.0, CHCl3) 
 

























The title compound was prepared according to the general procedure using 4-
fluorobenzaldehyde (24.8 mg, 200 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 8:1 → 5:1) provided 
the title compound (56.5 mg, 176 µmol, anti:syn = 3:1) in 88% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.37 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.37 – 7.29 (m, 2H), 7.12 – 7.06 (m, 2H), 6.94 – 6.87 
(m, 4H), 6.18 (ddd, J = 17.0, 10.2, 8.8 Hz, 1H), 5.29 (d, J = 10.2 Hz, 1H), 5.23 (dt, J = 
17.1, 1.2 Hz, 1H), 4.76 (d, J = 7.9 Hz, 1H), 3.46 (t, J = 8.4 Hz, 1H), 2.37 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 162.2 (d, J = 245.7 Hz), 139.5, 137.4 (d, J = 3.1 Hz), 
137.3, 131.6, 130.1, 128.4 (d, J = 8.1 Hz), 120.7, 119.1, 115.0 (d, J = 21.4 Hz), 76.6, 
58.9. 
 
19F NMR (471 MHz, CDCl3): δ = -114.61 – -114.69 (m). 
 
HRMS (CI) Calculated for C16H1479BrFO [M-H]+ = 319.0134, Found 319.0133. 
 
FTIR (neat) 3433, 3072, 2915, 1604, 1509, 1488, 1402, 1223, 1157, 1011, 924, 834 cm–1. 
 
[α]D
33	: –6.5 (c = 1.0, CHCl3) 
 





























The title compound was prepared according to the general procedure using 4-
bromobenzaldehyde (37.1 mg, 201 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 6:1) provided the title 
compound (67.5 mg, 177 µmol, anti:syn = 4:1) in 88% yield as a yellow oil. 
 
TLC (SiO2) Rf  = 0.28 + 0.22 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.37–7.31 (m, 4H), 7.02–6.96 (m, 2H), 6.94–6.88 (m, 
2H), 6.16 (dt, J = 17.1, 9.9 Hz, 1H), 5.29 (d, J = 9.9 Hz, 1H), 5.22 (d, J = 17.1 Hz, 1H), 
4.74 (d, J = 8.0 Hz, 1H), 3.45 (t, J = 8.0 Hz, 1H), 2.35 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 140.6, 139.3, 137.1, 131.7, 131.3, 130.1, 128.5, 121.6, 
120.8, 119.3, 76.6, 58.6. 
 
HRMS (CI) Calculated for C16H1679Br2O [M–H]+ = 378.9333, Found 378.9330. 
 
FTIR (neat) 3434, 3078, 2919, 1487, 1403, 1072, 1010, 925, 819, 745 cm–1. 
 
[α]D
34	: +6.0 (c = 1.0, CHCl3) 
 























The title compound was prepared according to the general procedure using 6-
bromopyridine-3-carbaldehyde (37.1 mg, 199 µmol) and 1-(4-bromophenyl)allyl acetate 
(102 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 4:1) 
provided the title compound (62.5 mg, 163 µmol, anti:syn 5:1) in 82% yield as a yellow 
oil.  
 
TLC (SiO2) Rf  = 0.21 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 8.05 (s, 1H), 7.39 – 7.31 (m, 4H), 6.95 – 6.90 (m, 2H), 
6.14 (ddd, J = 17.0, 10.3, 8.9 Hz, 1H), 5.32 (dd, J = 10.2, 1.4 Hz, 1H), 5.24 (dt, J = 17.0, 
1.1 Hz, 1H), 4.81 (dd, J = 7.8, 2.2 Hz, 1H), 3.43 (t, J = 8.3 Hz, 1H), 2.60 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 148.8, 141.3, 138.6, 137.0, 136.5, 136.4, 132.0, 130.0, 
127.6, 121.3, 120.0, 74.3, 58.7. 
 
HRMS (ESI) Calculated for C15H1379Br2NO [M+Na]+ = 403.9256, Found 403.9260.  
 




𝟑𝟎	: +8.3 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using 6-
bromopyridine-2-carbaldehyde (37.2 mg, 200 µmol) and 1-(4-bromophenyl)allyl acetate 
(102 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 6:1) 
provided the title compound (57.8 mg, 151 µmol, anti:syn 4:1) in 75% yield as a yellow 
oil.  
 
TLC (SiO2) Rf  = 0.25 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.41–7.37 (m, 3H), 7.33 (d, J = 7.8 Hz, 1H), 7.07 (d, J 
= 8.3 Hz, 2H), 6.96 (d, J = 7.5 Hz, 1H), 6.14 (ddd, J = 17.2, 10.5, 8.2 Hz, 1H), 5.16 (d, J 
= 10.5 Hz, 1H), 5.01 (d, J = 17.2 Hz, 1H), 4.88 (t, J = 6.2 Hz, 1H), 3.69 (t, J = 7.2 Hz, 
1H), 3.45 (d, J = 6.5 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 161.9, 141.2, 139.9, 138.7, 136.2, 131.7, 130.3, 127.0, 
120.8, 120.5, 118.6, 76.2, 56.6. 
 
HRMS (APPI) Calculated for C15H1479Br2NO [M+H]+ = 381.9437, Found 381.9447.  
 
FTIR (neat) 3411, 2923, 1582, 1556, 1488, 1437, 1406, 1125, 1072, 1011 cm–1. 
 
[α]D
𝟑𝟑	: –71.5 (c = 1.0, CHCl3) 
 






















General Procedure and Spectral Data for Iridium Catalyzed anti-(α-Aryl)Allylation 
of Fluoral Hydrate 1i to form Products 6.4a-6.4l  
 
A pressure tube was equipped with a magnetic stir bar and charged with preformed iridium 
catalyst (10.7 mg, 10 µmol, 5 mol%), K2CO3 (27.6 mg, 0.20 mmol, 100 mol%), allyl donor 
(0.40 mmol, 200 mol%) and 4A molecular sieves (90 mg, 300 wt%). The pressure tube was 
purged with argon. Anhydrous THF (1.0 mL, 0.2 M), 2-propanol (31 µL, 0.40 mmol, 200 
mol%), and fluoral hydrate (75% in H2O, 22 µL, 0.20 mmol, 100 mol%) were added via 
syringe. The sealed reaction vessel was stirred at 100 °C. After 24 h the solvent was 









The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-phenylallyl acetate (71 mg, 0.40 mmol, 200 mol%). 
Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the title compound 
(36.7 mg, 170 µmol, anti:syn = >20:1) in 85% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.60 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.35 – 7.17 (m, 5H), 6.15 (ddd, J = 17.0, 10.1, 8.5 Hz, 
1H), 5.27 (dt, J = 10.2, 0.9 Hz, 1H), 5.15 (dt, J = 17.1, 1.2 Hz, 1H), 4.20 (h, J = 6.4 Hz, 
1H), 3.69 (dd, J = 8.5, 5.1 Hz, 1H), 2.35 (d, J = 5.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 139.8, 135.0, 128.9, 128.2, 127.4, 124.8 (d, J = 283.2 
Hz), 119.9, 73.1 (q, J = 29.5 Hz), 50.2. 
 
19F NMR (471 MHz, CDCl3): δ = –76.0 (d, J = 6.9 Hz). 
 
HRMS (CI) Calculated for C11H11F3O [M]+ = 216.0762, Found 216.0766.  
 
FTIR (neat) 3443, 2927, 1266, 1165, 1109, 925, 852, 761, 735, 701 cm–1. 
 
[α]D
34	: –65.0 (c = 0.5, CHCl3) 
 




























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(4-bromophenyl)allyl acetate (102 mg, 0.40 mmol, 
200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the title 
compound (51.8 mg, 176 µmol, anti:syn = >20:1) in 88% yield as a yellow oil.   
 
TLC (SiO2) Rf  = 0.60 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.51 – 7.41 (m, 2H), 7.21 – 7.13 (m, 2H), 6.22 – 6.08 
(m, 1H), 5.32 (dt, J = 10.3, 1.0 Hz, 1H), 5.17 (dt, J = 17.1, 1.2 Hz, 1H), 4.20 (h, J = 6.5 
Hz, 1H), 3.69 (dd, J = 8.3, 5.0 Hz, 1H), 2.43 (d, J = 5.9 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 138.9, 134.5, 132.0, 129.9, 124.7 (d, J = 283.3 Hz), 
121.4, 120.3, 72.9 (q, J = 29.6 Hz), 49.5. 
 
19F NMR (471 MHz, CDCl3): δ = –76.0 (d, J = 6.8 Hz)  
 
HRMS (CI) Calculated for C11H10BrF3O [M]+ = 293.9867, Found 293.9868.  
 
FTIR (neat) 3460, 2923, 1489, 1405, 1270, 1168, 1108, 1075, 1011, 928, 817, 720 cm–1. 
 
[α]D
27	: –87.3 (c = 1.0, CHCl3) 
 





























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(4-(trifluoromethyl)phenyl)allyl acetate (98 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided 
the title compound (36.3 mg, 128 µmol, anti:syn = >20:1) in 64% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.18 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.63–7.58 (m, 2H), 7.46–7.41 (m, 2H), 6.19 (ddd, J = 
17.6, 10.2, 8.4 Hz, 1H), 5.35 (d, J = 10.2 Hz, 1H), 5.18 (dt, J = 17.6, 1.0 Hz, 1H), 4.25 
(pd, J = 6.5, 4.9 Hz, 1H), 3.80 (dd, J = 8.4, 4.9 Hz, 1H), 2.42 (d, J = 6.5 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 143.9, 134.2, 129.8 (q, J = 32.6 Hz), 128.6, 125.9 (q, J 
= 3.8 Hz), 124.6 (q, J = 284.0 Hz), 124.2 (q, J = 272.0 Hz), 120.6, 72.9 (q, J = 29.8 Hz), 
49.9. 
 
19F NMR (471 MHz, CDCl3): δ = –62.6, –76.1 (d, J = 6.5 Hz) 
 
HRMS (CI) Calculated for C12H10F6O [M]+ = 284.0636, Found 284.0636.  
 
FTIR (neat) 3434, 2923, 1325, 1266, 1164, 1110, 1067, 1019, 832, 700 cm–1. 
 
[α]D
33	: –59.3 (c = 1.0, CHCl3) 
 




























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(p-tolyl)allyl acetate (76 mg, 0.40 mmol, 200 
mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the title 
compound (35.5 mg, 154 µmol, anti:syn = >20:1) in 77% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.18 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.23–7.12 (m, 4H), 6.18 (ddd, J = 17.6, 10.2, 8.6 Hz, 
1H), 5.30 (dd, J = 10.2, 1.3 Hz, 1H), 5.19 (dt, J = 17.6, 1.3 Hz, 1H), 4.28–4.17 (m, 1H), 
3.70 (dd, J = 8.6, 5.2 Hz, 1H), 2.35 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 137.1, 136.8, 135.2, 129.6, 128.0, 123.7 (d, J = 283.5 
Hz), 119.7, 73.2 (q, J = 29.3 Hz), 49.9, 21.2. 
 
19F NMR (471 MHz, CDCl3): δ = –75.9 (d, J = 6.9 Hz) 
 
HRMS (CI) Calculated for C12H14F3O [M+H]+ = 231.0997, Found 231.0999.  
 
FTIR (neat) 3459, 2924, 1267, 1166, 1115, 924, 811, 783, 685, 669 cm–1. 
 
[α]D
33	: –77.8 (c = 1.0, CHCl3) 
 




























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(4-methoxyphenyl)allyl acetate (82 mg, 0.40 mmol, 
200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the title 
compound (34.9 mg, 142 µmol, anti:syn = >20:1) in 71% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.36 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.21 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 6.22 
– 6.11 (m, 1H), 5.29 (dt, J = 10.2, 1.0 Hz, 1H), 5.17 (dt, J = 17.2, 1.3 Hz, 1H), 4.24 – 
4.15 (m, 1H), 3.80 (s, 3H), 3.69 (dd, J = 8.4, 5.2 Hz, 1H), 2.42 (d, J = 6.2 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 158.8, 135.3, 131.8, 129.2, 124.8 (q, J = 283.3 Hz), 
119.5, 114.3, 73.2 (q, J = 29.2 Hz), 55.4, 49.4. 
 
19F NMR (471 MHz, CDCl3): δ = -75.89 (d, J = 6.9 Hz). 
 
HRMS (CI) Calculated for C12H13F3O2 [M]+ = 246.0868, Found 246.0866.  
 
FTIR (neat) 3458, 3007, 2360, 1738, 1512, 1366, 1232, 1111, 1032, 826 cm–1. 
 
[α]D
33	: –73.5 (c = 1.0, CHCl3) 
 































The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(2-chlorophenyl)allyl acetate (84 mg, 0.40 mmol, 
200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the title 
compound (30.1 mg, 120 µmol, anti:syn = >20:1) in 60% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.57 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.46 (dd, J = 7.7, 1.8 Hz, 1H), 7.40 (dd, J = 7.9, 1.5 
Hz, 1H), 7.27 (td, J = 7.5, 1.4 Hz, 1H), 7.22 (td, J = 7.6, 1.7 Hz, 1H), 6.24 (dddt, J = 
17.2, 10.1, 8.2, 1.0 Hz, 1H), 5.36 – 5.33 (m, 1H), 5.18 (dt, J = 17.2, 1.2 Hz, 1H), 4.40 – 
4.22 (m, 2H), 2.40 (d, J = 6.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 137.7, 133.4, 133.3, 130.1, 129.8, 128.6, 127.2, 124.7 
(d, J = 283.3 Hz), 120.7, 71.9 (q, J = 30.0 Hz), 45.6. 
 
19F NMR (471 MHz, CDCl3): δ = –76.5 (d, J = 6.9 Hz). 
 
HRMS (CI) Calculated for C11H10ClF3O [M]+ = 250.0372, Found 250.0367.  
 
FTIR (neat) 3466, 2926, 1474, 1271, 1170, 1128, 1101, 928, 751, 680 cm–1. 
 
[α]D
30	: –38.8 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(3,5-dichlorophenyl)allyl acetate (98 mg, 0.40 
mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1) provided the title 
compound (52 mg, 182 µmol, anti:syn = >20:1) in 91% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.34 (hexanes/ethyl acetate = 9:1).  
 
1H NMR (400 MHz, CDCl3): 7.30 – 7.27 (m, 1H), 7.23 – 7.19 (m, 2H), 6.13 (dt, J = 
17.8, 9.2 Hz, 1H), 5.35 (d, J = 10.2 Hz, 1H), 5.19 (d, J = 17.1 Hz, 1H), 4.21 (h, J = 6.4 
Hz, 1H), 3.68 (dd, J = 8.1, 4.4 Hz, 1H), 2.43 (d, J = 6.1 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 143.30, 135.34, 133.52, 127.70, 126.83, 125.65, 
123.39, 120.84, 72.76 (q, J = 30.0 Hz), 49.32. 
 
19F NMR (471 MHz, CDCl3): δ = -76.15 (d, J = 6.8 Hz). 
 
HRMS (CI) Calculated for C11H9Cl2F3O [M]+ = 283.9983, Found 283.9978.  
 
FTIR (neat) 3548, 2360, 1588, 1568, 1169, 1146, 738, 698 cm–1. 
 
[α]D
33	: –140.9 (c = 1.1, CHCl3) 
 





























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(benzo[d][1,3]dioxol-5-yl)allyl acetate (88 mg, 0.40 
mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 8:1) provided the 
title compound (43.7 mg, 168 µmol, anti:syn = >20:1) in 84% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.09 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 6.82–6.76 (m, 2H), 6.74 (dd, J = 8.0, 1.8 Hz, 1H), 6.14 
(ddd, J = 17.5, 10.3, 8.4 Hz, 1H), 5.95 (s, 2H), 5.29 (dt, J = 10.3, 1.0 Hz, 1H), 5.18 (dt, J 
= 17.5, 1.3 Hz, 1H), 4.22–4.13 (m, 1H), 3.64 (dd, J = 8.4, 5.1 Hz, 1H), 2.42 (d, J = 6.1 
Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 148.0, 146.8, 135.1, 133.6, 124.8 (d, J = 283.6 Hz), 
121.3, 119.7, 108.6, 108.5, 101.2, 73.2 (q, J = 29.4 Hz), 49.8. 
 
19F NMR (471 MHz, CDCl3): δ = –76.0 (d, J = 7.0 Hz) 
 
HRMS (CI) Calculated for C12H11F3O3 [M]+ = 260.0660, Found 260.0658.  
 
FTIR (neat) 3472, 2903, 1490, 1249, 1169, 1102, 1039, 931 cm–1. 
 
[α]D
32	: –177.8 (c = 1.0, CHCl3) 
 




























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(furan-2-yl)allyl acetate (66.5 mg, 0.40 mmol, 200 
mol%). Flash chromatography on silica (Hex/EtOAc 20:1) provided the title compound 
(25 mg, 120 µmol, anti:syn = >20:1) in 61% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.22 (hexanes/ethyl acetate = 9:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.38 (d, J = 1.2 Hz, 1H), 6.36 – 6.32 (m, 1H), 6.21 (d, J 
= 3.2 Hz, 1H), 6.14 – 6.04 (m, 1H), 5.36 (d, J = 10.2 Hz, 1H), 5.25 (d, J = 17.2 Hz, 1H), 
4.40 (d, J = 5.4 Hz, 1H), 3.87 (dd, J = 8.3, 4.3 Hz, 1H), 2.50 (d, J = 5.4 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 143.30, 135.34, 133.52, 127.70, 126.83, 125.65, 
123.39, 120.84, 71.43 (q, J = 30.0 Hz), 49.32. 
 
19F NMR (471 MHz, CDCl3): δ = -76.26 (d, J = 6.9 Hz). 
 
HRMS (CI) Calculated for C9H9F5O2 [M]+ = 206.0555, Found 206.0554.  
 
FTIR (neat) 3432, 2925, 1264, 1130, 895, 734, 703 cm–1. 
 
[α]D
33	: –103 (c = 0.1, CHCl3) 
 






























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(thiophn-2-yl)allyl acetate (72.8 mg, 0.40 mmol, 
200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1) provided the title 
compound (36.2 mg, 164 µmol, anti:syn = >20:1) in 82% yield as a yellow oil.  
 
TLC (SiO2) Rf = 0.53 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.24 (dd, J = 4.4, 2.0 Hz, 1H), 6.99 (d, J = 4.5 Hz, 2H), 
6.21 – 6.09 (m, 1H), 5.34 (dt, J = 10.2, 0.9 Hz, 1H), 5.25 (dt, J = 17.1, 1.2 Hz, 1H), 4.29 
(td, J = 6.9, 3.7 Hz, 1H), 4.09 (dd, J = 8.4, 3.7 Hz, 1H), 2.46 (d, J = 6.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 142.1, 133.9, 127.0, 125.5, 124.8, 124.5 (q, J = 283.3 
Hz), 120.1, 73.5 (q, J = 29.9 Hz), 45.4. 
 
19F NMR (471 MHz, CDCl3): δ = -75.8 (d, J = 6.9 Hz). 
 
HRMS (CI) Calculated for C9H9F3OS [M]+ = 222.0326, Found 222.0329.  
 
FTIR (neat) 3456, 2970, 2361, 1738, 1366, 1270, 1106, 927, 852, 695 cm–1. 
 
[α]D
33	: –74.5 (c = 1.0, CHCl3) 
 




























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(6-methoxypyridin-3-yl)allyl acetate (83 mg, 0.40 
mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 6:1) provided the title 
compound (42.8 mg, 173 µmol, anti:syn = >20:1) in 87% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.37 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 8.04 (dt, J = 2.6, 0.6 Hz, 1H), 7.55 (dd, J = 8.6, 2.5 Hz, 
1H), 6.72 (dd, J = 8.5, 0.7 Hz, 1H), 6.18 (dddd, J = 17.2, 10.2, 8.1, 0.9 Hz, 1H), 5.29 (dt, 
J = 10.3, 1.0 Hz, 1H), 5.15 (dt, J = 17.1, 1.2 Hz, 1H), 4.16 (h, J = 6.6 Hz, 1H), 3.89 (s, 
3H), 3.68 (dd, J = 8.2, 4.8 Hz, 1H), 3.28 (d, J = 6.3 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 163.5, 146.2, 138.8, 134.6, 128.5, 124.8 (d, J = 283.5 
Hz), 119.8, 111.0, 73.0 (q, J = 29.4 Hz), 53.7, 46.8. 
 
19F NMR (471 MHz, CDCl3): δ = –75.8 (d, J = 6.9 Hz)  
 
HRMS (CI) Calculated for C11H13F3NO2 [M+H]+ = 248.0898, Found 248.0897.  
 
FTIR (neat) 3450, 2951, 1608, 1495, 1395, 1271, 1163, 1128, 1029, 927, 831, 693 cm–1. 
 
[α]D
33	: –67.3 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using fluoral hydrate 
(75% in H2O, 22 µL, 200 µmol) and 1-(quinolin-4-yl)allyl acetate (91 mg, 0.40 mmol, 200 
mol%). Flash chromatography on silica (Hex/EtOAc 3:1 → 1:1) provided the title 
compound (44.7 mg, 168 µmol, anti:syn = >20:1) in 84% yield as a light yellow solid.  
 
TLC (SiO2) Rf  = 0.21 (hexanes/ethyl acetate = 1:1).  
 
1H NMR (500 MHz, CDCl3): δ = 8.4 (d, J = 4.6 Hz, 1H), 7.9 – 7.9 (m, 1H), 7.6 – 7.5 (m, 
1H), 7.5 – 7.4 (m, 2H), 7.4 (d, J = 4.6 Hz, 1H), 6.8 (s, 1H), 6.6 (dd, J = 17.7, 9.1 Hz, 1H), 
5.4 (dd, J = 10.3, 1.1 Hz, 1H), 5.2 (dt, J = 17.3, 1.0 Hz, 1H), 4.6 (dd, J = 8.6, 2.4 Hz, 1H), 
4.4 (dd, J = 7.1, 2.5 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 149.4, 147.9, 147.2, 132.8, 129.7, 129.1, 127.3, 125.8, 
125.1 (q, J = 283.4 Hz), 122.4, 121.1, 120.3, 71.8 (q, J = 29.9 Hz), 44.3. 
 
19F NMR (471 MHz, CDCl3): δ = –75.7 (d, J = 7.0 Hz). 
 
HRMS (ESI) Calculated for C14H12F3NO [M+H]+ = 268.0944, Found 268.0947.  
 
FTIR (neat) 3083, 2920, 2761, 1592, 1282, 1145, 1108, 980, 773 cm–1. 
 
[α]D






























General Procedure and Spectral Data for Iridium Catalyzed anti-(α-Aryl)Allylation 
of Difluoroacetaldehyde Ethyl Hemiacetal 1j to form Products 6.5a-6.5l  
 
A pressure tube was equipped with a magnetic stir bar and charged with preformed iridium 
catalyst (10.7 mg, 10 µmol, 5 mol%), K2CO3 (27.6 mg, 0.20 mmol, 100 mol%), allyl donor 
(0.40 mmol, 200 mol%) and 5A molecular sieves (28 mg, 100 wt%). The pressure tube was 
purged with argon. Anhydrous THF (1.0 mL, 0.2 M), 2-propanol (31 µL, 0.40 mmol, 200 
mol%), and difluoroacetaldehyde ethyl hemiacetal (90% in EtOH, 28 mg, 200 µmol, 100 
mol%) were added via syringe. The sealed reaction vessel was stirred at 100 °C. After 24 
h the solvent was removed in vacuo and the residue was subjected to flash column 








The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-phenylallyl acetate 
(71 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1 → 10:1) 
provided the title compound (31.5 mg, 159 µmol, anti:syn = >20:1) in 80% yield as a 
yellow oil.  
 
TLC (SiO2) Rf  = 0.53 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.37–7.34 (m, 2H), 7.29–7.28 (m, 3H), 6.20 (dt, J = 
17.8, 9.5 Hz, 1H), 5.54 (td, J = 55.6, 3.7 Hz, 1H), 5.29 (d, J = 10.2 Hz, 1H), 5.23 (d, J = 
17.2 Hz, 1H), 4.10 – 3.91 (m, 1H), 3.61 – 3.55 (m, 1H), 2.13 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 139.6, 136.0, 129.1, 128.2, 127.5, 118.9, 115.2 (t, J = 
243.2 Hz), 73.8 (dd, J = 23.1, 20.9 Hz), 51.0 (t, J = 3.6 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -129.2 (ddd, J = 286.4, 54.9, 6.0 Hz), -134.4 (ddd, J = 
286.4, 56.0, 15.7 Hz). 
 
HRMS (CI) Calculated for C11H12F2O [M]+ = 198.0856, Found 198.0852.  
 
FTIR (neat) 3442, 3030, 2984, 2926, 1493, 1455, 1150, 1057, 926, 758, 701 cm–1. 
 
[α]D
33	: –78.3 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(4-
bromophenyl)allyl acetate (102 mg, 0.40 mmol, 200 mol%). Flash chromatography on 
silica (Hex/EtOAc 20:1) provided the title compound (46.6 mg, 168 µmol, anti:syn = 
>20:1) in 84% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.17 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.50–7.45 (m, 2H), 7.20–7.16 (m, 2H), 6.16 (ddd, J = 
17.1, 10.2, 8.7 Hz, 1H), 5.56 (ddd, J = 56.2, 54.9, 4.3 Hz, 1H), 5.29 (dd, J = 10.2, 1.3 Hz, 
1H), 5.22 (dt, J = 17.1, 1.3 Hz, 1H), 4.03–3.92 (m, 1H), 3.55 (dd, J = 8.7, 5.8 Hz, 1H), 
2.20 (d, J = 4.5 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 138.8, 135.2, 132.1, 130.0, 121.3, 119.4, 115.2 (t, J = 
243.6 Hz), 73.5 (dd, J = 23.7, 21.3 Hz), 50.1 (dd, J = 4.0, 3.1 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = –129.1 (ddd, J = 286.5, 55.0, 6.2 Hz), –133.5 (ddd, J = 
287.6, 56.1, 14.7 Hz). 
 
HRMS (CI) Calculated for C11H1179BrF2O [M]+ = 275.9961, Found 275.9954.  
 
FTIR (neat) 3411, 2982, 2924, 1489, 1150, 1129, 1070, 1011, 929, 821, 760 cm–1. 
 
[α]D
33	: –72.0 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(4-
(trifluoromethyl)phenyl)allyl acetate (98 mg, 0.40 mmol, 200 mol%). Flash 
chromatography on silica (Hex/EtOAc 10:1) provided the title compound (43.7 mg, 164 
µmol, anti:syn = >20:1) in 82% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.09 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.63–7.59 (m, 2H), 7.46–7.42 (m, 2H), 6.20 (ddd, J = 
17.1, 10.2, 8.8 Hz, 1H), 5.59 (ddd, J = 56.3, 55.0, 4.5 Hz, 1H), 5.33 (dd, J = 10.2, 1.2 Hz, 
1H), 5.24 (dt, J = 17.1, 1.1 Hz, 1H), 4.02 (ddq, J = 14.1, 6.2, 4.6 Hz, 1H), 3.67 (dd, J = 
8.8, 5.3 Hz, 1H), 2.20 (d, J = 4.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 144.0, 134.8, 129.7 (q, J = 32.5 Hz), 128.7, 125.9 (q, J 
= 3.7 Hz), 124.2 (q, J = 272.1 Hz), 119.8, 115.2 (t, J = 243.7 Hz), 73.5 (dd, J = 24.3, 21.6 
Hz), 50.4 (dd, J = 4.6, 2.6 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = –62.6, –129.0 (ddd, J = 288.7, 55.1, 6.4 Hz), –133.0 
(ddd, J = 288.7, 56.3, 13.9 Hz). 
 
HRMS (CI) Calculated for C12H11F5O [M]+ = 266.0730, Found 266.0726.  
 
FTIR (neat) 3446, 2924, 1327, 1166, 1125, 1068, 1019, 931, 837, 771 cm–1. 
 
[α]D
33	: –54.0 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(p-tolyl)allyl acetate 
(76 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 15:1) 
provided the title compound (31.7 mg, 149 µmol, anti:syn = >20:1) in 75% yield as a 
yellow oil.  
 
TLC (SiO2) Rf  = 0.21 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.17 (s, 4H), 6.18 (ddd, J = 17.2, 10.3, 8.7 Hz, 1H), 
5.54 (ddd, J = 56.0, 54.8, 3.7 Hz, 1H), 5.27 (dd, J = 10.3, 1.5 Hz, 1H), 5.23 (dt, J = 17.2, 
1.3 Hz, 1H), 4.05–3.95 (m, 1H), 3.57–3.51 (m, 1H), 2.34 (s, 3H), 2.11 (d, J = 4.6 Hz, 
1H). 
 
13C NMR (125 MHz, CDCl3): δ = 137.2, 136.5, 136.2, 129.8, 128.0, 118.7, 115.2 (t, J = 
243.1 Hz), 73.7 (dd, J = 22.9, 20.7 Hz), 50.7, 21.2. 
 
19F NMR (471 MHz, CDCl3): δ = –129.2 (ddd, J = 285.9, 54.9, 5.9 Hz), –134.7 (ddd, J = 
286.0, 56.0, 16.1 Hz). 
 
HRMS (CI) Calculated for C12H14F2O [M]+ = 212.1013, Found 212.1010.  
 
FTIR (neat) 3411, 2981, 2924, 1514, 1150, 1127, 1057, 1001, 925, 816, 760 cm–1. 
 
[α]D
33	: –68.3 (c = 1.0, CHCl3) 
 


























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(4-
methoxyphenyl)allyl acetate (82.4 mg, 0.40 mmol, 200 mol%). Flash chromatography on 
silica (Hex/EtOAc 20:1-10:1) provided the title compound (37.2 mg, 164 µmol, anti:syn = 
>20:1) in 82% yield as a white solid.  
 
TLC (SiO2) Rf  = 0.26 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.20 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 6.17 
(ddd, J = 17.1, 10.2, 8.6 Hz, 1H), 5.53 (ddd, J = 55.9, 54.8, 3.7 Hz, 1H), 5.29 – 5.16 (m, 
2H), 3.97 (dddt, J = 16.2, 8.3, 6.3, 3.9 Hz, 1H), 3.80 (s, 3H), 3.56 – 3.49 (m, 1H), 2.23 (d, 
J = 4.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 158.8, 136.3, 131.5, 129.2, 118.5 (dd, J = 243.5, 25.1 
Hz), 115.2 (t, J = 243.3 Hz), 114.4, 73.8 (dd, J = 22.9, 20.7 Hz), 55.4, 50.2 (t, J = 3.7 
Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -129.19 (ddd, J = 285.6, 55.0, 5.8 Hz), -134.65 (ddd, J 
= 286.0, 56.0, 16.3 Hz). 
 
HRMS (CI) Calculated for C12H14F2O2 [M]+ = 228.0962, Found 228.0960.  
 
FTIR (neat) 3440, 2925, 2363, 1737, 1250, 1155, 1038, 1023, 817, 772 cm–1. 
 
[α]D

































The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 27.9 mg, 199 µmol) and 1-(2-
chlorophenyl)allyl acetate (84 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica 
(Hex/EtOAc 20:1 → 10:1) provided the title compound (35.1 mg, 151 µmol, anti:syn = 
>20:1) in 76% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.57 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.43 (dd, J = 7.7, 1.8 Hz, 1H), 7.40 (dd, J = 7.9, 1.5 
Hz, 1H), 7.29 – 7.25 (m, 1H), 7.21 (td, J = 7.6, 1.7 Hz, 1H), 6.23 (ddd, J = 17.1, 10.2, 8.7 
Hz, 1H), 5.64 (ddd, J = 56.4, 55.0, 4.6 Hz, 1H), 5.32 (dd, J = 10.2, 1.4 Hz, 1H), 5.25 (dt, 
J = 17.0, 1.2 Hz, 1H), 4.20 (dd, J = 8.8, 4.8 Hz, 1H), 4.08 (ddq, J = 14.0, 6.6, 4.8 Hz, 
1H), 2.16 (d, J = 4.9 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 137.6, 134.1, 133.5, 130.1, 129.9, 128.5, 127.2, 120.0, 
115.4 (t, J = 243.8 Hz), 72.6 (dd, J = 24.7, 21.5 Hz), 46.3 (dd, J = 4.7, 2.7 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -128.6 (ddd, J = 288.0, 55.0, 6.6 Hz), -132.0 (ddd, J = 
288.0, 56.5, 13.5 Hz). 
 
HRMS (CI) Calculated for C11H1135ClF2O [M]+ = 232.0466, Found 232.0465.  
 
FTIR (neat) 3443, 3074, 2985, 2920, 1474, 1442, 1150, 1066, 1001, 930, 751 cm–1. 
 
[α]D
27	: –44.3 (c = 1.0, CHCl3) 
 


























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(3,5-
dichlorophenyl)allyl acetate (98 mg, 0.40 mmol, 200 mol%). Flash chromatography on 
silica (Hex/EtOAc 20:1) provided the title compound (43 mg, 160 µmol, anti:syn = >20:1) 
in 77% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.38 (hexanes/ethyl acetate = 9:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.28 (t, J = 1.7 Hz, 1H), 7.22 (d, J = 1.7 Hz, 2H), 6.13 
(dt, J = 17.3, 9.6 Hz, 1H), 5.61 (ddd, J = 56.3, 55.3, 4.9 Hz, 1H), 5.29 (dd, J = 43.7, 13.7 
Hz, 2H), 4.03 – 3.93 (m, 1H), 3.55 (dd, J = 8.8, 4.6 Hz, 1H), 2.21 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 143.30, 135.34, 133.52, 127.70, 126.83, 125.65, 
123.39, 120.84, 73.41 (dd, J = 24.8, 22.0 Hz), 49.90 (dd, J = 4.9, 2.3 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -128.92 (ddd, J = 289.4, 55.1, 6.0 Hz), -132.45 (ddd, J 
= 289.4, 56.5, 13.4 Hz). 
 
HRMS (CI) Calculated for C11H10Cl2F2O [M]+ = 266.0077, Found 266.0080.  
 
FTIR (neat) 3432, 3083, 2984, 1567, 1433, 1059, 858, 759, 681 cm–1. 
 
[α]D
33	: –83.3 (c = 1.2, CHCl3) 
 


























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-
(benzo[d][1,3]dioxol-5-yl)allyl acetate (88 mg, 0.40 mmol, 200 mol%). Flash 
chromatography on silica (Hex/EtOAc 10:1) provided the title compound (43.0 mg, 178 
µmol, anti:syn = >20:1) in 89% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.13 (hexanes/ethyl acetate = 10:1).  
 
1H NMR (500 MHz, CDCl3): δ = 6.80–6.77 (m, 2H), 6.73 (dd, J = 8.0, 1.8 Hz, 1H), 6.13 
(ddd, J = 17.1, 10.2, 8.6 Hz, 1H), 5.95 (s, 2H), 5.55 (ddd, J = 56.0, 54.8, 3.7 Hz, 1H), 5.28–
5.25 (m, 1H), 5.22 (dt, J = 17.1, 1.3 Hz, 1H), 4.00–3.91 (m, 1H), 3.52–3.46 (m, 1H), 2.14 
(d, J = 4.5 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 148.1, 146.8, 136.0, 133.3, 121.3, 118.7, 115.2 (t, J = 
243.2 Hz), 108.8, 108.5, 101.3, 73.8 (dd, J = 23.1, 20.8 Hz), 50.6 (t, J = 3.7 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = –129.2 (ddd, J = 286.1, 54.7, 5.9 Hz), –134.6 (ddd, J = 
286.2, 56.0, 15.8 Hz). 
 
HRMS (CI) Calculated for C12H12F2O3 [M]+ = 242.0755, Found 242.0758.  
 
FTIR (neat) 3453, 2982, 2897, 1504, 1488, 1443, 1244, 1134, 1098, 1037, 929 cm–1. 
 
[α]D
32	: –53.0 (c = 1.0, CHCl3) 
 



























The title compound was prepared according to the general procedure using using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(furan-2-yl)allyl 
acetate (66.5 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 
20:1) provided the title compound (25 mg, 120 µmol, anti:syn = >20:1) in 65% yield as a 
yellow oil.  
 
TLC (SiO2) Rf  = 0.2 (hexanes/ethyl acetate = 9:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.39 – 7.37 (m, 1H), 6.35 (dd, J = 3.2, 1.9 Hz, 1H), 
6.19 (d, J = 3.2 Hz, 1H), 6.12 – 6.03 (m, 1H), 5.63 (ddd, J = 56.3, 54.9, 4.6 Hz, 1H), 5.33 
(dd, J = 10.1, 0.9 Hz, 1H), 5.27 (d, J = 17.2 Hz, 1H), 4.21 – 4.10 (m, 1H), 3.74 (dd, J = 
8.7, 5.1 Hz, 1H), 2.27 (dd, J = 8.9, 3.7 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 152.69, 142.15, 132.73, 119.98, 117.23, 115.29, 
113.36, 110.61, 107.44, 72.05 (dd, J = 24.6, 21.6 Hz), 44.86 (dd, J = 5.1, 2.9 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -128.92 (ddd, J = 288.8, 54.8, 6.0 Hz), -132.79 (ddd, J 
= 288.8, 56.3, 14.2 Hz). 
 
HRMS (CI) Calculated for C9H10F2O2 [M]+ =188.0649, Found 188.0644.  
 
FTIR (neat) 3435, 2926, 1717, 1265, 1062, 935, 734, 703 cm–1. 
 
[α]D
33	: –43.3 (c = 0.3, CHCl3) 
 





























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(thiophen-2-yl)allyl 
acetate (73 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 20:1) 
provided the title compound (28.7 mg, 140 µmol, anti:syn = >20:1) in 70% yield as a 
yellow oil.  
 
TLC (SiO2) Rf  = 0.54 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.24 (dd, J = 5.1, 1.2 Hz, 1H), 7.00 (dd, J = 5.1, 3.5 
Hz, 1H), 6.96 (s, 1H), 6.20 – 6.06 (m, 1H), 5.64 (ddd, J = 56.3, 54.9, 4.7 Hz, 1H), 5.34 – 
5.24 (m, 2H), 4.03 (dt, J = 14.4, 4.8 Hz, 1H), 3.92 (dd, J = 8.9, 5.0 Hz, 1H), 2.30 (d, J = 
4.3 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 142.3, 135.1, 127.2, 125.3, 124.8, 119.2, 115.3 (t, J = 
243.3 Hz), 74.0 (dd, J = 24.6, 21.4 Hz), 46.3 (dd, J = 5.1, 2.7 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -129.12 (ddd, J = 288.7, 54.9, 5.5 Hz), -133.10 (ddd, J 
= 288.6, 56.3, 14.3 Hz). 
 
HRMS (CI) Calculated for C9H10OF2S [M]+ = 204.0420, Found 204.0218.  
 
FTIR (neat) 3444, 1420, 1126, 1051, 928, 756, 697 cm–1. 
 
[α]D
33	: –73.3 (c = 1.0, CHCl3) 
 































The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 27.3 mg, 195 µmol) and 1-(6-
methoxypyridin-3-yl)allyl acetate (83 mg, 0.40 mmol, 200 mol%). Flash chromatography 
on silica (Hex/EtOAc 6:1) provided the title compound (33.5 mg, 146 µmol, anti:syn = 
>20:1) in 75% yield as a yellow oil.  
 
TLC (SiO2) Rf  = 0.37 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 8.07 (d, J = 2.4 Hz, 1H), 7.54 (dd, J = 8.6, 2.4 Hz, 1H), 
6.72 (d, J = 8.6 Hz, 1H), 6.21 – 6.11 (m, 1H), 5.60 (td, J = 55.7, 4.5 Hz, 1H), 5.28 (d, J = 
10.2 Hz, 1H), 5.21 (d, J = 17.1 Hz, 1H), 3.97 – 3.92 (m, 1H), 3.91 (s, 3H), 3.55 (dd, J = 
8.6, 5.4 Hz, 1H), 2.53 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 163.5, 146.3, 138.7, 135.2, 128.3, 119.2, 115.4 (t, J = 
243.6 Hz), 111.1, 73.7 (dd, J = 24.2, 21.4 Hz), 53.6, 47.4 (dd, J = 4.6, 2.5 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -128.9 (ddd, J = 288.4, 55.1, 6.1 Hz), -132.8 (ddd, J = 
288.5, 56.4, 14.0 Hz). 
 
HRMS (ESI) Calculated for C11H13F2NO2 [M+H]+ = 230.0987, Found 230.0994.  
 




29	: –79.5 (c = 1.0, CHCl3) 
 
























The title compound was prepared according to the general procedure using 
difluoroacetaldehyde ethyl hemiacetal (90%, 28 mg, 200 µmol) and 1-(quinolin-4-yl)allyl 
acetate (91 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 3:1→ 
1:1) provided the title compound (42.6 mg, 172 µmol, anti:syn = >20:1) in 86% yield as a 
white solid.  
 
TLC (SiO2) Rf  = 0.26 (hexanes/ethyl acetate = 1:1).  
 
1H NMR (500 MHz, Acetone-d6): δ = 8.81 (d, J = 4.5 Hz, 1H), 8.21 (ddt, J = 8.5, 1.3, 0.6 
Hz, 1H), 8.04 (ddd, J = 8.4, 1.4, 0.6 Hz, 1H), 7.74 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.66 
(dd, J = 8.4, 1.4 Hz, 1H), 7.62 – 7.60 (m, 1H), 6.51 (ddd, J = 17.2, 10.3, 8.8 Hz, 1H), 
5.82 (ddd, J = 56.5, 55.3, 5.1 Hz, 1H), 5.35 – 5.27 (m, 2H), 4.56 (dd, J = 9.0, 4.0 Hz, 
1H), 4.23 – 4.13 (m, 1H), 2.99 (s, 1H). 
 
13C NMR (125 MHz, Acetone-d6): δ = 150.7, 149.3, 147.4, 135.8, 131.0, 129.7, 127.5, 
127.0, 123.7, 121.7, 119.2, 117.1 (t, J = 243.6 Hz), 73.1 (dd, J = 24.9, 21.4 Hz), 45.3 (dd, 
J = 5.7, 2.5 Hz). 
 
19F NMR (471 MHz, Acetone-d6): δ = -128.48 (ddd, J = 285.2, 55.3, 6.4 Hz), -131.12 
(ddd, J = 285.0, 56.7, 14.0 Hz). 
 
HRMS (ESI) Calculated for C14H13F2NO [M+H]+ = 250.1038, Found 250.1036.  
 
FTIR (neat) 3086, 2361, 1737, 1589, 1280, 1054, 927, 768, 660 cm–1. 
 
[α]D





























Enantioselective Synthesis of Di- and Trifluoro-methylated Derivatives of d-
Hyoscyamine 6.8a and 6.8b 
tert-butyldimethyl(((2S,3R)-1,1,1-trifluoro-3-phenylpent-4-en-2-yl)oxy)silane (6.6a’) 
 
To a solution of alcohol 6.4a (216.2 mg, 1.000 mmol, 100 mol%) in CH2Cl2 (2 mL) was 
added imidazole (204.2 mg, 3.000 mmol, 300 mol%), TBSCl (301.5 mg, 2.000 mmol, 200 
mol%) and 4-(dimethylamino)pyridine (12.2 mg, 0.100 mmol, 10 mol%). The reaction was 
heated to 40 °C for 24 h. The contents were diluted with CH2Cl2 (2 mL) and washed with 
H2O (2 mL). The aqueous layer was extracted with CH2Cl2 (2 x 2 mL), and the combined 
organic phases were washed with brine (2 mL), dried (Na2SO4), filtered and the solvent 
was removed in vacuo. The residue was subjected to flash chromatography on silica 
(Hexanes) to furnish the title compound 6.6a’ (239.8 mg, 0.726 mmol) in 73% yield as a 
clear oil.  
TLC (SiO2) Rf  = 0.43 (hexanes).  
 
1H NMR (500 MHz, CDCl3): δ = 7.34 – 7.29 (m, 2H), 7.25 – 7.21 (m, 3H), 6.41 – 6.24 
(m, 1H), 5.25 (dd, J = 10.3, 1.6 Hz, 1H), 5.16 (d, J = 17.2 Hz, 1H), 4.23 (qd, J = 6.7, 3.7 
Hz, 1H), 3.75 (dd, J = 9.1, 3.6 Hz, 1H), 0.85 (s, 9H), -0.02 (s, 3H), -0.36 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 141.2, 134.9, 128.6, 128.5, 127.0, 124.8 (q, J = 284.9 
Hz), 118.2, 75.7 (q, J = 29.0 Hz), 50.6, 25.8, 18.3, -5.0 (q, J = 1.9 Hz), -5.2. 
 
19F NMR (471 MHz, CDCl3): δ = -74.43 (d, J = 6.6 Hz). 
 
HRMS (CI) Calculated for C17H25F3OSi [M+H]+ = 331.1705, Found 331.1706.  
 
FTIR (neat) 2931, 2860, 1473, 1382, 1260, 1145, 1115, 1002, 927, 876, 829, 779, 700 cm–
1. 
[α]D














(2R,3S)-3-((tert-butyldimethylsilyl)oxy)-4,4,4-trifluoro-2-phenylbutanoic acid (6.6a) 
 
To a stirred solution of 6.6a’ (195.0 mg, 0.590 mmol, 100 mol%), in 1.7 mL CCl4, 1.7 mL 
CH3CN, and 2.5 mL H2O was added NaIO4 (504.8 mg, 2.360 mmol, 400 mol%). After all 
the NaIO4 had dissolved, RuCl3.2H2O (14.4 mg, 0.059 mmol, 10 mol%) was added, and 
the reaction mixture was stirred vigorously for 24 h at 25 oC. The contents were diluted 
with EtOAc (5 mL) and washed with H2O (5 mL). The aqueous layer was extracted with 
EtOAc (2 x 5 mL), and the combined organic phases were washed with brine (5 mL), dried 
(Na2SO4), filtered and the solvent was removed in vacuo. The residue was subjected to 
flash chromatography on silica (Hex/EtOAc 5:1) to furnish the title compound 6.6a (145.2 
mg, 0.417 mmol) in 71% yield as a white solid. 
 
TLC (SiO2) Rf  = 0.43 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.40 – 7.29 (m, 5H), 4.60 (dq, J = 9.4, 6.1 Hz, 1H), 
3.97 (d, J = 9.5 Hz, 1H), 0.85 (s, 9H), 0.14 (s, 3H), 0.08 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 176.7, 132.7, 128.9, 128.6, 124.3 (q, J = 284.1 Hz), 
73.1 (q, J = 29.7 Hz), 55.1, 25.7, 18.3, -4.8 – -4.9 (m), -5.0. 
 
19F NMR (471 MHz, CDCl3): δ = -73.71 (d, J = 5.9 Hz). 
 
HRMS (CI) Calculated for C16H23F3O3Si [M+H]+ = 349.1447, Found 349.1449.  
 
FTIR (neat) 2932, 2861, 1709, 1363, 1265, 1174, 1131, 892, 834, 784 cm–1. 
 
[α]D




















A vial equipped with a magnetic stir bar was charged with 6.6a (19.9 mg, 0.0571 mmol, 
100 mol%), 2-methyl-6-nitrobenzoic anhydride (29.5 mg, 0.0857 mmol, 150 mol%), 4-
(dimethylamino)pyridine (0.7 mg, 0.0057 mmol, 10 mol%) and purged with argon. Freshly 
distilled CH2Cl2 (570 µL) and N,N-diisopropylethylamine (29.3 µL, 0.1713 mmol, 300 
mol%), were added sequentially via syringe. The resulting mixture was stirred at 25 °C for 
10 minutes. Tropine (12.1 mg, 0.0857 mmol, 150 mol%) was added in a single portion at 
25 °C. The reaction was stirred at 40 °C for 20 h. The reaction mixture was concentrated, 
and the residue was subjected to flash chromatography on basic alumina (DCM/MeOH 
98:2) to furnish the title compound 6.7a (23.7 mg, 0.0503 mmol, 7:1 dr) in 88% yield as a 
clear oil. 
 
TLC (Basic Alumina) Rf  = 0.50 (DCM/MeOH = 95:5).  
 
1H NMR (500 MHz, CDCl3): δ = 7.37 – 7.27 (m, 5H), 4.98 (t, J = 5.4 Hz, 1H), 4.70 (dq, 
J = 8.3, 5.8 Hz, 1H), 3.81 (d, J = 8.5 Hz, 1H), 3.05 (dt, J = 6.9, 3.2 Hz, 1H), 2.94 (dt, J = 
6.8, 3.0 Hz, 1H), 2.21 (s, 3H), 2.10 (dt, J = 14.2, 4.2 Hz, 1H), 2.02 (dt, J = 15.1, 4.5 Hz, 
1H), 1.91 (qdd, J = 10.6, 9.0, 7.3, 4.0 Hz, 1H), 1.81 – 1.72 (m, 2H), 1.70 – 1.65 (m, 1H), 





13C NMR (125 MHz, CDCl3): δ = 170.1, 134.1, 129.8, 128.7, 128.2, 124.9 (q, J = 284.3 
Hz), 72.3 (q, J = 30.3 Hz), 68.7, 59.8, 59.7, 53.4, 40.5, 36.4, 36.3, 25.5, 25.4, 25.2, 18.1, -
5.2 – -5.4 (m), -5.5. 
 
19F NMR (471 MHz, CDCl3): δ = -76.08 (d, J = 5.8 Hz). 
 
HRMS (APPI) Calculated for C24H36F3NO3Si [M+H]+ = 472.2489, Found 472.2498.  
 
FTIR (neat) 2931, 2859, 1731, 1473, 1269, 1168, 1128, 1034, 840, 782, 700 cm–1. 
 
[α]D



















To a polyethylene tube charged with 7a (10.0 mg, 0.0212 mmol, 100 mol%) in THF (420 
µL) was added HF-pyridine (100 µL) dropwise at 25 °C. The resulting mixture was stirred 
at 25 oC for 24 h. The reaction was diluted with CH2Cl2 (3 mL) and quenched by careful 
addition of saturated NaHCO3 (2 mL). The reaction mixture was extracted with CH2Cl2 (2 
x 2 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated 
in vacuo. The residue was subjected to flash chromatography on basic alumina 
(DCM/MeOH 95:5) to furnish the title compound 8a (6.7 mg, 0.0188 mmol) in 89% yield 
as a clear oil. 
TLC (Basic Alumina) Rf  = 0.30 (DCM/MeOH = 95:5).  
 
1H NMR (500 MHz, CDCl3): δ = 7.40 – 7.32 (m, 5H), 4.99 (t, J = 5.3 Hz, 1H), 4.75 (p, J 
= 6.5 Hz, 1H), 3.87 (d, J = 6.9 Hz, 1H), 3.14 – 3.05 (m, 1H), 3.01 – 2.92 (m, 1H), 2.22 (s, 
3H), 2.20 – 2.12 (m, 1H), 2.12 – 2.03 (m, 1H), 1.96 – 1.84 (m, 1H), 1.75 (dq, J = 10.4, 6.8, 
5.0 Hz, 2H), 1.68 (d, J = 15.5 Hz, 1H), 1.46 (d, J = 15.1 Hz, 1H), 1.24 (ddd, J = 13.3, 9.3, 
4.6 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 170.4, 133.0, 129.4, 129.1, 128.5, 124.7 (q, J = 282.3 
Hz), 70.4 (q, J = 30.7 Hz), 68.9, 59.8, 59.7, 52.2, 40.3, 36.2, 36.0, 25.4, 25.0. 
 
19F NMR (471 MHz, CDCl3): δ = -76.92 (d, J = 6.4 Hz). 
 
HRMS (ESI) Calculated for C18H22F3NO3 [M+H]+ = 358.1625, Found 358.1628.  
 
FTIR (neat) 2926, 2853, 1732, 1456, 1269, 1163, 1130, 1032, 700 cm–1. 
 
[α]D

















To a solution of alcohol 6.5a (99.1 mg, 0.500 mmol, 100 mol%) in CH2Cl2 (1 mL) was 
added imidazole (102.1 mg, 1.500 mmol, 300 mol%), TBSCl (150.7 mg, 1.000 mmol, 200 
mol%) and 4-(dimethylamino)pyridine (6.1 mg, 0.050 mmol, 10 mol%). The reaction was 
allowed to stir at 25 °C for 24 h. The contents were diluted with CH2Cl2 (1 mL) and washed 
with H2O (1 mL). The aqueous layer was extracted with CH2Cl2 (2 x 1 mL), and the 
combined organic phases were washed with brine (1 mL), dried (Na2SO4), filtered and the 
solvent was removed in vacuo. The residue was subjected to flash chromatography on silica 
(Hexanes) to furnish the title compound 6.6b’ (137.0 mg, 0.438 mmol) in 88% yield as a 
clear oil. 
TLC (SiO2) Rf  = 0.43 (hexanes).  
 
1H NMR (500 MHz, CDCl3): δ = 7.35 – 7.27 (m, 2H), 7.25 – 7.20 (m, 3H), 6.29 (dt, J = 
17.2, 9.8 Hz, 1H), 5.49 (ddd, J = 56.7, 55.1, 5.3 Hz, 1H), 5.27 (dd, J = 10.3, 1.7 Hz, 1H), 
5.20 (ddd, J = 17.2, 1.8, 0.8 Hz, 1H), 3.98 (dq, J = 13.6, 4.6 Hz, 1H), 3.63 (dt, J = 9.0, 3.2 
Hz, 1H), 0.82 (s, 9H), -0.03 (d, J = 1.9 Hz, 3H), -0.36 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 140.8, 135.4, 128.7, 128.5, 127.0, 118.7, 116.0 (dd, J 
= 245.7, 243.8 Hz), 76.0 (dd, J = 25.3, 20.3 Hz), 51.2 (dd, J = 5.6, 2.2 Hz), 25.9, 18.3, -
4.7 (d, J = 3.6 Hz), -5.2. 
 
19F NMR (471 MHz, CDCl3): δ = -127.12 (ddd, J = 284.9, 55.5, 5.1 Hz), -129.83 (ddd, J 
= 283.5, 56.7, 13.5 Hz). 
 
HRMS (ESI) Calculated for C17H26F2OSi [M+H]+ = 313.1799, Found 313.1806.  
 
FTIR (neat) 2955, 2930, 2858, 1473, 1256, 1138, 1117, 1069, 1005, 927, 838, 779, 701 
cm–1. 
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(2R,3S)-3-((tert-butyldimethylsilyl)oxy)-4,4-difluoro-2-phenylbutanoic acid (6.6b) 
 
To a stirred solution of 6.6b’ (109.4 mg, 0.350 mmol, 100 mol%), in 1.0 mL CCl4, 1.0 mL 
CH3CN, and 1.5 mL H2O was added NaIO4 (299.5 mg, 1.400 mmol, 400 mol%). After all 
the NaIO4 had dissolved, RuCl3.2H2O (8.5 mg, 0.035 mmol, 10 mol%) was added, and the 
reaction mixture was stirred vigorously for 24 h at 25 oC. The contents were diluted with 
EtOAc (3 mL) and washed with H2O (3 mL). The aqueous layer was extracted with EtOAc 
(2 x 3 mL), and the combined organic phases were washed with brine (3 mL), dried 
(Na2SO4), filtered and the solvent was removed in vacuo. The residue was subjected to 
flash chromatography on silica (Hex/EtOAc 5:1) to furnish the title compound 6.6b (85.4 
mg, 0.258 mmol) in 74% yield as a white solid. 
TLC (SiO2) Rf  = 0.43 (hexanes/ethyl acetate = 3:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.40 – 7.28 (m, 5H), 5.30 (td, J = 54.4, 1.5 Hz, 1H), 
4.43 (dddd, J = 19.1, 9.7, 6.0, 1.5 Hz, 1H), 3.88 (d, J = 9.6 Hz, 1H), 0.86 (s, 9H), 0.13 (s, 
3H), 0.07 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 176.6, 133.1, 129.3, 128.8, 128.7, 114.2 (dd, J = 
246.0, 242.6 Hz), 73.7 – 73.3 (m), 54.7, 25.9, 18.4, -4.5 (d, J = 3.7 Hz), -5.2. 
 
19F NMR (471 MHz, CDCl3): δ = -127.22 (ddd, J = 284.4, 54.5, 4.6 Hz), -135.17 (ddd, J 
= 284.2, 54.4, 19.1 Hz). 
 
HRMS (ESI) Calculated for C16H24F2O3Si [M+Na]+ = 353.1355, Found 353.1361.  
 
FTIR (neat) 2955, 2930, 2859, 1714, 1254, 1167,1115, 1065, 935, 837, 780, 699 cm–1. 
 
[α]D
29	: –95.5 (c = 1.0, CHCl3) 
 


















A vial equipped with a magnetic stir bar was charged with 6.6b (10.0 mg, 0.0303 mmol, 
100 mol%), 2-methyl-6-nitrobenzoic anhydride (15.7 mg, 0.0455 mmol, 150 mol%), 4-
(dimethylamino)pyridine (0.4 mg, 0.0030 mmol, 10 mol%) and purged with argon. Freshly 
distilled CH2Cl2 (300 µL) and N,N-diisopropylethylamine (5.2 µL, 0.0303 mmol, 100 
mol%), were added sequentially via syringe. The resulting mixture was stirred at 25 °C for 
10 minutes. Tropine (6.4 mg, 0.0455 mmol, 150 mol%) was added in a single portion at 
25 °C. The reaction was stirred at 25 °C for 20 h. The reaction mixture was concentrated, 
and the residue was subjected to flash chromatography on basic alumina (DCM/MeOH 
98:2) to furnish the title compound 6.7b (12.1 mg, 0.0267 mmol, 4:1 dr) in 88% yield as a 
clear oil. 
 
TLC (Basic Alumina) Rf  = 0.50 (DCM/MeOH = 95:5).  
 
1H NMR (500 MHz, CDCl3): δ = 7.36 – 7.30 (m, 5H), 5.59 (td, J = 55.8, 4.0 Hz, 1H), 4.99 
(t, J = 5.4 Hz, 1H), 4.53 – 4.43 (m, 1H), 3.75 (d, J = 7.4 Hz, 1H), 3.08 – 3.02 (m, 1H), 2.98 
– 2.92 (m, 1H), 2.22 (s, 3H), 2.14 (d, J = 14.5 Hz, 1H), 2.05 (d, J = 15.6 Hz, 1H), 1.88 – 
1.80 (m, 1H), 1.75 – 1.62 (m, 3H), 1.47 (d, J = 15.1 Hz, 1H), 1.23 – 1.17 (m, 1H), 0.73 (s, 





13C NMR (125 MHz, CDCl3): δ = 170.6, 134.7, 129.9, 128.6, 128.0, 115.7 (t, J = 245.4 
Hz), 73.1 (t, J = 22.9 Hz), 68.4, 59.9, 59.8, 53.7 – 53.5 (m), 40.4, 36.4, 36.1, 25.7, 25.4, 
25.0, 18.2, -4.9, -5.4. 
 
19F NMR (471 MHz, CDCl3): δ = -126.38 (ddd, J = 285.8, 55.2, 4.6 Hz), -130.11 (ddd, J 
= 285.7, 56.3, 14.4 Hz). 
 
HRMS (APPI) Calculated for C24H37F2NO3Si [M+H]+ = 454.2584, Found 454.2588.  
 

























To a polyethylene tube charged with 6.7b (10.0 mg, 0.0220 mmol, 100 mol%) in THF (440 
µL) was added HF-pyridine (100 µL) dropwise at 25 °C. The resulting mixture was stirred 
at 25 oC for 24 h. The reaction was diluted with CH2Cl2 (3 mL) and quenched by careful 
addition of saturated NaHCO3 (2 mL). The reaction mixture was extracted with CH2Cl2 (2 
x 2 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated 
in vacuo. The residue was subjected to flash chromatography on basic alumina 
(DCM/MeOH 95:5) to furnish the title compound 6.8b (6.0 mg, 0.0177 mmol) in 80% 
yield as a clear oil. 
 
TLC (Basic Alumina) Rf  = 0.40 (DCM/MeOH = 95:5).  
 
1H NMR (500 MHz, CDCl3): δ = 7.42 – 7.30 (m, 5H), 5.57 (td, J = 55.7, 4.9 Hz, 1H), 
5.04 (t, J = 5.4 Hz, 1H), 4.53 – 4.45 (m, 1H), 3.81 (d, J = 6.0 Hz, 1H), 3.17 – 3.09 (m, 
1H), 3.05 – 2.96  (m, 1H), 2.26 (s, 3H), 2.22 – 2.14 (m, 1H), 2.31 – 2.23 (m, 1H), 1.93 – 
1.84 (m, 1H), 1.78 – 1.63 (m, 3H), 1.49 (d, J = 15.2 Hz, 1H), 1.15 – 1.04 (m, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 171.2, 133.4, 129.5, 129.1, 128.4, 115.2 (dd, J = 244.8, 
241.8 Hz), 71.2 (dd, J = 25.0, 23.3 Hz), 68.5, 60.0, 59.9, 51.9 (dd, J = 5.2, 1.9 Hz), 40.2, 
36.1, 35.9, 25.3, 24.8. 
 
19F NMR (471 MHz, CDCl3): δ = -129.35 (ddd, J = 290.7, 54.9, 6.1 Hz), -131.39 (ddd, J 
= 290.6, 56.4, 13.1 Hz). 
 





FTIR (neat) 2933, 2856, 1727, 1455, 1276, 1222, 1140, 1065, 1032, 705, 667 cm–1. 
 
[α]D
















Single Crystal Diffraction Data for 6.4l		
Empirical formula  C14 H12 F3 N O 
Formula weight  267.25 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  orthorhombic 
Space group  P 21 21 21 
  Unit cell dimensions a = 7.0471(10) Å a= 90°. 
 b = 9.5750(14) Å b= 90°. 





Density (calculated) 1.438 Mg/m
3
 




Crystal size 0.260 x 0.150 x 0.060 mm
3
 
Theta range for data collection 4.833 to 75.048°. 
Index ranges -8<=h<=8, -11<=k<=11, -22<=l<=22 
Reflections collected 9466 
Independent reflections 2495 [R(int) = 0.0467] 
Completeness to theta = 67.684° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.651 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 2495 / 0 / 176 
Goodness-of-fit on F2 1.133 
Final R indices [I>2sigma(I)] R1 = 0.0404, wR2 = 0.1146 
R indices (all data) R1 = 0.0422, wR2 = 0.1176 
Absolute structure parameter -0.02(13) 
Extinction coefficient n/a 







View of 6.4l showing the atom labeling scheme. Displacement ellipsoids are scaled to the 







Chapter 7: Rhodium Catalyzed Formate Mediated Reductive Coupling 
of Aldehydes and Aryl Iodides* 
7.1 INTRODUCTION 
Since the discovery of pre-formed organometallic reagents1, the addition of 
organometallic reagents to carbonyl compounds and imines2 to form new C-C bond has 
been a milestone in chemical synthesis.3 While the requirement of cryogenic conditions 
and generation of stoichiometric metal byproducts complicate the applications of using 
organometallic reagents on practical scale. In most cases, the organometallic reagents were 
prepared from the corresponding organohalides, so metal catalyzed reductive coupling of 
organohalides with carbonyl compounds has become an alternative protocol to avoid 
organometallic reagents in carbonyl addition. The common reductants used in these 
reactions are metal reductants (Zn, Mn), toxic chromium(II) salts, pyrophoric 
organometallic reductants (BEt3, ZnEt2, AlMe3), and expensive silane reductant.4 Using 
relatively cheap, environment benign reductants, like hydrogen gas, 2-propanol and formic 
acid, which were used in the carbonyl and imine reductive coupling5 by our group, are 
more desirable (Figure 7.1).  
Except from Nozaki-Hiyama-Kishi reaction6,7, there are very few intermolecular 
reductive couplings of aryl halide with aldehydes and all of those were utilizing zinc metal 
or Mn-Cr alloy8 as terminal reductants or electrochemical reduction.9 Recently in our lab, 
a hydrogen mediated intramolecular Grignard-type cyclization was reported,10 while these 
conditions could not promote the intermolecular coupling reaction. Even though the related 
redox-neutral coupling of aryl halides with aldehydes to form ketone products have been 
                                                
*This chapter is based on the published work:  




reported.11 In this chapter, the first intermolecular metal catalyzed reductive coupling of 
aryl halide and aldehydes mediated by formate was discribed. 
 
 
Figure 7.1 Carbonyl Arylation Strategies Comparison. 
 
7.2 REACTION DEVELOPMENT AND SCOPE 
Initial experiments started with exposing piperonal 7.1a and iodotoluene 7.2a to 2-




Table 7.1 Selected Optimization Experiments for Carbonyl Arylation to Form Adduct 
7.3a. 
 
aYields are material isolated by silica gel chromatography. tBu2PMe·HBF4 was emplyed as 
ligand precursor. PtBu3 was used as a 1.0 M solution in toluene. Lithium formate was used 
as the monohydrate. The loading of bidentate ligands was 5.5 mol%. The loading of 
dimeric rhodium pre-catalyst was 2.5 mol%. See supporting Information for further 





In the conditions when Rh(acac)(CO)2 (5 mol%), PCy3 (11 mol%), sodium formate (300 
mol%), and Cs2CO3 (100 mol%) were used in dioxane under 130 ℃, the desired coupling 
product 7.3a was obtained with 12% yield (Table 7.1, entry 1). Diverse ligands were tested 
under these conditions (Table 7.1, entries 2-8), and it was found that tBu2PMe modified 
rhodium complex was relatively efficient in promoting the reductive coupling and provided 
adduct 7.3a in 40% isolated yield (Table 7.1, entry 8). Different solvents were evaluated, 
and yields were improved to 64% and 72% by using tert-amyl alcohol (Table 7.1, entry 9) 
and dimethoxyethane (Table 7.1, entry 10), respectively. Later on, more formate salts, 2-
propanol and hydrogen gas were also evaluated as terminal reductants, no improvement on 
the yield was observed. Other rhodium pre-catalysts could not provide the similar 
efficiency in the reaction. Lower loading of both aryl halide 7.2a and sodium formate led 
to the decrease of isolation yield of adduct 7.3a. 
With the optimal conditions in hand, a wide range of substrates were applied to the 
reductive coupling to form secondary alcohols 7.3a-7.3u (Table 7.2). Both aromatic 7.1a-
7.1p and aliphatic aldehydes 7.1q-7.1u were engaged in the reductive coupling with aryl 
halides efficiently and diverse functional groups were tolerated. In the formation of 7.3b, 
7.3f, 7.3j, 7.3o, and 7.3p, lower halides (aryl chloride and aryl bromide) didn’t disturb the 
activation of aryl halides to form the desired coupling adducts. Also, fluorine-containing 
functional groups were tolerated. Notably, 2-fluoroiodobenzene 7.2l and 2-
chloroiodobenzene 7.2o were converted to adducts 7.3l and 7.3o without potential aryne 
formation.12 Acidic hydrogens, like OH- and NH-groups, were also tolerated under our 
conditions, which was demonstrated by formation of 7.3g, 7.3i, and 7.3s. Heterocyclic 
moiety containing secondary alcohols 7.3e, 7.3h, and 7.3o were successfully obtained 




Table 7.2 Formate Mediated Reductive Coupling of Aldehydes 7.1a-7.1u to Aryl Iodides 







aYields are material isolated by silica gel chromatography. See supporting Information for 
further experimental details. b[RhCl(CO)2]2 (2.5 mol%) was used. 
 
was very impressive. Finally, both linear and branched aliphatic aldehydes 7.1q-7.1u were 
converted to the corresponding adducts 7.3q-7.3u with good yields. 
 
7.3 MECHANISM AND DISCUSSION 
Deuterium labelling experiments were conducted to help us to understand how the 
reaction proceeded (Scheme 7.1). When deuterio-7.1a and 7.2a were used under the 
standard conditions, dueterio-7.3a was isolated with 77% yield and the carbinol position 
was fully deuterium incorporated. When NaO2CD (300 mol%) was used instead under 
standard conditions, the isolated product did not have deuterium incorporated. These data 
suggested that the coupling adduct did not form via formate mediated reduction of ketones, 
which could derive from rhodium alkoxide via β-elimination. To further prove this, aryl 




Scheme 7.1 Deuterium Labelling Experiments and Proposed Catalytic Mechanism for 
Formate Mediated Arylation. 
 
 




Based on the deuterium study results, the catalytic mechanism for this rhodium 
catalyzed formate mediated reductive coupling of aryl halides and aldehydes was proposed 
(Scheme 7.1). Oxidative addition of aryl halide delivered rhodium(III) complex I. 
Coordination of aldehyde followed by carbonyl insertion into the rhodium-aryl bond to for 
the rhodium alkoxide II. Rhodium formate complex III was formed via ligand exchange 
with the sodium formate. Release of carbon dioxide gas via β-hydride elimination formed 
the rhodium hydride species IV. Final reductive elimination regenerated rhodium(I) and 
closed the catalytic cycle. 
 
7.4 CONCLUSION 
In summary, the first example of reductive carbonyl arylation using non-metallic 
reductant was reported here. This method was applied to a broad range of substrates with 
functional groups, for example, lower halides and protic functional groups, which were not 
compatible with traditional organometallic reagents. This work also expanded the scope of 





7.5 EXPERIMENTAL DETAILS 
General Information 
Unless otherwise noted, all reactions were performed using oven-dried glassware 
under an atmosphere of dry Ar. Rh-catalyzed cycloaddition reactions were conducted in 
pressure tubes (13 x 100 mm) sealed with PTFE-lined caps. Analytical thin-layer 
chromatography (TLC) was carried out using 0.25 mm commercial silica gel plates. 
Visualization was accomplished with UV light followed by dipping in a cerium ammonium 
molybdate, p-anisaldehyde, or potassium permanganate solution and heating. Purification 
of reaction products was carried out by flash column chromatography using 40-63 µm silica 
gel. Unless otherwise noted, reagents were purchased from commercial sources, and used 
as received. Deuterated substrate was prepared according to a previously reported protocol. 
1,2 dimethoxyethane was obtained from Sigma-Aldrich in a septum sealed bottle. Proton 
nuclear magnetic resonance (1H NMR) spectra were recorded on VARIAN INOVA, 
DirectDrive, or MR spectrometers (400 or 500 MHz) or on a Bruker AVANCE III 500 
equipped with a BBFO Prodigy liquid nitrogen CryoProbe. Carbon nuclear magnetic 
resonance (13C NMR) spectra were recorded on a Bruker AVANCE III 500. Chemical 
shifts (δ) for protons are reported in parts per million (ppm) downfield from 
tetramethylsilane, and are referenced to the proton resonance of residual CHCl3 in the 
NMR solvent (δ = 7.26 ppm). Chemical shifts (δ) for carbon are reported in ppm downfield 
from tetramethylsilane, and are referenced to the carbon resonances of the solvent peak (δ 
= 77.16 ppm). NMR data are represented as follows: chemical shift (ppm), multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant in Hertz 
(Hz), and integration. Exact mass determinations were obtained by electrospray ionization 




ionization (CI) on a Waters Micromass AutoSpec Ultima spectrometer. Infrared spectra 
were recorded on a Thermo Nicolet 380 spectrometer. Uncorrected melting points were 





General Procedure and Spectral Data for Arylation Reactions 
 
General procedure A: A resalable pressure tube (13 x 100 mm) was charged with 
Rh(acac)(CO)2 (2.6 mg, 0.01 mmol, 5 mol%), Di-tert-butyl(methyl)phosphonium 
tetrafluoroborate (5.5 mg, 0.022 mmol, 11 mol%), reactant aldehyde (0.20 mmol, 100 
mol%), and reactant aryl iodide (0.4 mmol, 200 mol%). The tube was sealed with a rubber 
septum and purged with Ar for 10 min. DME (1 mL, 0.2 M with respect to the aldehyde 
reactant) was injected, and the rubber septum was quickly replaced with a PTFE-lined 
screw cap. The tube was placed in a 130°C oil bath for 16 h. After cooling to room 
temperature, to the crude mixture was added a minimal amount of silica and concentrated 
in vacuo, the resultant powder was subjected to flash column chromatography (SiO2) to 
afford the desired product. 
 
General procedure B: A resalable pressure tube (13 x 100 mm) was charged with 
[Rh(Cl)(CO)2]2 (1.9 mg, 0.01 mmol, 2.5 mol%), Di-tert-butyl(methyl)phosphonium 
tetrafluoroborate (5.5 mg, 0.022 mmol, 11 mol%), reactant aldehyde (0.20 mmol, 100 
mol%), and reactant aryl iodide (0.4 mmol, 200 mol%). The tube was sealed with a rubber 
septum and purged with Ar for 10 min. DME (1 mL, 0.2 M with respect to the aldehyde 
reactant) was injected, and the rubber septum was quickly replaced with a PTFE-lined 




temperature, to the crude mixture was added a minimal amount of silica and concentrated 
in vacuo, the resultant powder was subjected to flash column chromatography (SiO2) to 








The title compound was prepared according to the general procedure A using piperonal 
(30.0 mg, 0.2 mmol, 100 mol%) and 4-iodotoluene (87.2 mg, 0.40 mmol, 200 mol%). Flash 
chromatography on silica (Hex/EtOAc 10:1) provided the title compound (34.8 mg, 144 
µmol) in 72% yield as a white solid.  
 
TLC (SiO2) Rf = 0.33 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.25 (d, J = 7.8 Hz, 2H), 7.15 (d, J = 7.8 Hz, 2H), 6.86 
– 6.81 (m, 2H), 6.76 (d, J = 8.5 Hz, 1H), 5.92 (q, J = 1.4 Hz, 2H), 5.72 (s, 1H), 2.34 (s, 
3H), 2.23 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 147.9, 147.0, 141.1, 138.3, 137.4, 129.3, 126.4, 120.0, 
108.2, 107.3, 101.1, 76.0, 21.2. 
 
HRMS (CI+): mass calculated for [M]+ (for C15H12O3) requires m/z 242.0943, found m/z 
242.0943 
 



















The reaction was conducted in accordance with general procedure A using m-anisaldehyde 
(24µL, 0.2 mmol, 100 mol%) and 4-chloroiodobenzene (95.2 mg, 0.4 mmol, 200 mol%). 
Flash column chromatography (SiO2, hexanes/EtOAc = 10:1) provided 40 mg (80%, 0.161 
mmol) of the title compound as a colorless oil. 
 
TLC (SiO2) Rf = 0.43 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.26 (s, 3H), 7.22 (t, J = 8.1 Hz, 1H), 6.87 (dd, J = 4.4, 2.1 
Hz, 2H), 6.81 – 6.70 (m, 1H), 5.70 (s, 1H), 3.74 (s, 3H), 2.45 (d, J = 3.1 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ 159.8, 145.1, 142.1, 133.3, 129.7, 128.6, 127.9, 118.9, 
113.2, 112.2, 75.5, 55.3. 
HRMS (CI+): mass calculated for [M]+ (C14H13O2Cl) requires m/z 248.0604, found m/z 
248.0602.  
 












The reaction was conducted in accordance with general procedure B with 4-
trifluoromethylbenzaldehyde (27µL, 0.2 mmol, 100mol%) and mesityl iodide (98.4 mg, 
0.4 mmol, 200 mol%). Flash column chromatography (SiO2, hexanes : EtOAc = 10:1) 
provided 36 mg (62%, 0.122 mmol) of the title compound as a white solid. 
 
TLC (SiO2): Rf = 0.6 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.56 (d, J = 8.2 Hz, 1H), 7.41 (d, J = 8.1 Hz, 1H), 6.88 (s, 
1H), 6.33 (s, 0H), 2.29 (s, 1H), 2.23 (s, 3H), 2.23 – 2.14 (m, 1H). 
 
13C NMR (125 MHz, CDCl3 δ 147.5, 138.0, 137.2, 136.0, 130.4, 128.9 (q, J = 32.3 Hz), 
125.9, 125.2 (q, J = 3.8 Hz), 124.4 (q, J = 271.8 Hz), 70.8, 21.0, 20.6. 
 
19F NMR (471 MHz, CDCl3) δ -62.31. 
 
HRMS (CI+): mass calculated for [M]+ (C17H17OF3) requires m/z 294.1232, found m/z 
294.1235.  
 
FTIR (neat): 3332, 2922, 1737, 1616, 1454, 1319, 1109, 1066, 1034, 859, 714 cm–1. 
 
















The title compound was prepared according to the general procedure B using 2-
fluorobenzaldehyde (24.8 mg, 0.2mmol, 100 mol%) and 3-fluoroiodobenzene (88.8 mg, 
0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 15:1 to 12:1) 
provided the title compound (33.5 mg, 152 µmol) in 76% yield as a light-yellow oil.  
 
TLC (SiO2) Rf  = 0.38 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.54 (td, J = 7.6, 1.7 Hz, 1H), 7.40 – 7.32 (m, 2H), 7.23 
(ddd, J = 15.9, 8.0, 2.9 Hz, 3H), 7.15 – 7.09 (m, 1H), 7.04 (td, J = 8.4, 2.5 Hz, 1H), 6.21 
(s, 1H), 2.50 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 163.1 (d, J = 246.1 Hz), 160.0 (d, J = 246.5 Hz), 145.4 
(d, J = 6.8 Hz), 130.6 (d, J = 13.1 Hz), 130.1 (d, J = 8.2 Hz), 129.6 (d, J = 8.3 Hz), 127.8 
(d, J = 4.0 Hz), 124.6 (d, J = 3.5 Hz), 122.0 (d, J = 2.9 Hz), 115.6 (d, J = 21.5 Hz), 114.7 
(d, J = 21.1 Hz), 113.4 (d, J = 22.3 Hz), 69.5 (dd, J = 3.5, 1.9 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -112.69 (td, J = 9.4, 5.6 Hz), -118.58 (m). 
 
HRMS (CI+): mass calculated for [M]+ (C13H10OF2) requires m/z 220.0700, found m/z 
220.0700 
 



















The title compound was prepared according to the general procedure B using 6-
methoxypicolinaldehyde (27.4 mg, 0.2 mmol, 100 mol%) and 2-methyl-3-
fluoroiodobenzene (94.4 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica 
(Hex/EtOAc 12:1 to 10:1) provided the title compound (35.5 mg, 143 µmol) in 72% yield 
as a yellow oil.  
 
TLC (SiO2) Rf  = 0.39 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.51 (t, J = 7.8 Hz, 1H), 7.18 – 7.02 (m, 2H), 6.97 (t, J 
= 8.8 Hz, 1H), 6.65 (d, J = 8.2 Hz, 1H), 6.57 (d, J = 7.3 Hz, 1H), 5.89 (s, 1H), 4.79 (s, 1H), 
4.00 (s, 3H), 2.26 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ = 163.3, 162.5, 160.6, 158.4, 143.2 (d, J = 3.7 Hz), 139.7, 
126.9 (d, J = 8.9 Hz), 123.7 (d, J = 16.6 Hz), 123.6 (d, J = 3.1 Hz), 114.5 (d, J = 23.5 Hz), 
113.5, 109.5, 72.4 (d, J = 3.1 Hz), 53.6, 10.6 (d, J = 6.2 Hz). 
 
19F NMR (471 MHz, CDCl3): δ = -116.53 (t, J = 7.7 Hz). 
 
HRMS (ESI+) Calculated for (C14H14NO2) [M+Na]+ requires 270.0901, found 270.0906.  
 





















The reaction was conducted in accordance with general procedure A with 4-
bromobenzaldehyde (37 mg, 0.2 mmol, 100 mol%) and 5-Iodo-1,3-benzodioxole (99 mg, 
0.4 mmol, 200 mol%). Flash column chromatography (SiO2, hexanes : EtOAc = 10:1) 
provided 45 mg (74%, 0.147 mmol) of the title compound as a colorless oil. 
 
TLC (SiO2) Rf = 0.33 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.45 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 6.85 – 
6.78 (m, 2H), 6.76 (d, J = 7.9 Hz, 1H), 5.93 (d, J = 2.1 Hz, 2H), 5.71 (s, 1H), 2.24 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ 148.1, 147.4, 142.9, 137.7, 131.7, 128.2, 121.5, 120.2, 
108.3, 107.2, 101.3, 75.5. 
 
HRMS (CI+): mass calculated (C14H11O379Br) requires m/z 305.9892, found m/z 305.9895. 
mass calculated (C14H11O381Br) requires m/z 307.9871, found m/z 307.9893 
 













The title compound was prepared following general procedure A using 3,4-
dimethylbenzaldehyde (33.2 mg, 0.2 mmol, 100 mol%) and (4-iodophenyl)methanol (93.6 
mg, 0.40 mmol, 200 mol%). Flash chromatography on silica (Hex/EtOAc 1:1) provided 
the title compound (36.4 mg, 133 µmol) in 66% yield as a white solid.   
 
TLC (SiO2) Rf  = 0.24 (hexanes/ethyl acetate = 1:3).  
 
1H NMR (500 MHz, CDCl3): δ = 7.36 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 6.91 
(d, J = 2.0 Hz, 1H), 6.87 (dd, J = 8.2, 2.0 Hz, 1H), 6.81 (d, J = 8.2 Hz, 1H), 5.79 (s, 1H), 
4.66 (s, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 2.33 (s, 1H), 1.77 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 149.2, 148.6, 143.5, 140.2, 136.6, 127.3, 126.8, 119.0, 
111.1, 109.8, 75.9, 65.2, 56.0, 56.0. 
 





FTIR (neat) 3332, 3219, 2919, 2839, 2360, 1739, 1595, 1558, 1419, 1360, 1258, 1231, 
















The title compound was prepared according to the general procedure A using 2-
phenylpyrimidine-5-carbaldehyde (36.8 mg, 0.2 mmol, 100 mol%) and 1-iodo-4-
(trifluoromethoxy)benzene (115.2 mg, 0.40 mmol, 200 mol%). Flash chromatography on 
silica (Hex/EtOAc 5:1) provided the title compound (38.2 mg, 111 µmol) in 55% yield as 
a yellow solid.   
 
TLC (SiO2) Rf = 0.19 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 8.71 (s, 2H), 8.46 – 8.26 (m, 2H), 7.47 (dd, J = 5.2, 2.0 
Hz, 3H), 7.42 – 7.36 (m, 2H), 7.21 (d, J = 8.2 Hz, 2H), 5.86 (s, 1H), 3.25 (s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 164.2, 155.8, 149.2 (q, J = 2.0 Hz), 140.9, 137.1, 133.9, 
131.1, 128.8, 128.3, 128.1, 121.5, 120.5 (q, J = 258.2 Hz), 71.8. 
 
19F NMR (471 MHz, CDCl3): δ = -57.87 
 






















tert-butyl (4-(hydroxy(4-(methylthio)phenyl)methyl)phenyl)carbamate (7.3i) 
 
 
The title compound was prepared according to the general procedure A using 4-
(methylthio)benzaldehyde (30.4 mg, 0.2 mmol, 100 mol%) and tert-butyl (4-
iodophenyl)carbamate1 (127.6 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica 
(Hex/EtOAc 4:1) provided the title compound (39.3 mg, 114 µmol) in 57% yield as a 
yellow solid.   
 
TLC (SiO2) Rf  = 0.59 (hexanes/ethyl acetate = 1:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.30 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 3.9 Hz, 2H), 7.24 
(d, J = 4.2 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 6.52 (s, 1H), 5.74 (s, 1H), 2.45 (s, 3H), 2.34 
(s, 1H), 1.50 (s, 9H). 
 
13C NMR (125 MHz, CDCl3): δ = 152.9, 140.9, 138.5, 137.9, 137.7, 127.4, 127.2, 126.8, 
118.7, 80.7, 75.5, 28.4, 16.0. 
 





FTIR (neat) 3368, 3250, 2972, 2914, 2359, 2342, 1699, 1522, 1412, 1309,1233, 1157, 












The reaction was conducted in accordance with general procedure A using 3-chloro-4,5-
dimethoxybenzaldehyde (40 mg, 0.2 mmol, 100 mol%) and 5-fluoro-2-methyliodobenzene 
(62µL, 0.4 mmol, 200 mol%). Flash column chromatography (SiO2, hexanes : EtOAc = 
5:1) provided 43 mg (75%, 0.138mmol) of the title compound as a colorless oil. 
 
TLC (SiO2) Rf = 0.22 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.24 (dd, J = 10.0, 2.8 Hz, 1H), 7.09 (dd, J = 8.3, 5.7 Hz, 
1H), 6.90 (td, J = 8.3, 2.9 Hz, 1H), 6.85 (d, J = 1.9 Hz, 1H), 6.78 (d, J = 1.9 Hz, 1H), 5.83 
(s, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 2.44 (s, 1H), 2.19 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ 162.6, 160.6, 153.9, 142.8 (d, J = 6.4 Hz), 131.9 (d, J = 
7.6 Hz), 130.7 (d, J = 3.2 Hz), 128.2, 120.6, 114.4 (d, J = 20.9 Hz), 113.1 (d, J = 22.7 Hz), 
109.8, 72.4 (d, J = 1.4 Hz), 60.7, 56.1, 18.7. 
 
19F NMR (470 MHz, CDCl3): δ -116.37 (q, J = 8.3 Hz). 
 
HRMS (CI+): mass calculated for [M]+ (C16H16O3FCl) requires m/z 310.0772, found m/z 
310.0766.  
 














The reaction was conducted in accordance with general procedure A using 2,4-
dimethoxybenzaldehyde (33 mg, 0.2 mmol, 100 mol%) and 2-methyl-4-
(trifluoromethoxy)iodobenzene (68µL, 0.4 mmol, 200 mol%). Flash column 
chromatography (SiO2, hexanes : EtOAc = 5:1) provided 51 mg (75%, 0.149 mmol) of the 
title compound as a yellow oil. 
 
TLC (SiO2) Rf = 0.25 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.58 (d, J = 8.5 Hz, 1H), 7.09 (d, J = 10.7 Hz, 1H), 7.00 
(s, 1H), 6.75 (d, J = 8.4 Hz, 1H), 6.50 (d, J = 2.4 Hz, 1H), 6.38 (dd, J = 8.5, 2.3 Hz, 1H), 
6.19 (d, J = 3.6 Hz, 1H), 3.87 (s, 3H), 3.79 (s, 3H), 2.80 (d, J = 3.8 Hz, 1H), 2.19 (s, 3H). 
 
13C NMR (125 MHz, CDCl3): δ 160.75, 158.28, 148.23, 139.44, 137.64, 128.59, 127.99, 
123.38, 122.50, 120.65 (q, J = 256.6 Hz), 118.24, 104.19, 98.75, 67.66, 55.61, 55.51, 19.31. 
 
19F NMR (470 MHz, CDCl3): δ -57.67. 
 
HRMS (ESI+): mass calculated for [M+Na]+ (C17H17F3O4) requires m/z 365.0971, found 
m/z 365.0969.  
 














The reaction was conducted in accordance with general procedure A using 3-fluoro-4-
methylbenzaldehyde (25 µL, 0.2 mmol, 100 mol%) and 2-fluoroiodobenzene (47 µL, 0.4 
mmol, 200 mol%). Flash column chromatography (SiO2, hexanes : EtOAc = 9:1) provided 
35.1 mg (75%, 0.149 mmol) of the title compound as a colorless oil. 
 
TLC (SiO2) Rf = 0.5 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.48 (td, J = 7.6, 1.8 Hz, 1H), 7.32 – 7.22 (m, 1H), 7.15 
(q, J = 8.0 Hz, 2H), 7.06 (d, J = 9.7 Hz, 2H), 7.04 – 6.94 (m, 1H), 6.09 (d, J = 3.4 Hz, 1H), 
2.43 (d, J = 3.8 Hz, 1H), 2.25 (d, J = 1.9 Hz, 3H). 
 
13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 183.9 Hz), 159.6 (d, J = 185.2 Hz), 142.6 (d, 
J = 6.8 Hz), 131.5 (d, J = 5.4 Hz), 130.7 (d, J = 13.0 Hz), 129.3 (d, J = 8.2 Hz), 127.6 (d, 
J = 4.0 Hz), 124.4 (d, J = 3.6 Hz), 124.2 (d, J = 17.3 Hz), 121.7 (d, J = 3.2 Hz), 115.5 (d, 
J = 21.4 Hz), 113.0 (d, J = 23.3 Hz), 69.4 (dd, J = 3.5, 1.8 Hz), 14.3 (d, J = 3.6 Hz). 
 
19F NMR (470 MHz, CDCl3): δ -116.97 (t, J = 9.3 Hz), -118.57 (dt, J = 12.2, 6.4 Hz). 
 
HRMS (CI+): mass calculated for [M]+ (C14H12OF2) requires m/z 234.0856, found m/z 
234.0858.  
 















methyl 4-(hydroxy(4-methoxyphenyl)methyl)benzoate (7.3m) 
 
 
The title compound was prepared according to the general procedure A using methyl 4-
formylbenzoate (32.8 mg, 0.2 mmol, 100 mol%) and 4-iodoanisole (93.6 mg, 0.40 mmol, 
200 mol%). Flash chromatography on silica (Hex/EtOAc 4:1) provided the title compound 
(33.9 mg, 125 µmol) in 62% yield as a colorless oil.   
 
TLC (SiO2) Rf  = 0.18 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ = 7.98 (d, J = 8.3 Hz, 2H), 7.45 (d, J = 8.3 Hz, 2H), 7.24 
(d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 5.82 (s, 1H), 3.89 (s, 3H), 3.78 (s, 3H), 2.47 
(s, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 167.1, 159.4, 149.1, 135.7, 129.9, 129.2, 128.2, 126.3, 
114.2, 75.6, 55.4, 52.2. 
 
HRMS (ESI+): mass calculated for [M+Na]+ (C16H16NO4) requires m/z 295.0941, found 
m/z 295.0942.  
 














The title compound was prepared according to the general procedure A using 4-fluoro-3-
methoxybenzaldehyde (30.8 mg, 0.2 mmol, 100 mol%) and 2-iodoanisole (107.4 mg, 0.40 
mmol, 200 mol%). Flash column chromatography (SiO2, hexanes/EtOAc 6:1) provided the 
title compound (43.4 mg, 166 µmol) in 83% yield as a colorless oil.  
 
TLC (SiO2) Rf = 0.22 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ =  7.30 – 7.23 (m, 1H), 7.18 (dd, J = 7.6, 1.8 Hz, 1H), 7.08 
(dd, J = 8.3, 2.1 Hz, 1H), 7.01 – 6.91 (m, 2H), 6.89 (dd, J = 8.2, 1.1 Hz, 1H), 6.82 (dddd, 
J = 8.4, 4.4, 2.1, 0.7 Hz, 1H), 6.00 (d, J = 4.3 Hz, 1H), 3.85 (s, 3H), 3.81 (s, 3H), 3.12 (d, 
J = 4.9 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 156.8, 151.6 (d, J = 244.7 Hz), 147.4 (d, J = 10.9 Hz), 
139.7 (d, J = 3.6 Hz), 131.8, 129.0, 127.8, 121.0, 119.0 (d, J = 6.9 Hz), 115.6 (d, J = 18.5 
Hz), 112.0 (d, J = 1.9 Hz), 110.9, 71.8, 56.3, 55.5. 
 
19F NMR (471 MHz, CDCl3): δ = -137.67. 
 
HRMS (CI+): mass calculated for [M]+ (C15H15FO3) requires m/z 262.1005, found m/z 
262.1010. 
 
FTIR (neat) 3414, 2941, 2838, 1601, 1513, 1463, 1417, 1271, 1241, 1118, 1028, 909, 815, 















The title compound was prepared according to the general procedure A using 4-
formylquinoline (31.0 mg, 0.2 mmol, 100 mol%) and 2-chloro-1-iodo-4-
(trifluoromethoxy)benzene (129 mg, 0.40 mmol, 200 mol%). Flash column 
chromatography (SiO2, hexanes/EtOAc 4:1) provided the title compound (42 mg, 119 
µmol) in 60% yield as a white solid.  
 
TLC (SiO2) Rf = 0.27 (hexanes/ethyl acetate = 1:1).  
 
1H NMR (500 MHz, CDCl3): δ =  8.90 (dd, J = 7.3, 4.4 Hz, 1H), 8.13 (d, J = 8.5 Hz, 1H), 
7.83 (dd, J = 8.5, 1.3 Hz, 1H), 7.69 (ddd, J = 9.6, 6.4, 1.4 Hz, 1H), 7.58 (d, J = 4.5 Hz, 1H), 
7.51 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 1H), 7.27 – 7.24 (m, 1H), 7.06 (dd, 
J = 8.8, 2.4 Hz, 1H), 6.92 (d, J = 3.3 Hz, 1H), 3.30 (d, J = 49.9 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 150.3, 149.1 (q, J = 2.1 Hz), 148.5, 146.7, 138.0, 134.0, 
130.2, 130.1, 129.3, 127.1, 125.5, 123.3, 122.2, 120.3 (q, J = 258.7 Hz), 119.8, 118.6, 68.2. 
 
19F NMR (471 MHz, CDCl3) δ = -57.92. 
 
HRMS (ESI+): mass calculated for [M+H]+ (for C17H12ClF3NO2) requires m/z 354.0503, 
found m/z 354.0508 
 
FTIR (neat) 3080, 2832, 2363,2341, 1736, 1509, 1392, 1313, 1256, 1214, 1143, 855  cm–
1. 















The title compound was prepared according to the general procedure A using 2,5 
dimethoxybenzaldehyde (33.2 mg, 0.2 mmol, 100 mol%) and 4-chloro-2-iodoanisole 
(107.4 mg, 0.40 mmol, 200 mol%). Flash column chromatography (SiO2, hexanes/EtOAc 
9:1) provided the title compound (51 mg, 166 µmol) in 83% yield as a colorless oil.  
 
TLC (SiO2) Rf = 0.17 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ =  7.25 (d, J = 2.7 Hz, 1H), 7.20 (dd, J = 8.7, 2.7 Hz, 1H), 
6.85 – 6.76 (m, 4H), 6.25 (d, J = 4.9 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.54 
(d, J = 5.2 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 155.4, 153.7, 151.1, 132.7, 131.5, 128.1, 127.8, 125.7, 
114.3, 112.8, 111.7, 111.7, 67.0, 56.0, 55.8, 55.7. 
 
HRMS (CI+): mass calculated for [M]+ (for C16H17O4Cl ) requires m/z 308.0815, found 
m/z 308.0813 
 











The reaction was conducted in accordance with general procedure B using heptaldehyde 
(28 µL, 0.2 mmol, 100 mol%) and 3-methoxyiodobenzene (47 µL, 0.4 mmol, 200 mol%). 
Flash column chromatography (SiO2, hexanes : EtOAc = 10:1) provided 29 mg (64%, 0.13 
mmol) of the title compound as a colorless oil. 
 
TLC (SiO2) Rf = 0.48 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.22 (m, 1H), 6.95 – 6.88 (m, 2H), 6.82 (ddd, J = 
8.3, 2.5, 1.1 Hz, 1H), 4.70 – 4.57 (m, 1H), 3.82 (s, 3H), 1.92 (s, 1H), 1.84 – 1.74 (m, 1H), 
1.69 (ddt, J = 18.0, 9.8, 5.2 Hz, 1H), 1.42 (ddd, J = 13.0, 7.8, 3.3 Hz, 1H), 1.36 – 1.23 (m, 
8H), 0.88 (t, J = 6.8 Hz, 3H). 
 
13C NMR (125 MHz, CDCl3): δ 159.9, 146.9, 129.6, 118.4, 113.0, 111.5, 74.8, 55.4, 39.2, 
31.9, 29.3, 25.9, 22.7, 14.2. 
 
HRMS (CI+): mass calculated for [M]+ (C14H22O2) requires m/z 222.1620, found m/z 
222.1616.  
 











The title compound was prepared according to the general procedure A using 3-
phenylpropionaldehyde (27 µL, 0.2 mmol, 100 mol%) and 2-iodocumene (64 µL, 0.40 
mmol, 200 mol%). Flash column chromatography (SiO2, hexanes/EtOAc 9:1) provided the 
title compound (31.4 mg, 123 µmol) in 62% yield as a colorless oil.  
 
TLC (SiO2) Rf = 0.49 (hexanes/ethyl acetate = 4:1).  
 
1H NMR (500 MHz, CDCl3): δ =  7.48 (dd, J = 7.5, 1.5 Hz, 1H), 7.31 – 7.15 (m, 8H), 5.03 
(dd, J = 8.6, 4.1 Hz, 1H), 3.05 (p, J = 6.9 Hz, 1H), 2.85 (ddd, J = 14.5, 9.6, 5.2 Hz, 1H), 
2.72 (ddd, J = 13.8, 9.3, 7.0 Hz, 1H), 2.10 (ddt, J = 14.1, 9.0, 4.5 Hz, 1H), 1.98 (tdd, J = 
13.9, 7.0, 4.1 Hz, 1H), 1.75 (s, 1H), 1.17 (dd, J = 6.9, 2.2 Hz, 6H). 
13C NMR (125 MHz, CDCl3): δ = 145.5, 141.9, 141.3, 128.5, 128.4, 127.7, 126.1 125.9, 
125.4, 125.4, 69.4, 40.5, 32.5, 28.0, 24.5, 23.8. 
 
HRMS (CI+): mass calculated for [M]+ (for xx ) requires m/z xx, found m/z xx 
 











The reaction was conducted in accordance with general procedure A using 
isovaleraldehyde (22 µL, 0.2 mmol, 100 mol%) and N-(2-(4-iodophenyl)propyl)propane-
2-sulfonamide (100.8 mg, 0.4 mmol, 200 mol%) . Flash column chromatography (SiO2, 
hexanes : EtOAc = 7:3) provided 37.4 mg (57%, 0.114 mmol) of the title compound as a 
white solid. 
 
TLC (SiO2) Rf = 0.54 (hexanes : EtOAc = 1:1). 
 
1H NMR (500 MHz, CDCl3δ 7.33 (d, J = 7.9 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 4.73 (dd, 
J = 8.4, 3.0 Hz, 1H), 3.86 (dd, J = 8.1, 4.7 Hz, 1H), 3.35 (ddd, J = 13.3, 7.9, 5.8 Hz, 1H), 
3.21 (ddd, J = 13.1, 8.7, 4.7 Hz, 1H), 3.05 (p, J = 6.8 Hz, 1H), 2.96 (p, J = 7.0 Hz, 1H), 
1.77 (d, J = 2.7 Hz, 1H), 1.71 (td, J = 13.2, 7.6 Hz, 2H), 1.54 – 1.43 (m, 1H), 1.30 (dd, J = 
6.9, 2.4 Hz, 6H), 1.26 (d, J = 6.8 Hz, 3H), 0.97 (d, J = 6.2 Hz, 2H). 
 
13C NMR (125 MHz, CDCl3): δ 144.1, 142.2, 127.4, 126.5, 72.5, 53.4, 50.3, 48.4, 48.4, 
40.5, 40.5, 24.82, 23.1, 22.2, 19.1, 16.6, 16.5. 
 
HRMS (ESI+): mass calculated for [M+Na]+ (C17H29NO3S) requires m/z 350.1760, found 
m/z 350.1761.  
 
FTIR (neat): 3246, 2956, 2867, 1738, 1385, 1311, 1132, 1061, 979, 691 cm-1 
 












The reaction was conducted in accordance with general procedure A using cyclohexyl 
carboxaldehyde (22.4 mg, 0.2 mmol, 100 mol%) and 1-Iodonaphthalene (60 µL, 0.4 mmol, 
200 mol%) Flash column chromatography (SiO2, hexanes : EtOAc = 10:1) provided 31 mg 
(65%, 0.13 mmol) of the title compound as a pale yellow oil. 
 
TLC (SiO2) Rf = 0.63 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 8.15 (d, J = 8.1 Hz, 1H), 7.90 – 7.84 (m, 1H), 7.78 (d, J = 
8.1 Hz, 1H), 7.59 (d, J = 7.1 Hz, 1H), 7.53 – 7.44 (m, 3H), 5.20 (d, J = 6.4 Hz, 1H), 2.00 
– 1.92 (m, 2H), 1.91 (s, 1H), 1.77 (s, 1H), 1.68 – 1.61 (m, 2H), 1.46 – 1.36 (m, 1H), 1.25 
– 1.08 (m, 5H). 
 
13C NMR (125 MHz, CDCl3): δ 139.6, 134.0, 131.0, 129.0, 128.0, 125.9, 125.6, 125.4, 
124.3, 123.8, 76.2, 44.5, 30.4, 28.4, 26.6, 26.5, 26.2. 
 
HRMS (CI+): mass calculated for [M]+ (C17H20O) requires m/z 240.1514, found m/z 
240.1521.  
 








tert-butyl 4-((3,5-dimethylphenyl)(hydroxy)methyl)piperidine-1-carboxylate (7.3u) 
 
The title compound was prepared according to the general procedure A using tert-butyl 4-
formylpiperidine-1-carboxylate (42.6 mg, 0.2 mmol, 100 mol%) and 1-iodo-3,5-
dimethylbenzene (92.8 mg, 0.40 mmol, 200 mol%). Flash chromatography on silica 
(Hex/EtOAc 5:1) provided the title compound (54.1 mg, 170 µmol) in 85% yield as a light-
yellow oil.  
 
TLC (SiO2) Rf  = 0.50 (hexanes/ethyl acetate = 2:1).  
 
1H NMR (500 MHz, CDCl3): δ = 6.90 (d, J = 10.0 Hz, 3H), 4.27 (d, J = 7.6 Hz, 1H), 4.19 
– 3.89 (m, 2H), 2.61 (d, J = 39.7 Hz, 2H), 2.31 (s, 6H), 1.96 (dt, J = 13.2, 2.8 Hz, 1H), 1.72 
(dt, J = 7.7, 3.7 Hz, 1H), 1.43 (s, 10H), 1.25 (td, J = 12.2, 3.9 Hz, 3H), 1.11 (dd, J = 12.7, 
4.4 Hz, 1H). 
 
13C NMR (125 MHz, CDCl3): δ = 154.9, 143.1, 138.0, 129.5, 124.4, 79.4, 78.8, 43.4, 28.6, 
21.5. 
 
HRMS (ESI+): mass calculated for [M+Na]+ (C19H29NO3) requires m/z 342.2040, found 
m/z 342.2045. 
 

















The title compound was synthesized over two steps from piperonal following literature 
procedures.2 
 
1H NMR (400 MHz, CDCl3): δ 7.46 – 7.38 (m, 1H), 7.34 (s, 1H), 6.93 (d, J = 7.9 Hz, 1H), 






benzo[d][1,3]dioxol-5-yl(p-tolyl)methan-d-ol (deutero- 7.3a) 
  
The reaction was conducted in accordance with general procedure A. Flash column 
chromatography (SiO2, hexanes : EtOAc = 4:1) provided 32 mg (66%, 0.132 mmol) of the 
title compound as a white solid 
 
TLC (SiO2) Rf = 0.33 (hexanes : EtOAc = 4:1). 
 
1H NMR (500 MHz, CDCl3): δ 7.23 (d, J = 6.3 Hz, 2H), 7.13 (d, J = 7.8 Hz, 2H), 6.82 (dd, 
J = 6.1, 1.8 Hz, 2H), 6.77 – 6.68 (m, 1H), 5.90 (s, 2H), 2.31 (s, 3H), 2.09 (s, 1H). 
 
2H NMR (92 MHz, CHCl3): δ 5.73 (s, 1H). 
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